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ABSTRACT
High Performance Liquid Chromatographic Separations in 
Biopharmaceutical Analysis
Harv Kelly
The application of high performance liquid chromatographic (HPLC) 
methods to the analysis of drugs in plasma was investigated. A 
method for the analysis in plasma of the diuretic drug, xipamide 
was developed from first principles. It was based on 
reversed-phase chromatography following liquid-liquid extraction 
of the drug and internal standard into diethyl ether. The method 
was validated and the coefficient of variation for within-day and 
between-day replicate analyses were 3.1 and 4.8% respectively.
In chapter 4, reversed-phase micellar chromatography was used to 
separate the drugs, chlorthalidone and xipamide. A method was 
developed for the determination of these drugs in plasma based on 
1 iquid-1iquid extraction into diethyl ether followed by 
chromatography on a Cg- column using an eluent containing 0.05 
M sodium dodecyl sulphate. The method was validated and the 
coefficient of variation for between-day and within-day replicate 
analyses were 3.1 and 4.6% respectively. In chapter 5, the 
retention characteristics of basic drugs on an unmodified silica 
column using reversed-phase eluents were studied. Drug retention 
as a function of pH was consistent with an ion exchange mechanism 
of retention. The analytical method, which used an 80% methanolic 
eluent, was coupled to a column switching arrangement in order to 
carry out on-line solid-phase extraction of the drugs from 
plasma. The mean coefficient of variation for 5 replicate 
analyses of each drug was less than 8%, even without internal 
standardisation.
In chapter 6, the retention characteristics of 31 drugs on an 
alumina column were investigated. Using reversed-phase eluents, 
retention mechanisms were found to be similar to those on 
unmodified silica, consisting principally of ion exchange, as 
shown by drug retention behaviour with changing pH and ionic 
strength. The analytical method was coupled to a column switching 
arrangement and on-line solid-phase extraction was carried out.
In chapter 7, the effect of varying the type of column and eluent 
composition on drug-free plasma profiles was investigated. The 
study was based on a Cj^ g- and a CN- column; methanol and 
acetonitrile were the organic modifiers used. The plasma profiles 
were evaluated quantitatively by measuring the number of 
interfering peaks greater than 2 mm (equivalent to 8 x 10 
absorbance units) in the area of interest along the chromatogram. 
Results were subjected to statistical treatment using a 3-factor 
analysis of variance design. The three factors were the column, 
type of organic modifier and either the percent organic modifier, 
pH or ionic strength. Analysis of the data revealed that 
significant effects were seen with changing eluent composition, 
particularly with regard to the percent organic modifier and 
that the observed effects were strongly dependent on the type of 
organic modifier and the type of column under consideration.
(xiv)
CHAPTER 1
THEORY AND PRINCIPLES OF CHROMATOGRAPHY
1.1. INTRODUCTION
Chromatography is a physical method of separation in which the 
compounds to be separated are distributed between a mobile phase 
and a stationary phase. The chromatographic process occurs as a 
result of repeated sorption onto and desorption from the 
stationary phase by sample components as they traverse the column 
bed. Separation between individual components arises fron 
differences in their distribution coefficients between the two 
phases.
Chromatography may be fundamentally divided into gas and liquid 
chromatographic techniques, based on whether the mobile phase is 
a gas or a liquid. In gas chromatography, the mobile phase is an 
inert gas and the stationary phase is either an adsorbent or 
(more usually) a liquid distributed over the surface of a porous 
inert support. In liquid chromatography, the mobile phase is 
liquid, and the stationary phase is a solid, an immiscible liquid 
coated onto a porous support, or a thin film of liquid chemically 
bonded onto the surface of a sorbent. Liquid chromatography may 
be operated in planar or column configurations; gas 
chromatography is only operated in the column configuration.
Liquid column chromatography may be carried out as an open-bed, 
or closed-bed technique. Gas chromatography can only be carried 
out as a closed bed technique. In the latter instance pressure 
gradients are employed to induce movement of the mobile phase 
down the column. The column is a glass or metal tube of 
sufficient mechanical strength to withstand operating pressures. 
In packed column chromatography the sorbent in granular form is 
packed into a homogeneous bed that totally fills the column. In 
open tubular chromatography, the sorbent is distributed as a thin 
film on the internal surface of the column.
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Thin-layer and paper chromatography are open-bed planar 
techniques where separation takes place on a flat surface without 
the use of pressure gradients and movement of the mobile phase is 
effected by the action of capillary forces. Thin-layer 
chromatography employs a layer of stationary phase coated onto a 
flat surface, and paper chromatography employs absorbent paper.
In both cases the stationary phase is a liquid.
The information obtained from a chromatographic experiment is 
contained in the chromatogram, which is a record of the 
concentration or mass profile of the sample components as a 
function of the movement of the mobile phase. As the sample 
components are successively eluted from the column they are 
detected using a suitable detection mode, for instance 
ultraviolet absorbance. Information from the detector is passed 
to a recording device which displays that data in a trace which 
constitutes the chromatogram. The kind of information revealed in 
the chromatogram includes an indication of the sample's 
complexity based on the number of peaks, concentrations based on 
peak heights or areas, qualitative identification of individual 
sample components based on accurate detection of peak position, 
and an indication of the column's performance over a period of 
t i me .
1.2. HISTORY OF CHROMATOGRAPHY
The word "chromatography" was coined by the Russian botanist, 
Tswett who in 1903, produced coloured bands by separating 
concentrated plant extract on a column of adsorbent material [1]. 
The technique then experienced a lull, but was later revived when 
in the 1930's, Kuhn and Lederer [2], and Reichstein and Van Euw 
[3], again employed column chromatography in the separation of 
natural products. The open-bed (thin-layer) version of 
chromatography was introduced in the 1950s by Kirchner [4], but 
it was Stahl who popularised the technique some time later [5].
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In 1941, Martin and Synge (who were subsequently awarded the 
Nobel prize) first described the method of 1iquid-1iquid 
partition chromatography, and in the same work, laid the 
foundation for gas-liquid chromatography, a technique which 
enjoyed enormous popularity in the following decades [6], Martin 
and Synge also introduced the concept of the theoretical plate 
[6], which is still a widely used index of chromatographic 
efficiency. They proposed that column performance was directly 
proportional to the number of theoretical plates in the system, 
that higher plate numbers could be achieved by the use of smaller 
particles at higher operating pressures, and that the mobile 
phase liquid could be replaced by a gas.
The practical application of gas chromatography was first 
realised by James and Martin some 10 year later in 1952 [7], and 
the technique then rapidly evolved into a far more sophisticated 
form of separation than liquid chromatography, which, excluding 
the pioneering work by Hamilton on ion exchange [8] and Snyder on 
adsorption systems [9], remained relatively neglected for a 
number of decades.
In the early 1960's Giddings showed that the theoretical 
principles developed to accommodate separation processes in gas 
chromatography could readily be applied to liquid chromatographic 
systems [10]. Development of the practical application of liquid 
chromatography is largely attributed to Horvath, Lipsky and 
Preiss [11], Huber [12], and Kirkland [13], who developed the 
method through the embryonic stages during the period 1967-1969. 
Their new high pressure systems (operating up to 5000 psi) were 
able to overcome the problem of high liquid mobile phase 
viscosities relative to gases, and thus the way was paved for 
efficient and rapid separations in high performance liquid 
chromatography (HPLC) which were comparable with those then being 
achieved with gas chromatographic separations.
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Advances in HPLC technology then centered around the production 
of support materials offering improved rates of mass transfer by 
reducing the distance over which solutes have to diffuse. Short 
diffusion paths were achieved (a) by coating impervious glass 
beads with the stationary phase [13,14]? or (b) by producing 
particles which were totally porous, but of smaller diameter - 
about 40 m. The latter approach has been widely adopted in the
quest for greater plate numbers, and nowadays, columns commonly
contain particles between 3 and 10 m in diameter.
The classical solid-liquid adsorption chromatography described 
above has been largely superceded by bonded phase chromatography, 
which employs surface-modified silica-based stationary phases.
The first bonded phases were produced by Halasz et al. who 
reacted silica with alcohols [15], and amines [16]. Subsequently, 
materials of greater hydrolytic stability have been manufactured 
by reacting silica with alkyl si lanes. It is now possible to 
produce a wide range of bonded supports which can be tailored to 
suit a variety of analytical needs, and it is the versatility, 
robustness, and simplicity of practical application which have 
contributed to the popularity of HPLC in the fields of 
pharmaceutical, clinical, forensic and environmental analysis.
1.3. THEORY
1.3.1. Retention and equilibrium
In HPLC, the migration rate of an individual sample component is 
determined by the equilibrium distribution of that component 
between the stationary and flowing phases. Compounds which are 
distributed mainly in the mobile phase move rapidly down the 
column, whereas the converse is true for solutes distributed 
mainly in the stationary phase. These differences in migration 
rates for individual samples form the basis of chromatographic 
separation as shown in Figure 1.1. At the beginning of separation 
following injection, the individual components remain clustered
4
Figure 1.1.
Schematic illustration of separation by differential migration.
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together at the top of the column (Figure l.l.a). As the sample 
mixture migrates through the system, the individual components 
gradually disengage and eventually separate into discreet bands.
A fundamental retention parameter in column chromatography is the 
retention volume, VR , defined as the volume of mobile phase 
required to flow through a column to effect elution of a given 
compound. The corresponding retention time, tR , is related to 
VR by the expression:
t = V /F 1.1
R R
where F is the volumetric flow rate in ml/min [17].
The measurement of tR for a 2-component chromatogram is shown 
in Figure 1.2. The time taken for the elution of an unretained 
compound is given by tQ , while the point of injection is at t =
0. The elution volume corresponding to t0 is V^, and may be 
expressed as:
V = t F 1.2
M o
Vfl represents the total volume of mobile phase within the 
column at any given time, and assuming negligible extracolumn 
volumes, is known as the dead volume. Retention times are 
measured at the band centre (apex of individual peaks), at which 
point the distribution of solute molecules in the stationary and 
mobile phases are considered to be approximately at equilibrium 
[17].
A useful measure of retention is R, the fraction of solute 
molecules in the mobile phase, or the probability that that a 
solute molecule will be found in the mobile phase at any given 
instant. R may be expressed as:
R = nM/nM + ns 1.3
6
Figure 1.2.
Hodel chroinatogratn for the séparation of two compounds
TIME (min)-----------------------      >
t - rétention time for an unretained compound 
o
t - rétention time of the first compound 
t » rétention time of the second compound
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nM is the number of moles of solute in the mobile phase, and
ng is the number of moles of solute in the stationary phase.
The ratio ng/n^ is known as the capacity factor k', and 
substituting this into equation 1.3 , R may be rewritten as:
R = 1/(1+k’ ) 1.4
The capacity factor is related to the distribution coefficient 
(K) for a solute between two phases as follows:
k 1 = n /n 
S M
k ’ - (V C )/(V C ])
S S M M
k 1 = (KV x/(V ) 1.5
S ; M
where V , V , and C , C are the volumes and 
S M S M
concentrations of solute in the stationary and mobile phases
respectively. Hence:
R = 1/(1+K(V /V )) 1.6
S M
The larger the value of R, the quicker the solute moves through 
the column. The average migration velocity of a solute (v ) 
may be expressed as:
v = vR 1.7
S
where v is the mobile phase velocity. But as vs = L/tR, and v 
= L/tQ, where L is the length of the column, equation 1.7 may 
be rewritten as:
L/t = (RL)/t_ 1.8
R °
or: t = t /R 1.9
R o
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Since t = V /F and t. = V /F: 
R R 0 M
1 . 1 0
But as R = 1/(1 + k 1), V may be written ass 
R
V = V + V k 
R M M
1.11
Since k = (KV )/V , V may now be written: 
S M R
V = V + KV 
R M S
1.12
According to equation 1.12, the retention volume of any given 
solute depends on the dead volume VM, and the factor KVg. The 
dead volume has no effect on differential migration or separation 
since it is the same for all sample components, but KVg does 
determine differential migration. Hence the net retention volume, 
VN may be defined*
Since V * t F, and V - t Fs
R R M o
where t is the adjusted retention time. Retention indices 
N
are frequently expressed in terms of capacity factor k'. By 
substituting equation 1.5 into 1.13, one obtains:
k' = (V - V )/V 
R M M
1.15
Substituting Ftp for VR , and Ft0 for VM , one obtains?
k ' -  \  -  v / t 0 1.16
9
since the capacity factor for a given solute may be expressed 
purely in terms of its retention and the time for elution of a 
non-retained species.
1.3.2. Band broadening
The separation of compounds during migration is accompanied by an 
increasing dispersion of the initially sharp zones. This 
dispersion is caused by exchange of compounds between phases, 
diffusion, and other factors. The extent of band broadening 
determines chromatographic efficiency! it leads to a distribution 
of the species in the direction of travel, which can have a 
detrimental effect on separation. The sample concentration 
profile which arises is often Gaussian in nature, and the 
variance a , of this Gaussian curve is proportional to the 
migration distance, z.
Chromatographic efficiency is frequently expressed in terms of 
either the number of theoretical plates, N, or the height 
equivalent to a theoretical plate, HETP, or H. The plate number,
N can be defined from the chromatogram of a single band (Figure
1.3), and may be expressed as:
2
N - (t At ) 1.17
R t
where crt is the standard deviation of the band in time units.
N, therefore, is a dimensionless quantity, and its calculation 
from experimental data is done more conveniently on peak width. 
The two parameters are related by the equation:
crf = 0.25W 1.18
r b
where W is the width of the peak at the baseline 
b
2
Hence: N = 16(t /W ) 1.19
R b
The HETP is related to N by:
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Figure 1.3.
Evaluation of a chromatographic peak for calculation of column 
efficiency
TIME (min)----------------------------------------------------- >
t - retention time for the peak
W - peak width at baseline
b
W - peak width at half height
W - peak width at inflection points
h = peak height
0.5 h - half height
.607h - height at Inflection points
t * retention time
R
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H = L/N 1 . 20
where L is the length of the column. HETP has the dimensions of 
length and is usually reported in mm or cm. The terms "plate 
number" and "plate height" have their origins in the plate model 
of the chromatographic process as first reported by Martin and 
Synge [6]. The plate model assumes that the column can be 
visualised as being divided into discrete units or plates in 
which complete equilibration of the solute takes place before it 
progresss to the next plate. It is assumed that distribution 
between plates is the same for all plates, and independent of 
solute concentration; that mobile phase flow occurs in a 
discontinuous manner between plates? and that diffusion of the 
solute in an axial direction is negligible. Deficiencies with 
this model arise when the real-life situation deviates from these 
assumptions, particularly in relation to dependence on solute 
concentration, particle size, and mobile phase velocity, 
experimental parameters which vary from one situation to the 
next. Another useful expression is the reduced plate height, h, 
which is the HETP divided by the particle diameter, d: i.e. h = 
H/d.
Where chromatographic efficiency is directly related to the 
number of theoretical plates, it is inversely proportional to 
plate height. Hence factors contributing to plate height are 
considered to promote band broadening, and so reduce efficiency.
Band broadening is regarded to be a result of three distinct
phenomena:
(i) :longitudinal diffusion?
(ii) sslow mass transfer rates? and
(iii)?uneveness of mobile phase flow.
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1 . 3 .2 .1 . L o n g i tu d in a l  d i f f u s i o n
Molecular diffusion in the longitudinal direction leads to band 
broadening that is dependent on mobile phase velocity. Its
contribution to band broadening increases with the amount of time
the solute spends in the column. Its contribution a 2 to the
total band broadening is given by the Einstein equation:
a 2 - 2D x t 1.21
where D is the diffusion coefficient, and t is time.
In general solute molecules spend the time t = L/v in the mobile
phase, so equation 1.21 now becomes:
CJ2 - (2D x L)/v 1.22
M
D is the solute diffusion coefficient in the mobile phase, v 
M
is the mobile phase velocity, and L is the length of the column. 
Since H = a 2/L, H , the contribution to band broadening 
from longitudinal diffusion may be written as:
H - /L = [2D x 7]/v 1.23
L L M
where 7  is an obstruction or tortuosity factor, which recognises 
that longitudinal diffusion is hindered by the packing or bed 
structure; also 7  is not totally independent of mobile phase 
velocity [18]. This arises from the fact that the lowest flow 
resistance is offered by gaps in the packing structure. Thus at 
low flow velocities the value of 7  is averaged over tightly and 
loosely packed domains, whereas at high velocities it is weighted 
in favour of the loosely packed domains where most flow occurs.
In practice H|_ is a small contribution to overall plate height,
H. Only when DM is large and the mobile phase velocity v is 
small does it become significant.
13
1 . 3 .2 .2 .  Mass t r a n s f e r  in t o  th e  s t a t i o n a r y  phase
Mass transfer in either the stationary or mobile phases is not 
instantaneous, and therefore total equilibrium is not established 
under normal operating conditions. The rate of mass transfer is 
controlled by diffusion for liquid stationary phases, and by 
adsorption-desorption kinetics in the case of solid stationary 
phases. As a result of non-instantaneous mass transfer, the 
solute concentration profile in the stationary phase is displaced 
slightly behind the equilibrium position, and the mobile phase 
profile is slightly ahead of the equilibrium position. Provided 
the degree of non-equilibrium is small, the plate height 
contribution arising from non-instantaneous mass transfer may be 
calculated by means of the one-dimensional random-walk model of 
Giddings [10]. As solute molecules traverse the column through 
flow and diffusion processes, they experience many random 
displacements away from the band centre. Displacements in the 
direction of flow are regarded as a series of forward steps 
relative to the continuously moving band centre, whereas 
dispacements away from the direction of flow are regarded as 
backward steps. When there is a large number of solute molecules, 
and hence, steps, there is a normal distribution of molecules 
around the band centre. Band variance may then be written as :
n 2
(J = 1 n 1.24
where 1 is the fixed step length, n the number of steps. These 
are assumed to be constant and large, respectively.
Solute retention may be regarded as a series of 
sorption-desorption steps by the solutes into and out of the 
stationary phase. Assuming simple first order kinetics, the rate 
of sorption and desorption is proportional to the total number of 
solute molecules, and the rate constant is independent of solute 
concentration, a requirement which is normally met at low solute 
concentrations. The rate constant is equal to the fraction of 
available molecules which are adsorbed or desorbed within a given 
unit time.
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Hences
Kd = desorption constant = l/td
where ta and t^ are the mean adsorption and desorption times, 
respectively. In the random walk model, adsorption represents a 
step backwards, and desorption represents a step forward. The 
total number of steps as the band migrates along a distance L, is 
the sum of all forward and backward steps, or twice the number of 
adsorption steps since one step follows the next.
The total number of steps may be written:
n - 2L/v x t 1.25
a
The length of each step, 1, can be evaluated from the
displacement of solute molecules relative to the band centre. The
band centre migrates with a velocity of v/(l + k '), so that
during one step of duration t , the band centre will be
a
displaced by a distance vt (1 + k'). During this time a
a
molecule in the mobile phase will be migrating with velocity v so
that it will have moved a distance equivalent to vt before
a
adsorption. The net displacement of the unadsorbed molecule from 
the band centre during this step is then given ass
1 = vt — (vt /(1 + k 1)) 
a a
hence 1 - (vt k ')/(1 + k ') 1.26
a
Substituting with equation 1.24 gives the variance resulting from
slow adsorption-desorption O^i
s
9 2 
a.2 = (2vt L )(k'/(1 + k' )) 1.27
a
Since the plate height contribution from the 
adsorption-desorption process, Hg is G  /L, Hs may be
Ka = a d s o r p t io n  c o n s t a n t  = l / t a ?
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g iv e n  by:
He = (2vt ) (k1/(1 + k')) 1.28
s a
It is more convenient to express Hs in terms of mean desorption
time, t rather than t . Since the fraction of time spent
d a  F
by the solute in the mobile phase is 1/(1 + k'), the fraction of
time spent in the stationary phase is k'/(l + k'). Hence the
ratio td/ta equals k ’, and substituting td/k' for tQ in
equation 1.28 gives
Hs = (2vt k ’ )/((l + k' )2 ) 1.29
s d
This equation shows that Hs increases with mobile phase 
velocity, and the time taken for desorption from the stationary 
phase to occur. This equation pertains to adsorption 
chromatography, but may be modified to apply to partition 
chromatography. The mean desorption time td is replaced by the 
mean diffusion time tp which may be expressed in terms of film 
thickness, d and solute diffusivity in the stationary phase,
Ds. Therefore:
2 2 
Hs - (qvd k')/(Ds (l + k ’} ) 1.30
where the term q is a shape factor included to account for the 
geometric configuration of the immobilised liquid stationary 
phase. Where the latter is a thin film on a stationary support, q 
has a value of 2/3.
1.3.2.3. Mobile phase mass transfer
Solute molecules in the mobile phase are displaced not only by 
diffusion, but also by flow. In a single flow stream the flow is 
not uniform. Mobile phase in close proximity to the stationary 
phase moves very slowly or not at all, whereas mobile phase in 
the centre of the flow stream moves quickly. Furthermore, small
2
16
and large flow inequalities are always present as a result of the 
irregular packing structure of the stationary phase. The moving 
mobile phase velocity contribution, HM , to overall plate height, 
H, is a function of eddy diffusion effects, Hf, and diffusion 
effects Hj. Hj^  is given by:
H = 1/(1/H + 1/H ) 1.31
M f d
As H = Cid 1.32
f 1 p
and H = C,(dn2 )/D . 1.33
d 2 P M
where d_ is the particle diameter, and C and C are
P 1 2
functions of the packing structure H may be written as?
M
H = (l/(C«dD )+D / (C?vdn2 ))-1 
M 1 P M 1 P
1.34
As mentioned above, mobile phase in close contact with the 
stationary phase moves very little, and in porous packings the 
intraparticulate void volume is filled with mobile pahse at rest. 
Solute molecules must diffuse through this "stagnant" layer to 
reach the stationary phase? thus an additional term HSH must be 
added to the overall plate height contribution. Hg^ is given by 
the equation:
Hsm = ((1 -tf* k' )2dp2v)/(30(l-^)(l + k')2D $
1.35
where^is the fraction of mobile phase inside the particle, 
andT is the tortuosity factor inside the particle.
1.3.2.4 Complete plate height equation
To summarise, the overall HETP may be expressed as the sum of the 
terms from longitudinal diffusion, H[_, stationary phase mass 
transfer, Hs, the moving mobile phase contribution, HM, and
17
the s t a g n a n t  m obile  phase c o n t r ib u t io n  h SM !
H - Hl + Hg + Hm + HSM 1.36
The dependence of each individual factor, and the sum of the 
individual factors on flow velocity is shown in Figure 1.4. The 
relative magnitudes of the individual plate height contributions 
vary depending on the type of chromatography and the capacity 
ratio. The hyperbolic HETP versus mobile phase velocity function 
is generally described by the Van Deemter equation [19], which may 
be written:
H = A + B/v + Cv 1.37
where A represents the contribution from eddy diffusion, B the 
contribution from longitudinal diffusion, and C contributions from 
mass transfer in the mobile and stationary phases to the total 
column plate height. The form of the Van Deemter equation is shown 
in Figure 1.5.
The minimum plate height, Hmjn , is observed at an intermediate 
optimun value of v, vQpt . By differentiating the Van Deemter 
equation with respect to mobile phase velocity, v, and setting the 
result equal to zero, expressions for vQpt, and Hmjn may be 
obtained:
H ~ / T T  2/{B x C) 1.38
min
v - /(B/C) 1.39
opt
In practice, the flow velocity is kept larger than vQpt to 
provide faster separations so that total band broadening is 
controlled by the mass transfer term Cv. Provided that the 
ascending portion of the Van Deemter plot is fairly flat at 
velocities higher than vQpt, then the loss in efficiency will be 
small and well worth the gain in analysis time.
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Figure 1.4.
Dependence of overall plate height. H and plate height 
increments on flow velocity
Hs * Stationary phase contribution; HM - Mobile phase
contribution; HSM - Stagnant mobile phase contribution; 
¥
Hl * Longitudinal Diffusion.
»
Figure 1.5.
The Van Deercter plot
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1 .3 .3 .  R e s o lu t io n
Resolution in chromatography is determined by two basic factors - 
the separation of the peak centres, and the size of the peak 
widths. This is illustrated in Figure 1.6. The degree of 
separation of two adjacent peaks is commonly defined as the 
distance between peak centres divided by the average peak width. 
If retention and and peak width are measured in units of time, 
the resolution, Rs, may be described as?
where t and t are the retention times of the two 
R1 R2
peaks, and W , and W are their peak widths, defined by 
bl b2
the tangents to the inflection points of a given curve. For
closely adjacent bands W =* W , and since W for a
bl b2 b
Gaussian curve, is equal to four standard deviations (a ),
R may be written as: 
s
The larger the value of Rs the greater the separation. When 
Rs - 1.5, baseline separation is achieved, but Rs - 1.0 is 
considered to be reasonably good resolution, and the peaks are 
distinguishable over a wide range of concentrations. At smaller 
values of Rs, resolution will be determined by the relative 
concentrations of the two peaks, and where there is a greater 
than 10-fold concentration differential, the smaller peak may not 
be recognisable.
Resolution is related to the adjustable variables of 
chromatography by the equation:
R - 2(t - t )/(W +W ) 
s R2 R1 bl b2
1.40
R - t -t /4a 
s R2 R1 t
1.41
R
s
(^N/4)(1 - t /t v 
R1 R2) 1.42
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Figure 1.6.
Measurement of resolution (Rs) for two closely related peaks
TIME (tin)  -----------  >
t - retention time of an unretained compound 
M
t^ - retention tine of the first compound
t * retention time of second compound
R2
- width at baseline for compound 1
W - width of baseline for compound 2
R - 2fft/<W + W ) 
s bl b2
21
Since:
(1 + k' ) /(I + k' ) 
1 2
Rs may be written:
R - (/N/4)((k' - k '  )/(1 + k' ))
s 2 1 2
1.43
where k'^ and k'^ refer to the capacity factors of peaks
1 and 2 respectively. As the separation factor a: = k /k
and k = k /q ;:
1 2
2 l '
1.44
Resolution is therefore seen to be a function of three separate 
factors: a column efficiency term, a selectivity term which 
varies with Oi, and a capacity term which varies with k2. Whena 
= 1, resolution is not possible in that system, and the larger 
the value of a  , the easier separation becomes. In practice, 
increasing k 1 will improve resolution up to a point, beyond which 
analysis time and band broadening may be unacceptably increased. 
It is not usual to try to optimise N, k ’ and a. simultaneously? 
experimental conditions are chosen to give the highest value of N 
within the constraints of convenience and reasonable separation 
times.
It is often convenient to combine the plate number and capacity 
factor terms in equation 1.44 Into a single parameter known as 
effective plate number, Neff, and which is related to N 
through:
The ultimate objective in any separation is to achieve maximum 
possible resolution in the shortest possible time. The time for 
separation, which is the retention time for the last eluting
2
Neff = N(k’/(1 + k')) 1.45
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peak, tj is related to resolution by the equations 
tj = (16Rg2) (ex/ (a-1) )2 ) ((1 + k')3/k,2))(H/v)
Where k' is the capacity factor of the last eluting peak. This
equation predicts a 4-fold increase in separation time if it is
sought to double Rs, but if ol is increased from 1.05 to 1.1, 
the separation time is decreased 10-fold. Maximum resolution per 
unit time is obtained when Rs equals 2. This expression also 
shows that it is desirable to operate at reasonably high flow 
rates provided the corresponding increase in H does not operate 
to the detriment of the separation profile. Because H is
inversely proportional to particle size, it is desirable to keep
the latter as small as possible. This approach is limited by the
increase in pressure across the system found with smaller
particles.
Because of the inter-relationship between time and resolution, 
parameters such as plates per second (N/t), or effective plates
per second (Neff/t) are more valid criteria in this regard.
Classical solid-liquid chromatography before 1965 was 
characterised by low values (0.01-0.1) of Neff/t, but with 
modern HPLC techniques it is possible to generate values of 25 or 
more.
1.46
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1.4 . MODES OF CHROMATOGRAPHY
As described in section 1.1., chromatographic inodes may be 
fundamentally divided into gas and liquid chromatographic 
techniques, although that distinction has become somewhat blurred 
with the advent of supercritical fluid chromatography where the 
eluent is a gas held at a temperature above its critical 
temperature. The supercritical gas behaves as a liquid in regard 
to equilibrium properties, and liquid chromatographic technology 
is frequently used in its operation.
Table 1.1. summarises the classification of chromatographic 
methods according to the type of mobile and stationary phases 
they employ. Also shown is the type of interaction which can take 
place in each of these modes. Sorption includes adsorption and 
partition, the latter (which is a bulk phase distribution 
process) is the dominant mechanism in gas-liquid chromatography, 
liquid-liquid chromatography and supercrititcal fluid liquid 
chromatography. Adsorption involves interaction of sample 
components at a surface with fixed sites. Ion exchange occurs 
where the stationary phase contains fixed charged groups and 
mobile counter ions with which ionic solutes can compete as they 
proceed through the column. In exclusion chromatography, which 
includes both gel filtration and gel permeation, sorption does 
not occur. Rather sample molecules which are small enough can 
drift into the pores of the stationary phase. Relative molecular 
si£e then determines the distribution of a compound between 
mobile and stationary phases.
More than one retention mechanism can operate in a given system 
(for instance, sorption with exclusion, adsorption plus 
partition). Although such effects are often accidental, it may be 
useful to deliberately create a dual mechanism of retention to 
enhance differences in migration of the sample components.
24
Table 1.1.
Classification of chromatographic modes based on mobile phase
MOBILE PHASE STATIONARY MECHANISM TECHNIQUE 
PHASE
Gas Solid Adsorption Column
Gas Liquid partition Column
Liquid Solid Adsorption Column, TLC,
Paper
Liquid Solid Ion exchange Column
Liquid Solid Exclusion Column
Liquid Liquid Partition Column, TLC,
Paper
Supercritical Solid Adsorption Column
Fluid
Supercritical Liquid Partition Column
Fluid
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Liquid chromatographic methods will now be discussed in further 
detail. Gas chromatography and supercritical chromatography will 
not be included as it is beyond the scope of this work to permit 
adequate discussion of these techniques.
1.4.1. Liquid-solid adsorption chromatography
Liquid-solid chromatography (LSC) involves distribution between a 
liquid mobile phase and a finely divided porous solid adsorbent 
stationary phase. The adsorbent should have a relatively large 
surface area, for example 50 to 1000 m2/g. The equilibrium 
which governs separation is based on distribution of the sample 
molecules between the bulk liquid phase and the surface of the 
adsorbent. In order to achieve this, eluent molecules already 
adsorbed onto the stationary phase must be displaced, and the 
system can be thought of as a reaction producing displacement.
1.4.1.1. Theory of liquid-solid chromatography
The thermodynamics of adsorption chromatography has been treated 
in detail by Snyder [9], and a simplified version of his argument 
is presented here. In almost all practical LSC systems, the 
surface of the adsorbent is completely covered by a monolayer of 
adsorbed molecules of solute i, or mobile phase M. The 
equilibrium for adsorption and desorption of sample molecules can 
be written as:
iM + nMa ^  ia + nMM 1.47
A solute molecule initially present in the mobile phase [iM ] 
adsorbs by displacing some number, n, of mobile phase molecules 
from the adsorbent surface. This then leaves an adsorbed solute 
molecule [ia ], and some number of desorbed mobile phase 
molecules [nM^]. This process is illustrated in Figure 1.7. The 
magnitude of n is determined by the relative sizes of the solute 
and mobile phase molecules on the adsorbent surface. In Figure
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Hypothetical representation of the equilibrium between solute 
molecules (i) and the mobile phase molecules (M)
Figure  1.7.
[3 0000
'0 EH s 0 
' 0 0 0 0 0  
' □ 0 0 0 0
□  H 
+
0  0  0  0  0 /  
0 C O 0  0
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0 0 0 0 0
i + 2M i + 2M 
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1.7., n - 2. The approximate equation relating the sample 
adsorption coefficient K' to properties of the adsorbent, the 
solute and the eluent can be derived and expressed as:
log K' - log Va + a ’(S° - A£°), 1.48
where V is the quantity of adsorbed (monolayer) mobile phase
per unit weight of adsorbent. V varies with the type,
a
surface area, and water content of the adsorbent, and to some 
extent, the nature of M;«' is the adsorbent activity parameter 
which measures the ability of a unit of adsorbent surface to bind 
adsorbed molecules; the largera1, the more strongly the
o
adsorbent binds both solute molecules and mobile phase. S
measures the adsorption energy of i onto a standard adsorbent
surface (a' =1), from a standard mobile phase M for which e°
equals 1. The parameter 6° refers to the solvent strength of
the mobile phase, and A is the molecular area of solute
i
molecule i.
1.4.1.2. The role of the adsorbent
The effect of the adsorbent on separations in LSC is determined 
by several adsorbent properties; primarily chemical type, surface 
area, and water content. "Chemical type" refers to the bulk 
composition of the adsorbent, for example, silica or alumina. 
Differences in chemical type imply differences in surface 
functional groups and in the type of interaction between 
adsorbent and adsorbed molecules. The common adsorbents can be 
divided into two major groups? polar adsorbents such as silica, 
alumina and other inorganic gels, and non-polar adsorbents such 
as charcoal. Microbead particles (diameters 5-10 n m) are now used 
for high performance LSC applications, with pellicular and 
macrobead particles (diameters 20-50 ¿tm), being used principally 
in preparative scale applications. Polar adsorbents interact with 
solutes via specific forces such as electrostatic attraction and 
hydrogen bonding. Adsorption energy and chromatographic
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retention, and solvent strength tend to increase with the 
polarity of the adsórbate? such as in the series saturated 
hydrocarbons < unsaturated and aromatic hydrocarbons < esters < 
alcohols < acids and bases. Polar compounds are not 
preferentially adsorbed on the non-polar adsorbents? in this 
case, dispersion forces are the dominant contribution to 
adsorption energy, so that higher molecular weight compounds are 
preferentially retained. The most common polar adsorbents are 
silica and alumina, and whereas most of the work in the area 
today employs silica, the classical work of Snyder [9] 
concentrated largely on alumina. Fortunately the surface 
structures of the two adsorbents are sufficiently similar to 
permit single consideration.
The active sites on silica are hydroxyl groups, and in the 
crystalline form, the groups are isolated, and are not in a 
position to interact with their nearest neighbours. In amorphous 
silica, such as that used for chromatography, the arrangement of 
the surface hydroxyl groups is not as ordered, and interaction 
between neighbouring moieties is possible [20]. In particular, 
hydrogen-bonded groups are present, the number of which depends 
on the pore diameter of the adsorbent. The surface of wide-pore 
silica is covered mainly with isolated hydroxyl groups, while the 
surface of narrow-pore silica is covered with hydrogen-bonded 
hydroxyl groups. If amorphous silica is heat treated, siloxane 
bridges are formed as shown in Figure 1.8. These functions are 
weak adsorbent sites, but are thought to partake in hydrophobic 
interactions [21]. Whether or not the formation of siloxane 
bridges is reversible is thought to depend on the relative 
position of the two reacting hydroxyl groups? if the hydroxyl 
groups are situated on adjacent sites, the reaction can be 
reversed by heating in the presence of water, but if the they are 
located on different, but nearby surfaces, such as would be found 
in narrow-pore silicas, the reaction is irreversible, and 
permanent loss of surface area occurs. The two types of 
chromatographically useful active sites (isolated and
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Surface processes occurring on heat and hydrothermal treatment 
of silica
Figure  1 .8 .
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hydrogen-bonded hydroxyl groups) have different adsorption 
properties; hydrogen-bonded groups are considered to be 
significantly stronger sites for adsorption, frequently yielding 
poor chromatographic characteristics. Therefore it is common to 
cause partial deactivation by the addition of a small amount of 
water or another polar solvent, thus removing hydrogen-bonded 
groups from the sphere of activity, and leaving adsorption to 
occur at a relatively uniform surface of isolated hydroxyl 
groups.
The surface area of an adsorbent affects Va in equation B, but 
has little effect on other parameters. An increase in adsorbent 
surface area therefore results in a general increase in K' for 
all solutes, but only slightly affects selectivity. When water is 
added to an initially dry adsorbent to effect deactivation of the 
surface, this causes a reduction in surface area, and also in 
retention. This variation in adsorbent activity with water 
content leads to a general problem in adsorbent and retention 
reproducibility: steps must be taken to minimise exposure of the 
adsorbent to air from which it would attract water molecules, and 
stringent control must be maintained over the water content in 
the mobile phase.
1.4.1.3. The role of the mobile phase
The mobile phase in LSC is usually selected to give the desired 
solute retention times. So-called strong solvents give low 
retention times whereas weak solvents provide large retention 
times. Solvent strength is defined quantitatively by the solvent 
strength parameter e°, and a series of solvents arranged in 
order of increasing strength or €° values is referred to as an 
eluotropic series. An eluotropic series for selected solvents on 
silica and alumina, in addition to viscosity and UV cut-off 
values, is shown in Table 1.2. Relative solvents strengths are 
roughly the same for all polar adsorbents. A suitable solvent 
strength for a given separation may be obtained from Table 1.2., 
or similar type, by trial and error. In this respect, thin layer
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Table 1.2.
Properties of some common solvents used ln HPLC
Solvent
e°
Si 1ica
e°
Alumina
Viscosity
cP.25%
UV cut- 
nm
Hexane 0.01 0.30 190
Cyclohexane -0.05 0.04 0.90 200
Carbon tetra­
chloride 0.14 0.18 0.90 265
Benzene 0.25 0.32 0.65 278
Diethyl ether 0.38 0.38 0.24 218
Chloroform 0.26 0.40 0.53 245
Dichloromethane 0.42 0.41 233
Tetrahydrofuran 0.45 0.46 212
Acetone 0.47 0.56 0.30 330
Dioxane 0.49 0.56 1.20 215
Ethyl acetate 0.38 0.58 0.43 256
Acetonitrile 0.50 0.65 0.34 190
Dimethylsulfoxide 0.75 2.00 268
1-Propanol 0.82 1.90 205
methanol 0.95 0.54 205
Water large 0.89
The solvent strength parameter, £°, is defined as the adsorption 
energy per unit area of standard adsorbent.
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chromatography (TLC) can prove particularly useful, since the 
relative migration rates of components in a sample mixture can be 
determined quickly and easily. Solvent strength is determined by 
how strongly solvent molecules adsorb on the adsorbent surface. 
Consequently, for polar adsorbents € °, increases with solvent 
polarity. On non-polar adsorbents, solvent strength is virtually 
the reverse of that for polar adsorbents, and hence water is the 
weakest solvent, while benzene has strong eluting power on 
surfaces such as charcoal
Fine adjustments in solvent strength are possible with solvent 
mixtures and a few pure solvents can cover the entire spectrum of 
solvent strength. Although the primary role of the solvent is 
control of retention, judicious choice of solvent can produce 
changes in separation factors. As solvent strength is increased, 
equation 1.48 predicts that the retention of solutes with larger 
molecular areas will decrease more rapidly than those of smaller 
molecules.
1.4.2. Liquid-liquid chromatography
Separation by liquid-liquid partition chromatography depends on 
the different distribution co-efficients of the components in a 
sample mixture between a liquid stationary phase and a liquid 
mobile phase. It was introduced in 1941 by Martin and Synge, who 
used a liquid-coated porous support to separate amino acid 
derivatives, and who presented the method in one of the classic 
papers on liquid chromatogaphy [6]. Two types of partition 
chromatography may be defined based on whether the stationary 
phase is coated or chemically bonded onto the surface of the 
support material. Chromatography carried out on the latter type 
of material is known as bonded phase chromatography (BPC), and 
lately, since the decline of the traditional coated phases, has 
become virtually synonymous with the term "liquid-liquid 
chromatography".
As regards coated columns, it would appear that the necessity
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for pre-saturation of the mobile phase with stationary phase to 
prevent stripping of the stationary phase, and the 
incompatibility of these systems with gradient elution is a 
severe restriction on their use except for special cases. The 
most important of these is normal-phase ion-pair partition 
chromatography, which has some application in the separation of 
ionisable compounds [22].
Bonded stationary phases are prepared by chemically bonding an 
organic moiety onto the surface of the adsorbent. The advantages 
of bonded phases are that there is much more freedom in the 
choice of mobile phase than in liquid-liquid partition 
chromatography? gradient elution techniques can be used without 
stripping the stationary phase? and polar and ionic molecules can 
be efficiently separated. The main disadvantages are that the 
bonded phase can be cleaved by off by buffer solutions which are 
too acidic or too basic, as well as by oxidising agents, and that 
incomplete coverage of the silanol groups can lead to poor 
chromatographic characterisics for basic drugs. Virtually all 
currently available bonded materials are based on silica gels, as 
alumina cannot be modified to produce a mechanically stable 
surface [23]. A diverse array of silica-bonded phases are now 
available, and these may be divided into three principal groups:
(i) Hydrophobic chains, especially octadecyl (C18), but also 
Cg, and chains.
(ii) Polar goups such as cyano, aminopropyl and 
ether groups.
(iii) Ionic groups such as sulphonate, amino, and quaternary 
ammonium groups.
Materials for exclusion chromatography have also been chemically 
reacted with si lane reagents to remove unwanted adsorptive 
effects [24].
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1 . 4 . 2 . 1 .  Theory o f  l i q u i d - l i q u i d  chromatography
The selection of the correct stationary (s) and mobile (m) phases 
for a given liquid-liquid chromatographic separation is of 
critical importance in the design of a working system. The main 
requirements of the two liquid are as follows:
(i) immiscibi1ity of the two phases;
(ii) retention values in the right range, i.e. l<k'<20 
approximately.
(iii) sufficiently large separation [a) for samples. The 
distribution coefficient Kj, for solute i between two
immiscible phases s and m is given by the expression
K - [i] /[i ] . 1.49
i s m
where [i]m and [i]s are the concentrations of i in the mobile 
and stationary phases respectively.
since: [i] - g /V , 1.50
s s s
and: [i] - g /V 1.51
m m m
where g , g and V , V are the weights and 
s m s m
volumes of i in the mobile and stationary phases respectively.
Hence equation 1.51 may be rewritten as:
g /g - K V /V 1.52
s m i s m
since K V /V equals k' the capacity factor,
i s m
k' *= g /g . 1.53
s m
The capacity factor is therefore proportional to the weight of 
the solute in the stationary phase, and indirectly proportional 
to the weight of the solute in the mobile phase. This argument 
ignores the effect of the stationary support on the distribution
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of solutes between the two phases. So-called support effects can 
alter Ki values from those observed in the equilibrium 
distribution of i between two unsupported phases. Support effects 
include adsorption of the sample onto the support, and 
ion-exchange interactions between the support and oppositely 
charged solutes, as is seen between basic compounds and residual 
silanols on bonded silica.
1.4.2.2. Preparation of Chemically bonded stationary phases
Organic groups are introduced onto the adsorbent by reaction 
with silanol sites on the silica surface. While there are about 
five -OH groups per nm of surface on silica gel (corresponding 
to 8-9 /imol/m2 ) [24], it is stereochemically impossible to 
react all of them completely even with compounds as small as 
trimethylsilane. The maximum surface concentrations of various 
groupings have been measured by a number of workers, and some of 
their results have been reviewed by Colin et al. [25]. The 
maximum concentrations of trimethylsi ly 1— , octadecylsi1y1 —, and 
triphenylmethylsi ly 1— groups are found to be about 4.5, 3.5, and 
2.5 ¿imol/nr respectively, indicating that at best, about half 
of the available -OH groups can be reacted. The realistic 
objective is then to obtain maximum possible coverage (up to 
about 50%), so that remaining silanols are inaccessible to solute 
molecules, and so do not affect their retention. In practice, 
however, a proportion of silanol moieties remain unreacted and 
accessible to solute molecules? interaction with these residual 
groups is considered to be responsible for poor chromatographic 
characteristics of basic drugs on bonded silica gel.
The main methods for preparing bonded phases are:
(i) reactions with alcohols and amines,
(ii) reactions involving Grignard and organolithlum reagents.
(iii) reaction with organosilanes.
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The majority of modern commercially available bonded materials 
are derived from reactions between organochlorosilanes or 
alkoxysilanes with the surface silanol groups, and it is only 
these which will be discussed here. Such reactions can be carried 
out under a range of conditions, as discussed by Majors [26]. 
There are two general approaches to the bonding of organosilanes 
to silica. The first one involves bonding under anhydrous 
conditions where the reaction is carried under conditions that as 
far as possible, exclude water form the reaction mixture. Typical 
reaction conditions might involve heating dry silica under reflux 
with octadecyltrichlorosilane in toluene [26,27]. In the absence 
of moisture, no hydrolysis of the Si-Cl bonds in the chlorosilane 
takes place, and therefore, polymerisation of the si lane does not 
occur. Bonding occurs by elimination of HC1 between the 
organosilane and one or more of the surface silanol groups. After 
removal of excess si lane, the product is hydrolysed to convert 
unreacted Si-Cl groups to silanol groups as depicted in Figure 
1.9.
Residual silanol groups, arising from either hydrolysis of Si-Cl 
groups as shown, or by non-reaction with the alkylsilane in the 
first place, may be end-capped, (that is, reacted with 
trimethylsilane), in order to minimise undesirable adsorptive 
and/or ionic properties. Some of the more common materials 
prepared via this scheme include octadecyl-, cyanoalkyl-, and 
phenyl- groups. Further reaction, for example sulphonation of 
phenylalkyl supports to form ion-exchange materials, is 
frequently carried out [28]. The advantage of supports prepared 
in this way is that the siloxane (Si-O-Si) bonds formed during 
the reaction are relatively stable to hydrolysis. Bonded phases 
are generally considered to be stable in the pH range 3-8 
[29,30]. Below pH 2-3, the organic groups become cleaved from the 
support, and above pH 8, the silica itself begins to dissolve, 
particularly where the eluent contains a high proportion of 
water.
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Figure 1.9.
Reaction of silanol groups to give an alkyl bonded phase using 
an alkyl tr i ch1oros i1ane
R
H H H
/  /  /
0 0 0 R S i C l .
Cl SI Cl
' ^  Si0 0 ^  ^ 0
4  ^
H20
oh — Si —  OH
0 0- ^ ^ 0
Figure 1.10.
Reaction of silanol groups with a partially polymerised si lane 
to give a polymeric stationary phase
H+/H20 » partially
RSiCl ----------> RSi(OH)  >
3 3 polymerise
—  0 — Si--- 0 —  Si —
OH OH
reaction with surface
0 OH
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The second approach involves hydrolysis. As shown in Figure
1.10., the organosilane is first hydrolysed to the silanetriol, 
which then partially polymerises. The polymer is then bonded to 
the support by multiple attatchments, again via stable siloxane 
linkages which confer good hydrolytic stability on these supports 
[31-33].
1.4.2.3. The range of chemically bonded stationary phases
Although in theory there is no limit to the range of chemically 
bonded stationary phases which can be prepared, only a fairly 
small number of bonded phases is required to cope with nearly all 
the HPLC separations encountered in practice. This is because 
selectivity may readily be adjusted by changing the composition 
of the eluent. This contrasts with the situation in GC where 
where the eluent has fixed properties, and selectivity can only 
be adjusted by altering the nature of the stationary phase, the 
support, or operating temperature.
As previously mentioned, bonded phase chromatatography can be 
operated (a) in the normal phase mode where the eluent is less 
polar than the stationary phase, (b) in the reversed phase mode 
where the eluent is more polar than the stationary phase, as well 
as (c) in an ion-exchange capacity. The latter method will be 
discussed in section 1.4.3.
1.4.2.3.1. Polar bonded phase chromatography
Polar bonded phases containing diol-, cyano-, diethylamino-, 
amino- or diamino- functional groups are commercially available. 
The diol- and diethylamino-bonded phases are used in size 
exclusion and ion-exchange applications, respectively, which will 
be dealt with later.
The alkylnitrile-, and alkylamine-bonded phases, when used with a 
solvent of low polarity, interact with solutes in a manner
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similar to that seen in solid-liquid adsorption chromatography; 
that is, retention of the sample increases with increasing 
polarity of the solute, and decreasing polarity of the mobile 
phase. The polar bonded phases are generally less retentive than 
adsorptive packings, but are less subject to problems such as 
chemisorption, tailing and catalytic activity associated with 
unbonded materials. In addition, polar bonded packings are more 
suitable for gradient elution than adsorbent packings as they 
respond quicker to changes in mobile phase composition; it is 
because of these and other advantages that these materials have 
been proposed as alternatives to microporous adsorbents for 
separating some sample types [33].
The alkylnitrile-substituted phase is of intermediate polarity 
and provides good selectivity for the separation of double-bond 
isomers and ring compounds differing in either the position or 
number of double bonds [34]. In the alkylamine-substituted 
phases, the amino function imparts strong hydrogen-bonding 
properties to the stationary phase, as well as acid or base 
properties depending on the nature of the solute. Certain 
problems can arise with the use of these stationary phases: they 
are readily oxidised so thorough degassing is required, and 
impurities in the mobile phase containing ketone or aldehyde 
groups may react chemically with the amine group to form a 
Schiffs base complex [35].
1.4.2.3.2. Reversed-phase chromatography
Reversed-phase chromatography is so called because it is a 
reversal of the original mode of sol id-liquid chromatography 
where the stationary phase is more polar than the mobile phase 
eluent. Reversed phase chromatography has now become the method 
of choice for the majority of applications, and it is estimated 
that between 70% and 90% of all HPLC separaions are carried out 
in the reversed phase mode [35]. The reasons for this include the 
fact that it is versatile, rugged and simple to use.
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The near-universal application of reversed-phase chromatography 
stems from the fact that practically all organic molecules 
possess hydrophobic regions In their structure which are capable 
of interacting with the non-polar stationary phase. Since the 
mobile phase in reversed phase chromatography is polar and 
contains water, the method is ideally suited to the separation of 
polar molecules which are either insoluble in organic solvents, 
or bind too strongly to solid adsorbents for normal elution» many 
samples of biological origin fall into this category. In 
addition, compounds of substantially different polarity may be 
separated in the same run using gradient elution, within a 
convenient time frame. Retention in reversed-phase chromatography 
is a function of solute hydrophobicity whereas selectivity 
results almost entirely from specific interactions between the 
solutes and the mobile phase [36].
Generally, the selectivity may be conveniently adjusted by 
changing the type of organic modifier in the mobile phase. For 
ionic or ionisable solutes, pH buffers which suppress ionisation, 
and ion-pairing reagents which form lipophilic complexes, are 
useful to promote transfer of the solutes into the stationary 
phase, and so prolong their retention times. These approaches 
form the basis of ion suppression and ion-pair chromatography, 
respectively.
Metal-ligand complexes and chiral reagents can be added to the 
mobile phases to achieve selectivity between optically active 
isomers, and to this end it is also becoming increasingly popular 
to bind chiral groups to the column surface itself.
Reversed-phase chromatography is gaining attention as a method 
for separating large biological molecules such as proteins and 
carbohydrates [37-41], and nowadays, tailor-made packings are 
commercially available for the separation of a number of large 
biomolecules.
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The mechanisms underlying retention in reversed phase systems 
have not been fully elucidated [42-45], but the solvophobic 
theory, discussed briefly below, provides a semi-quantitive 
explanation of solute retention. To generate a simple view of 
this theory, it must be assumed that solute retention occurs by 
adsorption of the solute to the stationary phase without further 
defining the nature of the stationary phase. The solvophobic 
theory assumes that mobile phases are highly structured owing to 
the tendency of water molecules to engage in hydrogen-bonding 
reactions, and that this structuring is perturbed by the presence 
of solute molecules. Due to the very high cohesive energy of the 
mobile phase, solute molecules are forced to partition into the 
stationary phase. If the solute contains polar groups then the 
dipolar or hydrogen-bonding interactions between the solute and 
mobile phase will oppose transfer into the stationary phase. The 
difference in interactive energies between non-polar and polar 
solutes with the mobile phase, and differences in hydrophobic 
solute molecular surface areas are responsible for the functional 
group selectivity observed in reversed phase chromatography. In 
practice, solute retention is often complicated by solute 
interactions, with residual silanols on the column surface, thus 
both solvophobic and silanophilic binding must be considered.
The solvophobic theory assumes a two-step process of solute 
solvation, and this is depicted in Figure 1.11. In the first 
step, a cavity of suitable size is created to accommodate the 
solute, and ¿>GC is the energy required to form this cavity. In 
the second step, the solute enters the cavity and interacts with 
the sorrounding solvent and the energy required for this process 
is given by ¿Gj^y. The energy required to bring a solute from a 
hypothetical gas phase into the solvent is the sum of these two 
terms. The complete equation relating capacity factor and mobile 
phase composition is as follows
In k' = 0 + l/RT[aA(NT+ a) + NAS7(X0-1)
+ V - 5l/ ] + In RT/P0V 1.54
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where
k' - solute capacity factor
6 - volume ratio of stationary and mobile phase
R = gas constant
T = temperature
6A = contact area
N = Avogadro's number
7  = Surface tension
W,a = solvent dependent constants arising from Van der Waals
contribution to binding energy 
V = mole volume of solvent
e = dielectric constant
5Z = contribution of electrostatic interaction to binding
Ag = surface area of solvent molecule
Xe = factor which adjusts macroscopic surface tension to
molecular dimensions 
P0 = 1  atmosphere
According to this equation the capacity factor decreases as 
surface tension decreases, and there is an approximately linear 
relationship between the natural logarithm of the capacity factor 
and the volume percentage of organic modifier in an aqueous 
mobile phase. It also predicts increased solute capacity factor 
for neutral solutes as salts are added to the mobile phase, and a 
reduction in retention for solute which ionise, in agreement with 
experimentally observed phenomena.
1.4.2.3.3. Ion suppession and ion pairing
Selectivity for polar and ionic molecules may be manipulated by 
secondary chemical equilibria. These equilibria are affected by 
changes in the mobile phase composition} by the addition of 
buffers and the adjustment of pH (ion suppression), and the 
addition of ion pair reagents (ion pairing).
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Figure 1.11.
Two-step process of solute solvation according to the 
solvophobic theory
V  V  V  V  V  V  
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(a) Cavity formation
(b) Reduction in free volume interaction
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As mentioned above, retention of solutes in reversed phase 
systems is adversely affected if these solutes are ionised under 
prevailing chromatographic conditions. By the addition of a 
suitable buffer and adjustment of pH it is possible to suppress 
ionisation by driving the equilibria of the following reactions 
in favour of the neutral species:
Low pH High pH
BASES: RNH3+ + OH- —  RNH2 + H20
ACIDS: RCOOH + H20 ~  - RCOCT + H30+
In some cases, however, where the species of interest is strongly 
acidic (pKg < 3.0), or even moderately basic (pKa > 8.0) 
adjusting the pH to or beyond these values will compromise the 
integrity of a bonded silica-based column, as low pH promotes 
stripping of the bonded phase, and high pH promotes dissolution 
of the silica packing.
Substances of this type can be separated on ion-exchange columns, 
but an attractive alternative is the employment of the ion pair 
chromatographic technique, which is performed on existing high 
efficiency, small particle normal or reversed-phase packings. Ion 
pair chromatography has its origins in the use of ion pairing 
reagents for liquid extraction of ionic compounds in aqueous 
solution with an immiscible organic solvent. Superficially, it is 
thought that the basis for ion pair chromatograhy is the 
formation of a lipophilic complex by association of two ions of 
opposite charge, that is, the solute and an oppositely charged 
counter ion which is added to the mobile phase. Ion pair 
formation occurs in the aqueous phase, and the net result is that 
the ionic solute is transferred to the stationary phase. Three 
different models have been proposed to account for ion pair 
separation mechanisms:
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(i) The ion pair model?
(ii) The dynamic ion exchange model;
(iii-)_The- ion interaction models ----
The ion pair model assumes that ion pair formation takes place in 
the mobile phase, and that this is followed by adsorption of the 
lipophilic complex into the stationary phase. This model 
describes quite adequately the situation in normal phase and
coated partition systems where the stationary phase is behaving
as a bulk liquid, but in bonded phase systems, where the 
stationary phase has a film thickness in the order of one 
monolayer, the dynamic ion exchange theory presents a more 
appropriate model. This hypothesis assumes that the ion pair 
regent is adsorbed onto the stationary phase where it behaves as 
a liquid ion exchanger, and that separation results from ionic 
interactions between the ionised solute and the "counterions" 
adsorbed onto the stationary phase.
The ion interaction model assumes that the the lipophilic ion 
pairing reagent is dynamically adsorbed onto the stationary phase 
forming an electrical double layer. Sample retention is assumed 
to result from coulombic attraction of the solute at the electric 
double layer due to the surface charge density provided by the 
charged counterion. This affinity is augmented by the attraction 
of the non-polar stationary phase for the lipophilic portion of 
the solute molecule. The net result is that a pair of ions (not 
necessarily an ion pair) are adsorbed onto the stationary phase.
The general technique of bonded reversed-phase ion pair 
chromatography is operationally more convenient than normal, or 
non-bonded phase, ion pairing methods. It lends itself well to 
gradient elution, and plate efficiencies are in no way inferior 
to those obtained using simpler chromatographic modes. Early 
examples of this form of ion pair chromatography were separation 
of members of the ephedrine class by Schill and co-workers [46] 
using 0.1M dioctyl hydrogen phosphate dissolved in chloroform as
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stationary phase. Not long after this Knox and Laird [47] 
developed the technique known as "soap chromatography" whereby a 
reversed-phase bonded silica was used to extract a detergent from 
an aqueous eluent. They employed cetyltrimethyl ammonium bromide 
as the pairing ion, and showed that this was extracted to give 
what amounted to a monolayer on the surface of the bonded 
support, a result which was independently confirmed by Kissinger 
[48]. To select a counterion for a particular separation, the 
most important consideration is charge compatibilty. The 
counterion should ideally be univalent, aprotic, soluble in the 
mobile phase, non-destructive to the chromtographic system, and 
should not undergo secondary equilibria. The pH of the mobile 
phase is chosen so that both the counterion and the solute are 
ionised, and it is usually controlled by adding a buffer salt to 
the aqueous component. Hence the factors which influence 
retention and selectivity in ion pair chromatography are pH, the 
nature and concentration of both the buffer salt and ion pairing 
reagent, as well as the type and percentage organic modifier in 
the mobile phase. This confers on these systems an added degree 
of flexibility which can be useful in the separation of complex 
mixtures.
Charged surfactants at concentrations below the critical micelle 
concentration are widely used as mobile phase modifiers in ion 
pairing chromatography. Because of the amphiphilic nature of the 
surfactants, there exists some controversy regarding the exact 
mechanism of separation, but some fundamental considerations have 
been described by Horvath et al. [49]. Aqueous solutions of 
surfactants above their CMC, where micelles exist along with 
monomers, dimers and trimers are used as mobile phases in a 
technique known as "micellar liquid chromatography. This 
technique is discussed in detail in chapter 4.
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4.3. Io n  exchange chrom atography
In ion exchange chromatography the chromatographic support 
contains ions which are capable of being exchanged with ionic 
solutes in the mobile phase. It has a long history of 
applications, including the analysis of amino acids [50,51], 
nucleic acid components [52], carbohydrates [53], and nucleotides 
[54]. Ion exchangers in HPLC normally use a bonded quaternary 
ammonium group [-(CH2 )nNR3+X~] for the separation of 
anions, and a bonded sulphonic acid group [C6H4S03-H+ ] 
for the separation of cations. In classical ion-exchange resins, 
the acidic or basic groups are bonded to a styrene-divinyl 
benzene co-polymer. The classical resins have the disadvantages 
that in HPLC their volumes change in different solvents due to 
swelling, they are compressible under high pressure, and their 
mass transfer characteristics are poor. The last defect arises 
from the fairly high degree of cross-linking required to enable 
them to withstand pressure. Only the smallest molecules can 
readily penetrate such resins, and even then, mass transfer is 
relatively slow because of the highly structured form of the 
aqueous phase within the pores of the resin.
An advance on the original homogeneous beads was made by Horvath, 
Preiss and Lipsky in 1967 [11] with the introduction of 
pellicular ion exchange materials where the resin is coated as a 
thin film on glass beads. They were followed by the "Zipax" ion 
exchangers in which a polymer was deposited as a porous layer on 
glass beads [55]. These materials are more rigid, i.e. are less 
compressible, and their mass transfer properties are somewhat 
better than homogeneous particles of the same size, as the 
solutes have a shorter distance to travel within the resin. The 
pellicular materials are, however, not as extensively used as the 
homogeneous bonded materials which are more efficient, and employ 
fully porous silica particles to which ion exchange groups are 
chemically bonded [28,56],
48
1 . 4 . 3 . 1 .  Theory o f  ion exchange chromatography
Ion exchange involves the displacement of a counter-ion, present 
in the eluent, by the solute ion. Considering the following 
equation, which would apply, for example to an anion exchange 
material:
RN+Y + X ^ R N +X- + Y~ 1.55
+ — 
where RN represents an ion exchange site, Y is the
associated counter ion, which is in the liquid phase. The counter
ion can be displaced by solute ion X to give the ion pair
RN+X~. When this displacement reaction is in equilibrium, the
retention is controlled by the equilibrium constant KIE, where
Kie = [Y ][RnV ] / [ x"][RN+Y~] 1.56
Hence:
Ki e [RnV] /[ Y~ ] - [RN+X~/[X~] 1.57
+ —
[RN X ] represents the amount of solute in the stationary
phase and [X ] the amount of solute in the mobile phase, the 
+ -
term KjE [RN Y ]/[Y ] equals the capacity factor k'.
Since the concentration of ion exchange sites [RN Y ] is 
constant and fixed by the structure of the matrix, k' is 
inversely proportional to the concentration the the counter ion 
in the eluent, [Y ]. Hence increasing the concentration of 
counter ions in the in the mobile phase, either by increasing
buffer concentration, or by the addition of a neutral salt,
increases the number of ions with which the solute must compete 
for sites on the stationary phase, and this generally produces a 
decrease in solute retention. Changing the pH of the mobile phase 
alters the character of the stationary phase and the degree of 
dissociation the solute, and this facility is usually used to 
adjust the separation between molecules.
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The operating range for a separation can be estimated from the 
pKa values of the sample components. For an acid-base 
equilibriums
+
HA + H 0 
2
1.58
solute pKa and mobile phase pH values can be related by the 
Henderson-Hasselbach equations
Only ionised solutes are retained through an ion exchange 
mechanism, and as a general rule of thumb, this equation predicts 
that optimum buffer pH should be 1 or 2 pH units below the pKg 
value of bases, and 1 or 2 units above the pKa value of acids. 
When choosing a buffer salt, two criteria must be met. First, the 
buffer must be able to establish the operating pH for the 
separation, and second, the exchangeable buffer counterion must 
provide the required solvent (ionic) strength. Typical buffer 
concentrations are 0.001-0.05 M.
1.4.3.2. Application and Operation of Ion Exchange
Ion exchange columns are generally less efficient than other 
column types used in HPLC. To improve diffusion and mass transfer 
these systems are often operated at elevated temperatures. In 
addition to improving efficiency, this measure also serves to 
reduce overall capacity factors. Small changes in column 
temperature frequently result in large alterations in separation 
selectivity, particularly for structurally dissimilar compound 
types.
Ion exchange separations are frequently operated at low mobile 
phase flow rates in order to maximise column efficiency. For most 
separations, the mobile phase is a wholly aqueous solution, but
pH = pK + log[HA]/[A ] 
a
1.59
Chromatography
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water-miscible organic solvents may be Incorporated to increase 
column efficiency and to control solvent strength. This measure 
is particularly valuable where retention is at least partially 
controlled by a reversed-phase mechanism, and in these cases, 
selectivity can be adjusted in the same way as in reversed-phase 
chromatography.
Interaction can take place between charged silanol groups on an 
unmodified silica surface and oppositely charged analytes. This 
interaction, which is thought to proceed largely via an ion 
exchange mechanism, is widely exploited in the separation of 
organic bases which show poor chromatographic characteristics on 
reversed-phase packings. The theory and application of this type 
of ion exchange chromatography is discussed in detail in chapter 
5.
1.4.4. Exclusion chromatography
Size exclusion chromatography is a liquid chromatographic 
technique which separates molecules according to size. Ideally, 
no interaction occurs between the sample and support. The support 
simply acts as a porous matrix containing mobile phase, and 
separation is effected by the ability of the solute to gain 
access to the stagnant mobile phase via diffusion through the 
support pore network. Unlike in other HPLC methods, the mobile 
phase in size exclusion chromatography is not varied to control 
resolution; it is chosen to provide good solution properties for 
the sample, and to be of low viscosity in view of the low 
diffusion coefficients of macromolecules. All the sample 
components elute ahead of the column dead volume, V^, which can 
be predicted in advance.
Size exclusion chromatography is principally used to separate 
samples of different molecular size, and is the preferred method 
for separating compounds of high molecular weight (MW> 2000). It 
is used to obtain information on molecular weight, and molecular
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weight distribution for polymers. Size exclusion columns with 
pore diameters of 60 A or 100 A are now available and can be used 
to separate molecules with molecular weights below 1000 [57].
In size exclusion chromatography, separation results from the 
distribution of the sample between the mobile phase inside and 
outside the pores of the column packing: there is no direct 
interaction with the stationary phase. The terminology used in 
exclusion chromatography has a different meaning to most liquid 
chromatographic techniques.
1.4.4.1. Theory of exclusion chromatography
The void volume relates only to the the interstitial particle
volume, and the term "capacity factor" is meaningless in this
context. Retention in size exclusion chromatography is better
described by the distribution coefficient K , which is
D
related to experimental parameters by the equation
V - V + K x V 1.60
e o D i
where V = elution volume of the solute 
e
V = column void volume (intraparticulate interstitial
0
volume)
K = solute distribution coefficient 
D
V = internal pore volume.
1
The solute distribution coefficient represents the ratio of 
average solute concentration in the pores of the stationary phase 
support to that outside the support. Thus, the stagnant mobile 
phase pool contained within the pores of the column packing may 
be regarded as the stationary phase. Solute concentration within 
the pores decreases with increasing molecular size. The 
distribution coefficient is limited to values between 0 and 1, 
representing the extremes of complete exclusion and complete 
permeability to the pore volume by the solute. The normal way of
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plotting exclusion data is in the form of a serai-logarithmic plot 
relating molecular weight to Ve, and a typical such curve is 
presented in Figure 1.12. Such curves have a fairly sharp 
exclusion limit at the high molecular weight end, a more or less 
linear portion, and a gradual curve away from the linear towards 
the region of total permeation. The extent of the linear region 
generally covers about 1.5 orders of magnitude of molecular 
weight, and outside this portion, the separation properties of 
the packing are poor. To separate two components of different 
molecular size, a column packing for which the two components 
elute in the middle of the fractionation range should be 
selected. All other things being equal,the column with the 
smallest gradient in the fractionation range will provide the 
highest resolution.
The conceptual idea of a theoretical plate can be used in 
exclusion chromatography to measure column efficiency and compare 
performance of packed columns. It is usually measured using small 
molecules, for example toluene, acetone, or benzyl alcohol, which 
can explore all the pores of the packing, and thus have Kp 
values of unity. In size exclusion chromatography the HETP value 
is due almost entirely to the contributions from stagnant mobile 
phase dispersion and interparticulate mobile phase mass transfer. 
Contributions from longitudinal diffusion are insignificant since 
the large polymeric molecules encountered in this type of 
chromatography have small diffusion coefficients.
Peak-to-peak resolution in size exclusion chromatography may be 
defined in terms of the specific resolution factor which relates 
peak resolution to sample molecular weight [58]. It is assumed 
that all measurements are made in the linear portion of the 
molecular weight calibration curve. In this case:
Rsp - Rs /log(M /M ) 1.61
where RSp -  s p e c i f i c  r e s o l u t i o n  f a c to r
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Figure 1.12.
Example of a calibration curve for microparticulate silica gel 
showing the relationship between molecular weight (MW) and 
elution volume ( Vp )
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Rs = chromatographic resolution
M /M = molecular weight ratio of two standards.
1 2
Assuming a resolution of unity, i . e .  R -  1, then the rat io
s
M /M can be defined as the minimum molecular weiqht 
1 2  
ratio  Rm:
Rsp -  1/log Rm 1.62
Rm is  a useful parameter in comparing column performance, and 
can be used to re la te  resolution to  the basic  properties of the 
chromatographic systems
log R = (4mV ) / (V (ffi)) 1.63
m e i
where
m = slope of  the linear region of  MW cal ibration  curve
V = e lution volume of standard M< 
e
V = pore volume 
i
N = number of theoretical  p lates .
This equation indicates that in order to  obtain increased 
resolving power, the column e f f ic ie n c y  and the internal pore 
volume of the packing must be maximised, and the slope of the 
calibration curve minimised.
1 .4 .4 .2 .  Application and operation of exclusion chromatography
The principal areas of application for s iz e  exclusion  
chromatography are gel f i l t r a t i o n  chromatography and gel 
permeation chromatography. The former technique is  used for the 
separation of  water-soluble macromolecules, often of biochemical 
origin. The following information may be obtained from such 
experiments:
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( i )  molecular fractions for characterisat ion for further use;
( i i )  molecular weight determination using calibration standards;
( i i i )  estimation of molecular association constants.
Gel permeation chromatography is  normally used as an analytica l  
technique for separating samples soluble in organic so lvents .  The 
following information may be obtained from such experiments:
( i)  small molecules may be separated by differences in s ize ;
( i i )  calculation of  molecular weight averages, or the molecular
weight distr ibution of polymers;
( i i i )  preparation of  molecular weight fractions for further use.
The two predominant types of packing material used in exclusion  
chromatography are cross- l inked polystyrenes and inorganic 
packings based on s i l i c a  gel or g lass .  The s i l i c a s  normally used 
for adsorption chromatography can also be used for s iz e  exclusion  
systems. Adsorption processes on these s i l i c a s  must be curbed, 
and th is  can be attained by judicious choice of eluent, or by 
chemically bonding functional groups in more extreme cases.
Cross-linked polystyrene cannot normally be used with aqueous 
mobile phases and as a re su l t ,  current emphasis is  sh i f t in g  
towards the use of  inorganic packings. The polystyrene materials  
do, however, have the advantage that they can be used to  separate 
small molecules, and for th i s  reason they are s t i l l  important.
The choice of packing depends on the s ize  of the molecules to  be 
separated and the compatibil i ty  of  the packing for the chosen 
mobile phase. In order to  obtain a molecular weight d is tr ibution  
of polymeric substances, a ca l ibrat ion  must be carried out, which 
is preferably done with characterised samples of the same 
polymer. Detection i s  usually based on the refractive index of  
the solutes,  as many polymers do not absorb in the UV, and 
although refract ive index detection has low se n s i t iv i ty ,  i t  is  
usually adequate in exclusion chromatography, as minimal d i lu t ion
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of the sample occurs. The characterisation of  polymers by s iz e  
exclusion chromatography requires a high degree of control of the 
mobile phase flow rate [59], as the working volume is  usually  
very small in re la t ion  to the molecular weight range of  samples 
undergoing separation. In addition e f f ic ien cy  general ly  decreases  
with increasing flow rate, although the quantitative  relat ionship  
has not been established and may be a function of  the nature and 
type of packing material [60].
Size exclusion chromatography has become a rapid technique for 
the determination of molecular weight distr ibution of  polymers 
and can be applied to the separation of  a large variety  of  other 
chemical compounds. With the advent of  chemically and 
mechanically stable  s i l i c a s  for s ize  exclusion purposes 
separation on the basis  of s ize  wi ll  join the ranks of  the 
accepted chromatographic techniques for the analysis  o f  any 
complex mixture.
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1 . 5 . INSTRUMENTATION IN  HPLC
The equipment used in modern HPLC is very different from the 
simple gravity-fed devices which dominated the practice of liquid 
chromatography for most of this century. Theory and practice have 
indicated that pressures well above atmospheric pressure are 
required to operate high efficiency columns, packed with 
particles of small diameters, at flow rates of a few millilitres 
per minute. A block diagram of a suitable instrument for HPLC is 
shown in Figure 1.13. The essential features of this assembly 
which will be discussed here are the pump, the injector, the 
column and the detector.
1.5.1. High pressure pumps
The pump is one of the most important components of the liquid 
chromatograph since its performance directly affects retention 
time reproducibility and detector sensitivity. In modern HPLC, 
the pumping system must meet certain general requirements. For 
analytical and semi-preparative applications the pump should be 
able to provide flow rates of 0.5 to 10.0 ml/min at pressures 
reaching 5000 psi. A high degree of accuracy in pump resetability 
and flow rate control, with a minimum of pump pulsation and drift 
are the hallmarks of a good pump. Other practical considerations 
are resistance to corrosion from a wide range of solvents, 
serviceability, ease of operation and time required for solvent 
changeover.
The types of pumps used in HPLC instruments can be divided into 
two categories: (i): CONSTANT PRESSURE PUMPS, e.g, gas
displacement pumps and pneumatic amplifier 
pumps.
(ii): CONSTANT VOLUME PUMPS, e.g, syringe pumps 
reciprocating pumps
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Figure 1.13.
Block diagram of a typical  high pressure chromatograph. The 
dotted lines refer to optional components
Solvent
Reservoirs
"  Data '  "  1 
Handling ■ 
Device J
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A diagramatic representation of the reciprocating type pump is  
shown in Figure 1.14.  This is  the most commonly used model in 
HPLC, and only i t  w i l l  be discussed here. The cheaper 
single-piston version uses an eccentric cam to drive a piston in 
and out of a low volume chamber (30-1000 m icro l i tres ) .  The 
pistons movement is  synchronised with the operation of in le t  and 
outlet  check valves , which between them, control the d irect ion of  
fluid flow during the f i l l  amd pump sequences. The flow output is 
determined by the length or frequency of piston strokes. The flow 
output is  delivered as a s er ies  of pulses which must be damped to 
prevent interference with detector operation. Pulse dampeners 
work in a manner analagous to  that of a capacitor in an 
e lec tr ica l  c i r c u i t .  They store  energy during the pressurising  
stroke, and re lease  i t  during the r e f i l l  stroke [61].  Pulse 
damping has been achieved using a variety of mechanical devices  
such as syringes, bellows and coiled tubes, frequently in 
conjunction with a f lu id  b a l la s t  reservoir. A commercially 
available pulse dampener uses a flattened length of te f lon  tubing 
immersed in a degassed compressible liquid. The f l e x i b i l i t y  of  
the tubing and the compressib il i ty  of the gas thus absorb any 
pressure f luctuations in the system.
Dual-and triple-headed reciprocating pumps may be operated 
without a pulse dampener. With a dual-head reciprocating pump, 
the two pistons are driven by the same motor via a common cam 
such that they are 180° out of phase. As one chamber is  
pumping, the other i s  r e f i l l i n g  so that the two p ro f i le s  overlap, 
leading to partial  cancel la t ion  of  the peaks and troughs in the 
total  flow output. Likewise, with a triple-head pump the three 
pistons are 120° out o f  phase and the degree of  pulse reduction 
is  accordingly greater.
Reciprocating pumps de l iver  a constant flow at a fixed back 
pressure. At high back pressures some minor flow v a r ia b i l i ty  may 
arise due to compress ib il i ty  of  the mobile phase. Reciprocating 
pumps can provide continuous solvent delivery,  fast  solvent
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Figure 1.14.
Reciprocating type pump for high pressure liquid chromatography
e
(a): Motor, (b): Cam, (c): Piston, (d): Chamber, (e): to 
Solvent resevoir, (f): Pulse Dampner, (g): Inlet check 
valve, (h): Outlet check valve
Figure 1.15.
Two methods for generating binary solvent gradients
(a): mixing on high pressure side.
(b): mixing on low pressure side.
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changeover, gradient e lution compatibil ity,  and have low 
maintenance requirements.
1 .5 .1 .1 .  Gradient elution
Samples having a wide range of capacity factor are not 
conveniently separated under isocrat ic  conditions, and gradient  
elution is  frequently employed in these cases.  A mobile phase 
gradient is  formed by mixing two or more solvents according to 
some pre-determined gradient ramp. The most commonly used 
gradients involve a binary mixture with a linear, concave or 
convex increase in the percent volume fraction of the stronger 
solvent. The gradient shape mentioned above can be described by 
simple mathematical functions [62].
Gradient devices are usually c l a s s i f i e d  according to whether the 
solvents are mixed in the high pressure side (Figure 1 .1 5 .a) or 
in the low pressure side (Figure 1.15.b) of the pump. Modern 
instruments use time-proportioning electrovalves,  control led by a 
microprocessor to control solvent del ivery to the pump [63,64].  
The low pressure arrangement i s  l i t t l e  influenced by solvent  
compressibility e f f e c t s  and can eliminate errors associated with 
thermodynamic volume changes due to  mixing of the solvents .  The 
high pressure arrangement necess i ta tes  two pumps which deliver  
the solvents separately to the mixing chamber. Solvent 
compressibility and thermodynamic volume changes on mixing can 
influence the accuracy of the mix ultimately delivered to the 
column. A s ign if icant  disadvantage of  th is  arrangement is  the 
need for two pumps.
1. 5.2.  Injection devices
The ideal sample introduction method should reproducibly and 
conveniently insert a wide range of  sample volumes into the 
column as a sharp "plug" without adversely affecting the 
e f f ic iency  of the column. These goals are met to varying extents  
by the following injector types:
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( i )  Septum
( i i )  Septumless
( i i i ) Stop-flow
(iv)  Valves
Microvolume sampling valves (Figure 1.16) are the most widely 
used injection devices in HPLC, and only their  operation wil l  be 
described here. Valve in jectors  permit reproducible sample 
introduction without s ig n i f i c a n t  flow interruptions. The sample 
is  loaded at atmospheric pressure into a groove in the valve  
core, or more commonly via an external loop, and the sample is  
introduced onto the column by short rotation of the valve.  The 
volume of sample injected i s  varied by changing the external  
loop, or i f  a very large loop (up to 2ml) is  used, by introducing 
the volume of sample required using an accurately calibrated  
syringe. Where the volume injected is  determined by the loop 
s ize ,  th is  method of sample introduction is  v ir tua l ly  operator 
independent and very reproducible with injection errors of less  
than 2%. Column e f f ic ien cy  i s ,  however, s l ig h t ly  degraded by the 
method of coupling the valve to  the column [65]. This degredation 
can be minimised i f  the valve-to-column tubing is  short,  is  of  
narrow internal diameter(< 0 .5  mm), and i f  low dead-volume 
f i t t in g s  are used.
1 .5 .3 .  Detectors in HPLC
Separations in liquid chromatography occur in a dynamic manner 
and therefore require detection systems which work on-l ine  to 
produce an instantaneous record o f  the column events.  There is  no 
equivalent in HPLC to the universal ,  sens i t ive  flame ionisation  
detector used in gas chromatography, and a variety of  detectors  
are necessary to cover the wide range of analytical s ituat ions  to 
which HPLC is  applied. Broadly speaking, the detectors used in 
l iquid chromatography may be c lassed as bulk property or solute  
property detectors.
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Figure 1.16.
Valve injector for sample introduction
Load posit ion Inject  position
(a): to Column
(b)i Mobile phase in le t
(c ) s Sample loop
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Refractive index and conductivity detectors  are examples of bulk 
property detectors. They measure the difference in some physical 
property of the mobile phase containing solute ,  as opposed to the 
solute-free mobile phase. These detectors  have fa ir ly  universal 
application, but have poor s e n s i t iv i t y  and a limited dynamic 
range. Bulk property detectors are adversely affected by small 
changes in mobile phase composition and temperature, which 
precludes their  use in flow programming or gradient elution.
Solute property detectors which include, fluorescence,  
spectrophotometric and electrochemical detectors , are the most 
widely used detection schemes in liquid chromatography. They 
respond to some inherent physical or chemical property of the 
solute, which is ,  ideally ,  independent of the mobile phase. 
Although th is  cr iter ion  is  in r e a l i t y  rarely met, the signal 
discrimination is  usually s u f f i c ie n t  to permit flow programming 
and gradient elution, and to provide high s e n s i t iv i t y  with a wide 
l inear response range. These detection schemes wi ll  now be 
discussed in further d eta i l ,  with more emphasis bing given to  
ultravio let  absorbance detection which was used throughout the 
course of th is  work.
1 .5 .3 .1 .  Spectrophotometric detection
UV-visible spectrophotometric detectors  have been a feature of  
HPLC instrumentation since i t s  inception and remain the most 
widely used of the HPLC detectors . Since many organic molecules 
possess some absorption in the UV region, th i s  detection mode has 
fa ir ly  universal application, though s e n s i t i v i t y  is  determined by 
how strongly the solute absorbs in the UV, what i t s  wavelength of 
maximum absorbance is and the a v a i la b i l i t y  of  a transparent 
mobile phase at the chosen operating wavelength. The latter  
feature is particulary important at the lower wavelengths since  
many common organic solvents absorb to some extent in the low UV 
region. The operation of spectrophotometric detectors is  based on 
the measurement of  the absorbance of monochromatic
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light by the solute in accordance with the Beer-Lambert laws
A = log I / I  = £ c l  1.64
o
where
A = Absorbance
I = the intensity  of  l igh t  that would emerge from the
o
ce l l  i f  i t  contained a completely transparent liquid
I = the intensity  of l igh t  folowing absorbance by a solute
£ = molar extinction c o e f f i c i e n t
c = concentration in mol/dm^ *
Very often the optical absorbing power of a substance in solution  
is  quoted not in terms of  i t s  molar ext inc t ion  c o - e f f i c i e n t ,  £  , 
but in terms of i t s  Al%(lcm) value. This i s  the absorbance A of a 
1% w/v solution of the solute when measured with an optical path 
length of 1 cm. The Al%(lcm) value and molar extinction  
c o e f f ic ien t  are related by the equation:
Al%(lcm) = 10 /MW 1.65
where MW is the molecular weight of  the so lute .  The f i r s t  
commercial flow photometers a l l  used low-pressure mercury arc 
sources, since such lamps have a long l i fe t im e  and give a highly 
intense and stable output of the resonance radiation at  the 254 
nm wavelength. This l ine accounts for about 90% of  emmision from 
the mercury arc source and only the simplest optical f i l t e r  is  
required to i so la te  i t .  Obviously, these detectors  are limited in 
their  application to samples which have at least  some absorbance 
(depending on s en s i t iv i ty  requirements) at  254 nm. These 
detectors are, however, simple, rugged and inexpensive, and with 
a highly regulated source and dual beam operation, a very high 
s ignal- to-noise  rat io  can be achieved.
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The original mercury lamp was then replaced by a more intense 
deuterium lamp giving a continuous output from 190-400 nm (or a 
tungsten filament lamp with an output from 400-700 nm) and a 
manually adjusted grating which allowed se lec t ion  of the 
detection wavelength to match the absorption maximum of  the 
sample. Nowadays, the most generally used detector is  the 
continuously variable multiple wavelength detector which might 
contain both a deuterium and a tungsten lamp, permitting 
wavelength se lec t ion  between 190-700 nm. Wavelengths are se lected  
manually, or in an automated version, the detector may be 
programmed to change wavelengths during separation. These 
detectors use high energy sources and stable  low noise  
electronics.  Multiple wavelength detectors produce a 
s ignal-to-noise  r a t io  which is  s l igh t ly  lower than the fixed 
wavelength detectors, though in general, deuterium lamps have a 
su f f ic ien t ly  stable output that the best single-beam instruments 
have noise levels  which are only marginally higher than those of 
the fixed-wavelength photometers. An example of a multiple 
wavelength detector i s  shown in Figure 1.17. Since the l ight  
intensity transmitted is  proportional to the band width of the 
radiation and the Beer-Lambert law applies to  monochromatic 
l ight,  a compromise bandwidth of 2-5 nm is usually used.
Careful consideration must be given to the design of  the detector  
c e l l ,  as i t  forms an integral part of both the chromatographic 
and and the optical systems. The detector c e l l  volume should be 
as small as possible  to  reduce extra-column band broadening, a 
requirement which is  becoming more important as advances in 
column technology are leading towards the use of  smaller, more 
e f f i c i e n t  and c o s t - e f f e c t iv e  columns. The c la s s i c a l  Z-shaped ce l l  
which is  commonly used is  shown in Figure 1 .1 8 .a, and a variant  
on this  was the s p l i t - f lo w  model introduced by Kirkland [66] 
which was designed to remove flow-derived disturbances which can 
produce noise and d r i f t .
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Optical diagram of multiple wavelength spectrophotometric 
detector
Figure 1.17.
Figure 1.18.
Some types of flow c e l l s  used in UV absorbance detection
(a)s Z-type c e l l  (b): Tapered c e l l
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A major source of flow disturbance is  non-homogeneous refract ion  
throughout the c e l l .  This ar ise s  from temperature gradients,  
incomplete mixing and turbulence in the mobile phase, which cause 
some of the incident l igh t  to  be refracted against the c e l l  walls  
where i t  is  not detected, and therefore mistakenly taken to  
represent sample absorption. When a sample of d ifferent  
refract ive  index enters the c e l l ,  a re fract ive  index gradient is  
created across the bore, and t h i s  gives  r i se  to a lens of  moving 
liquid within the c e l l ,  which i s  known as the "liquid lens" 
e f f e c t .  These refract ive  index phenomena are responsible for  
f luctuating baselines and d i f f e r e n t ia l  peaks near the solvent  
front. The tapered c e l l  developed by L i t t l e  and Fall ick [67] and
shown in Figure 1.18.b, is  designed so that no l ight  is
su f f ic ie n t ly  refracted to  reach the c e l l  wall,  and the liquid  
lens is  not created. Flow e f f e c t s  may also be minimised by 
controlling the temperature of  the eluent and the f lo w -ce l l ,  and 
th is  may be achieved by housing the column, tubing and the flow 
c e l l  in a thermostatted enclosure.
With a variable wavelength detector the column flow can be 
stopped, the solute arrested in the flow c e l l  and scanned 
manually or automatically to  produce an absorbance spectrum in a 
technique known as stop-flow scanning [68,69].  This exerc ise  can 
yie ld  information on the optimun wavelength for absorbance by an 
individual solute , in addition to providing character is t ic
wavelength rat ios  for q u a l i ta t iv e  analysis .  Obtaining a s ing le
spectrum by stop-flow scanning is  quite tedious and time 
consuming, and stopping the eluent flow requires re-equil ibrat ion  
of the column at the operating flow rate before the next analysis  
can proceed. A more recent innovation which can provide the same 
kind of data as stop-flow chromatography, is  the photodiode array 
detector. In th is  instrument, a beam of white l ight  is  passed 
through the flow c e l l ,  and the emergent l ight  is d if fracted by a 
grating so that i t  f a l l s  on an array of diodes, each diode 
receiving l ight  of a d i f feren t  wavelength. In th is  way a complete 
spectrum can be obtained instantaneously for each of
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the peaks as they e lu te  o f f  the column. This information is  
usually stored in a data handling system and i t  may be recalled  
and analysed at a la ter  point in time. The diode array 
spectrophotometer can be used for quantitative analysis  even when 
the peaks are only p a r t ia l ly  resolved; their s e n s i t iv i t y  and 
noise level are only s l i g h t ly  inferior to those of the more 
conventional spectrophotometers. The linear photodiode array 
detector is now commercially available  and has, in recent years, 
become a popular and famil iar feature in the analytical  
laboratory.
1 .5 .3 .2 .  Fluorescence detection
Many biological ly  a c t iv e  compounds and pharmaceutical products 
possess native fluorescence,  a fact which has contributed to the 
popularity of fluorescence detection in the f ie ld  of  
biopharmaceutical ana lys is .  In addition, derivat isat ion to  
produce fluorescent products is  readily achieved pre- or 
post-column, and the benef it  gain in terms of increased 
sen s i t iv i ty  is frequently worth the compromise in terms of speed 
of analysis.
When a molecule absorbs a quantum of light,  an electron is  
promoted from the lowest vibrational level of the ground state to 
higher energy e lec tron ic  s tates  in accordance with the rules  of 
quantum mechanics. Following th is  absorption of  energy, the 
molecule relaxes to  the lowest vibrational level of the excited  
electronic state by rad iat ion less  routes, from which point a 
transit ion occurs to  the ground electronic  s ta te  with energy 
emitted in the form o f  l igh t .  The wavelength of emitted 
fluorescence is always longer than that of the absorbed l ight,  
and i t  is  therefore poss ib le  to irradiate a solute with l ight  
which i t  absorbs strongly (usually i t s  maximum in the UV region) 
and observe the f luorescent  emission through a f i l t e r  which cuts 
out the irradiating l ig h t ,  and so creates a dark background. This 
fundamental property makes fluorescence a very a t tract ive  HPLC
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detection system, for whereas UV absorbance detection depends on 
the difference between a fu l l  and s l ig h t ly  attenuated l igh t  beam, 
fluorescence measurement s tarts  in principle  from a point of  zero 
in tensity .  Thus, fluorescence detection is 100 fold more 
sens i t ive  than UV absorption [22].
The s e le c t iv i t y  associated with fluorescence detection ar ises  
because two wavelengths are used in the measuring process,  and 
from the fact  that certain structural features are required for 
fluorescence to occur. For d i lu te  solut ions,  the measured 
fluorescence in tensity  can be related to sample concentration by 
the equation
1 = 1 x 0  x (2.3 c l )  1.66
f o f
where
I = fluorescence emission intensity  
f
I = excitation beam intensity  
o
= molar ext inction c o - e f f i c i e n t
1 = path length
c -  sample concentration
e = quantum e f f ic ien cy
= number of  photons emitted
number of photons absorbed
For fluorescence detectors used in liquid chromatography, the 
above equation is  generally linear over a concentration range of  
2-3 orders of magnitude. S e n s i t iv i ty  depends on the instrument 
(I0 and the reduction of scattered and stray l ig h t ) ,  the sample 
(quantum e f f ic ie n c y ) ,  and the composititon of  the mobile phase 
(solvents,  impurities e t c ) .
The optical  diagram of  a f i l t e r  fluorimeter is  show in Figure
o
1.19. The measuring optics  are arranged at a 90 angle to  the 
irradiating beam in order to i so la te  the emmision beam from the 
excitation beam. The f i l t e r  is  also used for th is  purpose. As the
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Figure 1.19.
Optical diagram of fluorescence detector
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Excitation Lens
Interchangeab le  
In te r fe ren c e  F ilte r
Beam Splitter
Excitation S h u t te r  
Sample
Reference  
A tte n u a to r  
Reference \
Photom ult ip lier  x
Sample 
Photom ult ip lier
\  Slit c .
\  Emission Lens
C o n t in u o u s  
In te rference  F i l te r
Cham ber Bar
Emitted Light
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Figure 1.20.
2 7r sterdian cuvette
Entering Light Beam  
( Excitation )
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signal Intensity is  directly  proportional to  the source 
intensity ,  high energy line or continuous (tungsten, deuterium, 
xenon) sources are used. Mercury sources produce a ser ies  of  
intense UV l ine  spectra superimposed on a weak continuum, thus 
only certain wavelengths are avai lable  for excitation,  and these  
may not coincide with the maximum excitation wavelength of the 
sample. Continuous arc sources are used for continuously variable  
se lect ion of the operating emission signal.  Examples of these arc 
sources are deuterium (190-400nm), tungsten (400-700nm) and xenon 
(259-850nm) lamps. As arc sources tend to be unstable, the 
excitation beam is  s p l i t  between sample and reference beams which 
are e lec tron ica l ly  coupled to compensate for fluctuations in 
source intensity .
Recently lasers have received much attention as excitation  
sources in fluorimetric detection [70]. Lasers are a more 
powerful source of incident l ight ,  and their  inherent spatial  
coherence and monochromaticity permits a l l  the radiation to  be 
e f f i c i e n t ly  u t i l i s e d  in a small detection volume. Wavelength 
i solat ion is  achieved using cut-of f  of interference f i l t e r s ,  or a 
monochromator dif fract ion  grating. Cut-off f i l t e r s  lack 
s e le c t iv i t y  since they transmit a l l  l ight above a certain  
wavelength. Interference f i l t e r s  and monochromators provide 
narrow bandpasses, though at somewhat lower signal intensity .
Flow fluorimeters have been available since the e a r l i e s t  days of 
commercial HPLC, but only recently have the problems of flow ce l l  
design been adequately resolved. A unique c e l l  which uses a 27r 
sterdian sample cuvette to maximise the intensity  of the emission 
signal is  shown in Figure 1.20. Sample fluorescence is  generated 
in a l l  d irect ions simultaneously and the high light scattering  
power and low c e l l  volume (3-5 f i l )  combine to make th is  design 
well -suited to modern, high e f f i c ien cy  HPLC columns. The 
fluorescence signal from a sample may be dramatically affected in 
both wavelength and emission intensity  by the mobile phase 
composition, and even by the presence of contaminants in the 
mobile phase. Some of the solvent e f f e c t s  are summarised below.
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Under less  than ideal conditions, the constancy with which the 
pump mixes and del ivers the mobile phase and the presence of  
contaminants in the mobile phase may influence detector  
s e n s i t iv i t y  more than fluctuations in the detector operating 
system. Fluorescence detection can be used with gradient elution,  
and unless the mobile phase contains as high level of fluorescent  
impurities,  the detector baseline changes very l i t t l e  during the 
solvent programme.
The types of problems which can develop in fluorescence ar ise  as 
a resu lt  of
( i ) :  too high sample concentration (non-linear responses due to 
self-absorption by the sample i t s e l f  or complete 
absorption of the beam before i t  reaches the c e l l  centre);
( i i ) :  quenching of the signal from low leve ls  of sample by 
impurities (especia l ly  oxygen) in the mobile phase;
( i i i ) :  solute-solvent  interactions where a s h i f t  in 
fluorescence spectrum is  observed as the 
d ie le c t r ic  constant of  the mobile phase is  increased-  
se n s i t iv i t y  is  reduced i f  the solvent absorbs any of the 
excitation or emission energy;
( iv):  photodecomosition induced by high intensity  energy sources 
which depends on the residence time of the sample in the 
flow cel 1; and
(v): fluctuations in the rate of mobile phase delivery by 
the pump will adversely a f fec t  detector s e n s i t iv i t y  and 
reproducibi1i t y .
Fluorescence detection is part icularly  useful when used in 
conjunction with pre- or post-column derivat isat ion  techniques 
for the trace analysis of  non-fluorescing compounds. Amines, 
amino acids and phenolic compounds can be detected with high 
s p e c i f i c i t y  and s e n s i t iv i ty  as the ir  fluorescent dansyl 
derivatives  or by post-column reaction with 
ortho-phthaldialdehyde. The la t ter  reagent produces strongly
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f luorescent derivatives with amino acids and biogenic amines in 
alkaline media which contain a reducing agent. Several anologues 
of dansyl chloride are also in use; dansyl hydrazine is  a 
se le c t iv e  agent for the analysis of primary amines. Fluorescamine 
is  frequently used for the detection of amines, amino acids and 
peptides after  ion-exchange chromatography.
1 .5 .3 .3 .  Electrochemical detection
Electrochemical detection is based on the e l e c t r o l y t i c  properties  
of solutes ,  and accordingly they are limited to  use with 
e l e c t r i c a l ly  conducting electrolyzable spec ies .  A range of 
therapeutically important species do exh ib it  these properties and 
lend themselves well to th is  detection mode. Examples of  
compounds which can be conveniently detected in th i s  way are the 
benzodiazepines, the t r i c y c l i c  anti-depressants,  antineoplastic  
agents such as c i sp la t in  and mitomycin C, a n t ib io t i c s  such as 
adriamycin, and cardioactive agents such as tiomolol and 
pindolol.  S e lec t iv i ty  in electrochemistry is  achieved by 
adjusting the applied potential in manner analagous to wavelength 
se lec t ion  in UV absorbance detection. This enables one 
electroact ive  species to be detected in the presence of another 
without interference. Electrochemical detection is  a useful 
alternative  where the species to be detected possesses no 
chromophore. Other advantages of electrochemical detectors  are 
their  r e l i a b i l i t y ,  simple low volume c e l l  design (0.1-5 f i l ) ,  and 
high s e n s i t iv i ty ;  under favourable circumstances, pi cogramme 
detection l imits  may be achieved.
Electrochemical detection requires the use o f  aqueous or 
hydro-organic mobile phase which are conducting and contain 
inorganic s a l t s .  These are eluents which are found in 
reversed-phase and ion-exchange chromatography but which are 
incompatible with other techniques. Detector operation is  
c r i t i c a l l y  dependent on the mobile phases flow rate constancy, 
pH, temperature, ionic
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strength and the presence o f  e lectroact ive  impurities,  especia l ly  
dissolved oxygen. I t  is  a lso  related to c e l l  geometry, and 
sen s i t iv i ty  is  adversely affected  by contamination of the 
electrode surface and o s c i l l a t i o n s  in pump output. Since the 
performance character is t ics  of  the electrochemical detector is  
profoundly influenced by the composition and flow rate of  the 
mobile phase, solvent programming methods are not normally 
possible.
Electrochemical detectors  include the amperometric, coulometric,  
and polarographic detectors  for the determination of compounds 
which can be e l e c t o l y t i c a l l y  oxidised or reduced at a working 
electrode [71-74], and the conductivity detector for the 
determination of ionic species .
Amperometric detectors are based on thin-layer or tubular 
electrode c e l l s .  The former are more popular as small c e l l  
volumes and a variety of e lectrode materials (such as carbon 
paste or glassy carbon) can be used [74], Two examples of  
thin-layer electrochemical c e l l s  are shown in Figure 1.21. The 
column eluent is  introduced e i ther  paralied to the electrode  
embedded in the channel wall as in Figure 1 .2 1 .a . ,  or 
perpendicular to the electrode surface followed by radial  
dispersion: the so-cal led  w a l l - j e t  detector. The w a l l - je t  
detector has high s e n s i t iv i t y ,  can be adjusted to provide various 
ce l l  volumes and is  r e la t iv e ly  free from surface adsorption 
problems. The reference electrode is  maintained at a constant 
potential re lat ive  to the working electrode, and the chromatogram 
is  recorded by measuring the detector ce l l  current at  a fixed 
applied potential as the sample is  eluted o f f  the column. As long 
as the mobile phase ve loc i ty  and composition do not change the 
background signal wil l  remain constant and be subtracted from the 
analytical signal.  In the amperometric mode, e l e c t r o ly s i s  is  not 
completed, ( typical ly  1-10%) but i f  the electrode surface area 
is  increased (for example in the tubular design) almost complete 
reaction can
76
Figure 1.21.
Thin-layer electrochemical amperometric detectors
Column
(a): Thin-layer detector (b): Wal1-jet detector
occur, and the system is now said to be operating in the 
coulometric mode. The coulometric detector i s  in sens i t ive  to flow 
rate and temperature changes, but is  more prone to electrode  
contamination, is  more d i f f i c u l t  to design, and requires s t r i c t  
potential control over the entire working e lectrode surface.
Microvolume dropping mercury polarographic detectors  can be used 
in HPLC for the determination of e lec tro-reduc ib le  species.  
Surface contamination is  rarely a problem as the electrode  
surface i s  continually being renewed. The disadvantages of 
polarographic detection include high background currents due to 
current o s c i l l a t io n s  over the l i fet ime of  the drop, turbulence 
caused by liquid flow in the region of  the drop, and the need for 
complex c e l l  designs. Recent innovations in c e l l  design and 
e lectron ic  damping of the signal have done much to improve the 
polarographic detector, though i t s  general use is  less  widespread 
than the amperometric detector.
Conductance i s  a fundamental property of  ions in solution and 
exhibits  a simple dependence on ion concentration.  The 
measurement of conductance is thus an obvious choice in the 
continuous s e le c t iv e  monitoring of ions in the column e f f luent .  A 
typical  detector c e l l  consis ts  of a low-volume cavity  or tube of  
insulating material,  in which electrodes,  made of  a noble metal 
or graphite,  are embedded. Generally, a constant alternating  
voltage i s  applied to the electrodes and the res is tance  is  
measured by a simple Wheatstone bridge arrangement. The c e l l  
resistance is  related to  sample concentration by Ohms law. 
Conductivity detectors  are simple to operate, and in the absence 
of background e le c t r o ly te  provide high s e n s i t i v i t y  (10-8
 Q
-10 g/ml).  Conducting impurities in the mobile phase limit  
absolute s e n s i t i v i t y .
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1.5.4. The column in chromatography
1 .5 .4 .1 .  Column selection
To design a chromatographic method using HPLC, the f i r s t  decis ion  
to be made is  the se lect ion  of the most appropriate column type. 
The analyst requires some information about the physico-chemical
properties of  the sample, in addition to  the nature of the
information desired for the separation. The decision as to  which 
method to try f i r s t  could be based on the r e la t iv e  s o lu b i l i ty  of  
the sample in polar and non-polar so lvents ,  i t s  molecular weight, 
or even past experience with d i f ferent  separation methods. An aid 
to the se lec t ion  of the f ir s t -ch o ice  chromatographic method for 
the various sample types is  shown in the flow diagram in Figure 
1.22. This se lec t ion  is  based f i r s t l y  on the molecular weight of  
the sample, i t s  so lu b i l i t y  in polar and non-polar solvents ,  and 
on whether or not i t  is  ionic.
1 .5 .4 .2 .  Column packings
The high performance packings used in modern liquid
chromatography are comprised of small, r ig id  part ic le s  having a 
narrow part ic le  s ize  d istr ibution.  There are bas ica l ly  three 
different  types of  packing materials avai lab le  which are shown in 
Figure 1.23: super f ic ia l ly  porous p a r t ic le s ,  large t o ta l ly  porous 
part ic le s ,  and very small t o ta l ly  porous p a r t ic le s .  The la tter ,  
also known as microparticulate porous p a r t ic le s  are nowadays 
the most commercially important packing materials .
Rigid porous polymeric beads prepared from polystyrene  
cross-l inked with divinyl  benzene were used for ion-exchange and 
s ize-exclus ion chromatography; these have largely been superceded 
by more e f f i c i e n t  and mechanically s table  s i l ica -based  packings 
for many applications.  Pe l l icu lar  packings were or ig ina l ly  
prepared to replace these porous polymer beads. Known also  as 
porous layer beads, they have diameters of  35-50 fim and cons is t
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Figure 1.22.
Flow diagram of column se lec t ion  based on sample s ize
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chromatography.
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of a g lass  bead core to  which porous s i l i c a  or alumina is  fused 
in a layer 1-3 fim th ick .  They can be used without modification in 
l iquid-so l id  chromatography, or they may be chemically modified 
for use in bonded phase chromatography. Porous layer beads have 
very small pore volumes, providing rapid so lute  d i f fus ion  in and 
out of  the s tat ionary phase. The use of  these p e l l i c u la r  type 
packings for ana ly t ica l  separations declined with the advent of 
to ta l ly  porous p a r t ic le s  in narrow p a r t ic le  s iz e  ranges with 
diameters of  10 m or l e s s .  They do, however, find application as 
materials for guard and pre-concentration columns and 
high-quality, modified and unmodified p e l l i c u la r  packings are 
widely commercially avai lable .  Small t o t a l l y  porous s i l i c a  
part ic le s  are general ly  employed as packings for HPLC. They have 
been described in d e ta i l  by Unger [75], and Scott [76,77].  
Chemically modified s i l i c a  packings are extensively  used for 
polar and non-polar separations, c o l l e c t iv e ly  known as bonded 
phase chromatography, in addition to both ion-exchange and s ize  
exclusion app l ica t ions .  The preparation and application of  bonded 
s i l i c a  gels  is  discussed in section 1.4.
1 .5 .4 .3 .  Types o f  columns
The column is  the core of any chromatograph, and i t  i s  e ssent ia l  
that the design o f  the chromatograph permits the f u l l  potential  
of the column to be rea l i sed  in the recorder trace. What th is  
e f fe c t iv e ly  means i s  that  the solute peak should not be 
s ign i f ican t ly  broadened by the operations of  inject ion  and 
detection, and by the passage of the solute through any 
intermediate tubing and connectors.
1 .5 .4 .3 .1 .  Standard analytical columns
The construction material for the column must be able to  
withstand the pressure at  which the column i s  to be operated and 
be chemically inert  to  a wide range of mobile phases. For th is  
reason, seamless polished s ta in less  s tee l  is  the preferred
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Figure 1.23.
Types of  part ic le s  used in chromatography
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(a)s sup e r f ic ia l ly  porous p a r t ic le .
(b)s microparticulate porous p a r t ic le .
( c ): t o t a l l y  porous part ic le .
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material. I t  is mechanically strong and is  inert to most 
solvents ,  with the exception of  so lut ions  of  halide sa l t s ,  
particularly at low pH [78]. Corrosion occurs when the mobile 
phase containing halide sa l t s  is  in contact with the column for 
prolonged periods. Regular flushing the system with water (for 
example at the end of  each day) w il l  usually  prevent serious  
problems. I f  corrosion i s  envisaged as a problem (and th is  is  
rarely the case) then glass  may be used instead of s ta in le s s  
s t e e l .  Heavy-walled glass  tubing with an upper operating pressure 
of 600 p . s . i .  is  commercially avai lable .  Glass-lined s ta in le ss  
s tee l  columns which combine the inertness of  glass  with the 
strength of s ta in le s s  s t e e l ,  are a lso  available [79],
The most common s ize  for analytical columns packed with 5 to 10fi 
m diameter materials is  25 to 40 cm in length with an internal  
diameter of 4.0 to 4.6 mm. With the introduction of column 
packing having diameters as low as 3 /¿m, there has been a trend 
towards the use of  shorter columns of  5 to 7.5 cm, with internal  
diameters of  4.0 to 4.6 mm [80]. Short and narrow bore columns 
are preferred for trace analysis as they consume less  solvent for 
a separation and provide less  peak d i lu t ion  for a component at  
the detector.  Wider bore columns can separate larger sample s izes  
without loss  in e f f ic iency  and are operated at higher flow rates  
to minimise the e f f e c t s  of extra column band broadening. When 
longer columns are needed for a particular  separation, superior 
resu lts  are obtained by the ser ies  coupling of standard length 
columns using short lengths of s ta in le s s  s tee l  capil lary tubing 
[81].
Column end f i t t i n g s  and connectors must be designed with a 
minimum dead volume to eliminate extra column band broadening. 
Some typical  low dead-volume f i t t i n g s  for HPLC are shown in 
Figure 1 .24 . ,  and these can be obtained from most chromatographic 
supply houses. Zero dead-volume f i t t i n g s  are also available  and 
these minimise extra column band broadening by eliminating the 
space between ends within the f i t t i n g .  The resolution of  solutes
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Figure 1.24.
Column end f i t t i n g s  and connectors for HPLC
(a): Low dead volume column end f i t t in g
(b): Standard column terminator
( c ) j Standatd reducing union
1: s ta in l e s s  s tee l  union 
2: porous metal f r i t  
3: s ta in l e s s  s tee l  nut 
4: s ta in l e s s  s tee l  ferrules  
5s Chromatographic column
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produced by a column can eas ily  be lo s t  i f  the connecting tubing 
i s  too long or has too wide a bore. The tubing bore should not 
exceed 0.25 mm, and although finer tubing can be used, problems 
such as pressure drop and blockage can ar ise .  The column packing 
is  held in the column by a packing retainer at e i ther  end. This 
is  generally e i ther  a fine porosity metal f r i t  or a d isc  of fine  
s ta in le ss  s te e l  gauze or cloth. These may be e i ther  incorporated 
into the column ends themselves or made an integral part of the 
column end f i t t i n g s .  The f r i t s  are made from porous s ta in le s s  
s tee l  or PTFE and have an average pore diameter le s s  than the 
part ic le  s i z e  o f  the packing material ( typ ica l ly  2 f im) . The 
column is  pressed home onto the metal f r i t  or screen by the act 
of tightening the coupling. Because of the problem of  tolerance 
with metal f i t t i n g s ,  i t  is  advisable to use the same column and 
end-coupling together from the f i r s t  time onwards.
1 .5 .4 .3 .2 .  Radial compression columns
Even in well-packed columns solute dispersion occurs to  a greater 
extent in the region of the column wall than at the core of  the 
column. This phenomenon is  known as the "wall e f fec t" ,  and i t  is  
due to the d ifferences  in packing density of p a r t ic le s  c lo se  to 
the wall and those at the column centre. This leads to  
inhomogeneous flow patterns across the diameter of  the column, 
and resu lt s  in lower overall column ef f ic ien cy .  Radial 
compression columns were designed to minimise both column void 
volumes and the wall e f fec t s  referred to above. Compared to 
standard packed columns they have two novel features .  A ser ies  of 
distr ibution p lates  at the entrance and ex i t  of each column 
prevents irregular flow patterns from forming in the direction of 
sample migration. Secondly, the columns are prepared from heavy 
wall polythene cartridges (packed with normal chromatographic 
packings) that  are uniformly radially  compressed by hydraulic 
pressure in a purpose-built hydraulic press.  The column wall is 
forced to deform and mould to the shape of the internal packing 
structure. This s t a b i l i s e s  the packing structure and reduces the
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number of channels available to  the mobile phase at the 
wall-packing interface. Radial compression columns are 
characterised by high permeability, low operating pressures, and 
high e f f ic iency  over a wide range of  flow rates [82].
Compared with a conventional s ta in le s s  s tee l  column packed with 
the same material, an increase in e f f ic ien cy  approaching a factor  
of  two might be expected. On an equivalent length basis ,  the 
pressure drop across the radial compression column wil l  be 
greater at a fixed flow rate, due to  i t s  higher packing density.  
Columns are available in 10 cm length with 5 or 8 /¿m packings. 
They have been shown to provide good separation for peptides  
[83], and low molecular weight serum components [84].
1 .5 .4 .3 .3 .  Microcolumns
There were three incentives for reducing the internal diameters 
of  the columns used in liquid chromatography. Analagous to 
capil lary gas chromatography, i t  was hoped to  r e a l i s e  in liquid 
chromatography the very high column e f f i c i e n c i e s  for the 
resolution of complex mixtures. Since these columns operate at 
flow rates of a few microlitres per minute, they are very 
economical in solvent consumption. In addition, the low flow 
rates can open up new p o s s i b i l i t i e s  for sens i t ive  detection  
techniques, provided that detection volumes can be s u f f i c ie n t ly  
miniaturised for th is  purpose.
Three types of  microcolumns are currently in use.
( i )  microbore columns are similar to  conventional columns 
except that the bore is  reduced to about 1 mm, and the 
mobile phase flow rate i s  about 30-40 microlitres  per 
minute.
( i i )  Packed microcapillaries  have a column bore of 70 microns 
or less ,  and are loosely packed with part ic le s  having 
diameters of 5-30 microns. Mobile phase flow rates are of  
the order of 1 microlitre per minute.
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( i l i )  Open microtubular columns are the equivalent of  the
capil lary column in gas chromatography. Idea l ly  they have 
column bores of 10-30 microns and contain a liquid phase 
or an adsorbent e i ther coated on, or chemically attatched 
to the column wall.  Flow rates may be in the 
sub-microlitre range for operation at  maximum ef f ic iency
Columns of very high e f f ic ie n c y  and of  small cross -sect iona l  
areas produce very narrow peaks in the sense that the to ta l  
volume of mobile phase contained in them may be in the  
sub-microlitre range. I f  such peaks pass through a detector  
connecting tube and c e l l  of s ign i f ican t  volume r e la t iv e  to that  
of the peaks, then the peaks wil l  be broadened. Such broadening 
is  due to both the dispersion result ing from the parabolic  
velocity  pro f i le  of the liquid through the tubes and the c e l l  and 
the logarithmic d i lut ion  e f f e c t  result ing from the f i n i t e  volume 
of the c e l l  [85,86].  The operation of  microbore columns near 
their  optimum e f f ic ien cy  is  possible  by modifying liquid  
chromatographs designed for use with wide-bore packed columns 
[86-90]. The injection valve should be miniaturised to  handle a 
sample volume of 0 .2 -0 .5  /¿l. Microbore HPLC is  performed at flow 
rates about 100-fold le ss  than conventional wide bore columns, 
thus necessi tating modification of the gradient former and pump. 
Since microtubular columns have l i t t l e  flow res is tance  at  the low 
mobile phase flow rates ty p ic a l ly  used, an a i r - t i g h t  50-250 /¿I 
syringe controlled by a micro-feeder can be used as a pump [91].
A micro-feeder cons is ts  of a small synchronous motor, gears, and 
a screw thread to advance the syring plunger at  a constant rate.  
The electronics  of  currently avai lable  commercial UV detectors  
may, however, be inadequate for use with microbore columns, 
particularly at high flow rates .  Though a spec ia l ly  designed UV 
detector with a tota l  dead volume of 1.0 l i1 for the connecting 
parts and 0.1 fi 1 for the detector c e l l  has been described [91]. 
On-column detection using the microtubular column i t s e l f  as the 
detector ce l l  eliminates the problems with dead volumes in 
connectors, and is now the method of choice in microtubular HPLC
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[92]. Other detection devices with low detection c e l l  dispersion  
volumes have been described. These include electrochemical 
detectors [93], infrared monitors [94], post-column reaction  
detectors [95], flame ionisation detectors [96] and fluorescence  
detectors [97]. A method for generating gradients with 
microtubular columns has also been discussed [98].
1 .5 .4 .3 .4 .  Guard and pre-columns
A guard column is  a short column located immediately in advance 
of the analytical  column. I t s  function is  to  protect the la t ter  
from damage resu lt ing  from particulate matter or contamination by 
strongly adsorbed substances. I t  also serves to  saturate the 
mobile phase with packing material and so helps to  prevent 
dissolution of the analytical  column. For the la t ter  purpose, an 
additional short column is  often placed betweem the pump and 
injector, in which case i t  i s  referred to as a pre-column. This 
strategy is  normal practice  when using unmodified s i l i c a  in 
either the adsorption or ion-exchange modes.
The guard column is  idea l ly  packed with the same material as the
analytical column, and is  discarded at intervals  dictated by the
contamination level  of  the sample. To maintain an adequate 
capacity for impurities without introducing excessive  peak 
dispersion, the volume rat io  of the guard column to the 
analytical column should be in the range 1:15 to 1:25. A well 
designed guard column should not increase peak dispersion by more 
than 5-10%, a small t rade-of f  for the extended l i fe t im e of the 
analytical column. The column should be connected to the
analytical column using low dead-volume f i t t i n g s .  Ideally  the
guard column should be slurry-packed with part ic le s  of  the same 
diameter as the ana ly t ica l  column, but for pract ical  convenience, 
they are usually dry-packed with with pe l l icu lar  packings 20 ¡im 
or greater in diameter. The la t ter  type of p a r t ic le  has the 
advantage of contributing l i t t l e  to the pressure drop across the 
system. Columns sharing many of the features of  guard columns in
88
terms of  packing material and column dimensions are widely used in 
on- or o f f - l i n e  so l id  phase sample preparation. The practical  
application of  these columns wil l  be discussed in deta i l  in 
Chapter 2.
1 . 5 .4 .3 .5 .  Semi-preparative columns
There is  no c lear  concensus as to the meaning of  the term 
"preparative chromatography" but depending on the intended use, i t  
may cover a very wide mass range; in the analyt ica l  laboratory, 
preparative chromatography is  normally used for the separation of  
milligramme to gramme quantit ies .  Liquid-solid chromatography 
remains the dominant technique for separating neutral organic 
compounds, and a typical  semi-preparative column 8 mm x 50 cm 
would separate around 500 mg of sample. The procedures used 
frequently represent the operations performed in c la s s ic a l  column 
chromatography; the sample is  separated by e lut ion ,  co l lec t ing  
su itab le -s ized  fractions ei ther manually or with a fraction  
co l lec to r .  A s ing le  development with 4 to  5 column volumes of  
mobile phase at a flow rate of 0 .5-5 .0  ml/min usually suf f ices  for 
simple separations. A stepwise gradient may be created by changing 
the polarity  of  the eluent in incremental steps .  At the end of the 
separation, the individual fractions are co l lec ted  and subjected 
to analysis;  for instance by TLC and/or HPLC.
As the c la s s ic a l  column chromatographic technique i s  slow and 
demands the constant attention of the operator several variations  
have been developed to e i ther automate the methods, improve 
resolution,  or improve sample throughput. All of  these goals are 
real ised simultaneously in preparative sca le  high performance 
l iquid chromatography which is  becoming widely used for the 
separation of  anything between 1 mg and 1 Kg of  sample material.
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CHAPTER 2
BIOPHARMACEUTICAL ANALYSIS
2.1. INTRODUCTION TO THERAPEUTIC DRUG MONITORING
Chemists and biochemists have been routinely analysing b io log ica l  
f lu ids  since the early part of th is  century when they discovered 
that a relat ionship existed between the concentration of  various 
endogenous substances, for example glucose, hormones, enzymes, 
e t c . ,  and the cause of a disease [1].  The analysis of drugs in 
biological  media, however has emerged re la t ive ly  recently ,  and i t  
i s  only in the last  twenty years that i t  has received widespread 
attention [2].  Growth in the f i e ld  of  biopharmaceutical analysis  
has paralleled the expansion in the number of new drug compounds 
introduced onto the market. Assays for proposed new drugs are 
essentia l  with a view to establ ishing protocols for new drug 
reg is tra t ion .  I t  is  necessary for a drug company to develop 
methods capable of determining low concentrations of the ir  
products in blood, plasma, urine and other biological  matrices in 
order to es tab l ish  the pharmacokinetic prof i le  of that  product. 
Pharmacokinetics is  the study of  absorption, distr ibution , 
metabolism and excretion of a drug.
Uncontrollable irregu lar i t ie s  in the absorption or d is tr ibut ion  
of a drug in the body often leads to  poor b ioava i lab i l i ty ,  and 
hence unsatisfactory response of  that product. In such cases , for 
example, where there is  a wide variation in individual absorption 
of a drug, i t  is  necessary to in s t i tu t e  a therapeutic monitoring 
programme for patients  receiving that treatment. Therapeutic drug 
monitoring is  also warranted where drugs have a very narrow 
therapeutic window (range). Examples of such drugs are c y to s ta t ic  
agents and cardioactive drugs (such as digoxin) where serious  
toxic  e f f e c t s  are seen at leve ls  even s l ig h t ly  above th e ir  
therapeutic dose. In such cases, sub-therapeutic doses could a lso  
be fatal  due to a depletion of th e ir  pharmacological e f f e c t .  
Certain disease s tates  can radica l ly  a l te r  the deposition of  a 
drug in the body. Individuals suffering from either renal or 
hepatic disease may require reduced amounts of drugs as a re su lt  
of impaired metabolism which enhances both the potency and 
duration of drug action in the body.
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Biopharmaceutical analysis  is  a lso useful where there i s  a 
question of patient compliance, and has obvious application where 
i t  i s  sought to es tab l ish  abuse of hedonistic drugs.
2.2. METHODS USED IN BIOPHARMACEUTICAL ANALYSIS
The f ie ld  of therapeutic drug analysis  is  largely dominated by 
chromatographic and immunoassay techniques although the c la ss ica l  
spectroscopic methods are applied to some extent. The 
requirements of an assay are that i t  is  spec i f ic ,  s e n s i t iv e ,  
reproducible and applicable to  a large range of compounds. I t  
should also be r e la t iv e ly  simple to develop and execute, and 
ideally  should not involve lengthy and tedious sample preparation 
stages. The above methods meet these c r i t e r ia  to varying degrees, 
but the choice of analytical  procedure wi l l  ultimately depend on 
the physico-chemical properties of the drug and the required 
se n s i t iv i ty  and s p e c i f i c i t y .
2 .2 .1 .  Spectroscopic techniques
Absorption and fluorescence spectrophotometry are techniques  
which do not involve a separation step, and although they are 
convenient, they lack the s e l e c t i v i t y  associated with 
chromatographic and competitive binding assay techniques.
Although the use of  s e le c t iv e  extraction techniques, colorogenic  
and fluorogenic react ions and d i f f eren t ia l  compensation using the 
sample matrix can enhance the s e l e c t i v i t y  of these methods [3], 
much attention has recently focussed on the development of more 
sophisticated instrumentation. This includes the use of diode 
array spectrophotometers, [4-6] ,  or luminescence 
spectrophotometers which permit the capture of  the ent ire  
luminescence excitation-emission matrix [7,8] ,  devices which 
considerably enhance s p e c i f i c i t y  in bioanalytical  applications.
2 .2 .2 .  Immunoassay techniques
The discovery of competitive binding assays by Yalow and Berson
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in 1959 [9],  has proved to be a s ign i f icant  development in the 
f ie ld s  of both c l in i c a l  and analytical chemistry. I n i t i a l l y  
applied only to biopolymers and proteins, these techniques have 
been extended to the realm of drug analysis  by covalently  
coupling a drug molecule to a protein in order to  confer upon i t  
immunogenic properties [10],
Immunoassays are competitive binding techniques where the drug 
binds to an antibody sp e c i f i c  for that drug. The basic principle  
of competitive immunoassays is  shown as follows:
Ab + Ag + Ag* ^—  -  AbAg + AbAg*
The free antigen (Ag) and the labelled antigen (Ag*) compete for 
a fixed and limited number of spe c i f ic  binding s i t e s  on the 
antibody (Ab). The antigen in th is  case is  a drug linked to a 
protein (usually bovine serum albumin). The label led antigen is a 
known concentration of labelled drug, and the unlabelled antigen 
is  the drug sample of  unknown concentration. Upon admixture of 
the labelled analyte, the unlabelled sample and the antibodies,  
the labelled and unlabelled versions of the drug compete with one 
another for posit ions on the antibody surface. After an 
incubation period, the free and antibody-bound antigen are 
separated from one another and the amount of label led  antigen in 
one of the fract ions is  determined. At higher concentrations of 
drug in the sample ( i . e .  unlabelled drug-antigen), fewer labelled 
drug-antigen molecules wil l  be bound to the antibody. I f  
drug-free samples are spiked with known concentrations of  
unlabelled drug, and the proportion of free and bound labelled  
drug following reaction i s  plotted as a function of  unlabelled 
drug concentration, a calibration curve may be constructed from 
which the concentration of unknown samples can be read. The form 
of a typical cal ibration curve is  shown in Figure 2 .1 .  In the 
past, immunoassays have principally  re l ied  on radioimmunoassays 
(RIA), which employ radioisotopes for the production of  labelled  
reagents.  Non-isotopic labels such as
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Figure 2J^
Typical form of a plot  of the ratio of bound to free  ligand 
versus total ligand in a protein binding assay.
Bound/Free
Total Ligand
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enzymes, fluorophores, p art ic le s  and c e l l s  are gaining broader 
acceptance because of enhanced user safety,  extended reagent  
she lf  l i f e ,  and ready adaptabil ity  to conventional  
instrumentation [10].
2 .2 .2 .1 .  Enzyme immunoassays
Enzyme immunoassays (EIA) may be c l a s s i f i e d  as heterogeneous or 
homogeneous procedures. Heterogeneous procedures originated some 
15 years ago in the work of  Van Weeman and Schuurs [11], and the 
principles  underlying the various assay protocols are identical  
to those in which other labels  are employed. EIA is  analagous to 
c la ss ica l  radioimmunoassay in that there is  competition between 
labelled and unlabelled antigen for a s p e c i f i c  amount of 
antibody. A widely used derivat ive of the original  heterogenous 
EIA is  the Enzyme Linked Immunosorbent Assay (ELISA) technique 
where the antibody is  label led with enzyme, reacted with antigen 
from the sample, and then added to  excess solid-phase antigen.
The enzyme a c t iv i ty  of antibody bound to the so l id  phase after  
washing is  inversely proportional to the concentration of  free  
antigen or ig inal ly  reacted with the label led antibody. This 
procedure is depicted in Figure 2 .2.  The so l id  support most 
frequently used in large scale  screening work required in the 
study of infectious diseases  has been the microti tration plate
[12]. These plates  are cheap and require only small volumes of  
reagent.
The most widely used homogeneous EIA system i s  the Enzyme 
Multiplied Immunoassay Technique (EMIT). Homogeneous immunoassays 
are so-cal led  because they do not require separation of bound and 
free ligand prior to measurement of  the percentage binding. This 
technique was developed by Rubenstein e t . a l . [13], and depends on 
a change in the s p e c i f i c  enzyme a c t iv i t y  when an antibody binds 
to enzyme-label led antigen. The more unlabelled antigen (drug) 
present, the less  the reduction in enzyme a c t iv i t y ,  Hence the 
calibration curve for th is  technique is  the reciprocal of that
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Figure 2.2 .
Competitive ELISA for antigen.
Solid-phase antigen 
bound to labelled antibody
Enzyme-label led antibody reacts s p e c i f i c a l ly  with with 
in the sample and is  then added to excess solid-phase  
After washing, the enzyme label s t i l l  attatched to  
phase is  measured.
antigen 
antigen, 
the solid
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obtained with ELISA. The principle  of the EMIT procedure is  
depicted in Figure 2 .3.  The e a r l i e s t  EMIT systems employed 
lysozyme as the enzyme label, though modern drug assays use 
glucose-6-phosphate dehydrogenase and malate dehydrogenase almost 
exc lus ive ly .  The la t ter  enzyme i s  used in an assay for thyroxine, 
in a rare instance where binding of  the enzyme-label led antigen 
actually  resu lt s  in increased enzyme a c t i v i t y .  This is  because 
binding of  the malate dehydrogenase to  thyroxine substantially  
inhib its  enzyme a c t iv i ty ,  an inhibit ion which is  at least  
p a rt ia l ly  overcome by antibody binding [14].
2 .2 .2 .2 .  Other immunoassays
Substrate label led fluorescence and f luorescence polarisation  
immunoassay are other homogeneous immunoassay techniques. In the 
former case, the label is  a fluorophore and the antigen is  a 
fluorophore-drug (F-D) conjugate which does not fluoresce until  
i t  i s  reacted with a fluorescence-inducing enzyme. Only the 
fraction of F-D which i s  not bound to the antibody (Ab) will 
react  with the fluorescence-inducing enzyme. Upon mixing of the 
label led  drug (F-D), the unlabelled drug (D), and the antibody, 
the labelled and unlabel led versions of  the drug compete for the 
antibody, and as a resu lt ,  the amount o f  fluorescence produced is  
proportional to the amount of unlabel led drug present. In 
fluorescence polarisation immunoassay the label is  again a 
fluophore and the antigen is  a drug-fluophore conjugate. The 
unlabelled drug, labelled drug and the antibody are irradiated 
with polarised l igh t .  Only the bound species  fluoresces  with 
l igh t  polarised in the same plane as the incident beam, as the 
unbound species  wil l  loose polarisat ion through Brownian motion. 
The more (unlabel led) drug present in a sample or standard, the 
less  bound fluorescent species produced, and the extent of 
polarisat ion wil l  decrease.
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Figure 2.3.
Principle of the EMIT system of  enzyme immunoasssay.
Hapten-labelled inactivates enzyme
active enzyme
Conjugation of hapten to enzyme does not destroy enzyme 
a c t iv i ty ,  but combination with hapten-specific  antibody 
causes marked inhibition of enzyme a c t iv i t y .  The 
measured enzyme a c t iv i ty  is  dependent on the re la t ive  
amounts of  free hapten and hapten-label led enzyme.
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2.2.2.3. Antibody reagents
An important limitation of immunoassays has been the res tr ic ted  
a v a i la b i l i ty  of ana ly t ica l ly  useful antibodies.  Antisera prepared 
by conventional animal immunisation techniques contain 
populations of d if ferent  antibodies varying both in antigenic  
s p e c i f i c i t y  and a f f in i ty  [15].  Large numbers of animals must be 
immunised, and careful ly  screened to identi fy  animals producing 
analyt ica l ly  useful antisera.  With the advent of  monoclonal 
antibody technology, the problems of lack of uniformity and 
unavailabil i ty  of antibodies are more readily solved. Monoclonal 
antibodies are produced by fusing an antibody-producing spleen 
c e l l  with a tumour c e l l  [16]. By cloning the progeny of a s ingle  
hybridoma, the result ing c e l l s ,  which are clones of  the parent, 
produce antibodies which are identical in chemical structure and 
homogeneous in binding a f f i n i t y .  Monoclonal antibodies are highly 
spe c i f i c  since a l l  the binding s i t e s  are directed at the same 
antigenic determinant. Large quantit ies  of monoclonal antibodies  
can be produced, since hybridomas, by virtue of  the ir  tumour 
origin, will  propagate readily.
2 .2 .2 .4 .  Future trends in immunoassay
More and more drugs are now being analysed on a routine basis  
using immunoassay techniques, partly because once they have been 
developed, the ready-to-use k i ts  permit rapid processing often 
without any sample pre-treatment. Large numbers of samples may 
conveniently be handled without any sample processing by s ta f f  
untrained in special ised methodology. As the technique has become 
more popular, advances in the area have concentrated on the 
development of more creative detection schemes for the labelled  
species,  part icularly with the decl ine of radioact ive labels  
which are subject to safety,  disposal and regulatory problems
[10]. The disadvantages of enzyme immunoassay techniques include 
the fact  that plasma constituents  may a f fe c t  enzyme a c t iv i ty ,
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measurement of enzyme a c t iv i ty  can be d i f f i c u l t ,  lack of  
se le c t iv i ty  when compared with chromatographic techniques, and 
development of an assay for a new drug can be time-consuming and 
costly .  However, once a method Is avai lable  for a drug, the 
technique has many advantages in terms of ease of  operation,  
v ersa t i l i ty ,  s e n s i t iv i ty ,  the fact  that only a small volume of  
sample is  required, and most s ig n i f ic a n t ly ,  that no sample 
pre-treatment is  required.
2.2.3 .  Chromatographic techniques in biopharmaceutical
analysis
High performance liquid chromatography (HPLC) and gas 
chromatography (GC) are the most widely used chromatographic 
techniques for quantitative analysis  of therapeutic drugs in 
biological media.
2 .2 .3 .1 .  Gas chromatography
Gas chromatography was once the dominant analytical  technique for 
therapeutic drug analysis ,  but with the development of e f f i c i e n t  
microparticulate packings and stable  bonded phases for liquid  
chromatography, gas chromatography has somewhat declined in i t s  
usage. Part of the reason for th is  is  the fact  that few drugs are 
v o la t i l e ,  and hence must be rendered so using derivat isat ion  
processes prior to analysis .
Gas chromatography is  carried out using e i ther  packed or 
capil lary columns. The large variety of packed columns avai lable  
for gas chromatography contributed in part to  i t s  widespread use 
as an analytical technique for many years. Another important 
reason for i t s  popularity is  i t s  a b i l i t y  to  incorporate the flame 
ionisation detector (FID) as a detection system. This is  regarded 
as an almost universal detection mode, with the added virtues of  
being cheap, s en s i t iv e  (5 x 10- ^2 g / s ) ,  of wide linear range
n
( lO ' . l ) ,  and simple to use. Gas chromatography i s  a lso
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compatible with other sen s i t iv e  detectors  which are more 
s e le c t iv e  than FID. These Include the nitrogen-phosphorous 
detector (NPD) sensi t ive  to nitrogen and phosphorous, and the 
electron capture detector (ECD), s e n s i t iv e  to electron-rich  
compounds, for example organo-halogens.
Although the need to der ivat ise  non-volat i le  samples is  regarded 
as a drawback of GC, modern ready-to-use reagents have rendered 
the derivatisation process l e s s  cumbersome. For instance, the 
a c id ic  nitrogen function of the barbiturate and hydantoin 
moieties are readily converted to  th e ir  N-methyl derivat ives  by 
reaction with trimethyl phenylammonium bromide and amines, 
alcohols,  and other groups with replaceable hydrogen may be 
acylated. Reagents which permit the introduction of d i f ferent  
acyl groups, for instance a c e ty l -  or isobutyl-  groups are 
commecially available. The introduction of  halogen groups 
f a c i l i t a t e s  detection by electron capture, and s i ly la t io n  is  
useful for the derivatisat ion o f  carboxyl groups, phenols and 
alcohols.  Another detection mode which lends i t s e l f  well to  GC is  
mass spectrometry (MS), and GC-MS has become a widely used tool  
in trace analysis of drug compounds [17].
Capillary GC offers  excel lent  reso lut ion  unparalleled in 
chromatography [10], though i t s  performance is  strongly affected  
by technical considerations, e s p e c ia l ly  the configuration of the 
injection device [18], and the qual ity  of the columns used.
2 .2 .3 .2 .  High performance l iquid chromatography
High performance liquid chromatography, unlike GC, is ideal ly  
suited to  the analysis of compounds which are thermo lab i le  and 
non-volat i le .  With recent advances in column technology in terms 
of the production of microparticulate packings and columns of  
shorter length and diameters, the e f f i c i e n c y  and s e n s i t iv i t y  of  
HPLC has been greatly improved. Liquid chromatography has the 
further advantages of almost never requiring derivatisation,  and 
of being well suited to simple methods of sample preparation. For
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example, in some instances, where plasma drug leve ls  are in the 
high ng/ml range and above, a simple protein prec ip itat ion  wi ll  
suf f ice  as sample pre-treatment. The rapid, e f f i c i e n t  technique 
of column switching for trace enrichment and sample clean-up is  
readily applicable to liquid chromatographic methods in both the 
automated and manual versions. In addition, a large number of  
separations can be carried out in the reversed-phase mode of  
1i qu i d chromatography.
The importance of reversed-phase materials cannot be 
over-emphasised» there have been many reports describing the  
theoretical and practical  aspects of  the technique [19],  and i t  
is estimated that somewhere between 75-90% of a l l  HPLC 
separations are carried out in the reversed-phase mode [20].  Most 
drugs possess s u f f i c i e n t  hydrophobic character to  be retained by 
the non-polar mechanisms involved in reversed-phase 
chromatography. In addition, retention and s e l e c t i v i t y  are eas i ly  
controlled by a l ter ing  the type and percentage of  organic 
modifier, by changing the pH, or by the addition of  ion pairing  
reagents for the separation of  ionic species.  A disadvantage of  
HPLC is  that the routinely used detectors are generally no match 
for those used in GC. U ltrav io le t  absorption (UV) is  the most 
widely used detection scheme in HPLC? adequate detection depends 
on the presence of a chromophore within the molecule and the 
l imit  of detection w il l  depend on the molar absorptivity  of  the 
drug at the detection wavelength. Where the therapeutic compound 
absorbs strongly at a reasonably high wavelength, and i s  present  
in jUg/m 1 concentrations in the plasma, HPLC is the ideal 
technique for analysis .  Problems can arise  where the compound has 
a weak chromophore and /or where i t  occurs in the low ng/nl range 
in the relevant b io logical  matrix: in these cases, where the 
detection wavelength is  in the low UV region, s e l e c t i v i t y  may be 
severely compromised and the analyst  may have to resort  to  
fluorescence detection with pre- or post-column der ivat isa t ion .
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2.2.4. Chromatographic versus immunoassay methods
in blopharmaceutlcal analysis
Several studies  have been reported in the l i terature  comparing 
chromatographic methods with immunoassay [21], and abundant data 
are available to support the fact  that both methods are e f f e c t iv e  
in drug determinations [10].  One of  the inherent disadvantages of  
immunoassay i s  because of  i t s  very s p e c i f i c i ty ,  an assay 
developed for a parent drug compound is  incapable of providing 
insight into the metabolite p ro f i l e  of the sample. On the other 
hand, extraction o f  the drugs from serum or plasma is  not a 
prerequisite for immunological analysis  whereas chromatographic 
techniques can ca l l  for sample clean-up procedures which can be 
quite elaborate, e sp ec ia l ly  i f  there i s  a der ivat isat ion  step 
involved. The need for sample preparation has received much 
attention in re la t ion  to chromatography, and recent innovations 
resulting from research in th is  area include the development of 
an automated centrifugal  apparatus for the extraction of  drugs 
from serum prior to  GC, GC-MS, or liquid chromatography [10].
Chromatographic methods enjoy an ease of method development not 
shared by immunological techniques, for which antibodies must be 
raised in the developmental stages , result ing in higher costs  per 
sample using the prepared k i t s .  Chromatographic methods are now 
highly developed and are routine, s en s i t iv e  and s p e c i f i c .  The 
mass spectrometer combined with GC or HPLC leads to  ultimate 
spec if ic  iden t i f ica t ion  for an unknown compound. This is  now 
widely used in conjunction with GC, though th is  hybrid technology 
is  not as advanced with respect to LC [10]. LC is  a serious  
contender for the low-cost automated c l in ic a l  analysis  of high 
molecular weight compounds as well as drugs, though thus far, i t  
cannot compete with immunoassay in the determination of whole 
c e l l s  and organisms. Unlike chromatographic methods many 
immunoassays can be performed simultaneously without the need for 
elaborate apparatus. This technique is  particularly suited to the 
hospital environment where a large throughput of samples is
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carried out by re la t iv e ly  unskilled s t a f f .  Chromatographic 
techniques are ideally  suited to the biopharmaceutical laboratory 
which has a greater need for ease of  method development, and 
requires apparatus which can be ta i lored  to a variety of  
analytical needs.
Immunoassay and chromatographic techniques have been combined in 
one case where an HPLC column e f fected  separation of the 
antibody-antigen complex prior to detection of  an activated  
fluorophore [22], or in another case where the antibodies were 
immobilised on an HPLC column in order to carry out the immune 
reaction. This approach has been christened "high performance 
immunoaffinity chromatography" and i s  a promising analytical  
technique [23].  The innovation of combining HPLC with immunoassay 
may be an indicator of  future trends as analysts exp lo i t  the 
power of  biochemical assays and apply the knowledge of  separation 
science to  further sophist icat ion in the f i e ld s  of  c l in i c a l  and 
biopharmaceutical analysis .
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2.3. SAMPLE PREPARATION IN HPLC
Before proceeding to discuss  the relevance and methodology of  
sample pre-treatment in biopharmaceutical analysis,  i t  i s  worth 
noting that in a few, limited instances i t  is  possible  to in jec t  
untreated body f lu ids  d ire c t ly  onto the analytical  column in 
l iquid chromatography. This approach i s  not possible in GC.
Direct injection is  only f e a s ib le  where the liquid sample,
(urine, b i le  serum) contains a high concentration of analyte. I t  
is  Important to ensure that the proteins are soluble in the 
mobile phase to prevent p rec ip i ta te  formation, espec ia l ly  for 
serum or plasma samples. Micellar chromatography is  part icularly  
advantageous in th is  respect s ince  d irect  injection of untreated 
plasma is  possible by virtue o f  the fact  that the micelles  
s o lu b i l i s e  blood proteins, thus eliminating the problem of  
protein precipitation on the ana ly t ica l  column. The application  
of micellar chromatography is  discussed in chapter 4.
When a pre-column and a column switching valve are used, protein 
and other interferences may be diverted to waste before HPLC 
separation of the analyte. This approach shall however be treated  
under the heading of "on-line so l id  phase extraction". Some 
workers prefer not to use a pre-column, but rather clean the 
analytical column by washing with an appropriate solvent  at  
regular intervals,  or replace the top 1-2 mm of the column when 
there are signs of contamination, as shown by an increase in 
column back pressure or peak t a i l i n g .  There are obvious 
l imitations to th is  procedure in terms of l imit  of detection and 
column l ifet ime.  Columns have been spec ia l ly  designed for d irect  
injection of serum, for example, internal surface reversed-phase 
(ISRP) chromatography, a concept which was developed by Hagestam 
and Pinkerton [24]. These columns t o t a l l y  exclude proteins while 
retaining smaller organic molecules.  Direct injection is  a time 
saving and cost e f fe c t iv e  exercise ,and should be considered 
whenever detection and interference are not problems; for 
instance in the determination o f  theophyll ine in serum.
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In most instances, a b io log ica l  sample containing a compound of 
in terest  requires some kind of  sample pretreatment. Such 
precedures are executed principal ly  to i so la t e  the drug from 
interfering matrix substances, but these measures a lso  serve to
( i )  l iberate  the drug from protein binding s i t e s
( i i )  concentrate the drug for more s e n s i t iv e  analysis
( i i i )  separate the drug from other drugs or metabolites
The amount of sample preparation required depends on the chemical 
nature and concentration of the drug and metabolite,  the type of 
sample, and on the nature of  the interfering substances. I t  also  
depends on instrumental factors  such as the s e n s i t i v i t y  of the 
detector to contamination, and in the case of UV absorbance 
detection, the detection wavelength. The sample preparation step 
should therefore, be capable of  reducing the concentration of 
endogenous compounds and of  concentrating the sample where th is  
is  required. Removal of  endogenous components i s  part icularly  
important where these interferents  become irrevers ib ly  adsorbed 
onto the packing material of  the column, as is  the case with 
l ip ids ,  or precipitated in the chromatographic system as is  the 
case with proteins. To achieve th is ,  e i ther the interfering  
substances may be removed from the sample while the compounds of 
interest  are retained in the original aqueous phase (for example, 
protein precip itat ion) ,  or the drugs are s e l e c t i v e l y  removed from 
the biological  specimens (for example, l iquid extract ion) .
2 .3 .1 .  Protein precipitat ion
The preparation of  protein-free  solut ions i s  e sp ec ia l ly  important 
for the HPLC analysis  of blood and t is sue  extracts .  There are 
many methods avai lable  and the more common ones are described 
here.
2 .3 .1 .1 .  Precipitation by addition of  organic solvents .
With the addition of  a water-miscible organic solvent such as
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methanol, ethanol, a c e t o n i t r i l e  and acetone to a biological  
sample such as plasma, the s o lu b i l i t y  of proteins is  lowered and 
they precipitate out. In addition,  drugs are released from 
protein binding s i t e s .  The sample is  centrifuged to produce a 
clear  supernatant containing the compound of interest,  and an 
aliquot is  injected onto the HPLC column. I t  is important to use 
a protein precipitating solvent in which the analyte is  highly 
soluble, otherwise i t  may adsorb onto, or co-precipitate  with the 
protein. I t  is  sometimes necessary to use a mixture of  two 
solvents  to obtain quantitat ive  recovery. For example, methanol 
with dimethyl sulphoxide has been employed to extract porphyrins 
from l iver  t is sue  [25].  In t h i s  case, methanol was added to 
precipitate  the protein, while dimethyl sulphoxide released the 
otherwise adsorbed porphyrins from the protein.
Diluting the serum up to threefold with the organic solvent wil l  
e f f e c t  removal of 99% of  the proteins  [26,27]. This degree of  
protein removal helps to  prolong column l i f e ,  but e f fe c t iv e ly  
decreases s en s i t iv i ty  o f  the method. This drawback can be 
counteracted to some extent  by increasing the volume of  
injection,  though th is  can adversely a f fe c t  chromatographic 
e f f ic ien cy  and peak shape. Alternatively ,  the supernatant may be 
evaporated, but th is  measure a l so  serves to concentrate any 
remaining interfering compounds.
2 .3 .1 .2 .  Precipitat ion by the addition of inorganic s a l t s
Proteins are pos i t ive ly  charged in strongly acidic  and negatively  
charged in strongly basic so lut ions ,  owing to their zwitterionic  
nature. Acidic or anionic précip itants  such as tr ichloroacetic  
acid or perchloric acid form insoluble protein s a l t s  with the 
cat ionic  form of proteins at  low pH. These two acids are widely 
used to  extract compounds from t i s s u e  and blood samples. A 10-20% 
(w/v) solution is  usual ly  used. After centrifugation, an aliquot  
of the supernatant may be injected onto the analytical column.
The mobile phase should, in t h i s  case, contain a high molar
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concentration of buffer to  protect the column from damage by a 
strongly ac idic  solution [28].  More commonly, the acid solution  
i s  neutralised with an a lkal i  or removed by extraction into ether 
before injection.  Acidic protein précipitants  are obviously 
unsuitable for compounds which are prone to acid hydrolysis.  A 
combination of an anionic precipitant with an organic solvent can 
a lso  be useful,  where the la t ter  can aid the so lub i l isa t ion  and 
extraction of  the analytes from the proteins.
Proteins may also be precipitated by forming insoluble sa l t s  with 
cat ion ic  précipitants such as copper or z inc in alkaline solution
[29], for example zinc sulphate in sodium hydroxide or barium 
hydroxide of  copper sulphate in potassium hydroxide. Cationic 
protein précipitants may also be used in conjunction with organic 
précipitants .  Again, adjustment of  pH prior to chromatography is  
advisable.  This method is  unsuitable for compounds having a 
tendency to form metal complexes.
The supernatant liquid contains other constituents  besides  
proteins,  and frequently the drug peak can be accompanied and 
complicated by several other peaks. Thus the likelihood of 
interfering peaks is  about the same as for d irect  injection, and 
i t  may be necessary to carefu l ly  manipulate the HPLC conditions  
to  obtain adequate separation of the drug peak. Moreover, small 
and la te -e lu t ing  peaks (including la te -e lu t ing  peaks from 
previous samples) may co-e lu te  with the drug peak, thereby 
distort ing  peak measurements and adversely af fect ing  assay 
precis ion.  The potential for la te -e lu t ing  peaks to undermine 
assay precision has been addressed by Van der Wal and Snyder
[30].  The deproteinisation procedure can sometimes give low 
recoveries for drugs which are strongly protein bound? and as 
mentioned above, certain précipitants  can co-precip itate  or 
degrade drugs or their  metabolites.  Where d i lut ion  of  the sample 
is  not of  major importance, organic précip itants  should be 
considered as they are le ss  aggressive than the ionic  
précip itants ,  with the added advantage of  not requiring
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neutralisation prior to  chromatography. Although methanol is  
aproximately only half  as e f f e c t iv e  as a c e to n i tr i le  as a protein 
precipitant [31], i t  should be used because of  i t s  low cost  and 
low to x ic i ty .  The protein precipitation method is  part icularly  
useful for highly polar drugs such as a n t ib io t ic s ,  and amphoteric 
drugs like the sulphonamides, which are d i f f i c u l t  to extract  from 
plasma with organic so lvents .  Analyses with good 
reproducibi l i t ies  are often possible ,  even without internal  
standardisation [32].
2 .3 .2 .  Protein removal by U ltraf i l tra t ion
A protein-free solut ion may be obtained by f i l t r a t io n  through a 
s ize  se lec t ive  semi-permeable membrane under pressure or by 
centrifugation in a membrane cone. The basic process d i f f e r s  from 
ordinary f i l t r a t io n  only in the s ize  of the part ic le s  which are 
separated, and in the hydrostatic pressure applied as a driving 
force for the separation process.  In u l tr a f i l t r a t io n ,  1-10
I
atmospheres of hydrostatic pressure is applied. U ltra f i l t ra t io n  
membranes are microporous in their  structure. All molecules 
greater than the largest  pore diameter wil l  be retained, and a l l  
molecules smaller than the smallest pore completely pass the 
membrane. All molecules smaller than the largest pores, but 
greater than the smallest  pores will  be f i l t e r e d  or retained in 
accordance with the pore s ize  disribution. Compounds which are 
protein bound wil l  remain behind with the proteins unless they 
can be displaced from the binding s i t e s  with a competitor before 
f i l t r a t io n .  Hence, u l t r a f i l t r a t io n  is a useful technique where i t  
is sought to  measure the free (and not protein-bound) fraction of 
a drug, though consideration must be given to  the fact  that the 
dynamic nature of the f i l t r a t i o n  process can disturb protein 
binding equil ibr ia .  The chances of an analyte adsorbing onto the 
inert membrane must be taken into account, particularly i f  i t  is  
present in trace l e v e l s .  A major factor l imiting the speed and 
ef fect iveness  of an u l t r a f i l t r a t io n  process i s  the build up on 
the upstream surface o f  the membrane of a layer of protein
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molecules which cannot traverse the membrane. This is  called  
concentration polarisat ion.  Since the layer serves to reduce the 
rate of  u l t r a f i l t r a t io n ,  control of the thickness of  the layer is  
of major importance. I f  a high shear i s  not maintained at the 
membrane surface, th i s  layer will  increase in thickness until  the 
flux rate drops to a very low level .  Higher shear can be obtained 
by using e i ther high flow rates across the membrane surface or 
with rapid s t irr in g .  Other problems asssociated with 
u l tr a f i l t r a t io n  are the fact  that non-ideal membranes may allow a 
higher f i l t r a t i o n  rate for water rather than solute molecules, 
thus result ing in d i lution of the drug concentration. The pH and 
temperature must be carefully  control led throughout the 
procedure.
2 .3 .3 .  Liquid-liquid extraction
Liquid-1iquid extraction is a very widely used method for the 
preparation of bio logical  samples for subsequent analysis ,  though 
the more recent on-line  solid-phase extraction techniques are 
steadily  gaining in popularity owing to  the advantages they can 
offer  in terms of s e l e c t iv i t y ,  ease of operation and 
compatibility with automation and computerisation. Liquid 
extraction however, remains an extremely v er s a t i l e  method of  
sample preparation [33,34]? convenience and ease of  
use have contributed to  the large popularity of the technique.
The separations are usually quite clean because the re la t ive ly  
small in terfac ia l  area between the two phases helps to avoid 
e f fec t s  analagous to  the undesirable coprecipitation phenomena 
which can adversely e f f e c t  precipitaion separations. In addition,  
l iquid- l iquid  extraction permits concentration of the analyte.
Liquid-liquid part it ion  is  based on the extract ion of an analyte 
depending on i t s  part it ion between an aqueous and an immiscible 
organic phase. The partit ion c o e f f ic ie n t  (K) of  the total analyte 
concentration i s  given by:
K -  [A]0 / [ A ] a
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where [A]Q and [A]a are the concentrations of  analyte in the 
aqueous and organic phases respect ive ly .  Hence, the degree of  
solvent extraction is  dependent on K, and since K is  dependent on 
the type of organic solvent as well as pH and ionic strength of  
the solution,  i t  is  obvious that these must be optimised [35].  I t  
is  well known that repeated extraction (two or more times) with 
small portions of solvent can recover much more analyte than a 
s ing le  batch extraction, but for practical  purposes, a bio logical  
sample would be extracted no more than twice in most 
applications.
2 .3 .3 .1 .  Solvent se lection
The solvent is  selected to provide maximum extraction e f f i c ie n c y  
(large K) and minimum contaminants. Polarity is  usually the most 
important factor in the choice of  the extraction solvent, and 
generally as th is  increases, the range of  compounds extracted  
also increases [34]. Hence, the solvent should be se lected with 
minimum polarity  consistent with high recovery of the drug. Drugs 
of high polarity  are d i f f i c u l t  to  extract  and require polar, and 
hence non-select ive  solvents .  Chin and Fastiich [36] have l i s ted  
a number of  drugs that are extractable in the presence of sodium 
dihydrogen phosphate with diethyl ether, but not with hexane. 
Bailey and Kelner have investigated the extraction recoveries  of  
acidic  drugs from water and plasma with hexane, diethyl ether,  
toluene, n-butylchloride and chloroform [37].  As c lasses  of  
compounds, the barbituates, sulphonamides and diuretics  were 
optimally extracted with dletyl  ether from plasma and water. 
Hexane i s  advised for the extraction of  the t r i c y c l i c  
antidepressants because i t  gives cleaner blank plasma 
chroamtograms [37]. Diethyl ether, though It extracts a wide 
range of drugs introduces many interfering substances from the 
biological  matrix. I t  will  not extract some alkaloids, and 
chloroform is  a more useful solvent in th is  case? a 
chloroform-isopropanol mixture is  frequently required to  extract  
amphoteric alkaloids such as morphine [38].
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I t  is  possible to s e le c t  a mixture of  solvents  which, although i t  
does not completely extract the drug, does give cleaner extracts .  
For example, barbiturates can be extracted from blood at pH 7.5 
with a mixture of equal volumes of hexane and ether. The use of a 
more polar solvent or lower extract ion pH substantia l ly  increases  
the co-extraction of interfering material [39].  Hexane mixed wih 
chloroform or ethyl acetate, and dichloromethane or chloroform 
mixed with alcohol are other common organic extractants.  Van 
Damme e t  a l . [40] have demonstrated increased recoveries of  
t r i c y c l i c  drugs using hexane and dichloromethane i f  5% 
isopropanol is  added to the extracting solvent.
As well as having the correct polarity  the solvent should be of  
the highest purity, non-toxic,  not highly flammable, and should 
have a suitable v o l a t i l i t y  to permit evaporation and 
concentration of the analyte. I t  should be r e d i s t i l l e d  i f  the 
preservative or a trace impurity is  found to react with the drug 
or produce an interfering peak on the chromatogram. The most 
popular solvents for extraction are diethyl ether and chloroform. 
Although ether is  flammable, i t  has the advantages of  being 
v o l a t i l e  which permits rapid evaporation following phase 
separation. Phase transfer is  f a c i l i t a t e d  by i t s  low density and 
the fact  that i t  forms the upper layer when mixed with aqueous 
solutions.  In addition, ether emulsions are easier to  break. 
Solvents such as benzene and carbon tetrachloride should be 
avoided because of their  tox ic i ty ;  toluene, chloroform or 
dichloromethane should be used in preference.
I t  i s  only the unionised form of a drug which is  extracted into 
the organic solvent, therefore suppression of ionisation is  used 
to increase the hydrophobicity of  a compound and promote i t s  
partit ion into the organic phase. Thus, ac id ic  drugs are 
extracted under acidic  conditions, and basic drugs are extracted  
under basic conditions. The optimum pH for acidic  species  is  1-2 
pH units  below their  pKa values, and for basic species i t  is  
1-2 pH units  above the ir  pKa values. The extraction of  neutral
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drugs is  independent of pH> i . e .  they are extracted over a wide 
range of pH, but they remain in the organic phase i f  a 
back-extraction into an alkaline or ac id ic  aqueous medium is  
carried out. Where possible ,  a higher pH is  often des irable  to  
ensure cleaner extracts  since many endogenous compounds are 
acid ic  and favour extraction at ac id ic  pH.
Another useful method is  pre-extraction of  the interferents  into 
an organic phase which is  then discarded. This is  then followed 
by an extraction ta ilored to remove the drug, poss ibly using a 
different  solvent.  Urine contains many endogenous compounds, and 
a preliminary extraction from acid ic  urine improves the purity of 
a subsequent basic extract .  Sometimes, where K or the amount of  
drug present is  large, the drug may be extracted into a very 
small volume of organic solvent (100 /¿I or l e s s ) .  After 
centrifugation, an al iquot of  the organic phase i s  taken for 
analysis  [41,42].  By eliminating the solvent evaporation step the 
p o s s ib i l i t y  of  drug loss  by evaporation, decomposition or 
adsorption onto glassware is  minimised, although t h i s  l im its  the 
s e n s i t iv i t y  of  the procedure. And while th i s  approach i s  quick 
and simple, i t  has obvious shortcomings in HPLC where only a 
limited amount of  non-polar solvents can be injected into an 
aqueous based-eluent stream.
2 .3 .3 .2 .  Back extraction
By adjusting the pH of  a new aqueous phase to  that which will  
reionise  the analyte, i t  can be back-extracted from the organic 
phase into the new aqueous layer. This should reduce the amount 
of neutral contaminants which wil l  remain in the organic phase. 
For back extraction of  basic drugs into an acidic  aqueous phase, 
sulphuric and phosphoric acids are preferred to hydrochloric acid 
because many hydrochlorides are soluble in organic so lvents .  
Either th is  solution i s  then used for separation, or more 
commonly, the pH of the aqueous phase is  again adjusted to
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suppress ionisation,  and the analyte i s  re-extracted into a fresh 
aliquot of organic phase. This solvent is  then evaporated and the 
residue reconstituted in the mobile phase. Back extraction is  more 
or less  mandatory in GC since extraneous substances in the in i t ia l  
extract tend to  contaminate GC detectors,  part icularly  the 
nitrogen-phosporous and electron capture detectors .  This approach 
i s  a lso  widely used prior to HPLC analysis  as i t  great ly improves 
the s e l e c t i v i t y  of  the solvent part it ion  technique, though overall 
recovery of the drug can be reduced and i t  adds considerably to 
analysis  time
2 .3 .3 .3 .  Extraction by ion pair formation
A useful method for dealing with a highly polar ionic drug is  to  
convert i t  into a neutral ion-pair complex by the addition of  an 
excess of suitable  ions of opposite charge, and extract  i t  into an 
organic solvent.  Common ion-pairing agents for acids are 
tetraalkylammonium s a l t s  (for example, tetrabutylammonium 
hydroxide or chloride) ,  and for bases are alkyl sulphonates (for 
example, heptane sulphonic ac id).  Formation of the complex depends 
on factors such as the pH of the aqueous phase, the type of  
organic solvent, and the nature and concentration of  the counter 
ion. The ion pair extraction technique i s  useful for a variety of  
ionisable compounds, but i t  o f fers  part icular advantages for 
compounds which are d i f f i c u l t  to  extract  in the uncharged form 
such as p e n ic i l l in s ,  amino acids and conjugated metabolites.  This 
method allows extract ion of quaternary ammonium compounds such as 
tubocuarine which are ionised at a l l  pH values. The application  
of ion-pair extraction has been discussed in deta i l  by Schil l  
[43], and Tomlinson [44].
2 .3 .3 .4 .  Extraction by sa lt ing  out
Extraction can be d i f f i c u l t  for compounds which are soluble in 
water at  a l l  pH values, for example water-soluble amphoteric and 
neutral drugs. In some cases, a "salting out" procedure may prove
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useful .  The addition of  buffer s a l t s  to an aqueous solution  
increases i t s  ionic  strength and hence i t s  po lar i ty .  This tends 
to decrease a f f in i ty  of polar compounds for the aqueous phase, 
and thus s h i f t s  the partition equilibrium in favour of  
extraction. Such an approach has been used by Horning e t  a l . [45]
in the screening of plasma and urine for ac id ic ,  basic and 
neutral drugs. By using ammonium carbonate as the s a l t  and ethyl 
acetate as the extracting solvent, they were able to  extract  
drugs with recoveries better than 80%. An advantage of sa lt ing  
out is  that emulsion formation is  minimised, as the combination 
of s a l t  and solvent helps to form better phase boundaries and 
reduce the water content of the organic phase. I t  i s  c learly  
important that the chosen solvent and the b io log ica l  f lu id  should 
be easy to  separate a f ter  mixing. Polar solvents  which are 
water-miscible (for example n-propanol) can be forced to  form a 
separate layer using th is  sa lt ing  out technique, resu lt ing  in a 
two-phase system with the upper layer consis t ing mainly of the 
organic solvent.
2 .3 .3 .5 .  Solvent extraction following der ivat isa t ion
Compounds in su f f ic ien t ly  soluble in organic solvents  can be 
extracted following preparation of derivat ives .  Derivatisation,  
however, is  more commonly used to improve d e te c ta b i l i t y  rather 
than s o lu b i l i t y  of  of  the analytes,  though in certain cases  
derivat isat ion is  necessary to release  analytes from their  
protein binding s i t e s .  The t ra n s-e s ter i f ic a t io n  of  plasma 
bil irubin  mono- and dimethyl e s ters  is  an example [46].
2 .3 .3 .6 .  Extraction of metabolites
Metabolites of a drug are usually more polar than the drug 
i t s e l f ,  and i f  i t  is  sought to measure the metabolites,  then the 
chosen solvent should be capable of  extracting a l l  the compounds 
of  interest  so that they can be subsequently separated and
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determined chromatographicaiiy. However, extract ion with solvents  
of increasing polarity,  and/or at d i f ferent  pH values can achieve 
se lec t iv e  separation of  a drug from i t s  major metabolites.
Another method for extracting the more polar metabolites is  to 
extract the drug, then add a high concentration of  a s a l t ,  such 
as sodium chloride to the aqueous phase which s h i f t s  part it ion in 
favour of extraction and forces the metabolites into the organic 
phase. This sa lt ing  out procedure has been used in the extraction  
of hydroxy metabolites of barbiturates from urine [34].
Occasionally the parent drug and metabolites are of  similar  
polarity and are co-extracted. Separation from metabolites may be 
achieved by partit ioning between an organic solvent and a buffer 
of appropriate pH, though absolute s p e c i f i c i t y  i s  d i f f i c u l t  to 
achieve and co-extraction of metabolites is  inevitable .
Separation of a parent drug and i t s  metabolites i s  usually  
achieved by chromatographic separation, and HPLC is  generally the 
method of choice [47,48].  Martin and Reid have reviewed the 
iso lat ion of metabolites by solvent  extraction and other methods 
[49].
2 .3 .3 .7 .  Problems with l iquid- l iquid  extraction
Solvent extraction is  r e la t iv e ly  time-consuming. I t  often  
requires the removal of  solvents  by evaporation. This lengthy 
step may also lead to  decomposition of  unstable compounds, 
particularly when heating i s  required. Losses can a lso  occur at  
the re-d isso lut ion  stage [40].  Another factor which must be 
considered here i s  the solvent used to reconst i tute  the residue 
following evaporation. Van Damme e t  a l . [40] demonstrated the 
e f fec t  on peak shape of the percentage organic solvent in a 
solution of barbiturates.  They found that as the percent 
a ce ton i tr i le  in the dissolving solvent was increased, there was a 
deterioration in peak shape and peak area. Another problem 
associated with solvent extract ion is  adsorption o f  analytes onto 
glassware which can occur at the extraction or solvent
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evaporation stage. Adsorption is  much more noticeable when a drug 
is  present at  low concentrations. This problem may be part ia l ly  
overcome by s i la n isa t io n  of  glassware, by the inclusion of 1-2% 
ethanol,  isopropanol or iso-amyl alcohol into the extract ing  
solvent, or where poss ible ,  the use of  polypropylene test - tubes .  
These measures are, however, not always e f f e c t iv e ,  and others may 
have to be devised [26].
2 .3 .4 .  Solid-phase extraction
Solid-phase extract ion is  a technique which can circumvent many 
of the problems associated with l iqu id- l iqu id  extraction.  The 
general approach to solid-phase ( l iq u id - so l id )  extraction is  the 
adsorption o f  the drug from the aqueous f lu id  onto a so l id  
adsorbent. So1i d-phase extraction us i ng s i 1i c a , a 1um i na, c e 1i t e , 
ta lc ,  charcoal, ion exchange or hydrophobic res ins  has long been 
common practice in the c l in ic a l  laboratory. The development of 
HPLC, however has lead to new methods in the solid-phase  
extraction technique. S i l i c a  ge ls  bonded with a wide range of  
functional groups, eg a lky l- ,  phenyl-, cyano- and d i o l -  moieties  
provide s p e c i f i c  interaction with analytes .  Simple procedures 
involve the addition of the so l id  to  the f lu id ,  ag itat ion  and 
separation by centrifugation.  However the most sa t is factory  
approach is  to  pass the f lu id  over the adsorbent packed in a 
short column, referred to  in th i s  tex t  as the "pre-column" or the 
"concentration column".
2 .3 .4 .1 .  Methods used in solid-phase extract ion
The materials used for so lid  phase extract ions f a l l  into two 
broad categories  according to whether they retain  a l l  the sample, 
or only the drugs and related compounds. In the f i r s t  category,  
hydrophilic packing materials such as inert p a r t ic le s  of 
diatomaceous earth (kieselguhr) are used to adsorb the sample, 
including water, over a large surface area. The sample forms a 
thin aqueous film over the surface of each p a r t ic le .  A small 
volume of  water-immiscible organic solvent such as chloroform is
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then passed through the column, and th is  e f f e c t iv e ly  extracts  the 
drug from the aqueous film of  sample. Water and endogenous 
materials,  such as pigments and other polar compounds are 
retained in the adsorbed phase. This method is  e s s e n t ia l ly  one of  
l iqu id- l iqu id  extraction, so i t  can be optimised using the same 
approaches discussed in that section.
The second, and most currently relevant, method is  based on 
chromatographic principles .  Compounds of interest  are retained on 
the adsorbent when samples are passed through. Certain 
undesirable compounds which are adsorbed at th is  stage may be 
removed by washing with a s p e c i f i c  solvent. The compounds of  
in terest  are then eluted by washing the column with an 
appropriate buffer or so lvent.  The elution solvent may be 
miscible or immiscible with water because (where i t  is  used) ' 
l i t t l e  sample water remains on the column. The eluate is  
processed further or introduced d irect ly  onto the the HPLC column
The chromatographic method of  so l id  phase extraction i s  usually  
carried out in small columns packed with material similar to that  
used for analytical  separations. These short columns have a 
number of  applications apart from simple extraction purposes.
2 .3 .4 .2 .  Uses for short or pre-columns
The use of pre-column is  multifunctional.  For instance,  
extraction columns are used in biopharmaceutical analysis  to 
i so la te  drugs from bio logical  matrices which which would cause 
rapid deteoriation i f  introduced onto the analytical  column. In 
th is  respect,  they perform the function of sample clean-up.  
Another function which can be carried out using a pre-column is  
that of trace enrichment. For compounds with a strong a f f in i ty  
for the sorbent used, adsorption wil l  take place in a small 
segment of  the sorbent bed and large amounts of analytes are 
retained. This function finds somewhat wider use in the analysis  
of large volumes of d i lu te  aqueous samples, but the same
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principle can be applied to drug analysis: a large volume (up to 
1 ml) of a biological sample may be injected onto the pre-column, 
and if the eluting solvent for the drug is kept small, for 
example 100 /tl, then a 10-fold concentration, or enrichment is 
obtained. Due to the relatively inert character of many of the 
sorbent materials, there is a good chance that a compound in the 
adsorbed state will remain unaltered for a prolonged period of 
time. Stabilisation of otherwise rather unstable compounds is 
useful when storage of samples is required. Pre-columns may also 
be used to carry out derivatisation reactions, and lately they 
have been employed in immunoassay techniques where the 
antigen-antibody complexation reaction takes place on an 
adsorbent within a column.
Solid-phase extraction may be performed off-line or on-line using 
a switching valve to channel the eluate from the pre-column 
either to waste or onto the analytical column. These two methods 
of solid phase extraction will be discussed separately, with most 
attention being given to the column switching technique which was 
used during some of this work.
2.3.4.3. Off-line solid-phase extraction.
Extractions of this type are often conducted with home-made 
columns, for instance, a Pasteur pipette packed with adsorbent. 
However disposable cartridges of various sizes (up to 20 ml) are 
available commercially, for example from Waters Associates 
(Sep-Pak), or Analytichem International (Bond-Elut). These 
columns have a high sample loading capacity, but are for single 
use only, since components retained on the column from a previous 
sample could affect performance in subsequent use. The most 
popular and useful bonded phases are the reversed phases, 
commonly, octyl-(Cg-) or octadecyl- (C18-) silica. This is 
due, at least in part to their versatility; all the methods 
described for the liquid-liquid partition of an analyte from an 
aqueous phase into an organic phase are also applicable to
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solid-phase extraction with C8- or Ci8- bonded silica. 
Furthermore, some workers [50,51] have shown that C18-bonded 
phase disposable columns can be regenerated and used again 
without any loss of performance. Drug retention by ion exchange 
has been applied to highly polar, ionisable drugs such as 
gentamycin, which are not extracted by hydrophobic packings [52]. 
The clean-up of gentamycin has also been carried out using 
unmodified silica [53]. The mechanism here is also one of 
ion-exchange involving the positively charged gentamycin and the 
negatively charged silanol groups. Charcoal and XAD resins are 
popular for screening of drugs of abuse in urine; XAD-2 has been 
used as an extraction medium prior to the determination of 
methaqualone in plasma by HPLC [54].
A more novel concept is the use of internal surface reversed 
phase packing materials which were developed by Hagestam and 
Pinkerton [24]. These surfaces present a hydrophilic external 
surface, while the internal surface (within the pores) retain a 
more hydrophobic character. When a biological fluid, such as 
serum or plasma, is injected onto a column packed with this solid 
phase, the macromolecules will only come into contact with the 
hydrophilic surface and will elute rapidly, whereas the small 
analyte molecules will penetrate into the pores where they 
encounter a more hydrophobic surface upon which they are 
retained. Large diameter (37-74 (im) particles of this type have 
been used in a pre-column to retain phenytoin [55]
A typical liquid-solid extraction procedure with reversed-phase 
cartridge is as follows;
(i) activate the cartridge with methanol;
(ii) equilibrate the cartridge with water or a buffer of 
controlled molarity and pH, with or without an ion-pairing 
reagent;
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(iii) load the sample onto the cartridge directly, or following 
centrifugation, dilution with water or buffer, pH adjustment, ion 
pair formation, derivatisation or complexation?
(iv) wash the cartridge with an appropriate eluent to remove 
early eluting impurities?
(v) elute the analyte selectively with a solvent mixture 
optimised for its recovery, leaving late-eluting compounds on the 
solid phase;
(vi) inject an aliquot of the eluate with or without 
concentration by evaporation.
The cartridge may be treated with a solution containing a masking 
agent (for example triethylamine or ammonium acetate) following 
activation with methanol. This supresses the ion-exchange 
properties of residual silanol moieties on reversed-phase 
packings, and so produces more reproducible extractions.
Unreacted silanols can have a deleterious effect on 
reversed-phase extractions in the same way as they adversely 
affect chromatographic efficiency in reversed-phase HPLC 
separations.
2.3.4.4. On-line solid-phase extraction
2.3.4.4.1. Single-pump systems
Apart from its protective function, a guard or pre-column is 
often used to carry out on-line solid-phase extraction. In its 
simplest form, the pre-column is mounted in place of the injector 
loop, and the various operations of column conditioning, column 
preparation, sample loading and sample clean-up are effected by 
manually injecting the appropriate solvent onto the column while 
the injector is in the "load" position. By switching the injector 
valve to the "inject" position, mobile phase eluent
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is introduced onto the column whence it desorbs the retained 
compounds and sweeps them onto the analytical column where they 
are separated. This method has been applied to the analysis of 
tricyclic drugs in serum using a C2~ clean-up column [56], and 
to the analysis of aminopyrine and metabolites in plasma using a 
C8- clean-up column [57]. In the latter work, the authors claim 
a high degree or reproducibility, and recoveries approaching 100% 
for aminopyrine and all its metabolites. The above method employs 
only one high pressure pump, and does not call for a switching 
valve. In this respect, it is less capital cost intensive, though 
it has obvious drawbacks in terms of ease of operation and the 
potential for automation. Furthermore, as pressure builds up on 
the pre-column, it becomes difficult to introduce successive 
injections of sample and washing solutions, and unless the volume 
of sample is kept low, It is necessary to change the pre-colummn 
quite frequently.
An upgrading in the sophistication of this method was the 
development by Wahlund [58] of the so-called pre-column venting 
technique which introduces a three port valve in order to 
separate the pre-column from the analytical column (Figure 2.4.). 
The pre-column serves the dual function of acting as a guard 
column as well as effecting pre-separation of the analytes from 
the biological fluid matrix. This is achieved due to the fact 
that the early-eluting matrix components (which are most damaging 
to the.analytical column) are eluted quickly off the pre-column 
and vented to waste while the compounds of interest are swept 
onto the analytical column and separated. This approach is well 
suited to systems where the eluent contains a low percentage of 
organic modifier; at high concentrations of organic component, 
proteins present in the biological sample would be precipitated 
within the tubing or on the columns. A further development on 
this theme, aimed at reducing the influence of organic modifier 
is the pre-column venting plug technique [59]. This system is 
shown in Figure 2.5. and includes a second injection valve with a 
large loop containing 2 ml of buffer. The biological sample is 
injected into the centre of this buffer plug which effectively
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Figure 2.4.
Pre-column ventino system.
(a): pre-column; (b); Three-port valve; (c): Pressure regulator;
(d): analytical column.
¥
Figure 2.5.
Pre-column venting plug system.
(a): Plug fluid injector; (b)j Sample injector; (c): Pre-column;
(d): Three-port valve,* (e)s Pressure regulator; (f): Analytical 
column.
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serves to isolate it from the hydro-organic mobile phase. An 
acidic (pH 2) phosphate buffer was found to be the best fluid 
regarding column stability which was greatly prolonged by this 
principle. It was applied to the quantitation of lidocaine 
(lignocaine) and its two main metabolites in plasma [59], 
producing inter-assay precisions of <2% for therapeutic 
concentrations of the compounds. The limitations with this type 
of arrangement are that flow to the analytical column is 
interrupted during the venting operation, and desorption of the 
retained compounds can only be done in the forward-flush 
direction. Forward-flushing of the pre-column can contribute 
significantly to band broadening.
2.3.4.4.2. Multi pie-pump systems
A typical scheme for an on-line sample clean-up procedure 
incorporating two pumps and a six-port switching valve is shown 
in Figure 2.6. This is the instrument arrangement which was used 
in all column switching operations in the present work (Chapters 
4, 5, 6 and 7).
Pump A is used to deliver the washing solvent, which is usually 
water or buffer, though a small percentage of organic solvent is 
sometimes added. The mobile phase eluent is delivered by pump B. 
When in position 1, washing solution is passed by pump A via the 
injector and the valve onto the concentration (pre-) column. 
Meanwhile, mobile phase is being pumped by pump B via the valve 
onto the analytical column, which is thus maintained in a state 
of constant equilibration. Injections are made when the valve is 
in this position. An injected biological sample, for example, is 
swept onto the pre-column by the washing eluent, whereupon the 
polar matrix components are eluted to waste and the compounds of 
interest are selectively enriched on top of a judiciously chosen 
adsorbent. After a pre-determined wash time, the valve is 
switched to position 2, which causes the mobile phase to be 
re-routed onto the concentration column where it desorbs the
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Figure 2.6.
column switching arrangement incorporating six-port switching
valve.
To Detector
POSITION 2
Injections are made with the valve in position 1. Analytes are 
desorbed from the concentration (pre-) column when the valve is 
in position 2. Operation is described in the text.
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retained compounds and flushes them onto the analytical column. 
While this is happening, the washing eluent is passing through 
the valve and thence to waste.
A paper by Roth et al. on "Fully Automated High Performance 
Liquid Chromatography" reported on a system which contained two 
pumps, one for the washing solvent, and one for the mobile 
phase,in conjunction with two switching valves and two 
pre-columns [60]. The instrument arrangement for an alternating 
pre-column system is shown in Figure 2.7. The most attractive 
feature of this arrangement, apart for the the possibility of 
injecting biological fluid directly without pre-treatment, was 
the so-called alternating pre-column sample enrichment technique. 
This involved an efficient and time-saving operation of the 
analytical column. The sample was injected and loaded onto the 
first precolumn, and after a purge phase, the analytes were 
backflushed on to the analytical column. Meanwhile, a new sample 
was injected onto the second pre-column, and while the first 
sample was eluted on the analytical column, the second sample was 
purged and backflushed into the mobile phase solvent stream.
While the contents of the second pre-column were being separated 
on the analytical column the first pre-column was switched back 
to the solvent stream of pump A, the washing solvent, which 
removes traces of organic solvent and prepares the pre-column for 
the next injection.
2.3.4.4.3. Multi-dimensional chromatography
Gradient elution analysis is frequently used for separating 
sample components with a wide range of capacity factor values. 
This situation, referred to as the "general elution problem", can 
also be solved by multi-dimensional chromatographic techniques. 
Both methods lead to an optimisation of resolution in minimum 
analysis time. Multidimensional chromatography is where the 
sample is separated by switching between two or more analytical 
columns posessing separate, but complementary separation
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Alternating pre-coiumn suitchino system for sample enrichment 
and backflush.
Figure 2 .1 .
II
i
I
k
(a): pump Aj (b)s injection valve; (c): to waste; (d): switching
valve 1; (e); switching valve 2; (f): pre-column 1; (g):
pre-column 2; (h): pump 2; (i): to waste; (j): analytical
column; (k); to detector. Operation is described in the text.
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characteristics. Technically speaking, column switching between a 
short concentration column for the purpose of sample clean-up (as 
described above) and the analytical column for separation also 
constitutes multidimensional chromatography, but for the sake of 
simplicity the term "multidimensional chromatography" in the 
present discussion shall be understood to mean the employment of 
two or more analytical modes subsequent to extraction.
A typical operation would consist of clean-up on a concentration 
column, followed by transfer of the remaining adsorbed materials 
onto a second column, which is usually the first analytical 
column. A zone from this column is then isolated and transferred 
to the second analytical column, where separation is continued, 
frequently in a different mode, but often using a mobile phase 
with greater elution strength on the same type of column. This 
process where a portion of the effluent from one column is 
transferred to another is known as "cutting". When the central 
portion of a chromatogram is isolated for further analysis, the 
technique is known as "heart-cutting", and it was first described 
by Deans in 1968 [61].
An example of multi-dimensional chromatography is the on-line 
combination of high performance gel permeation with reverse- 
phase chromatography which was first described by Johnson and 
co-workers [62]. Gel permeation was carried out on a cross-linked 
polystyrene column with tetrahydrofuran as the mobile phase. The 
problem with this system was that water-soluble samples could not 
be handled. An advance on this arrangement was described by Erni 
and Frei [63], in that porous glass particles were used as the 
exclusion media and thereby permitted the use of complex aqueous 
samples. With the development of microparticulate (10 /¿m) aqueous 
exclusion columns, improved elution profiles are obtained from 
the first column. The combination of aqueous exclusion 
chromatography and reversed phase chromatography is ideal from 
the standpoint that the solvents used in both techniques are 
compatible? the predominantly aqueous mobile phase used in 
exclusion chromatography is a weak mobile phase in reversed-phase 
chromatography, and therefore has little effect on the 
analytical separation.
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Apparatus requirements for multi-dimensional liquid 
chromatography can be approached at various levels of cost. If a 
between-column sample valve is used for heart-cutting, two 
complete chromatographic systems are required. If it is desired 
to perform heart-cutting using an intermediary column, then three 
pumps, columns and valves are required. In principle, the 
heart-cutting operation can be repeated in a variable number of 
columns, though if extended to many columns, the cost would 
become prohibitive.
A typical instrument arrangement for multidimensional 
chromatography incorporating three columns) one clean-up, two 
analytical) is shown in Figure 2.8. The sample is introduced via 
the injector and swept onto the pre-column by pump 1 eluent. The 
analytes are selectively retained while most of the impurities 
are eluted to waste. After a pre-determined wash period, the flow 
of pump 2 is directed for a finite period of time onto the 
pre-column by switching the position of the first switching 
valve. The stronger pump 2 eluent desorbs retained analytes from 
the pre-column and sweeps them onto the first analytical column 
where separation takes place. In what constitutes a heart-cutting 
operation, the section of interest in the resulting chromatogram 
is transferred via the second switching valve onto the second 
analytical column using the mobile phase from pump 2. When 
transfer is complete, valve 2 is returned to its original 
position, and mobile phase from pump 3 is introduced onto the 
second analytical column, where the final separation takes place. 
While this is occurring, mobile phase from pump 2 is re-routed 
into a reverse direction. This backflush operation rinses the 
first analytical column and the pre-column, and slowly moving 
compounds are backflushed from the top of the columns. After a 
pre-set time, switching valve 1 is returned to its normal flow 
direction, and re-conditioning of the pre-column by pump 1 eluent 
can then take place. The analyte bands are resharpened by the 
choice of the stationary phases and mobile phases in
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Figure 2.8.
Schematic diagram of coupled column system.
Operation is described in the text.
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the order of increasing elution power from the pre-column to the 
second analytical column. Hence, as solvent 2 is a weak solvent 
for the second analytical column, a large volume of mobile phase 
2 can be introduced onto the latter column to concentrate the 
sample at the head of this column. This is an example of 
on-column concentration. A detector may be positioned between the 
first and second analytical columns. This is not an essential 
component, but is a useful feature when analysing complex 
chromatograms where it is important to locate precisely the peaks 
of interest in order to minimise sample loss and contamination. 
When a detector is not used to control the switching process, a 
sequential timer can be used to automatically switch the peaks of 
interest.
This arrangement may be automated by the incorporation of 
pneumatically actuated valves and a microprocessor control 
system. Automation improves reliability, sample throughput, 
analysis time, and minimises sample loss, since analysis is 
performed in a closed-loop system. Phase exchanges from aqueous 
mobile phases to organic mobile phases, and vice versa in 
multidimensional liquid chromatography, may be realised by the 
incorporation of a purge-and dry sequence. Furthermore, a new 
chemical dimension may be introduced by the incorporation of a 
chemical derivatisation step between the first and second 
analytical columns.
This type of system may also be used for boxcar chromatography 
which is an advanced column-switching technique placing multiple 
samples simultaneously onto the analytical column for increased 
sample throughput [64]. This mode overcomes the objection to 
liquid chromatography that it is limited in its throughput, 
because analysis rates as high as 50 samples per hour can be 
achieved with columns of conventional length [27], and maximal 
frequency of injections is only limited by the resolution 
capability of the column. Nazareth and co-workers applied this
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arrangement to the analysis of phenobarbitone and primidone in 
serum [65]. They found no memory effects from the previous 
sample, achieved 100% transfer between the second and third 
columns (ie, the first and second analytical columns), and were 
able to execute up to 40 samples per hour.
2.3.4.5. Some technical considerations for
column switching operations
2.3.4.5.1. The valve
The majority of published methodology uses a six port two-way 
valve, obtainable from several manufacturers. The essential 
features of the six-port valve are as follows:
(i) there are two independent flow-paths through the valve, which 
enables the simultaneous cleaning and equilibration of one column 
whilst the other is being used: these flow paths are depicted in 
Figure 2.9.
(ii) the second solvent line can be backflushed.
Column-switching is more readily carried out with a ten-port 
multifunctional valve which is able to accommodate sample 
injection and solute switching in the same device for most 
applications. The more valves that are used, the more flexible 
the system becomes, particularly for multi-column separations and 
where it is necessary to monitor the eluent through various 
stages of the system. Each valve must be capable of high pressure 
operation without deterioration, and provide low dead-volume 
sample path so as not to significantly broaden the peaks which 
pass through it.
The arrangement may be plumbed in such a way that the contents of 
the concentration column are forward- or back-flushed onto the 
analytical column. Back-flushing is preferable since it will not 
exacerbate, and may actually reverse, band broadening which may 
have taken place during the wash step. It does have the
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Figure 2.9.
Flow paths in a six-port switching valve.
RESET SWITCHED
In the "reset" position ports 1 and 2, 3 and 4, and 5 and 6 are 
connected. In the "switched" position ports 2 and 3, 4 and 5,
and 6 and 1 are connected.
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disadvantage, however, of disturbing the column packing in the 
concentration column by applying mobile phases alternately in 
opposite directions.
2.3.4.5.2. Pre-column design
The subject of pre-column design has been discussed in detail by 
Goewie et al [66]. They recommended that for practical purposes, 
pre-columns having an inner diameter of 2-4.6 mm and a length of 
10 mm be used. This design allows high sampling flow rates with 
little pressure drop across the system. Within this range, the 
pre-column does not appear to be critical in the on-line trace 
enrichment of strongly-retained analytes. Short columns are, 
however preferable to longer ones. The latter, which must be 
packed under high pressure may have high efficiency to start 
with, but this efficiency deteriorates rapidly and good 
performance is only obtained in the backflush mode. Furthermore, 
long columns generate quite a substantial pressure drop, posess a
large dead volume and can be expensive to buy and repack.
Nazareth et al. [65] investigated the effect of using screens 
versus porous frits on pre-columns used for extraction purposes. 
They found that using a 0.2 mm retainer screen backed with a 2 fim
filter screen yielded higher eventual plate numbers on the 
analytical column than if 2 ¡m porous frits had been used. The 
importance on the use of screens instead of frits to prevent 
sample blockage has also been addressed by Roth [67].
2.3.4.5.3. Packing materials
It is generally agreed that the retention of the compounds of 
interest on the pre- or concentration column should ideally be 
similar, or even lower, to that on the analytical column in order 
to prevent band broadening problems during the desorption and 
actual separation step. However, there seems to be some 
disagreement as to which particle size range (for example 5-10 /¿m 
porous or 37-50 /xm pellicular) is the most appropriate for use in
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the pre-column. Roth and Beschke [68] investigated the use of 
commercially available reversed-phase materials of various 
particle diameters, and concluded that particles in the size 
range 30-50 /¿m are best suited for packing concentration 
columns. Furthermore, Nazareth et al. [65], working with serum 
and using a pre-column packed with 5 m particles, observed a 
large increase in back-pressure across both the extraction and 
analytical columns after less than 10 ml of serum had been 
injected. This increased pressure drop was accompanied by a 
reduction in plate number (indicating a deterioration in column 
efficiency). By switching to particles of diameter 30-70 ¿tm, they 
found that back pressure and plate count remained satisfactory 
for longer periods of time. In addition, they found that the use 
of pellicular as opposed to large-diameter porous packings can 
significantly reduce recovery of a drug; the recovery of 
primidone from C^g pellicular packing was only 5% whereas 30 fim 
porous C18 material yielded greater than 90% recovery for the 
same drug [65].
Werkhoven-Goewie et al. [69] assert that HPLC-quality sorbents,
i.e, materials having 5-10 /¿m particle diameter should be used. 
They based their results on work carried out on column capacity 
and band broadening of chlorophenols in water at high sampling 
rates (5 ml/min) over long periods. They found that not only were 
the column capacities much lower, but band broadening was much 
greater with the larger particles. While these findings may be 
worth considering in biopharmaceutical applications, factors such 
as blockage of smal1-particle columns by highly viscous 
biological media almost always demand the use or large-particle 
diameters. Disadvantages with the use of large particles, the 
most significant of which is band broadening can be minimised by 
using a short pre-column, operating in the backflush 
configuration, and employing low dead volume fittings to reduce 
band broadening from extra-column sources.
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2.3.4.5.4. Washing Solutions
One of the main problems with a biological sample that contains 
metabolites of differing polarity and 1ipophi1icity, is the 
choice of an appropriate solvent system so that the various drugs 
are retained on the pre-column, while the bulk of unwanted plasma 
constituents are washed through. Roth and Besche [68] studied the 
effect of using both water and 1% ammonium acetate on the 
recovery of oxazepam and endogenous interferences from dog urine. 
Their results show that with water as the washing solution, most 
of the polar compounds were removed from the pre-column, 
while the drug was retained. When ammonium acetate was used, 
however, all UV absorbing compounds were retained and the drug 
peak was obliterated.
Nazareth et al. [65] also varied the composition of the washing 
solution and found almost identical recovery for a number of 
barbiturates using either a water or buffer pH 3.5 wash; 
phenobarbitone was the only compound studied which had zero 
recovery with water, but almost full recovery with buffer. 
Nazareth concluded that phenobarbitone (pKa = 7.3) was ionised 
in water but unionised in the buffer, and therefore retained on 
the non-polar pre-column. This approach did not appear to affect 
the blank serum profile unduly, though the injection volume was 
only 20 fil. As many interfering compounds of biological origin 
are acidic, one would expect them to be retained on a non-polar 
column when the wash solution is buffer of low pH. This was found 
to be the case in the present work as will be discussed in 
further detail in chapter 4.
2.3.4.5.5. Breakthrough volumes and sample loading capacity
The breakthrough volume is defined as the volume of sample that 
can be passed through a sorbent bed before elution of the 
investigated compound will commence. The larger the breakthrough 
volume the greater the enrichment factor which can be obtained. 
The minimum size of the pre-column is a function of the absolute
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detection limit of the solute, its concentration in the original 
sample solution, and its retention, i.e. its capacity ratio k', 
in the stationary phase system under investigation. These aspects 
should be considered when conditions are selected so that the 
solute of interest is efficiently pre-concentrated without the 
occurrence of breakthrough phenomena. For the pre-concentration 
of low polarity compounds, only a very small volume of a 
hydrophobic adsorbent is required to retain large volumes of 
aqueous samples. The situation becomes more problematic when 
dealing with medium to high polarity compounds such as the more 
polar metabolites of low polarity parent compounds.
Pre-concentration based solely on hydrophobicity is often not 
sufficient, and breakthrough can occur after only a fraction of a 
millilitre of sample has deposited. In such cases, it becomes 
necessary to study the breakthrough behaviour of the analytes of 
interest on a particular adsorbent. What this means in terms of 
drug analysis, is studying the volume of washing solvent which 
can be used following injection before the sorbed drugs begin to 
elute. This can be carried out by measuring peak height on the 
analytical column after valve switching as a function of wash 
volume. If an analyte has a very low breakthrough volume on a 
particular adsorbent, then it is usually necessary to switch to 
another type of adsorbent, subject to restrictions in regard to 
the retention of unwanted materials.
Care should be taken to avoid over-loading the pre-column. In 
biopharmaceutical analysis it is not usually the overloading of 
drug which is a problem, but saturation of the pre-column with 
biological interferents. Such occurrences are manifested by a 
reduction in chromatographic efficiency and an increase in back 
pressure, and arise more rapidly if the sample is very viscous. 
Dilution and/or centrifugation can be used to reduce the 
consistency of the biological sample.
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2.3.4.6. Conclusion
The solid-phase extraction technique is becoming a serious 
challenger to conventional solvent extraction. It is simple to 
perform and saves in time and labour. There are no losses due to 
emulsion formation or evaporation, and efficiency and 
reproducibility are as good, or better than those of 
liquid-liquid extraction. Solid-phase extractions may be 
performed on compounds which are difficult to extract at any pH, 
for example antibiotics, and it has a much wider scope for 
automation than could be practically realised with 1iquid^liquid 
techniques.
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2.4. PRACTICAL CONSIDERATIONS 
IN BIOPHARMACEUTICAL ANALYSIS
2.4.1. Storage of samples
Collection of an uncontaminated sample at the correct time in 
relation to the dose is vital in any projects involving drug 
analysis. If insufficient care is taken in collection and 
handling of biological specimens, data generated by using even 
the most sophisticated techniques may be invalidated.
Considerable time may elapse between the collection of a sample 
and the analysis, and changes occurring during storage can be 
important. A common source of error is the adsorption of the drug 
by the container. Furthermore, some drugs can undergo 
decomposition, and temperature, pH, salt concentration and light 
can be involved. Thus, the stability of the drug in a biological 
fluid should be determined at various temperatures so that the 
effect of storage on the ultimate analysis can be established. 
This is especially true if samples arrive irregularly and assays 
are done on a batch basis. Fresh plasma or serum samples can 
usually be kept for 6 hours at room temperature, or for 1-2 days 
at 4°C. For longer term storage, samples should be held at 
-20°C. For instance, Jonkman et al. [70] have shown that
theophylline is stable in blood for one day at 25°C, and stable 
for one month at -20°C. Metabisulphite is sometimes added as a 
preservative to prevent the oxidation or photo-oxidation of drugs 
during storage, for example in the photodecomposition of LSD 
[71].
Changes to the biological material itself can occur as a result 
of putrefaction during storage, with the appearance of endogenous 
(breakdown) products which can interfere with the analysis. 
Bacteria in decaying biological material have been shown to cause 
the reduction of the nitro group in nitrazepam to an amino group 
[34].
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2.4.2. Sampling
The choice must be made as to whether whole blood, plasma or 
serum is to be analysed. In drug analysis, the most commonly 
sampled body fluids are plasma and serum because a good 
correlation between drug concentration and therapeutic effect is 
usually found [34]. The analyst could, however, be faced with no 
choice if the samples are haemolysed on arrival at the 
laboratory. Most drugs are concentrated in the plasma, yet there 
are a significant number which are concentrated in erythrocytes, 
such as clorthalidone or cyclosporin. Assays for such drugs will 
show enormous differences depending on whether analysis is 
performed on whole blood or on plasma, and if plasma or serum is 
analysed, the expressions "blood samples" or "blood levels" 
should not be used to describe the analysis of their 
concentrations.
On no account should the blood sample be frozen without 
treatment, because this would cause haemolysis. It is essential 
to avoid this, since haemolysis prevents subsequent separation of 
plasma or serum. After collection of blood (5-10 ml), a clot can 
be allowed to form, and the supernatant collected after 
centrifugation is serum. Serum contains no fibrinogen, a protein 
involved in the clotting process, and coagulation is complete in 
about 30 minutes at room temperature. Alternatively, the blood 
can be collected in a tube containing an anti-coagulant, and the 
supernatant which remains is plasma, and it does contain 
fibrinogen. Since the anticoagulant effect is temporary, 
collected specimens should be centrifuged quickly to avoid 
eventual clotting. Plasma is more frequently used than serum in 
drug analysis since the collected specimen can be centrifuged 
immediately, whereas the formation of serum is more 
time-consuming. Moreover, it is relatively easy to centrifuge 
blood which has been treated with anti-coagulant, as the plasma 
separates quickly and the maximal volume can be recovered if
2.4.2.1. Analysis in blood, plasma and serum
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required. With the use of plasma, temperature can have a marked 
effect on the recovery. For example, plasma phenytoin levels 
increase by 10% when a sample is equilibrated and centrifuged at 
4°C rather than 24°C [72]. In addition, the nature of the 
anticoagulant may dramatically affect results, particulary in 
relation to the presence of endogenous interfering peaks. Rapaka 
et al. [73] found that heparin caused the introduction of 
interference peaks in the chromatographic analysis of frusemide 
with fluorescence detection. Vacutainer tubes containing EDTA as 
the potassium salt resulted in no interfering peaks using both 
fluorescence and ultraviolet absorption detection. Containers 
with sodium oxalate as anticoagulant caused interference with UV 
detection, but not with fluorescence detection. Heparin has been 
shown to interfere with the immunoassay of gentamycin and 
tobramycin [74].
The effect of plasticizers in the body and stoppers of blood 
collection tubes on plasma levels of collected specimens is well 
known [72,75-77]. The presence of the plasticizer tris 
(butoxyethyl) phosphate in stoppers has been shown to cause 
redistribution into erythrocytes and distortion of the apparent 
concentration of the drug in plasma [76]. Drugs which were 
affected in this way include quinidine, propranolol, lignocaine, 
alprenolol, some tricyclic antidepressants and some 
phenothiazines. Other workers established a reduction of the 
apparent plasma levels of carbamazepine and disopyramide in one 
brand of a collection tube bearing a stopper containing this 
plasticizer [77], but no reduction with the same type of 
collection tube produced without this plasticizer. Collection 
tubes may also be a source of contaminants which can appear on 
the chromatogram, making quantitation of the compound of interest 
difficult or impossible. Some workers found that contaminants 
from plastic collection tubes caused interference with the 
analysis of cyclosporin in whole blood and plasma [78]. These 
interferents were not detected in various kinds of glass tubes. 
Other workers [79] co-extracted drugs and interferences from 
plastic extraction tubes, and found that the presence of
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interferences originating from the plastic container body 
increased the coefficient of variation of determinations of 25 
commonly administered drugs from 5% for samples collected in 
glass collection tubes, to >20% for samples collected in plastic 
tubes.
Many types of contaminants can be encountered in samples; these 
include, (apart from plasticizers) antioxidants, pesticides, food 
additives, and vulcanising agents. The problem of these 
interferents can only be minimised by careful manipulation of the 
sample. The need for close liasion between the analyst and the 
person taking the sample is most important, and a typical problem 
which can arise as a result of lack of communication in this 
respect, is contamination of a blood sample by a local 
anaesthetic while a catheter is being inserted.
Frozen samples of plasma or serum should be brought to room 
temperature and subjected to vortex mixing for 10 seconds to 
ensure homogeneity prior to analysis.
2.4.2.2. Analysis in other biological media
Urine analysis is useful where a drug or rapidly-formed 
metabolite is extensively excreted in it. Drug metabolites can be 
detected in urine for quite some time after they have become 
undetectable in blood. Analysis of drugs in urine is widely used 
in bioavailability studies; it is usually done on a single or 
24-hour specimen. Both pH and volume are important factors in 
urine drug analysis and must be recorded immediately on 
collection. If urine is allowed to stand at room temperature, 
bacterial action causes the conversion of urea to ammonium 
carbonate, and thence to ammonia which causes an increase in pH. 
Urine can be preserved by freezing at -20°C or by the addition 
of a preservative. Commonly used preservatives are toluene, boric 
acid or concentrated hydrochloric acid. Freezing is preferable to 
the latter approach since the preservative can interfere with 
subsequent drug analysis.
146
In emergency testing, urine analysis is a useful tool for 
detecting tricyclic antidepressants as their urine concentration 
is much higher than that of blood [74], The determination of 
drugs of abuse in urine is used in the screening of patients on 
detoxification programmes. Opiates are measured in urine to check 
a patients compliance with the dose regimen, and to screen for 
other drugs of abuse [40].
Less commonly analysed biological media are saliva and 
cerebrospinal fluid (CSF). Drug concentrations in saliva are 
sometimes assumed to represent free plasma levels, but this was 
found to be true only for a limited number of drugs, such as 
carbamazepine and phenytoin [26]. For other drugs, the 
correlations are less satisfactory or apparently non-existent 
[80]. It is not practical to analyse CSF routinely, and such 
analyses are normally only carried out when damage to the 
blood-brain barrier is suspected.
2.4.3. Drug conjugates and protein bound drugs
Many drugs and metabolites are present in the urine as 
glucuronide or sulphate conjugates which are more polar than the 
unconjugated drug, and not readily extractable into organic 
solvents.
HPLC offers the possibilty of measuring intact drug conjugates 
without derivatisation. For instance, paracetamol can be detected 
in its conjugated form by direct injection of urine with UV 
detection [81]. Few drugs, however, are present in high enough 
concentrations to permit this approach, and it is more usual to 
hydrolyse these conjugates and release the parent drug for 
extraction. This is done chemically with hydrochloric acid or 
sodium hydroxide, or enzymatically with enzymes such as 
glucuronidase or sulphatase. Chemical hydrolysis decreases the 
yield of labile comopounds, for instance certain benzodiazepines, 
and compounds sensitive to aggressive reagents. Enzymatic 
methods, on the other hand, offer mild conditions which are less
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likely to cause degradation of the drug in question, though 
sulphatase can only hydrolyse aryl sulphates [34]. Glucuronidase 
can be inhibited by high salt concentrations, hence, it is 
advisable to dilute the sample and to run control experiments to 
ensure that the enzyme is active. Generally, a urine sample is 
divided into two fractions, one of which is subjected to 
hydrolysis. This gives the total (conjugated and unconjugated) 
concentration following extraction, whereas the unhydrolysed 
fraction yields the proportion of drug which is non-conjugated. 
The amount of conjugated drug is obtained by subtraction. This 
procedure has been carried out in the determination of 
oxmetidine and its sulphoxide metabolite [82].
A common problem in the analysis of blood levels is protein 
binding. In pharmacokinetic and clinical studies, differentiation 
is made between free, protein-bound and total drug levels.' 
Albumin is the most significant binding protein for many drugs, 
particularly neutral and acidic drugs such as warfarin, phenytoin 
and valproic acid [83]. Basic drugs such as quinidine, 
propranolol,and the tricyclic antidepressants bind not only to 
albumin, but to other proteins such asce-acid glycoprotein and 
lipoproteins [84-86]. The extent of protein binding is of 
interest to the clinician, since for many years it was assumed 
that only the free fraction is active and available to interact 
with the drug receptor site. Though this would appear to be true 
for a number of drugs, more recent work [87] has shown that bound 
fractions of propranolol and lignocaine can be transported into 
tissues such as the brain. Of great importance, however is how 
the equilibrium binding is affected by the co-administration of 
other drugs. The classic example of this occurrence is when the 
administration of salicylate-based, drugs such as the 
non-steroidal anti-inflammatory drugs (NSAIDS) causes the 
displacement of warfarin from its protein-binding sites to which 
it is extensively bound. This displacement significantly 
increases the amount of free warfarin circulating in the blood 
and the concommitant increase in anti-coagulant effect can result
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in fatal internal haemmorrhage.
It is usually the total concentration of drug in plasma or serum 
which is measured rather than the free fraction. Unless 
specialised techniques which exclude bound drug, such as 
equilibrium dialysis or ultrafiltration, are employed, the 
measurement of free drug is difficult since many of the 
widely-used extraction techniques cause at least partial 
liberation of drugs from their binding sites. However, providing 
protein binding of drugs is normal and constant within, and 
between patients in a particular study, free drug concentration 
is a reasonably constant fraction of total drug. This 
relationship does not hold where protein binding is abnormal or 
affected by drug interaction as outlined above, or where there is 
individual variation in the extent of binding. One instance of 
this is phenytoin, and in such cases the free fraction would 
appear to offer superior correlation with therapeutic effect and 
toxicity than the total drug concentration [88,89].
Protein precipitation techniques will frequently liberate drugs 
from their protein binding sites, as will liquid-liquid 
extraction. Some protein bound-drugs such as propranolol, will 
bind strongly to reversed-phase packing material used in 
solid-phase extraction columns, and thus good recoveries will be 
obtained using this method of drug removal from plasma. In cases 
where the drug is very strongly-protein bound, the relatively 
mild extraction techniques outlined above will not release the 
drug from binding sites, and methods such as acid digestion and 
enzyme digestion have been employed to obtain a measure of the 
total drug.
Acid digestion can lead to hydrolysis of the drug, and the search 
for a more general procedure lead to the use of the proteolytic 
enzyme, subtilisin Carlsberg. Osselton et al. [90,91] employed 
this enzyme for the release of antibiotics and benzodiazepines. 
After incubation with the enzyme, the sample was filtered over a 
plug of glass wool and analysed in the usual manner. The enzyme
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was found to release the drug completely without affecting 
chemical structures. Enzyme subtilisin Carlsberg has been used to 
degrade liver tissues at high pH [92]; this has lead to good 
recovery for drugs, though is unsuitable for substances which 
degrade under alkaline conditions. Later work on subtilisin 
Carlsberg revealed that reaction can be carried out at lower pH 
values with considerable improvement in drug recovery [93].
Werkhoven-Goewie and co-workers [94] demonstrated the application 
of enzyme hydrolysis using subtilisin followed by automated 
on-line pre-concentration of the drug secoverine. After enzymic 
hydrolysis for 15 minutes at 55°C, the drug was liberated from 
its protein binding sites and 1 ml volumes of the hydrolysate 
were injected onto short (2-30mm) pre-columns containing cyano- 
packing material. Up to 50 ml of treated plasma could be injected 
without appreciable build-up in pre-column back-pressure or loss 
of performance. As enzymatic hydrolysis produces a large number 
of small peptides and amino acids, the method may require a 
selective detection system.
2.4.4. Internal standards
Optimal reliability of analysis is achieved with the use of 
internal standardisation. The role of an internal standard is to 
correct for variation in instrument response, injection volume or 
extraction or derivatisation yield. It is important to add the 
internal standard at the earliest possible stage in order to 
achieve maximum compensation for procedural variations. Most 
internal standards are compounds chemically similar to the drug 
to be assayed. The internal standard should elute clear of any 
endogenous interferents, and close to, but clear of the drug. The 
ratio of the detector response (peak height or area) for the drug 
and the internal standard is then used in the calibration and 
assay. In monophasic dilution (such as protein precipitation), 
the internal standard must only be soluble in the dilution 
solvent, and its selection then depends
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on chromatographic parameters. In 1iquid-1iquid or liquid-solid 
extraction, the behaviour of the internal standard in the 
extracting liquid or solid is important. The more its chemical 
structure resembles that of the drug, the better the control of 
variation achieved. A molecule having an identical acidity 
constant and a partition co-efficient similar to the compound of 
interest would serve as an ideal internal standard. It is 
essential also that the internal standard and the drug have 
similar responses in the detection scheme employed. For instance, 
in the highly sensitive electrochemical detection of imipramine 
at an oxidation potential of 1000 mV, the use of nortriptyline as 
an internal standard is precluded because it does not react to 
this potential [40].
The use of an internal standard belonging to the same chemical 
class as the drug of interest can present more problems than is 
commonly assumed. Even when there are close structural 
similarities, such as among chemical homologues, pronounced 
differences in physico-chemical behaviour may arise. In addition, 
while it is desirable that the internal standard belongs to the 
same chemical group as the drug being monitored, it is 
inadvisable to use a commonly prescribed drug or metabolite where 
the patients intake of medication is not closely monitored, 
especially in toxicology where little or no information can be 
collected about ingested drugs. The amount of internal standard 
introduced during the analysis must be selected so that the 
detector response ratio falls within one range of the calibration 
curve. An upper limit of 2 is generally chosen as the maximum 
response ratio [95].
2.4.5. Calibration
Samples of drug-free material {serum, urine) containing known 
drug concentrations should, where possible, be employed for 
calibration. This is sometimes not possible in the case of tissue 
samples such as liver or muscle. Alternative external 
standardisation based on assaying, or even simply injecting
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authentic drug standards ignore the specific peculiarities of the 
biological matrix? for instance protein-binding would not be 
accounted for using external standardisation. However, even 
spiked plasma or serum standards are subject to criticism, since 
an externally-added drug might not be present in the same 
physico-chemical state as the in vivo compound [10]. It follows 
that blank plasma used in the calibration should have been 
prepared using the same anti-coagulant as employed in taking 
patient samples; as outlined above, the type of anticoagulant can 
affect not only the appearance of interfering peaks, but the 
amount of drug recovered from plasma.
In chromatography, peak-height or peak-area ratios (compound to 
internal standard) are usually plotted against concentration. The 
calibration graphs are calculated by linear regression analysis, 
but in order to avoid inaccuacies near the origin, weighted 
regression analysis should be performed. This follows because 
carrying out linear regression of y upon x implies, amongst other 
constraints that there is no variance in x and a constant 
variance in y [96]
»
2.4.6. Evaluation
Several criteria have to be evaluated in order to check the 
reliability and the overall performance of an assay. Most 
regulatory agencies, like the Food and Drug Administration, have 
mandated Good Laboratory Practice regulations for clinical and 
non-clinical laboratory studies [97,98]. The parameters which are 
used to evaluate the overall performance of an assay include the 
drug stability, specificity, limit of detection, accuracy 
linearity and recovery.
2.4.6.1. Drug Stability
Drugs stored under different conditions of heat, light, humidity 
and pH should be examined for possible decomposition. If the drug 
is to be stored for an appreciable length of time, it is
152
necessary to establish its stability under prolonged storage 
conditions. The kinds of problems which can arise have been 
discussed in section 2.4.1., and the extent of this loss must be 
established before commencing with the assay. If the amount of 
drug lost is not reproducible then it may be necessary to alter 
the analytical protocol.
2.4.6.2. Specificity
It is necessary to determine whether endogenous compounds in the 
biological matrix will interfere with either the drug peak(s) or 
that of the internal standard. This is readily achieved by taking 
drug-free plasma (serum, urine, etc) through the sample work-up 
and analytical process. This procedure should be repeated with 
each batch during both calibration and assay of unknown samples, 
in case of a change in column performance or the development of 
artefacts have caused the appearance of peaks co-eluting with the 
drug or the internal standard. Drugs which are therapeutically 
combined with the drug (for instance, anti-hypertensives with 
diuretics) should be checked for possible interference or 
cross-reactivity. As caffeine is a common source of interference, 
it is usual for patients involved in a clinical trial to be given 
a caffeine-free diet. However, this is not always practicable, 
and if the samples to be analysed are likely to contain this 
compound, it may be necessary to exclude caffeine as a potential 
interferent.
Should any peak interfere with the assay, a systematic search 
should be undertaken to find the origin of the interference. It 
may, as mentioned above, arise from the diet, or it may be 
introduced from the equipment used in the assay. If it proves 
impossible to actually remove the source of an interfering peak 
(for instance a vital co-administered drug), it may be possible 
to eliminate the unwanted peak by selective extraction, more 
selective detection wavelengths or schemes, or by a revision of 
the chromatographic parameters.
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2.4.6.3. Limit of detection
The limit of detection (LOD) is defined as the lowest 
concentration of an analyte that the analytical system can 
reliably detect. In mathematical terms it may be expressed as 3a 
above the gross blank signal [99], where O ' is the standard 
deviation of the peak-to-peak noise. Where there is a linear 
dependence of signal (S) on concentration (C), the following 
equation may be written:
Vc* ‘ Vs*
where Sx is the signal corresponding to concentration Cx, 
and dg is the signal variability corresponding to 
concentration variability dr .
The limit of detection may vary from day to day as a result of a
change in detector response, for instance, but once the LOD has
been statisticaly defined, data obtained using this value is not 
valid and should not be reported.
2.4.6.4. Accuracy and precision
Assessment of accuracy is a fundamental problem because the true
value can never be known with absolute certainty. The term 
"accuracy" denotes the nearness of a measurement to its accepted 
value and is expressed in terms of error [35]. The accepted 
error is the difference between the observed and the accepted 
value. The relative error is expressed as a percentage of the 
accepted value, and is often used to express the accuracy of a 
chromatographic assay. It is common to test the accuracy of the 
method in hand by comparing it with another reliable method. 
Chromatographic methods are frequently compared with immunoassay 
techniques, and the correlation between the two is taken as an 
index of how accurate the method being validated is.
Precision or reproducibility of an assay is defined as the
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coefficient of variation (relative standard deviation) of the 
results at a certain drug concentration. In chromatographic 
methods of drug analysis, the reproducibility of a method should 
be determined on the basis of within-day (intra-assay), and 
between-day (inter-assay) results. In performing both inter-and 
intra-assays, at least four replicate analyses over the entire 
concentration range should be carried out. For intra-assay, the 
mean ratios of drug to internal standard are plotted as a 
function of concentration to generate a regression curve. The 
individual ratios are then interpolated as unknowns on this 
curve to obtain new values of concentration, and these new 
values are then used to determine precision. For inter-assay, 
individual regression lines are generated for each set of data, 
and each set is then interpolated on its own regression line.
The new values of concentration thus obtained are then used to 
determine inter-assay precision.
2.4.6.5. Linearity
The linearity of the assay is defined by linear regression 
analysis of replicates of spiked biological standards in the 
anticipated concentration range of the drug to be assayed. 
Linearity is frequently quoted in terms of the correlation 
coefficient of the single regression line used for intra-assay 
calculations. If the signal to concentration function is not 
linear over the entire concentration range, as is sometimes the 
case where a wide range of concentrations is to be covered, it 
may be necessary to split the calibration curve into two 
portions to permit quantitation of unknown samples. With some 
techniques, non-linear calibration graphs are frequently 
obtained. Some workers propose special approaches which extend 
the linear range artificially [100], but much greater accuracy 
can be obtained by calculating the actual non-linear calibration 
graph using weighted polynomial regression analysis [10].
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2.4.6.6. Recovery
The extraction recoveries of the drug and internal standard 
provide useful information and can be calculated either by 
running isotopically labelled compounds through the procedure, 
or by assaying drug-supplemented plasma (serum, urine) and 
comparing the peak heights of the extracted standards versus 
those of authentic (non-extracted) standards in the same 
concentrations. By generating a calibration curve of both 
extracted and non-extracted standards, the ratio of the two 
slopes can be obtained and used as a second measure of recovery.
2.4.6.7. Quality Control
Routine drug assays should regularly be checked for reliability 
using internal quality control schemes. This involves the 
preparation of plasma (serum, urine) pools to which a defined 
amount of drug (unknown to the analyst) are added. With each 
determination on patient samples, a control sample is also 
analysed, and the result is interpreted in terms of established 
limits of variation. It is recommended that at least 10% of the 
total samples should consist of quality control standards 
interspersed amongst the patient samples and calibration 
standards. If the results of the quality control standards are 
not within 10% of their anticipated values, then it is normal 
practice to repeat the batch [101].
Inter-laboratory surveys on a similar basis are currently 
organised by different institutions, and are often imposed by 
law. Control samples are distributed to the laboratories 
participating in such an external quality control programme and 
the results are statistically evaluated. In order for this type 
of system to be successful, it is necessary that equipment, 
materials and operating conditions are identical in each of the 
participating laboratories. In practice it can be difficult to 
realise this goal, since there is significant variation between
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batches of even the same brand and type of column, and 
differences in equipment performance can contribute to 
inter-laboratory variation in results.
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CHAPTER 3
THE DETERMINATION OF XIPAMIDE 
IN HUMAN PLASMA 
BY REVERSED-PHASE 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
3.1. INTRODUCTION
Xipamide (4-chloro-5-sulphamy 1-sal icy 1ic acid 2',6' 
dimethylani1ide) belongs to the diuretic group of drugs which 
increase urinary volume and renal excretion of sodium and 
chloride ions. Diuretics are usually classified according to 
their potency or site of action, two characteristics which 
largely determine the clinical responses of such medications [1]. 
Xipamide is considered to be a potent diuretic, though it acts on 
the distal convoluted tubule in the kidneys rather than on the 
loop of Henle like other potent (so-called "loop") diuretics such 
as frusemide [2]. Its mode of action is thought to involve 
interference with sodium ion re-absorption in the distal 
convoluted tubule, and it causes effective excretion of both 
sodium and chloride ions for 12-14 hours after oral 
administration [3]. It significantly decreases the glomerular 
filtration rate (GFR) and is a potent inhibitor of carbonic 
anhydrase [4].
Xipamide is used in the treatment of hypertension [5,6], as well 
as oedematous states due to cardiac, renal and hepatic disease 
[7-10]. Xipamide may be used alone [5,7,8] or in combined therapy 
with other drugs,[6,9,10], and it has been tried in cases of 
oedema with rheumatoid arthritis [11].
It has been reported to closely resemble hydrochlorothiazide in 
its mechanism of action [4,12], as well as in its kinetic 
properties [13]. Structurally, xipamide is a benzoic acid 
derivative bearing a free sulfamoyl moiety [4], and bears a 
superficial resemblence to both frusemide [14], and 
chlorthalidone, though the drug is not a phthalimidine or a 
thiazide [10]. Pharmacologically, xipamide is equipotent with the 
former drug with respect to its effects on sodium ion and water 
excretion [10], though they differ in their onset, duration, and 
sites of action, [2,3,10,15].
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After oral administration of a 20 mg dose, maximum plasma levels 
of 2.0 ± 0.3 g/ml have been shown to occur within one hour 
[15], and this had fallen to approximately 100 ng/ml after 24 
hours. The plasma levels can be described by a two-compartment 
open model, and the bioavailabliy was calculated to be 73% [15]. 
Xipamide has a half-life of between 6 and 8 hours and plasma 
levels are highest between 0.75 and 2 hours after oral 
administration [13]. Approximately 40% of the given dose is 
recovered unchanged in the urine [15], and xipamide-o-glucuronide 
was the only metabolite found in the liver [13]. It is almost 
completely bound to plasma proteins [13,15]: at a therapeutic 
concentration of 690 ng/ml it became almost 99% bound to plasma 
proteins in an in vitro experiment [16].
Xipamide is lipophilic as shown by its solubility and partition 
coefficient. At physiological pH it forms an anion having an 
octanol-water partition coefficient of 1 [17]. It has two pKa 
values: pH 4.75, when it forms a phenolate anion, and a second at 
approximately pH 10. At room temperature it is stable in both 
acidic and basic media. Solutions buffered to between 7.0 and 8.0 
are particularly suitable for determination of xipamide by 
spectrophotometry, though no colour reactions are known which are 
sensitive enough to permit quantitative determination for 
pharmacokinetic studies.
To date there has been practically no information published on
the determination of xipamide in plasma. Originally, the
pharmacokinetics of xipamide were followed using the method of
Hempelmann and Dieker [13] which involved injecting patients with 
35
S-xipamide and following the pharmacokinetics by 
measurement of the amount of radioactivity in various body 
fractions over a set time period.
In response to the need for an alternative to the injection of 
individuals with radiolabelled substances, a thin-layer 
densito-fluorimetric technique was developed by Sobel and
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Mutschler in 1980 [18]. In this method, following adjustment of 
the plasma or urine pH to 5.0 with citrate buffer, xipamide was 
extracted into ethylacetate by mixing for one hour. After 
centrifugation, the organic layer was decanted and evaporated to 
dryness in a clean test tube. To the residue was added a solution 
of the fluorescent reagent [4-(7-methoxy-2-oxo-2H-benzopyran- 
4-ylmethoxy)-benzoyl chloride? BBP-C1], and derivatisation took 
place over a three hour period. The derivatised residue was then 
spotted on a thin layer chromatographic (TLC) plate and the 
chromatogram was developed using a mixture of toluene and ethyl 
acetate (1*1). Fluorescence of the derivatised xipamide (Xi-BBP) 
was measured at 404 nm following excitation at 313 nm. At a 
spiked plasma level of 20 ng/ml of xipamide, the coefficient of 
variation was 6.5 % for eight replicate analyses. Recovery was 
almost 100%.
The authors claimed a limit of detection of 10 ng/ml if a 1 ml 
sample of plasma was used, but as little as 0.1 ml of plasma may 
be analysed if necessary. This technique has been adopted by 
other workers in the analysis of xipamide in plasma [15,19], and 
while it is clearly an advance on methods involving the 
introduction of radiolabel led xipamide into the body, it has 
drawbacks in terms of the need to derivatise the drug, synthesize 
the fluorescent reagent and the lengthy procedures involved in 
both the extraction and the actual derivatisation stages.
There have been no methods published for the analysis of xipamide 
in plasma by HPLC. One method was described where the clearance 
of xipamide from the body was measured by the direct injection of 
10 1 of urine onto a Cg reversed-phase column [20]. Direct
injection of untreated plasma in not a feasible proposition, and 
in order to determine low levels of the drug, it is necessary to 
to extract it from the plasma matrix and to incorporate a 
concentration step into the work-up procedure. The objective of 
the present study was to develop, from first principles, an HPLC 
method for the determination of xipamide in plasma, with emphasis 
on ease of operation without the need for elaborate
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instrumentation. The final protocol involved a simple one-step 
extraction, and using ultraviolet absorbance as the mode of 
detection, it offers a level of sensitivity suitable for 
pharmacokinetic studies, without the need to derivatise the drug 
prior to analysis
3.2. EXPERIMENTAL
3.2.1. Reagents and solvents
Xipamide was received as a gift from the Institute of Clinical 
Pharmacology, Dublin, Ireland. Mephenesin was obtained from Sigma 
Chemical Co. Ltd., Dorset, England. HPLC grade methanol, 
acetonitrile and diethyl ether were obtained from Labscan 
Analytical Sciences, Dublin, Ireland. Sodium acetate, acetic acid 
ethyl acetate, hexane, methyl isobutyl ketone and isopropanol 
(Analytical Grade) were supplied by Riedel de Haen, Hannover,
West Germany. Lithium chloride, calcium chloride, sodium 
sulphate, zinc sulphate, sodium hydroxide and ammonium chloride 
(AnalaR grade) were obtained from BDH Chemicals Ltd., Dorset, 
England, and trichloroacetic acid, sodium bicarbonate, sodium 
carbonate and calcium carbonate (analytical grade) were supplied 
by May and Baker Chemicals, Dagenham, England.
Deionised water was obtained by passing freshly distilled water 
through a Millipore water purification system. Dried human plasma 
from the Blood Transfusion Board, Dublin was dissolved in 
deionised water used within seven days of reconstitution.
3.2.2. Drug standards
Xipamide (10.00 mg) was dissolved in methanol to yield a stock 
solution of 100 [iq/ml (solution A). A working stock solution of 
50 ¿ig/ml was prepared by a 1*1 dilution of solution A in 
methanol-water (1:1) (solution B). This solution was diluted 1:9 
with mobile phase to give a working standard solution of 5^ig/ml.
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For calibration, a set of standards were prepared by serial 
dilution of solution B in methanol-water (1*1). A 1 mg/ml 
solution of mephenesin (the internal standard) in methanol was 
prepared. A 100 /¿g/ml working stock solution was pepared by 
dilution of the stock solution with methanol-water (1:1). This 
solution was diluted 1:9 with mobile phase to give a working
standard solution of 10^ig/ml.
3.2.3. Plasma standards
Aliquots of drug-free plasma were spiked with 50 fi\ xipamide and
50 fi 1 mephenesin working stock solutions. Plasma blanks were 
prepared by adding 100 fil methanol-water (1:1) to drug-free 
plasma.
3.2.4. Instrumentation and operating conditions
The drugs were separated on a Cg- reversed-phase column, 10 fim, 
4.6 x 220mm, supplied by Pierce Chemical Corporation, Rockford, 
IL, USA. It was protected by a guard column of Cg- Sepralyte 
(40 fim) packing, supplied by Analytichem International, Harbour 
City, CA, USA. The mobile phase was delivered by a Waters Model 
501 HPLC pump (Waters Associates, Milford, MA, USA).
Injections were made using a Rheodyne (Cotati, CA, USA) Model 
7125 6-port Injection valve fitted with either a 20 fil or a 50 fil 
loop. The drugs were detected by Ultra-violet absorption at 220 
nm using either a Waters Model 990 photodiode array detector with 
plotter set a chart speed of 5 mm/min, or a Waters Model 450 
variable wavelength detector with a Linseis recorder (Linseis, 
Selb, West Germany) at a chart speed of 200 mm/hr.
The pH of the solutions was adjusted using a standard glass 
electrode at ambient temperature. The pH meter was calibrated 
daily using aqueous standards prepared on a weekly basis.
A stock solution of sodium acetate (1 M) was prepared by
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dissolving the appropriate amount of substance in deionised 
water. The pH was adjusted using the pH meter by the addition of 
0.1 M acetic acid. The buffer was diluted with deionised water to 
give the required ionic strength. Mobile phases were prepared by 
mixing the aqueous component with either methanol or 
acetonitrile. The mobile phase was filtered through a 0.45 [im 
membrane and degassed by ultrasonication prior to use.
3.2.5. Procedures
3.2.5.1. Assay development
When developing the chromatography, 20 /¿I quantities of the 
working standard solutions (dissolved in mobile phase) were 
injected into the system. When investigating various extraction 
procedures, 0.5 ml aliquots of plasma were spiked with 50 fil of 
working stock solutions (solution B) of the drug and internal 
standard or with 100 /xl methanol-water (1*1) to generate plasma 
blanks. The plasma was then treated and subjected to various 
extraction procedures which are discussed in greater detail in 
the Discussion section.
3.2.5.2. Ca1ibration and ca1cu1ation
0.5 ml aliquots of drug-free plasma were spiked with 50 fil 
xipamide (X) standard solutions (prepared by serial dilution of 
solution B) so that the the final plasma concentrations of 
xipamide were 100, 250, 500, 1000, and 2000 ng/ml. The plasma
aliquots were also spiked with 50 fil of the working stock
solution of mephenesin (IS), so that its eventual concentration 
in plasma was 10 fig/ml. Plasma blanks were prepared by adding 
100 fi1 methanol-water (1*1) to 0.5 ml aliquots of drug-free 
plasma. Lithium chloride (200 mg) was added to each test-tube 
followed by vortex mixing for 10 seconds. After the addition of 3 
ml diethyl ether-isopropanol (19*1), the drugs were extracted by 
vortex mixing for 45 seconds. Following centrifugation at lOOOg 
for 15 minutes, the upper organic layer was transferred to a
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clean polypropylene test-tube and evaporated to dryness at 37°C 
under a gentle stream of air. The residue was dissolved in 100 fi 1 
mobile phase and a 50 fJLl aliquot injected for chromatography.
3.3 RESULTS AND DISCUSSION
3.3.1 Development of chromatography
The structures of xipamide, frusemide, chlorthalidone and 
mephenesin are shown in Figure 3.1.
The development of a chromatographic method for xipamide 
commenced with finding a mobile phase capable of eluting the drug 
on a Cg- column (a Cg- column had been used for the HPLC 
determination of xipamide in urine [20]). The chosen starting 
point was a simple binary mixture of methanol-water (1:1) which 
caused xipamide to elute with a retention time of 3.5 minutes. 
Methanol was chosen over acetonitrile because it is a less costly 
and less toxic solvent for frequent and routine use. It was found 
that a superior peak shape was obtained for xipamide if a sodiun 
acetate buffer (0.02 M, pH 7.0) was used as the aqueous 
component. The use of a buffer also has the advantage of allowing 
control of pH and thus contributes to reproducible 
chromatography. Using a 1:1 mixture of buffer and methanol, 
xipamide eluted with a retention time of 2.8 min. With this 
retention time, the drug would probably co-elute with endogenous 
components when it came to the stage of extracting the drug from 
the plasma matrix. It was therefore sought to increase the 
retention time by increasing the proportion of the aqueous phase. 
At a buffer-methanol ratio of 65:35 the retention time of 
xipamide was increased to 5.8 minutes.
The wavelengh of detection had hitherto been set at 240 nm and it 
was decided at this point to determine the optimum detection 
wavelength in order to maximise sensitivity. A three-dimensional 
plot of xipamide depicting peak height as a function of time and
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Figure 3.1.
Chemical structures of xipamide. related diuretics, and 
mephenesin. the internal standard
XIPAMIDE (I)
FRUSEMIDE (II)
CHLORTHALIDONE (III)
MEPHENESIN (IV)
o
OH
I
OCH^CHCH^OH
C O N H
COOH
171
wavelength, was generated on the UV photodiode array detector and 
is presented in Figure 3.2. It shows that xipamide absorbs 
strongly between 210 and 220 nm with a smaller peak at 230 nm. It 
was decided to use 220 nm as the operating wavelength since many 
plasma components absorb strongly in the low UV and would 
contribute significantly to interfering peaks in the 
chromatogram.
The next step was to select a suitable internal standard for 
xipamide. Among the compounds investigated as possible internal 
standards, mephensein proved to be the most suitable in terms of 
retention characteristics. The diuretic triamterene eluted with a 
retention time of 12.0 minutes (Figure 3.3.), but was not 
selected as an internal standard, partly because it is extremely 
light-sensitive and decomposes rapidly, but more importantly, 
because it is frequently co-prescribed with xipamide to 
counteract the kaluretic effects of the latter [1,20], and as 
such, would be unsuitable where xipamide was being measured in a 
combined preparation.
3.3.2 Development of an extraction procedure
Having chosen mephenesin as the internal standard, the next step 
was to extract the drug from plasma. Reconstituted drug-free 
plasma aliquots were spiked with the drug and internal standard 
which were dissolved in methanol water (1:1); plasma blanks were 
spiked with methanol-water only. As xipamide had previously been 
extracted from plasma at pH 5.0 into ethyl acetate [18], it was 
decided to repeat this method as a starting point for the 
development of an extraction procedure.
Following addition of the drug and internal standard, the pH of 
the plasma was adjusted to 5 by the addition of an equal volume 
of 0.1 M sodium acetate buffer, pH 5.0. The drugs were extracted 
into 3.0 ml of ethyl acetate by vortex mixing for 90 seconds. 
After centrifugation, the upper organic layer was transferred to
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Figure 3.2.
Three-dimensional chromatogram of xipamide showing peak height as 
a function of time (min) and wavelength (nm)
mm
(a) 45° to the left, (b), 45° to the right. mm
Mobile phase: 0.02 M Sodium acetate buffer, pH 7.0-methanol 
(65:35).
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Figu re  3 .3 .
Chromatogram o f  a u th e n t i c  s tan d a rd  o f  t r i a m t e r e n e
TIME (mini-
Mobile phase: 0.02 M Sodium acetate buffer, pH 7.0-methanol 
(65:35)
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a clean polypropylene test-tube and evaporated to dryness under a 
gentle stream of air. It was found that many of the endogenous 
plasma components were co-extracted and produced interfering 
peaks in the chromatogram.
It was then decided to extract the drugs using other solvents in 
an attempt to achieve more selective extraction. The least polar 
solvent tried was hexane, and although it gave cleaner blank 
plasma chromatograms, it failed to extract the drugs. The other 
solvents investigated were ether, ether-isopropanol (19:1), 
dichloromethane and methyl isobutyl ketone. None of these 
solvents gave satisfactorily clean blank plasma chromatograms, 
though the ether-isopropanol extract was possibly slightly 
superior to ethyl acetate. Recovery of the drug was poor with 
methyl isobutyl ketone though the blank extract contained many 
interfering peaks.
Blank and spiked plasma chromatograms following extraction by 
some of the solvents are shown in Figure 3.4. Since the 
ether-isopropanol mix gave slightly better results than ethyl 
acetate, it was decided to persist with this solvent, because it 
is easier to evaporate and more convenient to handle in terms of 
reactivity with equipment. In addition, Bailey and Kelner [21], 
when investigating the extraction of acidic drugs from water and 
plasma, found that the diuretics were optimally extracted from 
diethyl ether, and Van Damme et al. have demonstrated increased 
recoveries for drugs if 5% isopropanol is included in the 
extracting solvent [22]. The effect of excluding isopropanol 
from the extracting solvent was investigated. As may be seen from 
Figure 3.5., there is no advantage chromatographica1ly in 
excluding the alcohol, and from a practical point of view, 
emulsion formation became a significant problem when diethyl 
ether alone was used to extract the drugs.
The next approach was to change the buffer strength of the mobile 
phase from 0.02 M to 0.05 M, but this measure caused a 
deterioration in the shape of the xipamide peak and had no
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Figure 3.4.a.
Plasma chromatograms following ethyl acetate extraction
TIME («in)------------------------------------------------------>
Mobile phase: 0.02 M Sodium acetate buffer, pH 7.0-methanol 
(65:35)
(a): blank plasma
(b): plasma spiked with xipamide (X) and mephenesin (IS)
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Figure 3.4.b.
Plasma chromatograms following extraction into methyl isobutvl 
ketone
TIME (min)------------------------------------------------------>
Mobile phases 0.02 M Sodium acetate buffer, pH 7.0-methanol 
(65:35)
(a): blank plasma
(b): plasma spiked with xipamide (X) and mephenesin (IS)
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Figure  3 . 5 . a.
Chromatograms of blank plasma e x t r a c t e d  in to  d ie th v l  e th e r
Mobile phase: 0.02 M Sodium acetate buffer, pH 7.0-methanol 
(65:35)
(a): extraction solvent: diethyl ether alone
(b): extraction solvent: diethyl ether-isopropanol (19:1)
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Figure 3.5.b.
Chromatograms of spiked plasma extracted into diethyl ether
TIME («in)----------------------------------------------------- >
Plasma spiked with xipamide (X) and mephenesin (IS)
Mobile phase: 0.02 M Sodium acetate buffer, pH 7.0-methanol 
(65:35)
(a): extraction solvent: diethyl ether alone
(b): extraction solvent: diethyl ether-isopropanol (19:1)
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advantage in terms of plasma clean-up. By lowering the pH of the 
aqueous component in the mobile phase from pH 7.0 to pH 5.0 the 
retention of xipamide was markedly increased, i.e. from 5.0 
minutes to 10.5 minutes (Figure 3.6). This is presumably because 
xipamide becomes less ionised at the lower pH value, and hence 
has a greater affinity for the hydrophobic packing in the column. 
The lower mobile phase pH also served to prolong the retention of 
plasma components so that they continued to interfere with the 
xipamide peak. Lowering the extraction pH (by the addition of 
acetic acid) exacerbated the problem of plasma interferents. This 
is because many plasma components are acidic in nature and would 
favour extraction into an organic solvent under more acidic 
conditions. On the other hand, if the extraction pH was 
increased, the drug was not recovered as it is ionised at high pH 
and would not partition into the organic extracting solvent.
Acid, base and organic precipitations were also tried. A base 
precipitation was carried out by the addition of zinc sulphate 
(10%) plus sodium hydroxide (0.1 M). This was followed by vortex 
mixing, centrifugation, and injection of an aliquot (50 [i 1) of 
the supernatant. While this measure gave cleaner blank plasma 
chromatograms, the drug was not recovered. An acid precipitation 
was carried out by the addition of 10% trichloroacetic acid 
followed by the same procedure as was used with zinc sulphate.
The chromatograms resulting from this procedure contained many 
interfering peaks, and again recovery was poor. Precipitation 
with acetonitrile also gave very poor recovery of the drug? 
these observations may be explained by the fact that xipamide is 
highly protein bound [13,15,16], and possibly remains associated 
with the protein fraction following precipitation.
Because methanol and acetonitrile frequently produce differing 
selectivities on the same column, it was decided to substitute 
acetonitrile for methanol as the organic component. The order of 
elution between the two drugs remained the same, but because of 
the stronger eluting power of acetonitrile, it was necessary to
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Figure 3.6.
Effect of lowering mobile phase pH on the retention of xipamide.
TIME (ain)-
Mobile phase? 0.02 M Sodium acetate buffer, pH 5.0-raethanol 
(65 * 35)
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make some s l ig h t  m odification  o f  the mobile phase to  prolong the  
reten tion  o f xipamide on the column. This was achieved by 
lowering the pH o f  the aqueous component to  6 .7  and by increasin g  
the aqueous-organic r a t io  from 35:65 to  1*3. Using a c e t o n l t r i l e  
instead of methanol in the mobile phase a lso  achieved th e  desired  
o b jec t iv e  o f  improving the p r o f i l e  o f  drug-free plasma 
chromatograms.
As may be seen from the chromatograms presented in Figure 3 .7 . ,  
there s t i l l  remain some in te r fe r in g  peaks, so i t  was decided to  
in v e s t ig a te  a s a l t in g  out procedure prior to  ex traction  in to  the  
organic s o lv e n t .*1 As o u t l in ed  in Chapter 2, the ad d it ion  o f  a 
s a l t  to  the b io lo g ica l  medium increases  the ionic  s tren gth  o f  the  
aqueous phase and s h i f t s  the p a r t i t io n  equilibrium in favour of  
ex tra ctio n . Sa lting  out a ls o  helps to  minimise emulsion formation  
by reducing the water content o f  the organic phase and by 
imparting better  d e f in i t io n  to  the phase boundaries.
&
The procedure involved the ad d ition  o f  300 mg o f s a l t  to  spiked  
plasma followed by vortex mixing for  90 seconds. After the  
addition of d iethyl e ther-isopropanol (19:1) the drugs were 
extracted  by vortex mixing for  a further 90 seconds. A number o f  
d if fe r e n t  s a l t s  were in v es t ig a ted ;  th ese  were sodium hydrogen 
carbonate, calcium carbonate, calcium ch lor id e , sodium carbonate, 
ammonium chloride, z in c  su lphate  and lithium ch lor id e . The 
carbonate s a l t s  gave c le a r  blank plasma chromatograms, but poor 
recovery for xipamide.
*1 At th is  stage the Waters Model 450 detector  and L in se is  
recorder were brought in to  use . As t h i s  detector  is  l e s s  
s e n s i t iv e  than the photodiode array, a l l  the peaks appeared to  be 
sm aller. In addition the chart speed was s e t  a t  200 mm/hr, as the 
L in seis  recorder does not have th e  f a c i l i t y  o f  the 300 mm/hr 
chart speed used on the Waters p lo t t e r .  This g ives  the appearance 
o f sharper peaks, although obviously  column e f f ic ie n c y  remains 
unchanged.
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Diethyl ether extractions at pH 5.0 using acetonitrile in the 
mobile phase
Figure 3.7.
TIME ( B i n ) --------------------------------    >
(a): blank plasma
(b): plasma spiked with xipamide, (X) and mephenesin, the 
internal standard (IS)
Mobile phase: 0.02 M Sodium acetate buffer, pH 6.7-acetonitrile
(75:25)
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Ammonium chloride, on the other hand, retained interfering peaks 
in the blank plasma chromatogram, though it yielded better 
recovery than the carbonate salts (Figure 3.8) Overall, lithium 
chloride offered the most satisfactory compromise in regard to 
plasma clean-up and drug recovery. The amount of lithium chloride 
added was then reduced to 200, 100, and 50 mg in order to 
determine how little of the substance could be added to the 
plasma to achieve the desired results. It was found that below 
200 mg of lithium chloride, interfering peaks started to 
re-emerge, so it was decided that this amount would be added when 
preparing extracts for the validation procedure. The final 
experimental protocol employed for extraction is described in the 
experimental section. The mobile phase, as outlined above, was
0.02 M sodium acetate buffer, pH 7.5-acetonitrile (3sl), and the 
flow rate was increased to 1.5 ml/min. Under the above 
conditions, the mean retention times for the elution of xipamide 
and mephenesin were 5.4 and 9.0 minutes, respectively.
3.3.3. Assay validation
Evaluation of the assay was carried by the construction of a 
five-point calibration graph covering the concentration range 
100-2000 ng/ml of xipamide in plasma. The slope and intercept of 
the calibration curve were determined through linear regression 
of the drug to internal standard peak height ratios versus drug 
concentration. Individual peak height ratios were then 
interpolated as unknowns on the calibration graph to determine 
concentration found as compared to concentration added.
Chromatograms showing blank and spiked plasma chromatograms from
the validation study are presented in Figure 3.9.
3.3.3.1 Limit of detection
The limit of detection was taken to be 50 ng/ml for a signal to 
noise ratio greater than 3. The limit of quantitation was taken
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Figure 3.8.a.
Blank plasma extracts following the addition of salts
a b
(a): sodium carbonate
(b): ammonium chloride
Mobile phase* 0.02 M Sodium acetate buffer, pH 6.7-acetonitrile
(7 5 :2 5 )
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Figure 3.8.b.
Spiked plasma extracts following the addition of salts
3 6 9 12 15
TIME (min)------------------------------------------------------->
Plasma spiked with xipamide (X) and mephenesin (IS)
(a)» sodium carbonate
(b)s ammonium chloride
Mobile phase: 0.02 M Sodium acetate buffer, pH 6.7-acetonitrile
(75:25)
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Figure 3.9.
Chromatograms of extracted blank and spiked plasma from 
validation study
T "
12
IS
1 J j
i
1 2
IS
T
12
TIME(mins)----------------------------------------------------- >
(A) Blank human plasma. (B) Plasma spiked to 250ng ml-1 
xipamide (X) and 10/xg ml-1 mephenesin (IS). (C) Plasma spiked 
to 2000ng ml-* xipamide and ICtyig ml-1 mephenesin
Mobile phase: 0.02 M Sodium acetate buffer, pH 6.7-acetonitrile 
(75:25)
Detector sensitivity: 0.01 AUFS
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to be 100 ng/nl, the level at which quantitative measurement of 
the peaks was consistently possible. As outlined in the 
Introduction section, the plasma levels of xipamide 24 hours 
following an oral administration of a 20 mg dose were found to be 
approximately 100 ng/ml when the dose was administered on a 
weekly basis. It is to be expected that where the drug was given 
on a daily basis in a normal therapeutic regimen, the 
steady-state plasma levels, even 24 hours after dosing would be 
somewhat higher than this.
3.3.3.2. Precision
The data in Table 3.1 demonstrate the between-day (inter-assay) 
and within-day (intra-assay) variation in the method. The 
inter-assay variability was assessed singly in four replicate 
runs (on consecutive days) over the concentration range 100-2000 
ng/ml. A separate calibration curve based on the individual peak 
height ratios (drug:internal standard) was constructed for each 
of the runs? the individual peak height ratios were then 
interpolated as unknowns on the appropriate regression line to 
obtain new values of concentration ("drug found"). The mean 
coefficient of variation over the entire concentration range is 
taken as an index of the precision and in this case, the 
inter-assay precision was found to be 4.3%.
For assessment of the intra-assay variability a single regression 
line was constructed based on the mean (of four) peak height 
ratios at each concentration level. The individual peak height 
ratios were then interpolated as unknowns on the regression line 
to obtain new values of concentration ("drug found"). The means, 
standard deviations and coefficients of variation of these new 
values were calculated at each concentration level, where n was 
equal to four representing the quadruplicate runs. The 
variability as measured in terms of mean coefficient of variation 
was 4.1% for the intra assay study.
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3.3.3.3. Linearity
A measure of the linearity, as defined by the correlation 
coefficient (r) of the intra-assay regression line, is presented 
in Table 3.1. The correlation coefficient of the regression line 
for the mean intra-assay values was better than 0.999, and as may 
be seen from the equation of the regression line (also given in 
Table 3.1), the intercept does not differ significantly from 
zero.
3.3.3.4. Recovery
Recovery of xipamide from plasma was measured using two methods:
(i) by calculating the percentage difference between the peak 
heights of extracted standards, and those of authentic 
(unextracted) standards in the same concentrations as 
reconstituted residues assuming 100% recovery? and (ii) by 
comparing the slopes of the two regression lines obtained from 
the extracted and authentic standards used in method (i) with the 
"extracted" slope as a percentage of the "authentic" slope 
yielding a measure of the amount recovered. Both authentic and 
extracted standards were processed and injected in duplicate.
The mean recovery determined by method (i) was found to be 83.8%, 
and by method (ii) 82.5 %. The mean of these two values yields an 
overall mean percentage recovery of 83.2%. The results of this 
experiment are presented in Table 3.2.
3.3.3.5. Selectivity
As may be seen fron the chromatograms presented in Figure 3.9, 
the drugs are well separated from the plasma peaks and there is 
no interference present on the blank plasma chromatogram. The 
drugs chlorthalidone, and frusemide, propranolol and atenolol 
were tested as possible interferences in the assay. Of these, 
chlorthalidone and frusemide co-eluted with the xipamide peak.
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P r e c is io n  and L i n e a r i t y - INTRA-ASSAY
Amount
Xipara ide
Added
100
250
500
1000
2000
Peak Mean Amount
H e i g h t  R a t i o  Found
R a t i o    ( n g / m l )
0 .042  
0 . 0 3 0  
0 . 0 4 3  
0 .041
0 . 1 1 3  
0 . 1 0 6  
0. 111 
0 . 1  16
0 . 2 2 5
0 .2 23
0 .2 24
0 . 2 2 8
0 . 4 6 7
0 . 4 4 2
0 .4 1 8
0 .4 3 8
0 . 9 3 6
0 . 9 1 8
0.816
0 .9 1 7
0 .041
0.111
0 .2 2 5
0 .441
0 .8 97
102.9
102 .3  
77 .  1 
9 5 . 8
25 2 .6
25 3 .6
2 47 .7
2 6 2 .5
4 90 . 4
506 .4  
527.  I 
507.  I
1004.  1
9 79 .6  
1006 .9
9 6 5 .6
1999 .8  
20 0 8 .0
1991 .9  
201 1 . 6
Mean C o e f f i c i e n t  o f  V a r i a t i o n  ** 4.1%
R e g r e s s i o n  L i n e :  y = 4 . 4 9  x 10"^ x -  8 . 5 1  x 10~3
C o r r e l a t i o n  C o e f f i c i e n t  ( r )  » 0 . 9 9 9
TABLE 3.1
Mean S ta n d a rd  C o e f f i c i e n t
Amt. Found D e v i a t i o n  o f  V a r i a t i o n
________
9 4 . 5  12.1 12.8
25 4 .1  6 . 2  2 . 4
507 .7  15 .0  2 . 9
989 .1  19 .9  ,  2 . 0
2002.8 8.8 0.4
D i f f e r e n c e  be twee n  
added  and fo un d  (Z)
-  5 . 5
♦ 4.6
+ 1 .5
-  1 . 1
19
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Table 3.1. continued
Precision and linearity- Inter-assay
Amount Xipamide Peak height Amount
added (A) na/ml Ratio (F) na>
100 0.045 113.7
250 0.108 251.1
500 0.229 515.1
1000 0.428 949.4
2000 0.919 2020.7
100 0.041 87.7
250 0.111 245.2
500 0.242 524.0
1000 0.456 979.5
2000 0.938 2005.1
100 0.045 106.9
250 0.115 260.3
500 0.228 507.9
1000 0.433 957.2
2000 0.917 2017.8
100 0.041 110.8
250 0.113 261.1
500 0.214 471.9
1000 0.468 1002.1
2000 0.948 2000.6
Mean Amount 
Found ng/ml
Standard
Deviation
Coefficient of 
variation %
Difference 
between added 
and found %
100
Concentration ng/ml 
250 500 1000 2000
104.8
11.7
11.2
254.4 504.7 972.0 2011.0
7.6 22.8 23.8
3.0 4.5 2.4
+4.8 +1.8 + 0.9 -2.8
9.7
0.5
+0.5
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Table 3 .2 .
R esu lts  o f  recovery o f  xipamide s tu d ies
Xipamide peak height (mm)
Concentration Authentic Extracted Recovery
nq/ml standards_____ standards %
100 4.5 4.0 88.9
250 13.0 11.0 84.6
500 26.0 21.0 80.8
1000 53.5 44.0 82.2
2000 109.0 90.0 82.6
Method ( i ) i  mean recovery (± standard d ev ia tio n ) -  83 .8  + 3.1%
Method ( i i  )* mean recovery [s lop e  (e x tr a c te d ) /s io p e  (a u th e n t ic ) ]
x 100%
Authentic standards: y -  5.49x x 10-3 x -  0.11
r -  0.999
Extracted standards: y -  4 .53x x 10“3x -  0.19
r * 0 .998
s lo p e (e x tr a c te d ) /s lo p e (a u th e n t ic )  -  4 .5 3 /5 .4 9  -  0 .825  
Mean Recovery = 82.5%
Overall mean percentage recovery « 83.2%
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Separation was not attempted as it would be unusual for xipamide 
(a potent diuretic) to be co-administered with either of these 
two drugs, which are of moderate potency (chlorthalidone), or 
equipotent with xipamide (frusemide). If, however, it was desired 
to separate xipamide from these compounds, this could readily be 
achieved by minor adjustment of the eluent pH, because, as 
outlined in the text, the retention of xipamide is strongly 
influenced by pH under the employed experimental conditions.
3.4. CONCLUSION
A method was developed for the analysis of xipamide in plasma 
which offers an attractive alternative to previous methods 
involving densito-fluorimetric analysis of the derivatised drug 
on TLC plates. Employing a simple effective method of sample 
clean-up and drug extraction, analyses can be rapidly executed 
with the minimum of sample handling. Using a volatile extraction 
solvent, such as diethyl ether helps to minimise the time 
required for sample preparation, and with a chromatographic run 
time of less than 10 minutes, a set of samples may be processed 
within a conveniently short period of time.
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CHAPTER 4
THE DETERMINATION OF CHLORTHALIDONE 
IN HUMAN PLASMA 
BY REVERSED-PHASE 
MICELLAR LIQUID CHROMATOGRAPHY
4.1. INTRODUCTION
Chlorthalidone, 2-chloro-5-(l-hydroxy-3-oxo-l-isoindolinyl) 
-benzene sulphonamide, is a diuretic-hypertensive drug [1]. It 
may be given alone or in combined therapy with a hypotensive 
agent [2]. Pharmacologically, its actions resemble those of the 
thiazide diuretics although chemically, it differs from the 
latter in the nature of the heterocyclic ring. It is given in 
oral doses of between 50 and 200 mg daily: diuresis is initiated 
in about 2 hours and may last for 48 hours or longer. A number of 
studies have been carried out on the pharmacokinetics of 
chlorthalidone [3-10]. The drug is excreted mainly unchanged in 
the urine [10] and its prolonged duration of action is attributed 
to the fact that it has a biological half life of 30-80 hours 
[3-6]. The large inter-and intra-individual variation seen in 
biological half-life has been attributed to variations in 
bioavailabi1ity (which is relatively poor for chlorthalidone) 
[5,6], non-linear binding of the drug to red blood cells [7,8], 
and dose-dependent urinary excretion [9].
The drug appears to have a large volume of distribution (200-400 
1 [6]) resulting in relatively low peak plasma concentrations of 
100-1000 ng/nl depending on the dose [11]. Most of the drug is 
bound to red blood cells, and this binding is at a maximum after 
about 8 hours [4-7]. Approximately 50-70% of the drug which is 
not bound to red blood cells is bound to plasma proteins [2].
A limited number of methods have been published for the 
determinatiion of chlorthalidone in biological fluids. Pulver et 
al. used a spectrophotometric method for the determination of 
chlorthalidone in dogs' urine, but this method is not sensitive 
enough for human blood level measurements [12]. A 
spectrophotometric method was also presented by Tweedale and 
Ogilive [3], permitting the determination of a minimum
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concentration of 1 /¿g/ml. A very sensitive method based on 
radioactivity measurements was reported by Beizenherz et al.
[13], though this technique did not offer the potential to 
separate drug from metabolites, and the attendant problems with 
radioactivity-based studies are considerable. Gas chromatographic 
methods have also been published [14-16]? most of these methods, 
based on the conversion of chlorthalidone to its tetramethyl 
derivative, are still quite laborious and may pose considerable 
methodological problems for a large series of samples. A 
sensitive and selective GC method was developed by Fleuren and 
Van Rossum [16], and depending on the volume of sample taken, as 
little as 10 ng/ml can be determined. An HPLC method for the 
analysis of chlorthalidone was reported where the drug was 
extracted from whole blood from acetonitrile followed by HPLC 
analysis on a cyano- column [17]. The limit of detection was 200 
ng/ml, and this method demands the availability of whole blood 
samples. Chlorthalidone in blood, plasma and urine has been 
measured by HPLC on a C^g column using probenecid as the 
internal standard [10]. Recovery of chlorthalidone added to whole 
blood was 47.6%, and from plasma it was 70.0 %. Using UV 
absorbance detection at a wavelength of 226 nm, the limit of 
detection was 30 ng/ml.
The aim of the present study was to investigate the use of 
micellar chromatography for the determination of chlorthalidone 
in plasma. It was first sought to develop a suitable micellar 
chromatographic system, and to combine it if possible with an 
on-line solid-phase extraction system in order to carry out a 
rapid plasma clean-up procedure. It will be shown that 
chlorthalidone and the internal standards investigated showed 
predictable retention behaviour in the micellar chromatographic 
system, but that on-line solid-phase extraction (followed by 
micellar chromatogrphy) is difficult due to problems associated 
with protein binding and modification of the concentration column 
by surfactant monomers. An alternative liquid-liquid extraction 
scheme for the separation of the drug from plasma will be 
presented. The final method is fully validated, and should
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provide an analytically useful alternative to conventional 
reversed-phase methodology.
4.2. MICELLAR LIQUID CHROMATOGRAPHY
Reversed-phase high performance liquid chromatography has become 
one of the most widely used modes of liquid chromatography, in 
part because of the impressive selectivity available via mobile 
phase participation in the equilibrium distribution of solute 
molecules between the stationary and mobile phases. Retention in 
reversed phase chromatography is dominated by solute-solvent 
interactions, with solute-stationary phase interactions playing 
an important, but secondary role [18]. Thus, the key to selective 
separations lies in the ability to control solute-solvent 
interactions by changing the composition of the mobile phase. One 
way in which this has been achieved is by the addition of 
surfactants at low concentrations to enhance separation of 
oppositely charged solute ions, giving rise to a technique known 
variously as "ion-interaction chromatography", "soap 
chromatography", or more commonly, "ion pair chromatography".
Surfactant solutions at high concentrations where micelles 
co-exist with monomers, dimers etc, also form chromatographically 
useful mobile phases. The chromatographic technique involved is 
known as micellar liquid chromatography and it can offer an added 
degree of selectivity to separations because of the possibility 
of interaction between the solute and the micelle.
4.2.1. Normal micelles
Surfactants exist in a multitude of different forms in which the 
hydrophobic tail varies in length from 8 to 20 carbon atoms and 
the hydrophilic portion can be a partially dissociable 
carboxylate ion, a fully-ionised moiety (such as anionic 
sulphate, or cationic trimethylammonium ions) plus counterion, or 
an uncharged species such as polyethylene glycol. They vary not 
only in their charge type (zwitterionic, positive, negative or
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neutral), but in the nature of the hydrophobic portion (single or 
double hydrocarbon chains, multiple bonds etc.). At low 
concentrations in aqueous solution, surfactant molecules are 
dispersed as monomers, and to a lesser extent as dimers and 
trimers. Above a certain concentration, i.e. the critical micelle 
concentration (CMC), the monomers aggregate into micelles which 
are roughly spherical in shape, and consist typically of 60-100 
monomers (the aggregation number) [19]. As the surfactant 
concentration is increased above the CMC, more micellar 
assemblies are formed with the monomer concentration remaining 
approximately constant and equal to the CMC.
The alkyl chain length, size of the head group structure, and 
interactions of the alkyl chains with one another and the 
solvent, determine the CMC, the micelle size, aggregation number, 
and structure. Micelles are small enough (3-6 nm in diameters) 
that the macroscopic solution properties resemble those of a 
truly homogeneous solution, i.e. they cannot be filtered using 
conventional methods and they do not cause measurable light 
scattering error in conventional spectrometry. In aqueous 
solution, the hydrocarbon moiety is directed inward while the 
polar head faces the bulk environment. The resulting solution is 
microscopically heterogeneous, consisting of micellar aggregates 
approximating to charge-covered oil droplets in a sea of water. 
Typical surfactants are listed in Table 4.1., along with their 
respective CMC values. Of these, the surfactants most commonly 
used in chromatography are sodium dodecyl sulphate and 
cetyltrimethylammonium bromide.
Much of the understanding of micelle structure and behaviour can 
be attributed to the pioneering work of Hartley [20]. Later 
models proposed alignment of the hydrocarbon chain with some 
water penetration, or alternatively, non-alignment of the tails, 
with looping of the chains allowing hydration of the sections 
that would normally be considered completely hydrophobic. The 
original oil droplet model presents a relatively static picture. 
Over the years, it has been determined that micelles are
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Table 4.1.
Typical surfactants and their CMCs and aggregation numbers
Surfactant CMC (M)
ANIONIC
Sodium dodecyl sulphate 
CH3 (CH2 )11OS03" Na+
0.008
Sodium polyoxyethylene- 
dodecyl ether 
CH3(CH2 )n - 
(0CH2CH2 )120S03_ Na+
CATIONIC
0.030
Cetylpyridinium chloride 
c16H33N+C5H5G r
0 .0 0 0 1 2
Cetyltrimethylammonium bromide 
CH3(CH2 )15N+ (CH3)3 Br-
0.0013
NONIONIC
Polyoxyethylene dodecanol
c h 3(c h 2 )11-
(o c h2c h 2 )6oh
0.00009
ZWITTERIONIC
N-dodecy1-N,N-d i methy1ammon i um- 
3-propane-l-sulphonic acid
c h 3(c h 2 )11n+ (c h 3)2s o3"
0.003
Aggregation No.
62
81
95
78
400
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molecular assemblies in dynamic equilibrium with their bulk 
solvent phase [21]. Two basic processes are occurring! namely 
exchange with the solvent and other micelles by monomers, dimers, 
and trimers, occurring over a microsecond to millisecond time 
scale, and actual replacement of the entire micelle occurring by 
this process over a time frame of milliseconds to seconds. This 
dynamic nature of micelles has a profound impact on an analyte 
residing in or on the micelle, and on analytical measurements 
centered on the associated analyte.
The effect of micellar dynamics on analytical schemes is based on 
the ability of micelles to organise reactants on a molecular 
level [22]? that is they increase the proximity of the reagent 
and analyte in relation to each other. To take advantage of the 
micelles organising ability, the species involved must 
preferentially associate with the micelle over the bulk solvent. 
In other words, the analyte and associated reagents should 
exhibit significantly greater rate constants for entrance into 
the micelle compared to exit constants. A number of factors 
influence the relative magnitude of the exit and entrance rate 
constants of analytes in micelles. If the species of interest is 
highly polar, it may prefer to remain in the aqueous bulk 
environment. If the analyte is completely anionic, it may be 
electrostatically repelled by an anionic micelle, or stabilised 
by a cationic micelle, and vice-versa for a cationic solute. 
Additional factors which can favourably influence the association 
between micelle and analyte are pH and ionic strength. Simply by 
making small pH adjustments, the analyte can be converted to a 
form which interacts much more strongly with the micellar 
assemblies.
A useful measure of the strength of the analyte-micel le 
interaction is the analyte's solubility in water. Generally, in 
the absence of secondary effects, the less soluble the analyte is 
in water, the stronger its association with the micellar 
aggregate. The hydrocarbon nature of the micelle tail serves to 
greatly increase the aqueous solution solubility of species of
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extremely low solubility such as polynuclear aromatics. Low 
polarity species become solubilised or incorporated into the 
hydrophobic interior of the micellar assembly. This can greatly 
ease the solvent requirements for the analysis of highly 
insoluble organic molecules by permitting the use of non-toxic 
aqueous solutions.
4.2.2. Reversed micelles
When surfactants are dissolved in apolar solvents, the polar head 
groups and counterions orient themselves together in an inward 
fashion in contact with a small water pool where they are 
hydrated, and the aliphatic tails extend outward in contact with 
the non-polar solvent. These systems are often more complex and 
less understood than normal micellar systems. At low water 
concentrations, the water molecules fill the hydration sphere of 
the counterion so that solubilisd analytes encounter a more 
viscous, less polar environment than in ordinary bulk water. At 
higher water concentrations, there are more free water molecules 
available, so that the microenvironment is more polar, less 
viscous, and resembles ordinary bulk water in its properties.
Like normal micelles, these systems are characterised by CMC 
values and aggregation numbers, though CMC values are ill-defined 
for reversed micelles, with appreciable pre-CMC association 
occurring between monomers, dimers, etc. and the analyte.
Reversed micelles are also characterised by dynamic 
monomer-micelle association and analyte-micelle association with 
both processes occurring on a millisecond time frame. Their 
usefulness in analytical methodologies resides in their ability 
to solubilise polar analytes which are excluded from the 
hydrophobic interior of normal micelles. For example, polar 
hetrocyclic compounds may be preferentially solubilised into the 
water pool of normal micelles, thus permitting favourable 
mice11e-enhanced interactions.
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These systems have only recently entered the arsenal of the 
analytical chemist and although not yet fully evaluated or 
extensively employed in biopharmaceutical analysis, their 
usefulness as eluents for normal phase chromatography has been 
demonstrated [23].
4.2.3. General analytical applications of micelles
Generally, surfactant micelles are used in analytical schemes to 
effect changes in solubility, pKa , chemical equilibrium, 
reaction kinetics and spectral distributions or intensities. 
Acid-base titrations involving water-insoluble carboxylate and 
amine species using both potentiometric and visual indication 
systems have been performed using both cationic and anionic 
charged micelles to solubilise water-insoluble species, a process 
which can cause a pKa shift of 0.5 to 3 units [24].
In analyses of selected metals via their coordination with 
complex anions, surfactant micelles have been used to aid 
solubilisation of the resulting complex. Charged micelles can 
also be used to manipulate a molecules excited state acidity 
constant when the analyte meets certain criteria. One of these 
criteria is that the molecule must possess a fluorescence or 
absorption spectrum which distinguishes the ground and excited 
states of the acid and conjugate base forms. Another requirement 
is that the analyte possesses some amphiphilic properties to 
allow solubilisation within or on the micelle.
4.2.4. Micellar solutions in chromatography
The partitioning of solutes between micellar and aqueous phases 
in liquid chromatography was first treated theoretically by 
Herries [25], but it was Armstrong and Henry [26] who first 
effectively demonstrated the usefulness of chromatographic 
eluents containing micelles above the CMC. They employed as 
mobile phases, wholly aqueous solutions containing 0.1-0.2M 
sodium dodecylsulphate (SDS) to separate a range of phenols and
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polynuclear aromatic hydrocarbons. They showed that the presence 
of micelles in the mobile phase provides a hydrophobic site for 
interaction with the solute, and that surfactant solutions 
obviate the need for traditional organic modifiers such as 
acetonitrile and methanol.
If a solute is introduced into a micellar system, it may become 
solubilised preferentially into or onto the micelle by a process 
that is dynamic and is characterised by rate constants [27]. In 
traditional reversed-phase chromatography, selectivity is 
governed principally by the equilibrium that exists between the 
concentration of solute in the mobile phase and the amount in the 
stationary phase. Retention can be controlled by changing the 
composition of the mobile phase, so shifting the balance of the 
equilibrium. The situation is more complex in micellar systems: 
additional interactions of an electrostatic, hydrophobic and 
steric nature can occur, and these additional interactions impart 
an added degree of selectivity to the separation of drug and 
other analytes by HPLC. From a practical point of view, this 
additional selectivity of separation is what constitutes one of 
the major differences between hydro-organic and micellar eluents.
Retention of solutes generally decreases with increasing 
surfactant concentration, an observation first made by Armstrong 
and Henry [26], but the rate of decrease is strongly 
solute-dependent, and this frequently produces reversals in 
orders of retention. These inversions are the result of two 
competing equilibria: solute-stationary phase interactions, and 
solute-micelle interaction. These equilibria may be characterised 
by the partition coefficients, Kws and Kwm, defined as the 
water to stationary phase and water to micelle equilibrium 
constants respectively. Both of these can affect retention [27], 
and it is the second partition coefficient, Kwm, which imparts 
uniquness to micellar chromatography. The larger the value of 
Kwm the greater the effect of increasing micelle concentration, 
which is what accounts for the solute-dependent rate of decrease 
in retention. The situation is further complicated by the fact
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that surfactant monomers adsorb irreversibly onto reversed-phase 
packings [27-30], and interact with solutes as they progress down 
the column. Hence, one might expect the value of Kys to change 
with increasing surfactant concentration. However, the effect of 
Kws on retention is independent of micelle concentration since, 
as reported by Hung and Taylor [30], the amount of surfactant 
adsorbed on the stationary phase remains essentially constant 
after equilibration once the concentration is above the CMC.
Kwm and Kws are related to certain column parameters and 
micelle characteristics and have received detailed mathematical 
treatment from Armstrong and Nome [27].
An important micellar effect on retention is electrostatic 
interaction between an ionic surfactant and an ionisable solute 
in a manner analagous to ion interaction chromatography. The 
nature of this effect, whether it involves attraction or 
repulsion, depends on the ionic character of the surfactant and 
the solute. As previously stated, there is considerable 
adsorption of surfactant onto a non-polar stationary phase, 
thereby providing for electrostatic interactions of ionisable 
solutes with the stationary phase as well as the charged micelle.
When an acidic solute is separated using an anionic surfactant, 
electrostatic repulsion from both the micelle and 
surfactant-modified stationary phase can occur. The same holds 
true for a cation separated using a cationic surfactant.
Repulsion from both the stationary phase and the micelle means 
that the solute would reside exclusively in the bulk 
macro-environment and would move rapidly down the column.
Although a hydrophobic interaction with the stationary phase is 
still possible, its effect is diminished by the effect of 
electrostatic repulsion [31].
When a solute is separated using a surfactant of opposite charge, 
electrostatic attraction between the solute and the surfactant 
occurs. Considering the micelle first, this attraction would 
augment the solute-micelle hydrophobic attraction, and decreased
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retention would be expected. However, it has been found 
experimentally that switching from a like-charged to an 
oppositely-charged surfactant (for example, SDS to DTAB 
(dodecyltrimethylammonium bromide)) actually increased retention 
times for a range of phenols [31]. These observations have been 
accounted for in terms of electrostatic attraction between the 
charged surface of the stationary phase, supplemented by a 
solute-surfactant ion pair interacting hydrophobically with the 
stationary phase. As non-polar compounds are minimally affected by 
electrostatic effects, they can be separated from other compounds by 
judicious choice of surfactant and mobile phase pH.
A three-phase equilibrium model relating capacity factor to micellar 
mobile phase concentration has been developed by Arunyanart and 
Cline-Love [28], and equations have been developed to allow 
calculation of the equilibrium constant for the solute between the 
bulk aqueous phase and the micellar aggregate. They also showed that 
if the equilibrium constant is available from independent sources, it 
is possible to predict the chromatographic capacity factor at zero or 
greater micelle concentrations. This means that spectroscopic methods 
can be used to predict chromatographic retention, a goal not yet 
realised for hydro-organic phases. They later extended this work to 
account for the effect of prototropic equilibria on the association 
of weak organic acids and bases with micellar aggregates [29]. The 
equations they developed predicted a sigmoidal dependence of 
chromatographic capacity factors on mobile phase pH and a parabolic 
dependence of k' on micelle concentration.
One of the early problems with micellar mobile phases was poor 
chromatographic efficiency. This problem was first addressed in 
detail by Dorsey et al. [32]. They proposed that the poor mass 
transfer characteristics associated with wholly aqueous mobile phases 
on reversed-phase columns [33] are due to poor wetting of the 
stationary phase resulting in slow equilibrium across the interface 
of two highly dissimilar phases. To overcome this problem, they added 
a small amount of organic modifier to the mobile phase and found 
propanol to be superior to methanol, ethanol and acetonitrile in
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terms of improved efficiency and peak shape. Scott and Simpson 
investigated the modification of C^g phases by organic modifiers, 
and found that 3% propanol gave more than 90% coverage of the 
stationary surface, but the figure was only 50% for the same 
concentration of methanol [34]. This modification promotes faster 
mass transfer resulting in improved efficiencies. The higher 
concentrations of methanol which would be required to produce the 
same improvement as 3% propanol represents an unrealistic situation 
for micellar chromatography, as added alcohols can loosen the 
micellar structure and disturb the equilibria which it was originally 
sought to exploit. Dorsey found little improvement in efficiency or 
peak asymmetry at concentrations of propanol greater than 3%, though 
solute retention times are further reduced. For this reason, it may 
be beneficial to slightly increase the amount of propanol added [32].
A second parameter which can be adjusted to improve mass transfer 
characteristics is temperature [32,35]. Dorsey [32], found that 
operating at temperatures of up to 40° reduced peak asymmetry, but 
had little effect on efficiency if the mobile phase contained 10% 
methanol. On the other hand, Yarmchuck et al. [35], showed a steady 
increase in column efficiency as the temperature was increased from 
25°C to 60°C, although, in this case, the mobile phase contained 
no organic modifier. Yarmchuck further proposed that efficiency could 
be improved by keeping the surfactant concentration as low as 
possible, since an increase in plate height was observed as the 
concentration was increased from 0.02 M to 0.2 M. In addition, he 
found that an increase in linear velocity effected an increase in 
plate height, and that the addition of organic modifiers was of 
little benefit.
The disadvantages of working at elevated temperatures are 
considerable, some of the most important being the need to maintain 
strict temperature control, to preheat the mobile phase above 40°C 
in order to prevent peak distortion from thermal gradients [36] and 
the fact that the silica-based stationary support dissolves more 
rapidly at higher temperatures. The approach adopted in the present 
work was to add a small amount of organic modifier to the micellar
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mobile phase* this measure was found to provide satisfactory 
separation and peak shapes for the compounds under investigation.
Apart from providing unique selectivity in the chromatographic 
separation process, micellar liquid chromatography enjoys a number of 
distinct advantages over conventional reversed-phase liquid 
chromatography. For example, it permits gradient elution without the 
usual need for re-equilibration after each change in mobile phase 
composition. This is because, as outlined above, at concentrations 
above the CMC, any change in surfactant concentration affects only 
the number of aggregates; the amount of free surfactant in the mobile 
phase, and that adsorbed onto the stationary phase remains constant 
irrespective of the number of micelles present. This property of 
micellar solutions also renders them useful in the coupling of 
gradient elution to electrochemical detection. With conventional 
mobile phases, changes in the conductivity, viscosity, and pH of the 
mobile phase during a gradient programme give steeply sloping 
baselines owing to changes in residual current [37,38], Khaledi and 
Dorsey have demonstrated an improved compatibility of micellar (as 
opposed to hydro-organic) gradients with electrochemical detectors 
[39].
Being primarily aqueous-based, surfactant solutions have low 
compressibility, a factor which makes them well suited to refractive 
index detection [26]. Micellar solutions have been shown to increase 
fluorescence quantum efficiencies, and to permit unusual detection 
schemes, such as room temperature liquid-phase phosphorescence 
[40,41]. Its usefulness extends beyond the realm of pure organic 
analysis: both neutral and charged metallo-organic complexes have 
been separated on the same chromatogram using micellar systems [42], 
and Mullins and Kirkbright have demonstrated the determination of 
inorganic anions on a C^g- column using micellar systems [43].
4.2.5. Micellar chromatography in biopharmaceutical analysis
In 1985, DeLuccia et al. described the use of micellar mobile phases 
for direct serum injection (DSI) without prior sample treatment [44].
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This type of procedure is possible because of the unique solubilising 
power of the micelles by which they can form soluble protein-SDS 
complexes thus preventing protein precipitation on the analytical 
column. This process also displaces drugs from serum components, 
freeing protein bound drugs to partition into the stationary phase 
[44-48]. Granneman and Senello have shown that surfactant monomers 
will competitively bind proteins thereby releasing protein-bound 
antibiotics [48], In the direct serum injection technique described 
by DeLuccia et al. [44], 20 (JLl serum samples were introduced onto the 
column and detection was achieved using UV detection at 254 nm. While 
this method does permit direct injection, the sensitivity is limited 
by the low sample volume, the high serum background signal and by the 
fact that UV detection at 254 nm was employed, which is not 
necessarily the optimum wavelength for many drugs of therapeutic 
importance. The limits of detection offered by this scheme would 
appear to lie in the mid to low microgramme per ml of serum level.
An advance on the procedure of DeLuccia et al. was described by 
Arunyanart and Cline-Love [45]. In order to enhance chromatographic 
efficiency, they incorporated 10% propanol into the micellar mobile 
phase, a measure which did not promote protein precipitation. They 
also established in this work that approximately 0.02 M SDS was 
required to solubilise serum proteins. In this case, sensitivity was 
improved by the use of fluorescence detection, though again, the 
limit of detection was restricted by the high serum background 
signal. Using this technique it was possible to determine down to 
approximately 50 ng/ml propranolol in serum, but the limit of 
detection for morphine and codeine was greater than 1/ig/ml.
DSI is limited by the fact that there is no pre-concentration of the 
drug prior to analysis, so large volumes of untreated biological 
fluid would have to be injected to determine drugs whose therapeutic 
ranges lie in the low ng/nml range. Injecting large volumes of plasma 
or serum creates the further problem of blockage of the analytical 
column and build-up of strongly retained endogenous compounds.
Because there is no sample clean-up the biological matrix will 
produce a large signal eclipsing the peaks of early eluting
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compounds. Optimisation could be achieved by judicious selection of a 
detection scheme or by extracting the drug from the biological fluid.
The use of micellar mobile phases in on-line solid phase extraction 
processes has been described [47,49,50]. In these instances, the 
micellar mobile phase constitutes the wash solution. Following 
injection of the plasma onto the concentration column, the proteins 
were solubilised and eluted to waste by the surfactant while the 
drugs were selectively retained by the concentration column. The 
concentration column was then washed with a 10% methanol-aqueous 
mixture to remove the SDS and any remaining interferents.
This approach can lead to poor recovery of certain strongly protein 
bound drugs, and in one instance, increasing the concentration of SDS 
in the wash phase (with a view to promoting displacement of the drugs 
from their protein-binding sites) caused severe peak tailing and, in 
some cases, peak splitting [47]. Another problem with increasing the 
concentration of SDS in the wash phase is the reduction in drug 
breakthrough volume, since, as outlined previously, increasing the 
number of micelles is equivalent to increasing the elution strength 
of the mobile phase. Furthermore, if a micellar wash phase is to be 
followed by chromatography with a conventional hydro-organic mobile 
phase, it is necessary to remove the SDS before coupling the 
concentration column to the analytical column, otherwise the SDS will 
interfere with the chromatography, and if the concentration of 
organic modifier is high, the surfactant will tend to precipitate on 
the analytical column.
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4.3. EXPERIMENTAL
4.3.1. Reagents and solvents
Chlorthalidone and frusemide were purchased from Sigma, Dorset, 
UK. Xipamide, triamterene, propranolol, atenolol, metoprolol and 
pindolol were received as a gift from the Institute of Clinical 
Pharmacology, Dublin, Ireland. Biochemical grade sodium dodecyl 
sulphate, and AnalaR grade 1-propanol, sodium hydroxide, calcium 
chloride, sodium carbonate, sodium hydrogen carbonate and lithium 
chloride were received from BDH, Poole, UK. HPLC grade methanol, 
acetonitrile and diethyl ether were obtained from Labscan 
Analytical Sciences, Dublin, Ireland. Hydrochloric acid, zinc 
sulphate, trichloroacetic acid, salicylic acid, 
tetramethylammonium bromide, sodium dihydrogen phosphate, 
disodium hydrogen phosphate and ortho-phosphoric acid (all 
analytical grade) were obtained form Riedel de Haen, Hannover, 
West Germany.
Deionised water was obtained by passing freshly distilled water 
through the Millipore Milli-Q water purification system. Dried 
human plasma from the Blood Transfusion Board, Dublin, Ireland 
was dissolved in deionised water and used within seven days of 
reconstitution.
4.3.2. Instrumentation
The compounds were separated on a Cg- (10 fi m) reversed-phase 
column (220 x 4.6 mm i.d.) which was protected by a Cg- 
disposable guard column cartridge (15 x 3.2 mm i.d.), both 
supplied by Pierce, Rockford, IL, USA. The mobile phase was 
filtered through a 0.45 /¿m membrane and degassed by sonication 
prior to use. It was delivered at a flow rate of 1 ml/min (unless 
otherwise specified) by a Waters (Milford, MA, USA) model 501 
HPLC pump. Detection was achieved by ultraviolet absorption using 
a Shimadzu (Kyoto, Japan) SPD-6A spectrophotometric UV detector 
with a Linseis (Selb, West Germany) recorder at a chart
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speed of 200 mm/hr. Some measurements were made with a Waters 
Model 900 photodiode array spectrophotometric detector. The drugs 
were detected at 235 nm.
For direct injection, samples were introduced onto the column 
using a Rheodyne (Cotati, CA, USA) Model 7125 injection valve 
fitted with a 20, 100, or 500 ¡11 loop according to the experiment 
being performed.
For the purpose of column switching a second Waters Model 501 
HPLC pump and the concentration column were connected via a 
Rheodyne six-port, two-position switching valve, the operation of 
which has been described in Chapter 2, and a 500 /x 1 loop was 
fitted onto the injection valve. The 10 x 1.5 mm i.d. 
concentration columns were dry-packed with Corasil (Waters 
Associates) RP-18 (37-50 ¿im), Sepralyte (Analytichem 
International, Harbour City, CA, USA) RP-8 (40fxm) or Supelco 
(Bellefonte, PA, USA) cyano- (25-45 ¿im) pellicular packing 
materials. The washing solvent delivered to the concentration 
column was filtered degassed deionised water at a flow rate of 1 
ml/min.
The pH adjustments were made using a standard pH glass electrode 
at ambient temperature. The pH meter was calibrated on a daily 
basis using aqueous standards prepared on a weekly basis.
4.3.3. Standards
Stock solutions of the drugs were prepared by dissolving 10.00 mg 
of drug in 10.0 ml methanol. Working stock solutions containing 
25 jtig/ml were prepared by a 1:3 dilution of the concentrated 
solutions in methanol-water (1:1). These solutions were then 
diluted with mobile phase for direct injection or added to an 
aliquot of blank plasma prior to extraction.
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4.3.4. Procedures
4.3.4.1. Effect of pH on the retention of
chlorthalidone and frusemide
A solution containing 0.08M SDS was made by dissolving the 
required amount of SDS in 0.01 M disodium hydrogen phosphate. 
Aliquots of this solution were adjusted to between 4.5 and 7.0 
(in increments of 0.5 pH units) by the addition of phosphoric 
acid. Mobile phases were prepared by mixing the buffered SDS 
solutions with 1-propanol to produce a 5:95 alcohol-aqueous 
mixture. Mobile phases were filtered and degassed prior to use.
The 25 /¿g/ml working stock solutions of chlorthalidone and 
frusemide were diluted (1:9) in mobile phase and a 20 fil aliquot 
injected for chromatography. The retention times of the two drugs 
was measured as a function of eluent pH.
4.3.4.2. Effect of SDS concentration on the retention
of chlorthalidone and frusemide.
A solution of 0.1 M SDS in 0.01 M phosphate buffer, pH 4.5 was 
prepared. This was then diluted with phosphate buffer, pH 4.5 to 
give solutions containing 0.025, 0.05 and 0.075 M SDS. Mobile 
phases were prepared by mixing the buffered SDS solutions with 
1-propanol to produce a 5:95 organic-aqueous mixture. Mobile 
phases were filtered and degassed prior to use.
The 25 fig/ml working stock solutions of chlorthalidone and 
frusemide were diluted (1:9) in mobile phase and a 20 [L\ aliquot 
injected for chromatography. The retention times of the two drugs 
were measured as a function of SDS concentration.
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4.3.4.3. Effect of percentage of 1-propanol in the mobile 
phase on the retention of chlorthalidone and 
frusemide
A solution containg 0.05M SDS in 0.01M phosphate buffer, pH 4.5, 
was prepared. Mobile phases were prepared by mixing this solution 
with 1-propanol to generate either a 5:95 or 3:97 aqueous-alcohol 
mixture. The 25/¿g/ml working stock solutions of chlorthalidone 
and frusemide were diluted (1:9) In mobile phase and a 20 fil 
aliquot injected for chromatography. The retention times of the 
two drugs were measured as a function of percentage organic 
modifier.
4.3.4.4. On-line solid-phase extraction by column switching
The instrument arrangement used in this section has been 
previously described in chapter 2. The concentration columns were 
packed with either RP-18, RP-8, or cyano- packing material. The 
wash solutions delivered to the concentration column were as 
fol lows*.
(i) deionised water
(ii) deionised water containing 0.1% phosphoric acid
(iii) deionised water containing 5% methanol
(iv) 0.01 M phosphate buffer, pH 5.0, containing 0.005 M
tetramethylammonium bromide
The wash solution was delivered at a flow rate of 1.0 ml/min and 
for 60-90 seconds, and the drugs were swept from the 
concentration in a backflush mode in order to minimise band 
broadening effects. Various pre-treatment operations carried out 
on the plasma prior to injection will be described in the 
section 4.4.
4.3.4.5. Extraction procedure
Aliquots of drug-free plasma were spiked with 50 /¿I of
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chlorthalidone and 50 fi 1 of xipamide working stock solutions, or 
with methanol-water (1*1) to generate plasma blanks. The plasma 
was then treated either by the addition of an equal volume of 
0.067 M potassium dihydrogen phosphate, 0.1 M phosphate buffer of 
pH 7.4 or 8.0, or by the addition of 200 mg lithium chloride, 
calcium chloride or sodium bicarbonate. Following vortex mixing 
for 10 s , 4 ml diethyl ether-isopropanol (19:1) were added, and 
the drugs were extracted by further vortexing for 60 s. After 
centrifugation for 15 min at 1000 g, the upper organic layer was 
transferred to a clean polypropylene tube and evaporated to 
dryness at 40°C under a gentle stream of air. The residue was 
reconstituted in 200 [i 1 of mobile phase, and an aliquot of 100 fi\ 
was injected for chromatography.
4.3.4.6. Ca1ibration and Ca1cuIation
For calibration, a set of standards containing 50-800 /xg/ml of 
chlorthalidone was prepared by serial dilution of the working 
stock solution in methanol-water (1:1). 0.5 ml aliquots of 
drug-free plasma were spiked with 50 ¡il of chlorthalidone (C) and 
50 fil xipamide, the internal standard (IS). Plasma blanks were 
made by adding 100 fil methanol-water (1:1) to 0.5 ml aliquots of 
drug-free plasma. The plasma pH was adjusted to 7.4 and subjected 
to the extraction procedure described above. Evaluation of the 
assay was carried out by the construction of a six-point 
calibration graph covering the concentration range 50-800 ng/ml 
of chlorthalidone in plasma. The slope and intercept of the 
calibration graphs were determined through linear regression of 
the drug to IS peak height ratios versus drug concentration. 
Individual peak height ratios were then interpolated on the 
calibration graphs to determine the values of "concentrations 
found" compared with "concentrations added".
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4.4. RESULTS AND DISCUSSION
4.4.1. Micellar chromatographic characteristics
of chiorthalidone and frusemide.
Initially, the micellar chromatographic characteristics of 
chlorthalidone and frusemide were investigated with the aim of 
using the latter as an internal standard for the former. The 
chosen starting point was a mobile phase consisting of 
l-propanol-0.08 M SDS in 0.01 M phosphate buffer, pH 7.0 (5:95). 
This concentration of SDS was selected as it is 10 times the 
critical micelle concentration (0.008 M [51]), and thus abundant 
micelles would be available to interact with solutes. Propanol 
was chosen as the organic modifier because Dorsey et al. found 
that propanol produces more than double the increase in plate 
number than methanol when added in the same concentration to 
solutions of SDS [32]. Under these chromatographic conditions, 
frusemide and chlorthalidone eluted with retention times of 2.3 
and 8.0 minutes, respectively. Whereas this represented an 
adequate retention for chlorthalidone, frusemide would have to be 
held longer on the column to permit its separation from the 
solvent front and its eventual quantitation in plasma. The 
approach adopted at this point was to alter the mobile phase pH 
since frusemide is an organic acid (pKa = 3.6 [52]) and at pH 
7.0, would exist principally as the carboxylate anion. Since 
negatively charged SDS monomers become adsorbed onto the 
hydrophobic stationary phase [27-30], the like-charged anionic 
form of frusemide would be electrostatically repulsed by the 
column surface, and would therefore elute rapidly with the 
solvent front. This effect is augmented by a similar 
electrostatic repulsion between the charged drug and the 
negatively-charged micellar assemblies which induces the drug to 
move rapidly down the column in the bulk medium. Although 
hydrophobic interaction with the stationary phase is still 
possible, its effect will be reduced by the electrostatic 
repulsion.
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The effect of varying the pH between 7.0 and 4.5 on the retention 
of the chlorthalidone and frusemide is shown in Figure 4.1. As as 
may be seen, the retention time of chlorthalidone remained 
virtually unchanged while frusemide was retained longer on the 
column, consistent with an increased population of the uncharged 
species as the pH is lowered. Since pH 4.5 yielded satisfactory 
retention for the two drugs, this value was the chosen pH for 
following experiments. Chromatograms depicting the retention of 
chlorthalidone and frusemide are shown in Figure 4.2.
The next variable to be changed was the concentration of SDS in 
the mobile phase. It has been well established since the 
inception of micellar liquid chromatography [26] that there is a 
general decrease in retention as the concentration of surfactant 
is increased, and as the rate of decrease is solute-dependent, 
reversals in elution order are frequently encountered. The effect 
of varying the SDS concentration between 0.1 M and 0.025 M on 
solute retention is shown in Figure 4.3. This graph shows that 
the effect of surfactant concentration on chlorthalidone is more 
pronounced than on frusemide, and at higher SDS concentrations 
the two lines approach intersection. The smaller decrease in 
retention observed for frusemide may possibly be explained by the 
shift to a higher pKa value induced by the anionic surfactant 
system, an effect which generally increases with increasing 
surfactant concentration [53,54]. If the pKg of frusemide is 
raised, a greater proportion of molecules will be uncharged thus 
promoting increased retention, which operates to counteract 
shorter retention times caused by increased surfactant 
concentration. For the purpose of the present work, a 
concentration of 0.05 M SDS was chosen since it gave good 
separation of the two drugs in a reasonable elution time (8.5 and
11.0 minutes for frusemide and chlorthalidone, respectively).
As Dorsey et al. found little improvement in efficiency (though 
reductions in retention times were observed) with concentrations 
of 1-propanol greater than 3% [32], the next step in the present 
work was to reduce the percentage propanol from 5 to 3%.
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Figure 4.1.
Effect of buffer pH on drug retention time
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Figure 4.2.
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(a)s mobile phase = 0.08 M SDS in 0.01 H phosphate buffer,
pH 7.0-isopropanol (95:5)
(b) mobile phase = 0.08 M SDS in 0.01 M phosphate buffer,
pH 4.5-isopropanol (95:5)
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Figure 4.3.
Effect of SDS concentration on drug retention time
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Lowering the percentage of 1-propanol was found to increase the 
retention times of both compounds, so that chlorthalidone was 
retained for 13.2 minutes on the column. This finding, coupled 
with the fact that the higher percentage of propanol helps to 
reduce the considerable frothing generated when working with 
micellar solutions, contributed to the decision to continue using 
5% 1-propanol in the mobile phase. Higher concentrations of 
organic modifier were not investigated since it is desirable to 
keep the concentration low in order to maintain the integrity of 
the micelle and minimise expense. Chromatograms showing the 
retention of the drugs with 3% and 5% isopropanol in the mobile 
phase are presented in Figure 4.4.
4.4.2. Application of on-line solid-phase extraction with
column switching to micellar chromatography
The analytical arrangement was coupled to a column-switching 
assembly as previously described. The general approach was to 
start with the simplest system possible, and to introduce 
elaboration only if necessary. The concentration column was 
packed with RP-18, RP-8 or cyano- packing materials with a wash 
solution of deionised water at a flow rate of 1 ml/min for 1 min. 
This wash regimen was maintained throughout the development work, 
unless otherwise stated. The analytical column was connected to 
the concentration column for the duration of the chromatographic 
run, and 250 fil aliquots of plasma or authentic (aqueous) 
standards in concentrations of 1.0 fig/ml were injected for 
analysis.
The three types of packing materials were evaluated in terms of 
drug recovery (as compared to direct injection) and the amount of 
plasma interferences appearing on the chromatogram. Of the three, 
the Cg- concentration column proved most promising in terms of 
recovery of aqueous drug standards: recovery was 55% and 70% for 
frusemide and chlorthalidone, respectively. However, drug 
recovery from plasma was 50% or less for chlorthalidone in all
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Figure 4.4.
Chromatograms of chlorthalidone and frusemide showing the effect 
of percentage organic modifier on retention time
TIME(min)--------------------------------------------------------- >
Cs chlorthalidone; F: frusemide
(a): mobile phase = 0.05 M SDS in 0.01 M phosphate buffer,
pH 4.5-isopropanol (95:5)
(b); mobile phase - 0.05 M SDS in 0.01 M phosphate buffer,
pH 4.5-isopropanol (97:3)
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cases and frusemide was not recovered at all from plasma. It was 
decided to persist with the investigation of the Cg- 
concentration column with a view to increasing retention of both 
drugs, (especially frusemide) on this column. It was also sought 
to increase recovery of both drugs from plasma. As frusemide is 
an acidic drug, its affinity for the hydrophobic packing material 
will be enhanced at low pH when its ionisation is suppressed. To 
this end, 0.1% phosphoric acid was added to the wash solution, a 
measure which improved recovery of the drug, but which caused the 
appearance of interfering peaks originating in the plasma. This 
problem developed because many plasma components are also acidic, 
and their affinity for reversed-phase packing materials is also 
enhanced at low pH.
Blank plasma profiles were improved by the addition of 5% 
methanol to the wash solution but offered no advantage in terms 
of drug recovery from plasma, and the breakthrough volumes for' 
the pure drug solutions were somewhat reduced. Another wash 
solution tried was 0.005M tetrabutylammonium bromide in phosphate 
buffer, pH 5.0. This yielded good recovery (> 70%) for the 
aqueous standards of both drugs and the blank plasma chromatogram 
was peak-free. However, the peak heights for both drugs in spiked 
plasma were reduced to less than 20% of the aqueous standards. 
Chromatograms showing authentic standards, blank plasma and 
spiked plasma using TMA-Br in the wash solution are presented in 
Figure 4.5.
It was decided to attempt treatment of the plasma prior to 
injection which might enhance drug recovery, particularly 
frusemide, from plasma, without generating unwanted peaks on the 
chromatogram. 1 ml samples were treated with an acid, a base and 
various salts, and 250 fil aliquots were injected. The addition of 
salicylic acid affected only slight improvement in the amount of 
drug recovered, and a large interfering peak appeared in the 
chromatogram. Hydrochloric acid produced a more pronounced 
increase in drug recovery from plasma, but also produced 
interfering peaks in the chromatogram (Figure 4.6). It was found
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Chromatograms showing drug standards and plasma extracts using 
TMA-Br as the washing solvent
Figure 4.5.
TIME (min )--------------------------------------------------------- >
C: chlorthalidone 2.5/ig/ml; F: frusemide 2.5/xg/ml
(a): authentic standards, (b): blank plasma? (c): spiked plasma
Mobile phase ! 0.05 M SDS in 0.01 M phosphate buffer, 
pH 4.5-isopropanol (95:5)
Wash solution: 0.005 M TMA-Br in 0.01 M phosphate buffer, pH 5.0
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Effect of pretreatInq plasma with 20», 1 H HCL prior to injection 
onto concentration column
Figure 4.6.
TIME(min)--------------------------------------------------------- >
Blank plasma
Mobile phase : 0.05 M SDS in 0.01 M phosphate buffer, 
pH 4.5-Isopropanol (95:5)
Wash solution: deionised water
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that if 10% of a 1 M solution of NaOH was added to the plasma, 
cleaner blank plasma extracts were obtained, but the drugs were 
not recovered from spiked plasma (Figure 4.7). Adding salts such 
as sodium carbonate, sodium bicarbonate and lithium chloride 
generated peak-free blank plasma chromatograms, but recovery was 
less than 10% for both frusemide and chlorthalidone.
In addition to the problems of poor recovery and interfering 
plasma peaks, a pressure drop across the concentration columnm 
was observed to build up very quickly. It was then found if blank 
plasma was injected repeatedly using deionised water to wash the 
concentration column, that with continued injections, 
progressively more plasma remained on the concentration column, 
only to be swept onto the analytical column in the next 
back-flush operation. This process is illustrated in Figure 4.8. 
It is thought that the concentration column was continually being 
modified by alternate layers of surfactant and plasma components. 
It is known that surfactant monomers adsorb onto reversed-phase 
materials, and it is quite possible that this phenomenon gave the 
Cg- packing an additional retentive capacity for endogenous 
plasma constituents, which is absent in unmodified reversed-phase 
surfaces. Ultimately back-pressure in the system became 
prohibitive, and as there was a distinct possibility of 
contaminating the analytical column, it was necessary to perform 
a pre-treatment step, which would not only encourage drug 
retention on the concentration column, but would effect removal 
of contaminants as well.
The approach adopted was to add 10% trichloroacetic acid followed 
by centrifugation of the precipitated proteins and injection of 
the clear supernatant. It was hoped that this would release 
frusemide from protein binding sites. This measure, however, 
yielded poor recovery for both drugs as well a high background 
from plasma. A chromatogram depicting a spiked plasma sample 
after a trichloroacetic acid precipitation and injection onto the 
concentration column is shown in Figure 4.9. Adding the basic 
precipitant zinc sulphate plus sodium hydroxide similarly gave
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Figure 4.7.
Effect of pretreat1no Plasma with 20% of 1 H NaOH prior to 
in I action onto concentration column
TIMEUin)
Mobile phase
>
chlorthalidone 2.5 /¿g/ml and frusemide 2.5/i 
g/nl in plasma
0.05 M SDS in 0.01 M phosphate buffer, 
pH 4.5-isopropanol (95»5)
Wash solution: deionised water
Figure 4.8.
Plasma build-up on concentration column with repeated Injection 
of 250/xl aliquots.
\
n  I I 1 I I T
2 4 6 8X11214
TIME(min)-
(a-d) : second, fourth, sixth and eight injections of 250 fi 1 
aliquots of blank plasma onto concentration column
Mobile phasei 0.05 M SDS In 0.01 M phosphate buffer, 
pH 4.5-isopropanol (95*5)
Wash solution« deionised water
r~ r  i — n — I I I " I 
2 4 6 8101214
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Figure 4.9.
Spiked plasma chromatogram following precipitation with TCA and 
injection onto the concentration column
Plasma spiked with 2 .5  /xg/ml chlorthalidone (C) and 2 .5  /xg/ml 
frusemide
Mobile phase : 0 .0 5  M SDS in 0.01 M phosphate b u ffer ,  
pH 4 . 5 - isopropanol (95:5)
Wash solution: deionised water
2 4 6 8 10 12 14 16
Time(min) >
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poor recovery though less interferences from the plasma. Repeated 
injections of up to 500 fx1 of plasma deproteinised with an equal 
volume of acetonltrile produced none of the problems associated 
with the injection of untreated plasma. When drug-spiked 
protein-precipitated plasma samples were injected, however, 
recovery of both drugs was unacceptably low owing to the 
acetonitrile effecting elution of the drugs during the wash 
phase. The acetonitrile was then removed by partial evaporation, 
but this resulted in a high plasma background (Figure 4.10) and 
poor recovery of frusemide, possibly due to the fact that it is 
highly protein bound.
4.4.3. Liquid-liquid extraction of chlorthalidone
and xipamide followed by micellar chromatography.
At this stage it became obvious that a reasonably elaborate 
plasma clean-up procedure was being employed, i.e., addition of 
acetonitrile, vortexing, centrifugation, decanting and 
evaporating the supernatant, followed by column switching, a 
technique originally devised to obviate the need for all the 
foregoing steps. It had also, as outlined above, become obvious 
during the course of this work, that it would be necessary to 
carry out some kind of pre-treatment to permit repeated 
injections of plasma onto the concentration column. It was 
therefore decided to eliminate the column switching step and, if 
possible, develop a rapid one-step liquid-liquid extraction 
method which would remove plasma interferents and enrich the drug 
through pre-concentration. Co-extraction of the two drugs into 
an organic solvent would have been difficult as frusemide (pKg 
- 3.6) would favour low pH for extraction, whereas chlorthalidone 
is extracted at pH 7.4 [16].
An alternative diuretic was sought to serve as a suitable 
internal standard for chlorthalidone . Metolazone, which is 
structurally related to, and elutes with a similar retention time 
as chlorthalidone, proved not to be a viable alternative owing to 
Its high instability under the experimental conditions employed.
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Blank plasma chromatogram following precipitation with 
acetonltrlle, evaporation and inlection onto concentration column
Figure 4.10.
Time(nin)
Mobile phase » 0.05 M SDS In 0.01 M phosphate buffer, 
pH 4.5-isopropanol (95:5)
Wash solution» deionised water
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Another diuretic, xipamide, was more stable than metolazone, and 
was selected as the new internal standard.
In order to reduce the retention time of xipamide from 16.5 
minutes, the pH of mobile phase was increased from 4.5 as used 
above, to pH 5.8. Under these conditions, chlorthalidone and 
xipamide eluted with mean retention times of 11.5 and 14.5 
minutes, respectively. By further increasing eluent pH, it would 
have been possible to further reduce the retention time of the 
weakly acidic xipamide (pfCa - 4.75) [55], but this would cause 
it to merge with the peak for caffeine, which is frequently 
present in plasma, and would therefore interfere with the assay. 
The first approach was to add 200 mg lithium chloride to the 
plasma, followed by extraction of the drugs into diethyl 
ether-isopropanol (19:1), a method which had worked successfully 
in the extraction of xipamide into diethyl ether in previous work 
described in chapter 3.
In this case, although the drugs were extracted, the blank plasma 
chromatograms contained interfering peaks, and the same result 
was found for other salts, i.e., calcium chloride and sodium 
bicarbonate (Figure 4.11). As outlined in the introduction, 
Fleuren and van Rossum [16] developed a sensitive GLC method 
which involved the extraction of chlorthalidone from plasma 
buffered to pH 7.4 and an HPLC method was described by Guelen et 
al. [10] in which an equal volume of 0.067 M potassium dihydrogen 
phosphate solution was added to plasma prior to extraction into 
diethyl ether. Both buffers were tried followed by extraction 
into diethyl ether-isopropanol (19:1). The higher pH buffer 
yielded cleaner blank plasma chromatograms and comparable 
recovery for chlorthalidone. Buffering (with sodium phosphate 
buffer at pH 8.0) was also tried, a measure which did not 
increase the recovery of chlorthalidone, but caused a marked 
reduction in the recovery of xipamide.
Finally, an equal volume of 1 M phosphate buffer at pH 7.4 was 
added to the plasma and the drugs were extracted using the
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Blank plasma extractions into dlethvl ether-isopropanol following 
treatment with inorganic s a l t s
Figure 4.11.
Tioe(min)-
(a). NaHC03> (b): L1C1» (c): CaCl2
Mobile phase : 0 .05  M SDS in 0.01 M phosphate b u ffer ,  
pH 5 . 8 - isopropanol (95:5)
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procedure outlined in section 4.3.4.5. The residues following 
evaporation were reconstituted in 200 1 mobile phase and 100 1
was injected for chromatography. The mobile phase was 0.05 M SDS 
in phosphate buffer (0.01 M, pH 5.8) and it was delivered at a 
flow rate of 1.3 ml/min in order to reduce run times. Under these 
chromatographic conditions, the mean retention times for the 
elution of chlorthalidone and xipamide were 8.4 and 12.0 min, 
respectively, and both peaks were separated from endogenous 
plasma interferents and an added caffeine peak. Chromatograms 
showing blank and spiked plasma following this extraction 
procedure and the described chromatography are depicted in Figure
4.12.
4.4.4. Assay validation
Evaluation of the assay was carried out by the construction of a 
six-point calibration curve covering the concentration range 
50-800 ng/ml chlorthalidone in plasma as outlined in section
4.3.4.6. A number of parameters, which have been discussed in 
section 2.6.6., were measured in order to check the reliability 
of the method.
4.4.4.1. Limit of detection
The limit of quantitation of the method was 50 ng/ml: this was 
the level at which quantitative measurement of the peaks was 
consistently possible. The chromatograms presented in Figure
4.12. indicate that it should be possible to detect 25 ng/ml or 
lower, although it is improbable that consistent measurement at 
this level would be feasible. Although peak plasma levels of 
chlorthalidone may be as low as 100 ng/nl, they can rise to 1000 
ng/ml, depending on the dose.
4.4.4.2. Precision
The data presented in table 4.2 demonstrate the inter- and 
intra-assay variation of the method. The same methods used in
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Figure 4.12.
Sample chromatograms from validation study
3 6 9 12 15
TIME (min)
(a): drug-free human plasma; (b): plasma containing 100 ng/nl 
chlorthalidone (C) and 2.5 g/ml xipamide (IS); (c): plasma 
containing 800 ng/ml chlorthalidone and 2.5 g/ml xipamide
Mobile phase s 0.05 M SDS in 0.01 M phosphate buffer, 
pH 5.8-isopropanol (95*5)
Detector sensitivity* 0.02 AUFS
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Ta
bl
e 
4.
2
Amount R a t i o  Mean
C h l o r t h a l i d o n e  R a t i o
Added ( g / r e l )  ______
0 .0 54
50 0 . 0 4 9  0 . 0 5 3
0 .054  
0 . 0 5 5
0 . 01 9
100 0 . 1 1 2  0 . 10 4
0.101 
0 .0 9 2
0 .2 09
200 0 .2 0 5  0 . 2 0 0
0 .19 4
>4 0 . 1 9 0f0 W
io ° -434
1 400 0 . 4 1 8  0 . 4 2 0
2  0 . 4 0 9
£  0 . 4 1 9
>4 0 .631
600 0 .6 3 4  0 .6 16
I !  0 . 6 0 7
S  0 .591
c
0 .8 99
_  800 0 . 8 9 9  0 .5 88
C  0 . 81 210
co
w
0 .8 2 3
Mean Z C o e f f i c i e n t  o f  V a r i a t i o n  = 4 , 6 2  
O R e g r e s s i o n  L i n e :  y = 1 .00  x 10- J  x -  6 . 4 5  >
^  C o r r e l a t i o n  C o e f f i c i e n t  ( r )  = 0 . 9 9 9
Amount
Found
( n g / m l j
56 .8  
53 .0
56 .8  
5 7 .7
108.5 
1 1 2 . 0  
100.9
9 2 . 5
2 0 2 .4
198.6  
188.3
184.5
4 1 4 . 7
39 8 .7
3 9 1 .2
3 97 . 8
598 .8
6 0 2 .6
576 .3
561 .2
8 5 0 . 6
8 5 0 . 6
768 .9
779 .2
I0"3
Mean S t a n d a r d  C o e f f i c i e n t  D i f f e r e n c e  b e tw een
Amt. Found D e v i a t i o n  o f  V a r i a t i o n  added  and found (%)
(n g / m l )  ( n g / m l )  %
56.1  2 . 1  3 . 7  12.2
103 .5  8 . 7  8 . 4  3 . 5
193 .5  8 . 4  4 . 3  3 .3
4 0 0 . 6  10 .0  2 . 5  0 . 2
584 .7 19 .5 3 . 3 2.6
44 .4 5 . 5 1.5
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Table 4.2 continued
Precision and linearity Inter-assay
Amount Peak Height Amount Found
added na/nl ratio_____  ng/ml_______
50 0.061 53.7
100 0.128 109.4
200 0.230 194.3
400 0.470 393.8
600 0.697 582.8
800 0.978 816.2
50 0.056 58.5
100 0.106 102.0
200 0.220 196.4
400 0.450 388.9
600 0.695 593.7
800 0.954 810.3
50 0.060 60.5
100 0.111 108.1
200 0.217 198.8
400 0.445 399.7
600 0.600 536.3
800 0.952 846.5
50 0.062 54.9
100 0.126 111.6
200 0.218 193.0
400 0.436 385.9
600 0.667 590.4
800 0.921 814.3
Concentration ng/ml
50 100 200 400 600
Mean Amount 56.9 107.8 195.6 392.1 575.8
Found ng/ml
Standard 3.1 4.1 2.5 6.0 26.6
Deviation
Coefficient of 5.4 3.8 1.3 1.5 4.6
variation %
Difference +13.8 +7.8 -2.2 -2.0 -4.0
between added 
and found %
Mean coefficient of variation - 3.1%
800
821.8
16.6
2.0
+2.7
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chapter 3 for the determination of xipamide were applied here. 
Inter-assay variation was assessed singly in four replicate runs 
covering the concentration range 50-800 ng/ml chlorthalidone in 
plasma. Inter-assay variation was determined in quadruplicate in 
the same concentration range. The precision of the method (mean 
coefficient of variation) was determined for chlorthalidone to 
xipamide peak height ratios after they had been interpolated as 
unknowns on the regression lines. For inter-assay variation, the 
interpolations were based on the four regression lines generated 
from four replicate runs, and the mean coefficient of variation 
was found to be 3.1%. For intra-assay variation, the 
interpolations were based on a single regression line from the 
quadruplicate run, and the mean coefficient of variation was 
found to be 4.6%.
4.4.4.3. Linearity
Measures of linearity, as defined by the correlation coefficient 
of the regression line and the percentage difference between 
added and found concentrations for intra-assay values are 
presented in Table 4.2. The correlation coefficient (r) of the 
regression line for the mean intra-assay values was better than 
0.999 and, as can be seen from the equation of the regression 
line (also given in Table 4.2), the intercept does not differ 
significantly from zero.
4.4.4.4. Recovery
Recovery of chlorthalidone from plasma was measured by two 
methods:
(i) by calculating the percentage difference between the peak 
heights of extracted standards and those of authentic 
(unextracted) standards at each of the six points over the 
concentration range 50-800 ng/ml chlorthalidone in plasma?
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(ii) by comparing the slopes of the two regression lines 
generated from the extracted and authentic standards used to 
calculate recovery by method (i), with the extracted slope as a 
percentage of the authentic slope yielding a measure of the 
amount recovered. Both authentic and extracted standards were 
processed and injected in duplicate.
Using these methods, the mean overall percentage recovery of 
chlorthalidone from plasma was found to be 71.6%. Results of this 
experiment are presented in Table 4.3.
4.4.4.5. Selectivity
The drugs are separated from any endogenous plasma components as 
can be seen from the chromatograms presented in Figure 4.12. A 
number of drugs likely to be co-administered with chlorthalidone 
were investigated as potential interferents with the method.
These included the diuretic triamterene, the beta-blocking agents 
propranolol, atenolol, pindolol and metoprolol, and the xanthines 
theophylline and caffeine. None of these drugs interfered with 
either the chlorthalidone of xipamide peaks, but atenolol was 
found to elute just after xipamide, showing that it could act as 
an internal standard for either of these drugs (or indeed, 
vice-versa). Of greater significance, however, is the fact that 
chlorthalidone and atenolol are available commercially as a 
combined preparation, and this method could be applied, possibly 
without modification, to their co-determination in body fluids. A 
chromatogram showing the three drugs is presented in Figure 4.13.
4.5. CONCLUSION
Micellar chromatography presents an attractive alternative to 
conventional hydro-organic mobile phases. The solvents used are 
cheaper, less hazardous and less toxic than many organic 
solvents. It offers an added degree of selectivity to separations 
owing to the unique nature of micellar solutions, and retention 
may be controlled simply by altering the surfactant
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Table 4.3.
Results of recovery of chlorthalidone studies
Mean peak height (mm) (n - 2)
Concentration Authentic Extracted Recovery
na/ml standards______ standards %
50 9.0 5.8 64.4
100 18.0 12.5 69.4
200 35.0 26.5 75.7
400 69.5 50.5 72.7
600 103.0 72.5 70.4
800 148.0 107.5 72.6
Method (i)s Mean recovery (+ standard deviation) = 70.9 ± 3.8%
Method (ii): Mean recovery - [slope)extracted)/slope(authentic)) 
x 100%
Authentic standards: y - 0.018x - 0.125; r = 0.999
Extracted standards: y - 0.013x - 0.104; r = 0.997
Siope(extracted)/slope(authentic) - 0.013/0.018 - 0.722 
Mean percentage recovery - 72.2%
Overall mean percentage recovery = 71.6%
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Figure 4.13.
Sample chromatograms from selectivity study
TIME (min)------------------------------------------------------->
Chlorthalidone (C), xipamide (X) and atenolol (A)
Mobile phase : 0.05 M SDS in 0.01 M phosphate buffer, 
pH 5.8-isopropanol (95:5)
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concentration. The principal disadvantage of micellar systems, 
loss of chromatographic efficiency, can be overcome by the 
addition of a small amount (3-10%) of propanol, and by operating 
at elevated temperatures.
The results of this study indicate that micellar chromatography 
does not lend itself as readily as traditional hydro-organic 
systems to coupling with an on-line column-switching method of 
plasma clean-up, and that direct injection onto reversed-phase 
concentration columns is not a practical proposition for large 
volumes of untreated body fluids. Where drugs are present in 
large concentrations, filtered raw serum may be introduced 
directly onto the analytical column, whereupon the proteinaceous 
material is solubilised and the compounds are separated free of 
interferences.
As shown in the present work, the problems associated with direct 
injection may be circumvented by combining micellar 
chromatography with a suitable 1iquid-1iquid extaction scheme. 
Since the attraction of micellar chromatography lies at least in 
part in its ability to offer added selectivity in the separation 
of closely related compounds, employment of the technique for 
this purpose should not present any problems as far as the 
co-extraction of analytes is concerned.
Statistical evaluation of the inter-and intra-assay results for 
the chlorthalidone assay reveals that this method can offer 
levels of reproducibility, linearity and recovery comparable with 
traditional hydro-organic mobile phases. A limit of detection of 
50 ng/ml is adequate for plasma measurements, provided the dose 
is not very low (i.e. less than 20 mg per day). It should be 
quite possible, however, to apply this extraction scheme to whole 
blood samples in order to capitalise on the selective uptake of 
chlorthalidone into red blood cells, and to follow this with 
micellar chromatography in order to exploit the unique features 
of this novel chromatographic mode.
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CHAPTER 5
RETENTION CHARACTERISTICS 
IN HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
OF BASIC DRUGS AND PLASMA EXTRACTS 
ON AN UNMODIFIED SILICA COLUMN
USING REVERSED-PHASE ELUENTS
5.1. INTRODUCTION
Reversed-phase chromatography, where the eluent is more polar 
than the solid support, has become the method of choice for a 
wide range of analytical applications, particularly in the field 
of biopharmaceutical analysis. It is now possible to produce a 
diverse array of bonded phase materials which can be tailored to 
meet a variety of analytical needs. In spite, however, of the 
advanced technology in this area, it is possible only to achieve 
some 50% coverage of the hydroxyl groups on the silica surface 
[1,2]. These silanol moieties are acidic in nature, and are 
therefore ionised at neutral or basic pH? indeed some silanol 
groups are more strongly acidic than others, and these are 
ionised even under moderately acidic conditions [3]. Since 
reversed-phase materials are widely used for the chromatography 
of polar molecules, silanol groups which remain accessible after 
bonding has taken place are likely to make an important 
contribution to the chromatography of such compounds [4-6]: in 
particular, solute molecules containing an amine functionality 
interact electrostatically with these residual silanol moieties 
[4-11]. Ionic interactions between the residual acidic sites and 
oppositely charged protonated bases give rise to badly tailing 
peaks for basic componds (including drugs of therapeutic and 
forensic interest) on reversed phase columns [4-6,8,12-15].
Much attention has been paid to circumventing the problem of 
unreacted silanol groups through ion suppression [16], paired ion 
techniques [16,17], or by the use of end-capping [18]. 
Bidlingmeyer et a I. [12] have proposed that it is not 
specifically the presence or number of residual silanols which is 
responsible for the poor chromatographic characteristics, but how 
accessible they are. He supported this hypothesis by showing no 
deterioriation in efficiency in going from a fully- to a 
partially- bonded silica column. He further proposed that on a 
"fully" bonded column, the remaining silanols may be located in 
micropores which are blocked by the thicker mobile phase, and as 
a result of diminished accessibility, mass transfer is reduced,
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leading to poor efficiency and peak shapes.
If, instead of vigorously trying to eliminate the surface silanol 
contribution to retention on bonded columns, an unmodified silica 
column in conjunction with a reversed-phase eluent is employed, 
as first reported by Jane in 1975 [19], the amine-silanol 
interaction is exploited, and efficient separations have been 
obtained using buffered aqueous methanol-rich mobile phases at 
high pH in a chromatographic mode which has since been described 
as "pseudo reversed-phase" [15].
5.1.1. Mechanisms of interaction
The mechanisms involved in these polar interactions on silica 
with mixed aqueous-organic eluents at high pH have not been fully 
elucidated. Much work has been devoted to the determination of 
the factors influencing retention and separation [4,8-10,12-15], 
One of the ways silica can interact with solutes is felt by some 
to involve ion exchange [9,10,12-14,20]. This has been supported 
by data which show a decrease in retention with an increase in 
ionic strength [4,9,12-14,20], and an increase in retention for 
quaternary amines with an increase in pH [10,12-14].
In support of an ion exchange theory, Sugden et al. [8] 
demonstrated a linear relationship between retention and the 
reciprocal of the ionic strength on an unmodified silica column 
for cocaine and a number of other local anaesthetics of varying 
basicity. Hansen [21] reported that the retention of opiates 
using eluents containing 50-90% water was governed almost 
exclusively by ion exchange processes. In a later publication 
Flanagan and Jane [3] demonstrated a linear relationship between 
the log1Q of the capacity factor and the log^Q of the ionic 
strength at constant pH. They also showed increased retention for 
basic drugs with increasing pH until their pKg values were 
approached, whereupon retention started to decrease concommitant 
with reduced solute ionisation. The ion exchange theory has also 
been supported in recent work by Law [20] where he showed
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that using alkaline aqueous-organic eluents, retention decreased 
with increased buffer strength. He also established a linear 
relationship between the log^Q of the retention and drug pKa, 
and showed that within any group of homologous compounds, the 
correlation coefficient for this relationship ranged between 
0.959 and 0.996.
The mechanism of chromatography encountered on unmodified silica 
with mixed aqueous-organic eluents at high pH has been attributed 
to factors other than ion exchange. Sugden et al. [8] 
demonstrated reduced retention for the amines as the hydrogen ion 
concentration was increased, and attributed this phenomenon not 
to reduced silanol ionisation, but to greater ion-pair formation 
between the cationic solute and the counter-ion in the mobile 
phase. Crommen [7], using acidic aqueous eluents of an 
appropriate pH and ionic strength, also concluded that ion pair 
formation was the major influence on the retention of the 
compounds studied. In addition, Flanagan and Jane [3] found some 
factors which were difficult to reconcile with the simple 
ion-exchange model of retention. Notably, there was an elution 
sequence of a series of fully protonated amines and and a 
quaternary ammonium compound in the order primary, secondary, 
tertiary, quaternary, meaning that there is increased affinity 
for the column according to ionic size, which is opposite to that 
predicted by the ion exchange model. One possible explanation for 
this is the greater solvation for the less substituted analytes, 
to give them larger effective ionic radii and hence shorter 
retention times.
Cox and Stout [15] found a positive intercept when plotting 
retention against the reciprocal of the competing ion 
concentration. They took these findings as evidence for retention 
mechanisms additional to ion exchange, since ion exchange theory 
[22] predicts that for a pure ion exchange mechanism, the plot of 
retention against the inverse of competing ion concentration 
should give a straight line passing through the origin of the 
plot, with the slope being proportional to the ion exchange
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equilibrium constant and the ion exchange capacity of the packing 
material. Law [20] found a near linear relationship between 
retention time and the reciprocal of the buffer concentration.
The fact that there was a slight deviation was attributed to the 
operation of more than one retention mechanism. This was also 
suggested by the fact that the curves did not have a common 
y-intercept, a phenomenon which is commonly observed with ion 
exchange media [22].
Bidlingmeyer et al. [12] proposed that the retention of organic 
amines on silica depended on both electrostatic and adsorption 
forces. In support of the adsorption theory, they demonstrated 
increased retention for a series of basic drugs (for example, 
propranolol, promethazine and chlorpheniramine) as the amount of 
water in the mobile phase was increased from 30% to 70%. The 
observed linear relationship of a plot of log^0 capacity factor 
versus solvent composition was typical for reversed-phase 
systems. They concluded that "reversed-phase" behaviour of silica 
under these conditions was due to solutes interacting with 
siloxane bridges, and that the mechanism by which this 
hydrophobic retention is mediated is similar to the ion 
interaction model of ion pair chromatography.
Cox and Stout [15] studied the retention of thiamine and morphine 
under conditions of varying methanol concentration in 0.05 M 
phosphate buffer pH 4.6. Unlike Bidlingmeyer et al. [12], they 
found low retention at both very high and very low concentrations 
of methanol. In agreement with other workers they attributed the 
U-shape of the curve to hydrophobic interactions at low methanol 
concentrations and changes in counter-ion solvation at high 
methanol concentrations [8,23]. In agreement with Bidlingmeyer et 
al.. Cox and Stout also proposed some interaction between 
analytes and siloxane bridges, but found that it contributed more 
significantly to the retention of unionised species such as 
caffeine, than ionised species such as morphine. By carrying out 
experiments on the retention of solutes both on silica which had 
been prepared by a standard procedure, and silica which had been
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subjected to a hydroxyl at ion procedure analagous to that of 
Kohler and Kirkland [24], they found that the retention of 
unionised solutes was reduced on the rehydroxylated silica. As 
rehydroxylation reduces the population of siloxane bridges on the 
silica surface by their conversion to silanol groups, they 
concluded that for unionised species, retention occurs via 
interaction with siloxane bridges.
On the other hand, Flanagan and Jane [3] found that 
non-protonated bases (for example, diazepam) were unretained and 
concluded that there was no evidence to suggest that interaction 
between unionised silanols and/or siloxane bridges and 
non-protonated bases was taking place. Law [20] found that 
retention was influenced by the stereochemistry of the analyte 
and the degree of substitution at or near the basic centre. 
Because the effects of certain types of substitution were 
difficult to rationalise in terms of a simple ion exchange model 
(for example N-methylation or N-oxidation), he concluded that 
other factors contribute to retention, but that they did not 
involve reversed phase or dipole-dipole interactions.
Clearly there are conflicting opinions as to what factors are 
responsible for the control of retention in this type of 
chromatography, particularly in relation to the importance of the 
ion exchange mechanism and the nature of secondary, though 
obviously still relevant, interactions. Apart from ion exchange, 
retention has been variously attributed to partitioning of ion 
pairs [7,8], dipole interactions, Van der Waals forces and 
hydrogen bonding [25], salting out [8], or adsorption and 
reversed-phase effects [12]. Most likely, a mixture of some or 
all of these interactions are taking place and the reason for 
confusion probably stems from the fact that in a number of the 
above studies, results have been compounded by the analysis of 
differing and multifunctioal compounds which are more likely to 
engage in mixed retention mechanisms [20].
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5.1.2. Stability of unmodified silica
It is well known in the literature that liquid chromatographic 
columns which are based on silica fail rapidly if eluents of high 
pH are used [26]. Horvath et al. suggested that C18- bonded 
columns should not be used with eluents above pH 7 [27]. This 
failure may be as a result of increased solubility of silica in 
aqueous media as the pH is increased. Sosman [28] has reported 
that the solubility of silica in water depends on the physical 
characteristics of silica and that it increases with temperature. 
For an amorphous form, he reported solubility of about 10 fig/ml 
at room temperature, and 250 /ig/ml at 100°C. Wherli et al. [29] 
used atomic absorption (AA) spectrometry to measure the silica 
content of strongly basic solutions (both organic and inorganic) 
in contact with C^g-, Cg- and non-bonded silica packing 
materials. They found that the rate of dissolution was linear 
with time, and that sodium hydroxide and the strongly basic 
ammonium hydroxides promote the most rapid dissolution. They also 
found that the non-bonded silica dissolved at a much faster rate 
than alkyl-modIfied silica, and that the octadecyl silica was 
better protected against attack than octyl silica. Having 
investigated a range of organic bases, they concluded that 
triethylamine provided the most suitable alternative in terms of 
minimal silicate attack, retention and separation properties, as 
well as availability, handling and good solubility.
Atwood et al. [26] also used an AA spectrometric method to detect 
silica eluting from the column to measure quantitatively the loss 
of silica under different analytical conditions. Their findings 
supported those of Wherli et al. [29] in relation to the 
dissolution of silica at high pH, at elevated temperature and 
after prolonged contact with aqueous solutions. They also 
established that the rate of dissolution decreased with 
increasing flow rate, and that water flowing through the column 
at room temperature approaches an equilibrium concentration of 
silica. Using pure methanol as the mobile phase caused negligible 
dissolution of the silica packing. By placing a pre-column
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between the pump and the injector, the mobile phase was 
pre-saturated with silica and the dissolution of silica was 
greatly reduced.
Rabel [30] has shown that dissolution of silicaceous reversed- 
phase packings can occur at lower pH values than previously 
thought, and Barker [31] demonstrated appreciable dissolution of 
silica in water and salt solutions at pH values as low as 5.5. 
Barker also showed that in the slightly acidic region of pH 3-6, 
which is frequently used for chromatography, the concentration of 
salt in solution is an important parameter. In a recent 
publication which represents a radical departure in opinion on 
the subject, Law [32] undertook a systematic study to produce 
quantitative data to demonstrate the stability of silica in the 
presence of organic-rich eluents. Using a mobile phase of 
methanol-ammonium acetate buffer pH 9.2, (9*1), he showed that 
there was no significant loss in efficiency (as measured using 
five compounds with a range of retention times) when up to 46 1 
of mobile phase had passed through the column. A dramatic loss in 
efficiency was observed between 46 and 65 1, but this could 
easily be restored by repacking the top of the column. This 
particular study by Law was carried out without the use of a 
saturation column to represent the worst case situation, though 
pre-saturation of the mobile phase is recommended for routine use 
[29,32]. Wheals [25] stated that silica dissolution was not a 
problem providing ammonium hydroxide was the source of hydroxyl 
ions and the organic content was high. If, in addition, the 
mobile phase is pre-saturated with silica, this would further 
help to alleviate the problem, and these precautions were 
observed throughout the course of the present work.
5.1.3. Applications of unmodified silica with reversed
phase eluents in drug analysis.
Jane [19] developed a method for the separation of basic drugs on 
unmodified silica with reversed-phase eluents in response to a 
need for a chromatographic technique which could separate a wide
252
range of drugs of abuse without gradient elution. Many drugs 
(which are used for both legitimate and illicit purposes) contain 
a basic amine functionality: their chromatography on reversed 
phase materials is characterised by poor efficiency, and 
gradient elution is usually required. In addition, each of the 
systems proposed is suitable for only one drug type. The method 
developed by Jane incorporated an ammonium nitrate buffer and 
methanol mobile phase, and was capable of separating a variety of 
narcotic analgesics (morphine, codeine, papaverine), 
amphetamine-type stimulants and cocaine-type drugs. The retention 
characteristics of some opium alkaloids was studied in detail by 
Hansen [33], and in 1983, Law et al. [34] published retention 
data for 84 basic drugs of forensic interest using a mobile phase 
of ammonuim nitrate buffer, pH 10.1-methanol (1:9) on a 
standardised Spherisorb S5W column.
Other applications on unmodified silica include the analysis of 
analgesics and decongestant drugs in commercial antihistamine 
preparations [35], the determination of biogenic amines using 
aqueous acidic mobile phases [36], and the determination of 
doxorubicin in pharmaceutical preparations using a mobile phase 
containing acetate buffer, pH 4.5, in isopropanol [37],
These type of separations have also found application in the 
field of biopharmaceutical analysis. As early as 1979, White [38] 
demonstrated a method for the analysis of morphine and its major 
metabolite, morphine-3-glucuronide, in blood which employed 
electrochemical detection. The mobile phase was ammonium nitrate 
buffer, pH 10.2-methanol. The method was very sensitive, though 
the 1iquid-1iquid extraction procedure was rather lengthy and 
tedious. This type of chromatography has also been used in 
conjunction with off-line solid-phase extraction. Law [39] 
demonstrated the separation of beta-blocking drugs in the same 
run following extraction from plasma on a C^g- Bond-elut 
extraction column. Beta-blockers are particularly well suited to 
ion exchange on unmodified silica gel since they are difficult to 
chromatograph together in reversed-phase systems owing to the
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wide range of 1ipophi1icities which the group covers. In the same 
work, Law also demonstrated the chromatography of the tricyclic 
antidepressants and chlorproguani1 and metabolites following 
solid phase extraction. Other drugs which have been 
chromatographed in this way using off-line extraction techniques 
are LSD [40], amiodarone and its metabolite [41,42] and quinidine 
[43].
Chromatography on unmodified silica using methanol-rich eluents 
has been applied to an on-line solid-phase extraction technique. 
In this work, Schmid and Wolf [14] extracted a series of 
tricyclic antidepressants on a C2- concentration column. The 
latter was mounted in place of the injector loop, and with the 
valve in the "load" position. Clean-up of plasma samples was 
effected manually by injecting water and a series of weak 
methanolic solutions onto the concentration column. The drugs 
were introduced onto the analytical column by the action of 
switching the valve to the "inject" position, thus bringing the 
concentration column into the mobile phase stream which desorbed 
retained analytes and swept them onto the analytical column where 
they were separated.
Although this type of arrangement has advantages in that it 
requires only one column and dispenses with the need for a 
switching valve, its limitations in terms of ease of operation, 
level of manning and reproducibility are obvious. The objectives 
of the work presented in this chapter were firstly, to develop an 
analytical system which could accommodate the separation of a 
number of basic drugs of therapeutic interest, and secondly , to 
combine the analytical column with a column switching arrangement
in order to facilitate on-line solid-phase extraction of the
drugs followed by chromatography by ion exchange on unmodified 
silica gel. In this arrangement, the concentration column is 
mounted independent of the injector and a second pump is used to
deliver the washing eluent. Switching between the two columns is
achieved using a six-port valve and in this way, the 
concentration column may be re-equilibrated while separation of 
the previous sample is completed on the analytical column.
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5.2. EXPERIMENTAL
5.2.1. Reagents and solvents
The 29 drugs used in this study were received as a gift from the 
Institute of Clinical Pharmacology, Dublin, Ireland. Ammonium 
nitrate (reagent grade) was obtained from BDH Chemicals Ltd, 
Poole, England, and analytical grade ammonia solution (25%) from 
Riedel de Haen, Seelze, Hannover, West Germany. HPLC grade 
methanol was supplied by Labscan Analytical Sciences, Dublin, 
Ireland. Deionised water was obtained by passing freshly 
distilled water through a Millipore Milli-Q water purification 
system. Dried human plasma from the Blood Transfusion Board, 
Dublin was dissolved in Milli-Q water and used within 7 days of 
reconstitution.
5.2.2. Drug standards
Stock solutions equivalent to 1 mg/ml of the drugs in methanol 
were prepared. Working stock solutions were prepared in 
methano1-water (1:1) to concentrations of 1-50/¿g/ml, depending 
on the detector response of the drug. Standard solutions were 
made to 50-10000 ng/ml. They were prepared in mobile phase for 
direct injection and in water for column switching. For 
ultra-violet absorbance measurements, the 1 mg/ml stock solutions 
were diluted 1:9 in mobile phase.
5.2.3. Plasma standards
Aliquots of drug-free plasma (1 ml) were spiked with working 
stock solutions (50 fi 1) to produce the required concentrations. 
Plasma blanks were prepared by adding 50 /¿I of methanol-water
(1:1) to 1 ml of drug-free plasma. These plasma solutions were
then diluted with deionised water (1:1) and 500 /¿I loopfuls were 
introduced into the chromatographic system.
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5.2.4. Instrumentation and operating conditions
The ultraviolet absorption spectra for the drugs were measured on 
a Hewlett Packard (Palo Alto, CA, USA) Model 8452A diode array 
spectrophotometer. For chromatography, the drugs were separated 
on a LiChrosorb silica 60 (5/xm) column (250 mm x 4.6 mm i.d.), 
supplied by HPLC Technology, Macclesfield, UK. It was protected 
by a Waters (Waters Associates, Milford, MA, USA) Guard-Pak 
module fitted with a silica insert. A pre-column was placed 
between the pump and the injector. It was packed with Lichrosorb 
silica (10fim) (E. Merck, Darmstadt, West Germany) in order to 
saturate the mobile phase with silica and so prolong analytical 
column life. The pH of solutions was measured at ambient 
temperature using a standard glass electrode, which was 
calibrated daily using aqueous standards prepared on a weekly 
basis.
Stock solutions of ammonia and ammonium nitrate (both 0.1 M) were 
prepared by dissolving the appropriate amount of substance in 
deionised water. These solutions were mixed to produce the 
required pH (using the pH meter). The resulting solutions were 
diluted with deionised water to produce the desired ionic 
strength. Mobile phases were prepared by mixing the aqueous 
component with the required amount of methanol. The mobile phase 
was passed through a 0.45/xm filter and degassed by sonication 
prior to use. The solutions were stored in glass containers which 
were capped at all times to prevent the absorption of carbon 
dioxide from the atmosphere, thus raising the hydrogen ion 
concentration above its initial value.
The mobile phase was delivered by a Waters Model 501 HPLC pump 
(pump B) at a flow rate of 1.0 ml/min for development work and
1.3 ml/min for evaluation. The drugs were introduced into the 
system using a Rheodyne (Cotati, CA, USA) Model 7125 6-port 
injection valve. The valve was fitted with either a 20 fil loop or 
a 500 ¿il loop. The drugs were detected by ultra-violet absorption 
at 254 nm using an Applied Chromatography Systems (Macclesfield,
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UK) Model 750/11 fixed wavelength detector, and chromatograms 
were recorded with a Linseis (Selb, West Germany) recorder at a 
chart speed of 200 mm/hr.
For the purposes of column switching, a second Waters Model 501 
pump (pump A) and the concentration column were connected to the 
analytical assembly via a Rheodyne Model 7000 6-port switching 
valve. The 10 x 1.5 mm i.d. concentration columns were dry-packed 
with either Corasil (Waters Associates) RP-18, (37-50 fim), 
Sepralyte (Analytichem International, Harbour city, CA, USA) RP-8 
(40 fim) or with Supelco (Bellefonte, PA, USA) CN- material 
(25-40 fim). The washing eluent delivered to the concentration 
column by pump A was deionised water filtered through a 0.45 fin 
membrane and degassed under vacuum.
5.2.5. Procedures
5.2.5.1. Effect of pH on drug retention
Ammonium nitrate buffer solutions of pH 6.0, 7.0, 8.0, 9.0, 9.5, 
and 10.0 were prepared by mixing 0.1 M solutions of ammonium 
nitrate and ammonium hrdroxide. These mixtures were then diluted 
(1:3) to produce 0.025 M solutions. Mobile phases containing 1:4 
aqueous-methanolic components were made by mixing the aqueous 
phase with methanol. The retention times of the drugs were 
investigated as a function of eluent pH.
5.2.5.2. Ultraviolet absorbance spectra
The 1 mg/ml stock solutions of the drugs were diluted (1:9) with 
mobile phase at both pH 9.5 and at pH 7.0. The absorption spectra 
of each drug in both mobile phases were measured.
5.2.5.3. Column switching procedure
The operation of the column switching arrangement has been 
described in chapter 2. The concentration column was packed with
257
RP-18, RP-8 or cyano- material and the wash solution was 
delivered at a flow rate of 1 ml/min. The wash time was 1 minute 
after which the concentration column was connected to the 
analytical column by actuating the switching valve. The mobile 
phase delivered to the analytical column was 0.025 M amonium 
nitrate/ammonium hydroxide, (the pH depended on the pKa of the 
drug) plus methanol (1:4). Working stock solutions were diluted 
in deionised water to generate standards containing 50-10000 
ng/ml according to the detector response of the drug at 254 nm. 
The drugs were introduced in 500 fi 1 loopfuls onto the 
concentration column and following the wash regimen outlined 
above, the drug peak heights were investigated as a function of 
the type of packing in the concentration column.
5.2.5.4. Assay Evaluation
The following procedure was carried out for each of the drugs 
investigated: drug-free aliquots of plasma (1 ml) were spiked 
with either 50 fi 1 methanol-water (1:1) or 50 fi\ working stock 
solution of the drugs to yield plasma blanks and plasma 
standards, respectively. The mixtures were vortexed for 10 
seconds. The plasma standards were diluted (usually 1:4) with 
drug-free plasma to generate dilute plasma standards. 500 pi 1 
deionised water was then added to the spiked and blank plasma 
solutions, followed by vortex mixing for 10 seconds. This 
procedure was repeated four times for the concentrated plasma 
standards and four times for the dilute plasma standards to 
generate quintuplicate standards at both concentration levels.
500 fil of each of the standards were injected into the system, 
and the plasma blanks were injected in duplicate. Aqueous 
standards of the drugs were injected in duplicate instead of 
quintuplicate. Having measured the peak heights for each of the 
compounds, the means, standard deviations and coefficients of 
variation at both concentration levels were calculated. Drug 
recoveries from plasma were calculated by comparing the mean peak 
heights of the quintuplicate plasma standards versus the 
duplicate aqueous standards at both concentration levels.
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5 . 3 RESULTS AND DISCUSSION
There were 29 drugs investigated in this study. Several 
therapeutically important classes of compounds were represented: 
the tricyclic antidepressants, some major tranquillisers such as 
the phenothiazines, antihistamines, beta-blocking agents such as 
propranolol, narcotic analgesics, local anaesthetics and and 
antimalarial drugs. These drugs possess a primary, secondary of 
tertiary amine functionality, and apart from this shared amine 
function there are significant structural dissimilarities among 
some of the drugs which may be seen from the structures of
representative compounds shown in Figure 5.1.
5.3.1. Development of chromatography
In the interest of reproducible chromatography, it is necessary 
that the pH and the ionic strength at the silica surface be 
defined, stable and in equilibrium with those of the eluent [14]. 
To this end, the aqueous component should contain some kind of 
buffering salts which do not precipitate in methanol-rich 
solvents and which preferably do not tend to dissolve the silica 
packing. Phosphate salts would be unsuitable since they have low 
solubility in organic solvents, and ammonium salts are preferable 
to sodium salts as their solutions tend less to dissolve silica 
[29]. In addition, Sugden et al. found that greater 
chromatographic efficiency was obtained for the quarternary 
ammonium compound, amprolinium when the ammonium as opposed to 
the sodium cation was used in the mobile phase [8]. Referring to
the literature on the subject, it became obvious that even within
the constraints of these criteria, a number of options were 
available, ranging from ammonium nitrate as originally used by 
Jane [19], to ammonium formate [8], or ammonium perchlorate [3].
As pointed out by Law, the ammonium nitrate-methanol eluent is 
widely used in this type of chromatography on unmodified silica 
[14,20,34],and since Schmid and Wolf [14] had separated five
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Figure 5.1,
Some representative drug structures
Amitriptyline (I)
Propranolol (II)
Pheny1propanolamine
(CH2Ì2
h 3c c h 3
O H
o  c h 2 c h  c h  n h c h
N H -
h o -h 2c — c — c h 3
(III)
tricyclic drugs using a mobile phase of 0.003 M ammonium 
nitrate/ammonium hydroxide-methanol (1:4) and as a number of 
tricyclc drugs were included in the present study, the chosen 
starting point was an eluent composed of 0.005 M ammonium 
nitrate/ammonium hydroxide at pH 10.0-methanol (1:4). It was 
decided not to use the 1:9 ratio of aqueous to organic phase 
employed by Law and other workers [14,20,34] since this might 
create problems of protein precipitation when it came to the 
stage of on-line solid-phase extraction of the drugs from plasma.
As outlined in section 5.2, pH measurements were performed on the 
aqueous component prior to the addition of the organic phase, and 
all references to pH are based on the pH of the aqueous 
component. It is, however, well known that solute pKa can be 
reduced in the presence of organic modifier [20]. Also, in the 
present study, it was observed that the apparent pH of the mobile 
phase following addition of 80% methanol was lower than the 
starting pH, and the magnitude of the reduction depended on the 
original pH in pure aqueous solution (Figure 5.2). The changes in 
mobile phase pH were not taken into account since meaningful 
discussion on the subject would warrant measuring solute pKa 
values in the mobile phases (the quoted pKa values were aqueous 
solution values taken from the literature). The objective of the 
present study was to observe the trends obtained as the mobile 
phase pH was altered and to generate suitable mobile phases for 
the separation of the drugs of interest and plasma components 
following extraction.
With the above mobile phase, amitriptyline was found to elute 
with a retention time of 39.3 minutes. If the assumed retention 
mechanism is one of cation exchange, then increased ionic 
strength should reduce the retention time. This effect had been 
widely reported in the literature, and was confirmed here when by 
increasing the ionic strength to 0.025 M NH^*, the retention 
time of amitriptyline was reduced to 10.5 min. The other 
tricyclic drugs used were nortriptyline, imipramine, desipramine 
and protriptyline. As may be seen from the results
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FIGURE 5.2.
Effect of the addition of 80% methanol on apparent pH
Apparent pH
i n i t i a l  p H
Mobile phase: 0.025 M NH40H/NH4N03-methanol (1:4)
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presented in Table 5.1, the drugs (except for desipramine and 
protriptyline) are separated, though all elute quite late, and 
there is a large difference between the retention time of the 
first peak (amitriptyline) and the last peak (desipramine).
Lowering the pH produced different effects on the drugs depending 
on whether they possess secondary or tertiary amino 
functionalities; the tertiary amines, amitriptyline and 
imipramine elute later at the lower pH, while the secondary 
amines nortriptyline and desipramine elute earlier. These data 
may be explained by considering the pKa values of these amines 
(Table 5.1) and the charged nature of the silanol groups under 
these conditions. At pH 10.0, due to the acidic nature of silica 
[3], the silanol moieties are highly dissociated and the column 
is behaving as a cation exchanger. On the other hand, ionisation 
of the less basic tertiary amines will be partially suppressed, 
thus reducing their affinity for the charged silanol groups on 
the silica packing. As the pH is lowered, their degree of 
ionisation is increased, though the degree of column ionisation 
is reduced. However, increased solute ionisation would appear to 
be the overriding effect since the retention of these amines is 
prolonged at lower pH values.
The more strongly basic secondary amines are dissociated to a 
greater extent at pH 10.0 than the tertiary anologues, and with 
these compounds, the predominant effect observed by lowering pH 
is a reduction in retention resulting from reduced silanol 
ionisation. The degree to which the retention of the tertiary 
amines is increased is less than the degree to which retention of 
the secondary amines is decreased, possibly because two opposing 
forces are controlling retention of the tertiary amines at this 
point, with the increase in drug dissociation overriding the 
effect of reduced silanol ionisation. Furthermore, it can be 
noted that even within the secondary amine group, the degree to 
which the amine is affected by lowering the pH depends on drug 
pKa ; the higher the pKa, the greater the reduction in 
retention time. This observation agrees with the findings of
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Table 5.1.
Influence of pH on the separation 
of some tricyclic antidepressants
DRUG RETENTION TIME (min)
pKj pHIO.O pH9.5 PH9.0
Amitriptyline 9.5 10.5 12.9 13.2
Nortriptyline 9.8 24.0 20.8 15.9
Imipramine 9.5 14.0 17.0 16.8
Desipramine 10.2 32.4 24.1 17.7
Protriptyline 10.0 29.1 21.0 16.9
Mobile phase s 0.025 M NH40H/NH4N03-methanol (1:4).
pH8.0
12.0
9.0
13.5
9.6
8.7
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Law when he studied the relationship between retention and pKa 
[20]. If the pH is lowered again, there is a further general 
decrease in retention, which can be explained in terms of a 
reduction in the charged silanol sites. Other workers [3,12,14] 
have studied the effect of increasing the pH to 10.0 and greater, 
and have found that at higher pH values, there is a general fall 
off in retention as the amines become progressively less ionised. 
Thus reversals in elution order between secondary and tertiary 
amines can be achieved, and this can prove an analytically useful 
tool in the separation of closely related species.
Owing to the high solubility of silica in alkaline media, and in 
spite of the high methanol content and presaturation of the 
mobile phase with silica, it is still desirable to use as low a 
pH as possible. It was found that good separation of the 
tricyclic drugs was achieved at pH 9.5, and so this was chosen as 
the operating pH. A chromatogram showing the separation of four 
tricyclic drugs is presented in Figure 5.3.
The other basic drugs of interest were also tested on this 
system, and all drugs were tested in mobile phases of pH 6.0 and 
pH 7.0. As different relative amounts of ammonium nitrate and 
ammonium hydroxide would be required to generate these different 
pH values, the nitrate concentration varied from one solution to 
the next. The cation (NH4+ ) concentration was, however kept 
constant, and as the proposed retention mechanism is one of 
cation exchange, it was assumed that a variation in the nitrate 
concentration would not seriously affect changes resulting from 
an alteration in pH. The results of this experiment are presented 
in Table 5.2., and they confirm the trend observed with the 
tricyclic drugs: i.e. there is a general increase in retention as 
the pH is raised from 6.0 to 7.0. As the pH is further increased 
to 9.5, there is a further increase in retention for the more 
basic amines, while the less basic amines elute earlier.
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FIGURE 5.3.
Chromatogram of four tricyclic antidepressants
I
TIME (n in)    ------------------- — >
A: amitriptyline! I s  imipramine; Ns nortriptyline 
Di desipramine.
Mobile phase» 0.025 M NH40H/NH4N03-methanol (1*4)
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Table 5.2.
Influence of pH on retention
DRUG RETENTION TIME (min)
pKj pH 6.0 pH 7.0 pH 9.5
Acetopromazine NA 4.5 8.4 15.9
Amitriptyline 9.4 5.7 9.6 12.6
Atenolol 9.6 2.9 6.3 16.5
Chlorpheniramine 8.9 14.6 15.0 19.2
Chlorpromazine 9.3 4.1 11.3 14.6
Clemastine NA 7.2 7.5 16.2
Codeine 8.2 5.9 9.6 13.4
Desipramine 10.2 4.4 6.8 24.2
Dextromethorphan 8.3 4.1 8.8 28.8
Diltiazem NA 4.1 5.7 4.8
Fluphenazine 8.1 3.6 5.1 5.1
Imipramine 9.5 6.3 11.0 17.2
Lidocaine 7.9 3.5 5.1 3.6
Mefloquine NA 3.0 7.8 20.9
Mepivacaine 7.7 3.5 5.1 3.3
Nortriptyline 9.8 4.1 6.3 20.2
Perphenazine 7.8 4.2 5.4 3.9
Phentoloxamine 9.1 6.0 6.0 8.7
Pheny1propano1am ine 9.5 2.6 4.8 11.0
Pindolol 9.7 2.6 5.1 11.3
Promethazine 9.1 9.3 9.3 7.5
Propranolol 9.5 2.6 3.2 11.9
Protriptyline 10.0 4.4 6.2 21.1
Quinine 8.5 3.3 7.5 9.0
Setastine NA 6.0 6.6 12.6
Trimethoprim 7.2 3.0 4.2 3.5
Tripelennamine 9.0 5.9 7.2 13.7
Tyramine 10.2 2.7 5.1 16.8
Verapami1 NA 3.5 4.8 3.6
NA = Not available in standard reference texts
Mobile phase: 0.025 M NH40H/NH4N03-methanol (1:4)
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One of the main considerations was that the drugs should elute 
clear of the plasma components following on-line solid-phase 
extraction. Based on the data presented in Table 5.2., it was 
clear that some of the drugs, notably the less basic amines, 
would probably co-elute with the plasma peak at pH 9.5, and that 
the peaks of many of the more basic compounds would merge at the 
lower pH values. It was therefore decided to divide the drugs
into two groups- one which would be separated using a mobile
phase of pH 9.5 (group A) and the other (group B) which would be 
chromatographed using a mobile phase of pH 7.0. To the latter 
group was also assigned some of the more strongly basic compounds 
which had very long retention times at pH 9.5 (for example, 
dextromethorphan). Some other drugs were included in this group 
because they could be chromatographed more conveniently at pH 7.0 
with other drugs of the same therapeutic class. Table 5.3. lists
the drugs in groups A and B.
5.3.2. UV Absorbance measurements
At this stage it was decided to carry our some ultraviolet
absorbance measurements to determine whether it was justified to 
continue using 254 nm as the operating wavelegth for the majority
of drugs under study. As a fixed wavelength detector was being
employed, the options were limited to 215 nm, 254 nm and 280 nm
filters. The absorbance of the drugs was measured in both of the
chosen mobile phases using a photodiode array spectrophotometer. 
The results obtained suggest that there was little difference in 
the UV maxima between one mobile phase and the other, and most of 
the drugs had strong absorbance between 230 and 270 nm.
Therefore, 254 nm continued to be used as the operating 
wavelength. The absorption spectra for a number of representative 
compounds are given in Figures 5.4.a and 5.4.b.
5.3.3. Column switching
Having developed the mobile phases for the drugs, the next stage
was to combine the analytical system to a column switching
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Table 5.3.
Drug groups
GROUP A
Acetopromazine
Amitriptyline
Atenolol
Chlorpromazine
Desipramine
Imipramine
Mefloquine
Nortriptyline
Pheny1propano1am i ne
Pindolol
Promethazine
Propranolol
Quinine
Tyramine
GROUP B
Chlorpheniramine
Clemastine
Codeine
Dextromethorphan
Diltiazem
Fluphenazine
Lidocaine
Mepivacaine
Perphenazine
Phentoloxamine
Protriptyline
Setastine
Trimethoprim
Tripelennamine
Verapami1
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Some ultraviolet absorbance spectra in 0.025 M buffer. pH 
9.5-methanol (1;4)
FIGURE 5.4.a .
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Figure 5.4.b.
Some ultraviolet absorbance spectra in 0,025 M buffer. pH
7.0-methanol (1:4)
I
I *
VP
! -
I :
I ° a 
: a
I
m
A4
f V, 1 
■ M
j 1 *-
\
I;
? »  , f \  '
i t ;
B l '
j J* i i
a< - ■j V
I J
—  i  1
< A
1 C . '
BB-VU *V
2QÙ
PHEMVLPPO^
— 9 = 2 as
3&Q
Mi .’I 1 nr
320;
Cat»
4
t
_ i
• “ Ù 4
c s
J i. * ta
* a
J • 0 - |V
•I i
'
il
PPQP&flNOL0 .
4B&
r> p  t  ft ( *  ______________
271
arrangement with view to performing on-line solid-phase 
extraction of the drugs from spiked plasma samples. The operation 
of the column switching arrangement has been described in chapter
2. It was necessary to determine which type of packing in the 
concentration column would prove most suitable in terms of drug 
recovery and sample clean-up. Hence the drugs were first 
introduced directly onto the analytical column, and then with the 
second pump and the six-port switching valve in place, they were 
injected via the concentration column, and back-flushed onto the 
analytical column. The wash solution delivered by pump A (eluent 
A) was filtered and degassed, deionised water delivered at a flow 
rate of 1.0 ml/min, using a wash time of 1 min. Eluent B was
0.025 M ammonium nitrate/ammonium hydroxide (pH 7.0 or 
9.5)-methanol (1:4) delivered at a flow rate of 1.0 ml/min. Three 
types of packing material were investigated; namely RP-18, RP-8 
and cyano-. The results of this experiment are presented in Table
5.4., and recovery was determined by comparing the peak heights 
of recovered versus directly injected samples.
In many cases it can be seen that the apparent recovery is 
greater than 100%. This is most likely because compounds 
introduced via the concentration column are concentrated from a 
large (500 /¿I) to the smaller volume of the concentration column 
and associated tubing. The smaller volume of injection produces 
larger and sharper peaks for the same quantity of drug. In 
addition, the drugs must be dissolved in water for column 
switching; if dissolved in the mobile phase, the high methanol 
content will effect elution of the drugs off the concentration 
column, which of course, is behaving like a mini-reversed-phase 
system, and as water is a weaker solvent, it will produce sharper 
peaks than the mobile phase which must be used for direct 
injection purposes. This illustrates one advantage of column 
switching in the analysis of drugs and other compounds, that even 
where extraction from a biological matrix is not required, large 
volume dilute solutions may readily be enriched to facilitate 
their quantitation, and where the compound of interest
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Table 5.4.a.
Comparison of recoveries from concentration columns
DRUG GROUP A
DRUG % RECOVERY VERSUS DIRECT INJECTION
^8   - ^ 1 8 ------------
Acetopromazine 70.8 39.6 21.9
Amitriptyline 100.2 90.2 17.6
Atenolol 118.6 39.3 NR
Chlorpromazine 79.7 63.7 23.7
Desipramine 114.4 80.0 6.7
Imipramine 119.7 103.2 7.4
Mefloquine 90.9 36.4 29.5
Nortriptyline 104.7 55.9 17.7
Phenylpropanolamine 113.3 93.3 NR
Pindolol 81.8 72.7 NR
Promethazine 110.0 105.9 7.4
Propranolol 109.5 107.7 NR
Quinine 102.3 26.8 0.9
Tyramine 109.7 NR NR
NR = Not recovered from concentration column
Mobile phase: 0.025 M NH40H/NH4N03, pH 9.5-methanol (1:4)
Wash solution: deionised water at 1.5 ml/min for 1 min.
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Table 5.4.b.
Comparison of recoveries from concentration columns
GROUP B
DRUG % RECOVERY VERSUS DIRECT INJECTION
Ç8- -18- CN
Chlorpheniramine 114.4 41.7 NR
Clemastine 123.6 116.1 21.2
Codeine 94.4 84.1 NR
Dextromethorphan 117.4 94.6 NR
Diltiazem 120.6 114.6 NR
Fluphenazine 104.8 108.3 124.4
Lidocaine 124.4 70.4 NR
Mepivacaine 119.8 69.8 NR
Perphenazine 95.5 98.3 126.8
Phentoloxamine 121.9 122.6 NR
Protriptyline 140.3 128.4 58.1
Setastine 121.7 115.2 20.8
Trimethoprim 127.0 105.7 8.2
Tripelennamine 123.1 114.2 NR
Verapamil 119.3 137.2 37.7
NR = Not recovered from concentration column
Mobile phase 0.025 M NH40H/NH4N03, pH 7.0-methanol(1s4)
Wash solution: deionised water, 1.5 ml/min for 1 min.
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does not occur in a highly contaminated matrix, the volume 
capacity of these small columns is substantially increased.
Referring to Table 5.4., it may be seen that for the drugs in 
group A, there is a significant difference between the recoveries 
from the different column packings. Overall, recovery is optimum 
from the Cg- concentration column. For the drugs in group B 
(Table 5.4.b), however, overall recovery (with a few exceptions) 
is similar from both Cg- and C^g- materials. For the majority 
of drugs in both groups, recovery was poor or non-existent from 
the cyano- packing material. These trends may be accounted for in 
terms of polarity differences between the various packing 
materials? water has stronger eluting power on the more polar 
cyano- (as opposed to C18- or Cg-) material, thus allowing 
little or no enrichment, whereas on reversed phase materials, 
water is a much weaker eluent and the drugs are retained to a 
much greater extent. The difference in recovery between C18- 
and Cg- materials may be accounted for in terms of the greater 
hydrophobicity of the latter, and its inability to retain the 
more polar analytes.
Hence, while it appears that the Cg- material offers the best 
match for most drugs, another factor which must be considered is 
how the various packing materials behave in relation to plasma 
removal. As cyano- material has little affinity for the drugs 
(with the notable exceptions of fluphenazine and perphenazine) 
under the employed experimental conditions, it was omitted from 
the next stage of the investigation. Blank plasma aliquots were 
injected onto both concentration column types, and sample 
chromatograms generated in this experiment are presented in 
Figures 5.5.a and 5.5.b. As might be expected, the C^g- 
material retained less of the polar plasma components (Figure
5.5.a) than the C^g- material. These chromatograms also show 
that in contrast to the drug compounds, there is little 
difference between the blank plasma profiles as the pH of the 
mobile phase is changed. This is presumably because the acidic 
plasma components would have little affinity for the column under
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blank plasma chromatograms following solld-phase extraction on a 
C^g— concentration column
Figure 5.5.a.
b
TIHE Uin)------------------------------------ — ----->
(a): mobile phase 0.025 M NHdOH/NHANO,, pH 7.0-methanol
(1.4)
(b): mobile phase 0.025 M NH40H/NH4N03, pH 9.5-methanol
(1.4)
Detector sensitivity. 0.04 AUFS
276
Figure 5.5.b.
Blank plasma chromatograms following solld-phase extraction on a 
Co- concentration column
b
a
TIME (min)------------ ■----------------------- ->
(a): mobile phase 0.025 M NH40H/NH4N03, pH 7.0-methanol
(1:4)
(b): mobile phase 0.025 M NH40H/NH4N03, pH 9.5-methanol
(1:4)
Detector sensitivity* 0.04 AUFS
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the employed experimental conditions. These results indicate that 
it is possible to produce the most appropriate retention times 
for the compounds of interest by manipulation of the eluent pH 
with little danger of introducing interfering peaks from the 
plasma matrix.
For the drugs in group A, the level of plasma removal achieved 
with Cg- was considered sufficient, as none of the plasma 
components interfered with the drug peaks. For the drugs in group 
B, however, it was apparent that some of the drugs would co-elute 
with the plasma components, irrespective of the type of packing 
material used in the concentration column.
It was then decided to investigate the effect on group B of 
changing the pH from 7.0 to pH 5.0 and pH 8.0, in order to obtain 
better separation between the plasma components and the compounds 
of interest. The results of this study are presented in Table
5.5, and they reveal that there is a general decrease in 
retention at the lower pH, possibly due to suppression in the 
ionisation of the silanol moieties. At pH 8.0 most of the drugs 
had longer elution times, and though others were hardly affected, 
it was concluded that this pH would be the most suitable for the 
compounds in group B.
5.3.4. Analysis in plasma
The drugs in group A were analysed with a mobile phase of pH 9.5, 
and extraction was performed on a Cg- concentration column.
Water had been established as a suitable solvent for the wash 
phase, and based on previous work in this area [44,45], a wash 
time of 1 min at 1.0 ml/min was deemed a suitable regimen for the 
removal of plasma, while retaining the compounds of interest. It 
has previously been shown [44] that increasing the wash time will 
not usually remove endogenous compounds or interferents which are 
retained on the concentration column under the above conditions, 
but that it will cause band broadening in all retained species, 
including the peaks of interest. The flow rate of the analytical
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Table 5.5.
Effect of pH on the retention of drugs In group B
DRUG RETENTION TIME (min)
dH 5.0 pH 7.0 dH 8
Chlorpheniramine 8.4 14.8 18.1
Clemastine 4.2 7.2 8.4
Codeine 7.5 9.6 11.7
Dextromethorphan 5.7 8.9 9.8
Diltiazem 5.4 5.8 6.3
Fluphenazine 5.0 5.0 5.4
Lidocaine 5.1 4.8 4.8
Mepivacaine 5.4 5.1 4.6
Perphenazine 5.1 5.5 5.7
Phentoloxamine 5.7 6.1 9.4
Protriptyline 3.6 6.2 8.9
Setastine 4.5 6.5 6.9
Trimethoprim 4.0 4.2 4.6
Tripelennamine 6.0 7.5 12.2
Verapaml1 4.8 4.8 3.6
Mobile phase: 0.025 M NH40H/NH4N03-methanol (1:4)
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mobile phase was increased from 1.0 ml/min to 1.3 ml/min in order 
to reduce run times. This measure did not cause merging of the 
last plasma interferent and the first compound of interest. The 
drugs in group B were analysed at pH 8.0 using the C18- 
concentration column, as it had previously been established that 
most drugs in this category were recovered to similar degrees on 
both columns and less plasma is retained by the C18- packing 
material.
It was then sought to measure the reproducibility of the methods 
in relation to every drug and to determine the percentage 
recoveries from the plasma matrix. Each drug was injected five 
times at two concentration levels in spiked plasma (10 
injections), and in dupicate as authentic standards. The mean 
(x), standard deviation (SD), and coefficient of variation (CV) 
were calculated for the five spiked plasma standards at both 
concentrations. Recovery of the drugs from plasma was estimated 
by comparing the peak heights of the quintuplicate extracted 
standards versus the peak heights of the duplicate authentic 
standards.
Results of the plasma analyses are presented in Table 5.6 (group 
A) and Table 5.7 (group B), and some sample chromatograms are 
shown in Figures 5.6 and 5.7. As may be seen from the results, 
the coefficient of variation never exceeded 8%, was usually less 
than 5% and was frequently less than 3%. The low levels of 
variability, even in the absence of an internal standard, are 
possible because of the inherent reproducibility of the column 
switching technique, especially when compared with liquid-liquid 
extractions which can involve many different steps, and may 
permit the introduction of artefacts. Recovery from plasma using 
column switching is generally high. As the results show, recovery 
is usually in excess of 70%, and is frequently greater than 90%. 
Some drugs do, however, exhibit particularly small percentage 
recoveries, especially at low concentrations. The most likely 
explanation for these observations is that some drugs are protein 
bound, and would require more vigorous extraction methods such
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Table 5.6.
Plasma assays- Drug group A
DRUG CONC MEAN PKHT* SD CV RECOVERY
NG/ML MM MM %_________ %
Acetopromazine 250 78.0 1.4 1.8 83.4
Acetopromazine 50 14.6 0.5 3.4 78.9
Amitriptyline 500 42.6 1.1 2.6 91.6
Amitriptyline 100 8.4 0.5 5.9 93.3
Atenolol 5000 83.0 0.7 0.8 96.5
Atenolol 1000 16.4 0.5 3.0 96.5
Chlorpromazine 250 72.4 2.3 3.2 53.6
Chlorpromazine 50 13.4 0.9 6.7 58.3
Desipramine 500 46.0 1.4 3.0 93.9
Desipramine 100 11.1 0.2 1.8 89.8
Imipramine 500 71.4 1.1 1.5 97.1
Imipramine 100 15.8 0.8 5.1 101.9
Mefloquine 2000 31.6 0.5 1.6 47.2
Mefloquine 400 4.5 0.4 7.8 36.0
Nortriptyline 500 21.0 0.7 3.4 76.4
Nortriptyline 100 4.8 0.3 6.3 80.1
* : PKHT = Peak height, detector sensitivity = 0.04 AUFS
Mobile phase: 0.025 M NH40H/NH4N03, pH 9.5-methanol (1:4)
SD: Standard deviation 
CV: Coefficient of variation
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Table 5.6. continued
DRUG CONC MEAN PKHT* SD
NG/ML MM MM
CV RECOVERY
Phenylpropanolamine 10000 97.6
Phenylpropanolamine 2000 19.4
0.9
0.6
0.9
3.1
92.9
92.4
Pindolol
Pindolol
500
100
164.0
36.2
7.3
0.4
4.5
1. 1
95.1
104.9
Promethazine
Promethazine
250
50
97.2
18.0
2.3
0.7
2.4
3.9
84.5
100.4
Propranolol
Propranolol
1250
250
81.8
15.2
0.8
0.5
1.1
3.3
97.4
98.1
Quinine
Quinine
2000
400
191.8
34.4
1.3
0.9
0.7
2.6
93.6
88.3
Tyramine
Tyramine
2000
400
69.0
24.8
0.7
0 . 8
1.0
3.2
35.3
51.3
*: PKHT = Peak height, detector sensitivity = 0.04 AUFS 
Mobile phase: 0.025 M NH40H/NH4N03, pH 9.5-methanol (1:4)
SD: Standard deviation 
CV: Coefficient of variation
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Table 5.7.
Plasma assays-Drua group B
DRUG CONC MEAN PKHT* SD CV RECOVERY
NG/ML MM MM %_________ % _
Chlorpheniramine 2500 125.0 2.9 2.3 96.5
Chlorpheniramine 625 27.6 0.5 1.8 92.0
Clemastine 5000 15.0 0.7 4.7 51.7
Clemastine 2500 5.9 0.2 3.4 40.7
Codeine 5000 95.0 1.7 1.8 109.8
Dextromethorphan 5000 69.6 0.5 0.7 91.6
Dextromethorphan 1250 20.2 0.4 2.0 96.2
Diltiazem 250 124.8 1.8 1.4 76.8
Diltiazem 50 23.0 0.7 3.0 92.0
Fluphenazine 250 89.8 4.8 5.3 86.8
Fluphenazine 100 27.6 2.1 7.6 81.2
Lidocaine 5000 77.6 0.5 0.6 161.6
Lidocaine 200 31.2 0.5 1.6 96.5
Mepivacaine 5000 39.6 0.4 1.2 141.5
Mepivacaine 2000 15.6 0.5 3.2 111.4
Perphenazine 250 82.0 1.2 1.5 75.6
Perphenazine 100 29.8 0.4 1.3 71.0
*! PKHT = Peak height, detector sensitivity - 0.04 AUFS 
Mobile phase; 0.025 M NH4OH/NH4NO3, pH 8 .0-methanol (1:4)
SD: Standard deviation 
CV: Coefficient of variation
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Table 5.7. continued
DRUG CONC MEAN PKHT* SD CV RECOVERY
NG/ML MM MM %_________ %
Phentoloxamine 2500 94.8 2.0 2.1 85.0
Phentoloxamine 625 21.5 0.5 2.3 72.9
Protriptyline 500 90.4 3.8 4.2 76.3
Protriptyline 125 21.8 0.4 1.8 72.7
Setastine 5000 42.6 0.9 2.1 97.9
Setastine 2500 18.8 0.4 2.1 85.5
Trimethoprim 350 109.2 3.9 3.6 53.6
Trimethoprim 80 24.2 0.8 3.3 53.7
Tripelennamine 500 53.0 0.7 1.3 99.1
Tripelennamine 125 12.5 0.5 4.0 89.3
Verapamil 2000 113.8 0.4 0.4 92.9
Verapamil 500 38.8 0.4 1.0 107.5
*: PKHT - Peak height, detector sensitivity - 0.04 AUFS 
Mobile phase: 0.025 M NH40H/NH4N03, pH 8.0-methanol (1.4) 
SD: Standard deviation 
CV: Coefficient of variation
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as liquid-liquid extraction or protein precipitation to liberate 
them from their binding sites.
It is possible, of course, to subject a sample to column 
switching subsequent to protein precipitation, but acid or base 
précipitants would first have to be neutralised, and organic 
précipitants evaporated, as they would effect rapid elution of 
the drug off the concentration column. In addition, precipitation 
can cause the loss of some of the sample, and contributes to the 
elaboration of the system. Another useful measure which can be 
adopted is to add salicylic acid to the plasma to free drugs from 
protein binding sites. As salicyate has an extremely high 
affinity for plasma proteins, it will displace drugs which are 
already bound, but which have a lower affinity for the binding 
site. As outlined in chapter 2, the addition of an enzyme, such 
as subtilisin Carlsberg, can cleave bound drugs from proteins, 
and this measure has the added advantage of prolonging the 
lifetime of the concentration column [46]. A more novel approach 
has been to add a small (to minimise dilution effects) volume of 
a solution of sodium dodecyl sulphate to the plasma prior to 
injection onto the concentration column [47]. This measure has 
been shown to prolong the lifetime of the concentration column, 
and to promote liberation of drugs from protein binding sites. So 
far this method has been applied only to relatively high drug 
concentrations (1 0 /xg/ml) and its usefulness for measurements in 
the ng/ml region has not yet been demonstrated.
In the case of some of the drugs, recovery was greater at lower 
concentrations, possibly because extraction efficiency is greater 
as there is less drug to partition from the liquid into the solid 
phase. In two instances (lidocaine and mepivacaine), the apparent 
recovery from plasma was greatly in excess of 100%. In these 
cases it proved difficult to obtain reproducible recovery of the 
authentic standards, and it was concluded that the presence of 
plasma components on the concentration column actually enhances 
their retention, and so leads to better recovery. In the case of 
one drug (clemastine), recovery was substantially lower than
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Figure 5.6.
Plasma standards extracted on a Co- concentration column
I
TIME (min)
( a )
1250 ng/ml propranolol
5000 ng/ml atenolol
Mobile phases 0.025 M NH40H/NH4N0 
Detector sensitivity: 0.04 AUFS
b
 >
(b)
(P) 250 ng/ml
(A) 1000 ng/ml
, pH 9.5-methanol (ls4)
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Figure 5.7.
Plasma standards extracted on a C^g- concentration column
TIME (min)------------------------------------------------------>
(a) (b)
500 ng/ml protriptyline (PR) 125 ng/ml
2500 ng/ml phentoloxamine (PT) 625 ng/ml
500 ng/ml tripelennamine (T) 125 ng/ml
2500 ng/ml chlorpheniramine (C) 625 ng/ml
Mobile phase: 0.025 M NH40H/NH4N03, pH 8.0-methanol (1:4) 
Detector sensitivity: 0.04 AUFS
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its sister drug (setastine) to which it is closely structurally 
related. It was found that recovery of this drug depended heavily 
on the batch of plasma into which it was spiked. This may, in 
fact, be the case of many drugs, though it was beyond the scope 
of the this project to test recovery of all drugs from a number 
of plasma sources. It does, however, illustrate the point that in 
biopharmaceutical analysis, the condition of the plasma and the 
factors affecting its composition may play a significant role in 
determining the amount recovered, and seemingly low levels of a 
drug may be a result of poor yield from a particular subjects 
plasma, rather than inefficient bioavailability of that 
preparation.
5.4. CONCLUSION
It has been shown in this and other studies that a silica column 
used with a methanol-rich buffered aqueous eluent has wide 
applicability in the separation of basic compounds of medicinal 
and forensic interest. In this case, two methods have been 
developed which can accommodate the analysis of a number of 
therapeutically important compounds, and these methods have been 
successfully combined with an on-line column switching assembly 
to permit rapid extraction of the drugs from plasma. Over the 
range of drugs studied, the method has been shown to be 
reproducible, with a coefficient of variation of 3% or less for 
most compounds, without the need for internal standardisation.
The method offers drug recoveries comparable with, and in many 
cases, superior to conventional liquid-liquid extraction methods. 
Apart from being less tedious and time-consuming, column 
switching has the advantage of being less hazardous and expensive 
than liquid-liquid extraction, as it does not require any organic 
solvents. The only consumable (apart from filtered water) is the 
concentration column packing. Obviously, the capacity of the 
column will depend on how viscous and heavily contaminated the 
sample is, the size of the concentration column and the nature of 
the two mobile phases? but it has been shown [44,45] for the type
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of concentration columns and packings used in the present study, 
that a single column can accept up to 7.5 ml of plasma without 
significant deterioration in column performance, back pressure or 
peak width.
Ion exchange chromatography on unmodified silica using an 
organic-rich mobile phase is ideally suited to column switching 
as the high content of methanol in the mobile phase effects 
almost total removal of any endogenous components which are 
retained on the concentration column throughout the wash phase.
In this way, the concentration column is regenerated more 
effectively than if a mobile phase containing low concentrations 
of organic solvent are used, such as would be common in many 
reversed-phase separations. In these cases, if there is no 
separate regeneration step (with methanol) between elution of the 
drugs from the concentration column and re-equilibration with the 
wash solution, residual plasma components can build up on and 
modify the concentration column, necessitating the use of an 
internal standard and creating problems with regard to 
contamination and blockage.
A limitation with the use of high concentrations of organic 
modifier is precipitation of plasma components by the organic 
solvent, resulting in pressure build-up across the system and the 
need to change the concentration column frequently. This problem 
can be minimised by allowing adequate re-equilibration of the 
concentration column with the aqueous washing solution. Ion 
exchange chromatography on unmodified silica is particularly 
suitable for drug screening purposes, e.g. examination of illicit 
drug preparations [19,34]. It is capable of eluting a wide range 
of compounds within a relatively small time frame which allows 
for rapid analysis. However, because of its very suitability in 
the chromatography of a wide range of basic drugs, it has limited 
discriminating power, arising from the fact that a large number 
of compounds are eluting within a relatively short period of 
time. This means that any identification of unknown substances is 
tentative and must be confirmed by other tests. This technique
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Is, therefore, a useful adjunct to other methodologies in the 
analytical laboratory, and is all the more powerful a tool since 
it can be combined with column switching to permit plasma 
analysis, and of course, it can be optimised to develop a 
specific analytical method for one or more particular compounds.
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RETENTION CHARACTERISTICS 
IN HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
OF BASIC DRUGS AND PLASMA EXTRACTS
CHAPTER 6
ON AN ALUMINA COLUMN
6 . 1 . INTRODUCTION
For a number of practical reasons, most separations are carried 
out on silica (modified or unmodified) rather than on alumina. 
Silica is less likely to promote unwanted reactions of the sample 
during separation; it is available in a wide range of 
chromatographically useful forms,- and the literature is replete 
with applications for silica in both column chromatography and 
TLC [1]. Furthermore, silica has a higher specific surface area - 
500m2/g for neutral silica as compared to 70 m2/g for basic 
alumina. A higher surface area means greater capacity for silica 
over alumina, and this results in higher capacity ratios and more 
predictable retention behaviour [2]. Occasionally, however, it is 
advantageous to consider the use of alumina in place of silica, 
and the differences in selectivity between the two adsorbents 
have been reviewed in detail [3],
6.1.1. Structure and properties of alumina
The crystalline alumina generally used in chromatography is known 
as 7 -alumina and is obtained by dehydration of the mineral 
Bayerite at elevated temperature (200-600°C) [4]. Alumina is 
hygroscopic and its adsorption properties for chromatographic 
solutes depend on the amount and the form of water present at its 
surface [5]. At room temperature, the IR spectrum of hydrated 
alumina displays two broad bands at 3300 and 1650 cm-1 
characteristic of water adsorbed in its molecular form. When, for 
chromatographic use, alumina is subjected to a higher 
temperature, the above mentioned bands are replaced by bands near 
3700 cm-* characteristic of the hydroxyl group [6 ]. Apparently, 
the water molecule decomposes into a hydroxyl group, which 
becomes attatched to the aluminium atom, and a proton which 
becomes attatched to the oxygen atom. Thus water, through 
chemisorption gives rise to two hydroxyl groups on the alumina 
surface. These retain the acidic or basic character of the 
underlying site and explain the amphoteric properties of alumina 
as an ion exchanger. It can act as an anion exchanger by
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displacing the hydroxyl group chemisorbed to the aluminium atom 
and it can act as a cation exchanger through the proton 
chemisorbed to the oxygen atom. Hence, like silica, alumina may 
be regarded as a typical polar adsorbent with most separations 
proceeding in the same way on the two oxides. However, whereas 
silica is only active through its surface hydroxyl groups, 
alumina posesses two alternative possibilities for interaction 
with solutes.
Alumina acts as a typical ion-exchanger [7] but since it is 
amphoteric, its ion exchange properties are strongly pH 
dependent. The ion exchange properties of alumina have been 
studied by Laurent et al. [4] who used the adsorption of copper 
ions to demonstrate cation exchange processes on neutral and 
acidic alumina. He showed that when neutral alumina is washed 
with sodium hydroxide, as is common practice in preparing 
chromatographic alumina, protons which are chemisorbed onto an 
oxygen atom will be neutralised and replaced by more loosely 
bound sodium ions. The sodium ions present on alkaline alumina 
can exchange with other cations, and are responsible for the 
cation exchange properties of alkaline alumina. In this 
environment, hydroxyl groups which are chemisorbed onto aluminium 
ions are too firmly bound to be exchangeable with other anions. 
When alkaline alumina is washed with hydrochloric acid, the 
protons desorb the hydroxyl groups, which are then replaced by 
chloride ions which give rise to the anion exchange properties of 
acidic alumina. In addition, the protons displace the sodium 
cations chemisorbed to the oxygen atoms, and it is likely that 
these processes proceed simultaneously [4].
6.1.2. Ion exchange chromatography on alumina
Ionic solutes on bonded silica columns require a special approach 
to diminish their interaction with remaining silanol groups, 
which results in poor chromatographic efficiencies and peak 
tailing. As outlined in chapter 5, this may be accomplished by 
exploiting the amine-silanol interaction through the employment
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of a buffered aqueous-organic eluent at high pH. In this respect, 
alumina also offers interesting possibilities for separation. The 
amphoteric character of alumina permits its use as either a 
cation or anion exchanger. In acidic media, the cation exchange 
capacity is small and the anion exchange capacity is large, and 
vice-versa in basic media. However, the variation with pH is 
gradual, and either cation or anion exchange properties are seen 
over fairly broad pH ranges. Alumina has proved to be very stable 
at extremes of pH. Laurent et al. have demonstrated less than 1% 
dissolution of the packing material after one months continuous 
use at pH 13 [4]. This broad pH range is available for 
chromatographic experiments and it is here that alumina offers an 
attractive alternative to silica. As a result of its resistance 
to strongly alkaline environments, basic compounds can be 
separated in the ion exchange mode in a manner analagous to that 
on unmodified silica as described in chapter 5, without the 
problem of loss in efficiency arising from dissolution of the 
packing material.
It is possible to define a pH where the net charge at the alumina 
surface is zero. This pH is known as the zero point charge (ZPC) 
and various methods have been employed to determine its value, 
including electrosmosis [8 ], streaming potential measurements 
[9], electrophoresis [10], and chromatography [11]. Generally, 
the ZPC of an aqueous suspension does not differ significantly 
from the solid metal hydroxide. However, the structure of the 
oxide and the presence of other ions co-precipitated during its 
preparation exert a large influence on the ZPC [11]. Abrahamson 
et al. [12] stressed that the determination of the ZPC should be 
made in the absence of all ions other than hydrogen, hydroxyl 
groups or those ions inherent in the solid. The specific 
adsorption of anions tends to increase the negative charge of the 
surface and shifts the ZPC to a lower pH. The Al-anion-H sites 
are generally more acidic than the original A1-0H groups.
For example, Clearfield [13] has shown that in the presence of 
10“  ^ M H2PO4 , the ZPC of alumina is shifted from 9.2 (as
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originally quoted by Parks [14]) to a value of 6.2. Laurent et 
al. [1 1 ], using chromatographic techniques, demonstrated a 
similar acidic shift to pH 6.5 (approximately) for the ZPC of 
alumina in the presence of acetate ions. In the presence of 
citrate ions, the ZPC was shifted as far down as pH 3.5. Hence, 
the ZPC moves along the pH scale depending on the nature of the 
buffer (specifically, the buffer anion) used. Generally speaking, 
alumina behaves as a cation exchanger at pH values above the ZPC, 
and as an anion exchanger at pH values below the ZPC. It is usual 
to select as operating pH, a value which lies between the pKa 
of the analyte and the ZPC of the column in the presence of the 
chosen buffer. In this way, the column and the analyte will be 
oppositely charged, and hence, available to partake in ionic 
interactions.
The use of unmodified silica and alumina as stationary supports 
in liquid chromatography had declined in popularity with the 
advent of chemically modified hydrophobic silicaceous suports. In 
particular, the use of alumina became even less widespread, as 
chemical modification of its surface in a manner analagous to the 
reaction of silica with alkyl si lanes proved not to be a 
practicable proposition [4].
Many investigators have attempted surface modification of 
alumina. Knox [15] reported the reaction of alumina with 
aminosilane, cyanosilane and pyridylsilane. Elemental analysis 
was then used to show the presence of carbon on the surface. On 
the basis of this result Novotny [16] caused reaction in situ by 
passing octadecy1chiorosilane through a microcapillary column 
containing alumina particles. In consecutive reversed-phase 
chromatographic experiments, the material was observed to have 
become less polar. The experience of Laurent et al. [4] was 
somewhat different to these earlier reports. They found that most 
chemical reagents which have been used successfully with silica 
showed no reactivity toward alumina. Even trimethylchlorosilane 
(TMCS), which reacts rapidly with silica, is quite inactive. 
However, hexamethyldisilazane (HMDS) was found to react with
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silica and to generate a non-polar surface. Furthermore, this 
surface was observed to remain intact up to 200°C, and various 
experiments revealed that HMDS had replaced water molecules on 
the alumina and rendered the surface less polar. Unfortunately, 
this did not mean that modified alumina can be used as a 
stationary phase in reversed phase liquid chromarography. When 
contacted with polar solvents, especially water, HMDS was rapidly 
displaced again. Evidently, however, the silazane was not 
chemically bonded onto the alumina, but only strongly adsorbed, 
and hence was rapidly removed on contact with the more strongly 
attracted water molecule. The Al-0 bond is stronger than the Si-0 
bond. As a result, in silanised alumina the Al-O-Si bond is less 
stable than the Si-0-Si bond [3].
In the same work, Laurent et al. [4] demonstrated the separation
of a range of compounds, including benzoic acid derivatives and 
basic drugs using an alumina column and a wholly aqueous mobile
phase. The factors which influenced retention of the analytes on
the column were consistent with both cation and anion exchange 
processes. It was found, however, that the applicability of the 
technique was somewhat limited, that it could only be applied to 
a few components in a sample mixture, and that it was difficult 
to manipulate the selectivity of the system. In a later work, 
Laurent et al. [5] demonstrated a more flexible way to influence 
retention by the introduction of an organic modifier to the 
aqueous solvent.
They found that while the elution order or a series of primary 
amines remained intact, there was a retention maximum with 
increasing additions of organic modifier. They interpreted this 
maximum in terms of the operation of at least two competing 
retention mechanisms. This effect was most manifest for 
acetonitrile and tetrahydrofuran. As the tetramethylammonium 
hydroxide used as a competing ion would experience enhanced 
solvation in the presence of an organic modifier [17,18], its 
competition with the solute ion would decrease, resulting in
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longer retention for the latter. They attributed the opposing 
effect (which became more obvious at higher percentages of 
organic modifier) to reduced solute ionisation in water-organic 
mixtures, the effect of which would be to cause a reduction in 
solute retention. In contrast to reversed-phase chromatography 
[19], there was no significant difference in eluting power 
observed between methanol, acetonitrile and tetrahydrofuran: 
hence solute retention remains approximately constant whether 
binary or ternary mixtures are employed as long as the total 
organic modifier content remains the same.
Laurent et al. [17] applied this type of aqueous-organic system 
to the separation of morphine, codeine and some other alkaloids. 
Using a buffer of citric acid and TMA at pH 6.0, all components 
were appreciably ionised in water and selectivity was imparted to 
the system by the addition of 75% acetonitrile. They found that 
if a ternary mixture was used consisting of methanol, 
acetonitrile and the aqueous component, separation, though not 
radically altered was improved for most of the compounds studied.
Laurent et al. [11] have also demonstrated the applicability of 
alumina in the separation of proteins using wholly aqueous 
buffered mobile phases. The retention mechanism in this case is 
principally one of ion exchange though size exclusion phenomena 
also play a significant role. The pH dependence of the 
ion-exchange mechanism is explained on the basis of the 
isoelectric point of the protein and the ZPC of the alumina, 
which as stated previously, can be manipulated by judicious 
choice of buffer anion. They found that for basic proteins, it 
was profitable to use a buffer such that the ZPC of the alumina 
surface is well below the isoelectric point of the proteins. This 
is easily realised by the use of a citrate buffer, which lowers 
the ZPC to 3.5.
Laurent et al. [20] have also used ion exchange on alumina to 
separate a wide range of opiates including illicit heroin samples 
and natural opium originating from a variety of sources.
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Quantitation of morphine without the need for internal 
standardisation was possible. Lingeman et al. [21] have also 
investigated the retention mechanisms on alumina using a range of 
basic amines of therapeutic interest. They also made a comparison 
between unmodified silica and alumina in terms of eluent pH, type 
and concentration of competing ion and counter ion in addition to 
the nature and concentration of organic modifier. Lingeman showed 
that in some cases, silica is preferred over alumina in the 
analysis of tetracyclines, and that alumina is preferred for the 
analysis of anthracycline derivatives. The anthracyclines 
adriamycin and daunorubicin cannot be separated with the silica 
system, but can be separated on a comparable alumina system [2 2 ].
The objective of the present study was to investigate the effect 
of changing pH, ionic strength, methanol content, and buffer ion 
on the retention of 31 basic drugs of therapeutic interest. As 
the on-line column switching technique has lent itself well to to 
the separation of basic analytes by ion exchange chromatography 
on unmodified silica gel (chapter 5), it was hoped to attempt 
similar experiments employing the alumina column in place of the 
si 1ica column.
6.2 EXPERIMENTAL
6.2.1. Reagents and solvents
The drugs used were received as a gift from the Institute of 
Clinical Pharmacology, Dublin, Ireland. Potassium dihydrogen 
phosphate (analytical grade) was obtained from May and Baker, 
Dagenham, England, and potassium hydroxide and ammonium nitrate 
(AnalaR grade) from BDH Chemicals Ltd, Poole, England. 
Orthophosphoric acid, dipotassium hydrogen phosphate and ammonia 
solution (25%) (all analytical grade) were supplied by Riedel de 
Haen, Seelze, Hannover, FRG. HPLC-grade methanol was purchased 
from Labscan Analytical Sciences, Dublin, Ireland. Deionised 
water was obtained by passing distilled water through a Milli-Q
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water p u r i f i c a t i o n  system . D r ie d  human p la sm a  was o b ta in e d  from 
the  B lood  T r a n s f u s io n  Board, D u b l in  and d i s s o l v e d  in  d e io n is e d  
water. T h i s  p la sm a was then used w ith in  seven  d ay s  o f  
r e c o n s t i t u t i o n .
6 .2 .2 .  D rug s o lu t i o n s
S to ck  s o l u t i o n s  e q u iv a le n t  to  1 mg ml- * o f  th e  d r u g s  in  
methanol were p re p are d .  Working s to ck  s o l u t i o n s  were p repared  in  
m ethano l-w ater  (1 :1 )  t o  c o n c e n t r a t io n s  o f  1-50 f i g / m l  a c c o r d in g  to  
the  d e te c to r  re sp o n se  o f  the drug. S ta n d a rd  s o l u t i o n s  were made 
t o  50-10000 n g /m l.  They were prepared  in  m o b i le  p h ase  f o r  d i r e c t  
i n j e c t io n  and in  water f o r  column s w it c h in g .
6 .2 .3 .  P lasm a s o lu t i o n s
A l iq u o t s  o f  r e c o n s t i t u t e d  d ru g - f r e e  p lasm a (1 m l)  were sp ik e d  
w ith  drug s o l u t i o n s  (50 ¡x1) to  produce the  d e s i r e d  
c o n c e n t r a t io n s .  P la sm a b la n k s  were prepared  by a d d in g  50 /il o f  
m ethano l-w ater  (1 :1 )  t o  1 ml a l i q u o t s  o f  d r u g - f r e e  p la sm a. These  
plasma s o l u t i o n s  were then d i lu t e d  (1 :1 )  w ith  w ate r  p r i o r  to  
i n j e c t io n  o f  500 1 l o o p f u l s  in to  the  ch ro m a to g ra p h ic  system .
6 .2 .4 .  In s t r u m e n ta t io n  and o p e r a t in g  c o n d i t i o n s
The d ru gs  were se p a ra te d  on a Techsphere a lu m in a  5 fim column (150 
mm x 4.6 mm i . d . ) ,  s u p p l ie d  by HPLC Techno logy , M a c c l e s f i e l d ,  
Eng land . The pH o f  th e  b u f fe r  s o lu t i o n s  and th e  a q u e o u s -o r g a n ic  
m ixtu re s  were measured a t  ambient tem perature  u s i n g  a s ta n d a rd  pH 
g l a s s  e le c t r o d e .  The pH meter was c a l i b r a t e d  d a i l y  u s i n g  aqueous  
s ta n d a rd s  p rep ared  on a weekly b a s i s .
S to ck  s o l u t i o n s  o f  ammonia and ammonium n i t r a t e  were mixed to  
produce the  r e q u i r e d  pH (u s in g  the pH m eter),  a s  were s to c k  
s o lu t i o n s  o f  p o ta s s iu m  d ih ydrogen  phosphate  and d ip o t a s s iu m  
hydrogen p h ospha te .  P h o sp h o r ic  a c id  was added t o  p o ta s s iu m  
d ihydrogen  p h osp h a te  t o  g i v e  a s o lu t i o n  o f  pH 3.0, and p o ta ss iu m
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h ydrox id e  was added to  d ip o ta s s iu m  hydrogen  phosphate  t o  ge ne ra te  
s o l u t i o n s  o f  pH 9.0 and 11.0. A l l  component s o l u t i o n s  were 1 M, 
and the m ix tu res  were d i l u t e d  w ith  water t o  g i v e  the  d e s i r e d  
i o n i c  s t re n g th .  M o b i le  phases  were made by m ix in g  the  aqueous  
component w ith  methanol t o  produce s o l u t i o n s  c o n t a in in g  30-90% 
o r g a n ic  m o d i f ie r .  The m ob ile  phase was p a sse d  th ro ugh  a 0.45^un 
f i l t e r  under vacuum and d egassed  by s o n i c a t io n  p r i o r  t o  use. The 
s o lu t i o n s  were s to r e d  in  g l a s s  c o n t a in e r s  which were capped a t  
a l l  t im es to  p reve n t  th e  a b s o r p t io n  o f  carbon  d io x id e  from the  
atmosphere th u s  r a i s i n g  the  pH above th e  i n i t i a l  v a lu e .
The m obile  phase was d e l i v e r e d  by a W aters  ( M i l f o r d ,  MA, USA) 
Model 501 HPLC pump (pump B) a t  a f low  r a t e  o f  1.0  ml min- 1 .
The d ru gs  were in t ro d u ce d  in to  the system  u s in g  a Rheodyne 
(C o ta t i ,  CA, USA) Model 7125 6 -p o r t  i n j e c t i o n  v a lv e .  The v a lv e  
was f i t t e d  w ith  e i t h e r  a 20 f ll  o r  a 500 1/iloop. The d ru g s  were 
detected  by UV a b s o r p t io n  a t  254 nm u s in g  a Shimadzu SPD-6A  
v a r i a b le  w avelength  d e te c to r  w ith  a d e te c to r  s e t t i n g  o f  0.04  
AUFS. The r e s u l t i n g  chromatograms were reco rded  w ith  a L i n s e i s  
(Se lb ,  FRG) r e c o rd e r  a t  a c h a r t  speed o f  200 mm h r - * .  For  
d i r e c t  i n je c t io n ,  20 /¿I a l i q u o t s  o f  the  d rug  s o l u t i o n s  in  m ob ile  
phase were in tro d uce d  in to  the  ch ro m atog raph ic  system . For  the  
purposes  o f  column s w i t c h in g ,  a second Waters model 501 HPLC pump 
and the c o n c e n t r a t io n  column were connected  to  the a n a l y t i c a l  
assem b ly  v ia  a Rheodyne Model 7000 s i x - p o r t  s w i t c h in g  v a lv e .  The 
10 x 1.5  mm i . d .  c o n c e n t r a t io n  column was d ry -p a ck e d  w ith  C o r a s i l  
(Waters A s s o c i a t e s )  RP-18 (37-50 /¿m) p a c k in g  m a t e r ia l .  The second  
pump e lu e n t  was d e io n i s e d  water f i l t e r e d  th ro ugh  a 0 . 4 5 /xm f i l t e r  
and degassed  under vacuum. The in strum ent arrangem ent and 
o p e ra t io n  o f  the  column s w i t c h in g  procedure  have been d e sc r ib e d  
in  ch ap ter  2.
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6.2.5. Procedures
6 .2 .5 .1 .  E f f e c t  o f  pH on r e te n t io n .
Phosphate  b u f fe r s  o f  pH 5.0 and pH 7.0 were prepared  by m ix in g  1
M s o l u t i o n s  o f  d ip o ta s s iu m  hydrogen phosphate and p o ta s s iu m  
d ihydrogen  phosphate. P h o sp h o r ic  a c id  (0.1 M) was added to  
po ta ss iu m  d ih yd ro gen  phosphate  to  g iv e  a s o lu t i o n  o f  pH 3.0, and
po ta ss iu m  h ydro x id e  (0 .1  M) was added to  d ip o ta s s iu m  hydrogen
phosphate  to  g i v e  s o l u t i o n s  o f  pH 9.0 and 11.0. These m ix tu re s  
were d i lu t e d  w ith  d e io n i s e d  water to  produce 0.04 M s o l u t i o n s .  
M o b i le  phases  were made by m ix in g  the  aqueous phase w ith  methanol 
(1 :4 ) ,  and the r e t e n t io n  t im e s  o f  the  d rugs  were i n v e s t i g a t e d  a s  
a fu n c t io n  o f  e lu e n t  pH. The pH o f  the  b u f fe r  s o l u t i o n s  f o l l o w in g  
the  a d d i t io n  o f  methanol was p lo t t e d  a s  a f u n c t io n  o f  th e  i n i t i a l  
pH in  o rde r  to  dem onstra te  the  e f f e c t  o f  methanol on ap p are n t  pH.
6 .2 .5 .2 .  E f f e c t  o f  i o n i c  s t r e n g th  on r e t e n t io n
P o ta ss ium  phosphate  b u f f e r  (1 M, pH 7 .0 )  was d i lu t e d  t o  produce  
s o l u t i o n s  o f  0.04 M and 0.02 M. F o l lo w in g  the p r e p a r a t io n  o f  
m obile  phases c o n t a in in g  b u f fe r -m e th an o l  (1 :4 ) ,  the  r e t e n t io n  
t im es  o f  the 31 d ru g s  were measured a s  a fu n c t io n  o f  i o n i c  
s t r e n g th .
6 .2 .5 .3 .  E f f e c t  o f  methanol con ten t  on r e t e n t io n
A 0.04 M po tass ium  phosphate  b u f f e r  s o lu t i o n  o f  pH 7.0  was 
prepared  by d i l u t i o n  o f  a 1 M s to c k  b u f fe r  s o lu t i o n .  M o b i le  
phases  were p repared  by a d d in g  methanol to  produce s o l u t i o n s  
c o n t a in in g  o r g a n ic -a q u e o u s  phase in  the r a t i o s  3:7, 5:5, 7 :3 ,  8 :2  
and 9:1. The r e t e n t io n  t im e s  o f  n in e  re p r e se n ta t iv e  d ru g s  were 
measured as  a f u n c t io n  o f  th e  perce n tage  methanol in  th e  m ob ile  
phase.
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6 .2 .5 .4 .  Measurement o f  the zero  p o in t  ch a rge
o f  a lum ina  in the presence o f  n i t r a t e  io n s
S to ck  s o l u t i o n s  c o n t a in in g  1 M ammonium n itra te -am m onium  
h ydro x id e  a t  pH 5.5, 6.5, 7.0, 7.5, 8.0, 9 .0  and 10.0 were 
prepared . The r e t e n t io n  t im es  o f  tyram ine, which i s  p o s i t i v e l y  
charged  over the  pH range, and b enzo ic  a c id  which i s  n e g a t i v e ly  
charged  o ve r  t h i s  pH range  were measured a s  a f u n c t io n  o f  e lu e n t  
pH. The ze ro  p o in t  ch a rge  was determined from th e  p o in t s  o f  
i n f l e c t i o n  o f  th e  two c u rv e s .
6 .2 .5 .5 .  Com parison  o f  ammonium n i t r a t e  and 
p o ta ss iu m  phosphate  b u f fe r s
S tock  s o l u t i o n s  c o n t a in in g  1 M ammonium n i t r a t e  and p o ta ss iu m  
phosphate  b u f f e r s  o f  pH 7.0 were d i lu t e d  t o  produce s o l u t i o n s  o f  
0.04 M. M o b i le  p h ase s  c o n t a in in g  a q u e o u s -o r g a n ic  p h ase s  in  the  
r a t i o  1:4  were p repared  by th e  a d d i t i o n  o f  m ethanol. Drug  
r e t e n t io n  t im e s  in  th e  presence  o f  the d i f f e r e n t  b u f f e r s  were 
compared.
6 .2 .5 .6 .  Column s w it c h in g  and plasma exp er im en ts
A second pump and c o n c e n t r a t io n  column were connected  to  the  
a n a l y t i c a l  column a s  p r e v io u s ly  d e sc r ib e d .  The c o n c e n t r a t io n  
column was packed w ith  RP-18 m a te r ia l  and th e  wash s o l u t i o n  was 
water d e l i v e r e d  a t  a f low  r a te  o f  1.5  m l/m in f o r  1 min, a f t e r  
which the  c o n c e n t r a t io n  column was p laced  in  the  m ob ile  phase  
stream  by a c t u a t in g  the  s w i t c h in g  v a lv e .  The m ob ile  ph ases  
d e l i v e r e d  to  th e  a n a l y t i c a l  column co n ta in e d  b u f fe r -m e th a n o l  in  
the r a t i o  1 :4 .  The aqueous component was 0 .02  M phosphate  b u f fe r ,  
pH 5 .0 ;  0.02 M phosphate  b u f fe r ,  pH 8.0; 0.04 M phosphate  b u f fe r ,  
pH 8 .0 ;  0.04 M ammonium n i t r a t e  b u f fe r ,  pH 7 .0  o r  pH 9 .5 .  The 
e f f e c t  o f  m ob ile  phase co m p o s it io n  on d r u g - f r e e  and sp ik e d  plasma  
p r o f i l e s  f o l l o w in g  s o l i d - p h a s e  e x t r a c t io n  was i n v e s t i g a t e d .
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6.3. RESULTS AND DISCUSSION
There were t h i r t y  one d ru g s  chosen f o r  t h i s  s tud y .  Se v e ra l  
t h e r a p e u t i c a l l y  im po rtan t  c l a s s e s  o f  compounds were re p re se n te d ,  
f o r  in s ta n ce ,  th e  t r i c y c l i c  a n t id e p r e s s a n t s ,  major t r a n q u i l l i s e r s  
such a s  the p h e n o th ia z in e s ,  a n t ih i s t a m in e s ,  b e ta - b lo c k i n g  a g e n t s  
such a s  p r o p r a n o lo l ,  n a r c o t i c  a n a l g e s i c s ,  lo c a l  a n a e s t h e t i c s  and  
a n t im a la r ia l  d ru g s .  These d ru g s  p o s s e s s  e i t h e r  a prim ary,  
secondary o r  t e r t i a r y  amine f u n c t i o n a l i t y .  A very  weakly b a s i c  
drug (n itrazepam ) and an a c i d i c  d ru g  ( f ru se m id e )  were a l s o  
inc luded .  A part  from th e  amine fu n c t io n  shared  by the  o th e r  
compounds, th e re  were s i g n i f i c a n t  s t r u c t u r a l  d i s s i m i l a r i t i e s  
among some o f  the  d ru g s ,  a s  may be seen from the  s t r u c t u r e s  o f  
r e p r e se n ta t iv e  compounds p re sen ted  in  F ig u r e  6.1.
6 .3 .1 .  E f f e c t  o f  pH on r e t e n t io n
The r e t e n t io n s  o f  the  t h i r t y  one d ru g s  s tu d ie d  on the  a lum ina  
column were in v e s t i g a t e d  a s  a f u n c t io n  o f  pH over the  range  pH
3.0 to  pH 11.0. The m o b i le  phase  co n ta in e d  0.04 M po tass ium  
phosphate b u f fe r -m e th a n o l  ( 1 :4 ) .  A d d i t i o n s  were not made to  
compensate f o r  v a r i a t i o n s  in  i o n i c  s t r e n g th  from s o lu t i o n s  o f  one 
pH to  the next, a s  i t  was assumed t h a t  the  changes in  c a t i o n  
c o n c e n tra t io n  would be sm a l l  in  r e l a t i o n  to  the changes in s o lu t e  
and column i o n i s a t i o n  a r i s i n g  from pH v a r i a t i o n .
The r e s u l t s  o f  t h i s  s tu d y  are  p re se n te d  in T ab le  6.1. From t h i s ,  
i t  can be seen th a t  th e  d ru g s  may be r o u g h ly  d iv id e d  in to  th r e e  
groups?  namely (A), th o se  d ru g s  w ith  r e t e n t io n  t im es  which  
in c re a se  between pH 3.0 and pH 5.0 , fo l lo w e d  by a d e c l in e  in  
r e te n t io n  a t  h ig h e r  pH; (B ),  th o se  d ru g s  which e x h ib i t  decreased  
r e te n t io n  a s  the pH i s  in c re a se d ;  and (C ),  d ru gs  whose r e t e n t io n  
t im es a re  l a r g e l y  u n a f fe c te d  by pH. These o b s e rv a t io n s  may be 
e x p la in e d  by c o n s id e r in g  the pKa o f  the  d ru g s ,  the pH o f  th e  
m obile  phase, and th e  am ph o te r ic  n a tu re  o f  the  a lum ina p a c k in g .  
G roup(A ):  A lthough  th e se  compounds a re  f u l l y  p ro tonated  a t  low 
pH, in t e r a c t io n  w ith  th e  a lum ina  p a c k in g  i s  m inimal a s  the
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Figure 6.1.
Structures of some drug compounds
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Table 6.1.
Effect of pH on retention
DRUG d K, RETENTION T IM E  (m in)
GROUP A
pH3.0 d H5.0 pH 7.0 d H9.0 d H I I
A m i t r ip t y l i n e 9.5 7.5 9.6 6.0 5.1 4.2
A te n o lo l 9.6 3.9 5.4 2.7 2.1 2.0
Acetoprom azine NA 6.0 7.6 3.6 3.6 3.0
C h lo rp he n iram ine 8.9 8.7 13.8 7 .2 6.6 5.1
Ch lo rprom az ine 9.3 6.2 7.5 3.6 3.0 2.7
D e s ipram ine 10.2 5.4 7.5 7 .8 6.6 5.4
Im ipram ine 9.6 8.1 9.6 6.0 5.1 3.9
M e f lo qu in e NA 7.5 10.8 5.1 4.5 3.6
N o r t r i p t y l i n e 9.7 5.4 8.7 7 .5 6.3 5.4
Phento loxam ine 9.1 6.2 7.8 7.2 3.6 3.0
P r o p ra n o lo l 9 .5 3.6 4.5 3.5 3.0 2.7
P in d o lo l 9.5 3.3 3.6 2.4 2.1 2.1
Prom ethazine 9.1 7.4 10.5 5.1 3.3 3.0
P r o t r i p t y l i n e 10.1 4.8 6.6 6.9 6.3 6.0
Q u in ine 8.5 4.5 8.2 3.0 2.4 2.1
T ripe lennam ine 9.0 4.5 5.4 2.7 2.7 2.1
Tyramine 10.2 4.2 9.9 6.6 3.6 3.0
NA = not a v a i l a b l e  in  s ta n d ard  re fe re n c e  t e x t s  
M o b ile  phase: 0.04 M phosphate  b u f fe r -m e th a n o l  (1 :4 )
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Table 6.1. continued
DRUG eKa___  RETENTION TIME (m in )
d H3 .0 pH5.0 pH7.0 pH9.0 d H I I . i
GROUP B
D i l t i a z e m NA 4.2 3.3 1.8* 1 .8 * 1 .8*
Dextromethorphan 8.3 4.8 4 .5 3.0 2.7 2.4
F luph en az in e 8.1 6.1 6.0 2.4 2.4 2.4
L id o c a in e 7.9 3.0 2.7 2.4 2.1 2.1
M e p ivaca ine 7.7 3.0 2.7 2.1 1 .8 * 1 .8 *
Perphenaz ine 7.8 6.9 5.1 3.3 3.0 2.7
Phentermine 10.1 5.4 4.5 3.3 3.0 2.4
Pheny1p ro pan o 1am i ne 9.5 7.2 4.8 4.8 2.7 2.4
Trim ethoprim 7.2 4.5 2.7 1 .8 * 1 .8 * 1 .8 *
V erapam i1 NA 3.0 3.0 2.4 2.4 2.4
GROUP C
C a f fe in e 14.0 1 .8 * 1 .8 * 1 .8* 1 .8* 1 .8*
Frusem ide 3.6 1 .8 * 1 .8 * 1 .8 * 1 .8 * 1 .8*
N itrazepam 3.2 2.1 2.0 1.8* 1 .8* 1 .8*
Su lfam e th o xa zo le 5.6 1 .8 * 1 .8 * 1 .8 * 1 .8* 1 .8*
NA = Not a v a i l a b l e  in  s ta n d ard  r e fe r e n c e  t e x t s  
* = d ru g  un re ta in e d  under th e se  c o n d i t i o n s .
M o b i le  phase: 0.04M phosphate  b u f fe r -m e th a n o l  (1 :4 )
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a lum ina  w i l l  a l s o  bear  a p o s i t i v e  ch arge ,  th u s  r e p e l l i n g  th e  
l i k e - c h a r g e d  p ro to n a te d  b a se s .  As th e  pH i s  in c re a se d  t o  5.0,  
th e re  was an ob se rved  in c r e a s e  in  r e t e n t io n  c o n s i s t e n t  w ith  th e  
reduced p o s i t i v e  ch a rge  on th e  column. However, a s  th e  pH was 
f u r t h e r  in c rea sed  t o  7 .0  and above, th e re  was a ge n e ra l  d e c re a se  
in  r e t e n t io n .  These r e s u l t s  may be e x p la in e d  in terms o f  reduced  
p r o to n a t io n  o f  th e  a n a l y t e s  a t  h ig h e r  pH, and p o s s i b l y  a s h i f t  
upwards o f  the ZPC o f  a lum ina ,  a s  th e  c h a n g in g  b u f fe r  c o m p o s i t io n  
ca u se s  a re d u c t io n  in  th e  n e g a t iv e  ch a rge  o f  the column [21].  
Furthermore, i t  i s  w e l l  known t h a t  pKa v a lu e s  o f  a c i d s  and  
base s  v a ry  w ith  th e  c o m p o s i t io n  o f  h y d r o -o r g a n ic  m ix tu re s  
[23-25], and Lau ren t  e t  a l . [17] have dem onstrated  an in c r e a s e  in  
the apparen t pH in  th e  p re sen ce  o f  o r g a n i c  s o lv e n t s .
The r e s u l t i n g  d e c re a se  in  r e t e n t io n  i s  e x agge ra ted  by a 
concommitant d ec rea se  in  s o l u t e  pKa . An in c re a se  in  a p p are n t  pH 
upon a d d i t io n  o f  80% methanol t o  0 .04 M phosphate  b u f f e r  i s  
i l l u s t r a t e d  in F ig u r e  6.2, where i t  can be seen th a t  th e r e  i s  a 
s u b s t a n t i a l  d i f f e r e n c e  between the  i n i t i a l  and apparen t pH v a lu e s  
o f  s o l u t i o n s  o f  i n i t i a l  pH 3 .0 -7 .0 .  T h i s  becomes le s s  pronounced  
f o r  i n i t i a l  pH v a lu e s  o f  8 .0 -1 0 .0 ,  u n t i l  f o r  a s o lu t i o n  o f  
i n i t i a l  pH o f  11.0, the  a d d i t i o n  o f  methanol has the  e f f e c t  o f  
p ro d u c in g  a lower a p p are n t  pH v a lu e .
Group ( B ) s The d ru g s  in  t h i s  c a t e g o r y  e x h ib i t  reduced r e t e n t io n  
t im es  w ith  in c r e a s in g  pH. As th e y  g e n e r a l l y  have lower pKa 
v a lu e s  than th o se  in  Group A, i t  i s  t o  expected  th a t  th e se  
compounds would be l e s s  i o n i s e d  than  th e  more b a s ic  am ines a t  any  
g iv e n  pH, and t h a t  th e re  would be a more pronounced r e d u c t io n  in  
t h e i r  r e t e n t io n  t im e s  under c o n d i t i o n s  o f  in c r e a s in g  e lu e n t  pH.
Group ( C ) s As expected, s o l u t e s  which do no t  io n i s e ,  such a s  
c a f fe in e ,  a re  u n re ta in e d  by th e  column in t h i s  ch ro m atog rap h ic  
system where the p r i n c i p a l  mechanisms o f  so lu te -co lu m n  
i n t e r a c t i o n  are  known to  be i o n i c  in  n a tu re .  L ik ew ise ,  compounds  
w ith  low pKa v a lu e s ,  e . g .  n i t ra ze p am  (pKa *  3 .2 ) ,  are  
s i m i l a r l y  un re ta in e d  a s  th e y  would no t  be s u f f i c i e n t l y  io n i s e d  to
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E f f e c t  o f  the a d d i t i o n  o f  80% methanol on i n i t i a l  pH o f  phosphate  
b u f fe r
Figure 6.2.
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i n t e r a c t  w ith  the  column a t  th o se  pH v a lu e s  where a lum ina  behaves  
as a c a t i o n  exch anger.  The a c i d i c  d rug, f ru se m id e  was a l s o  
in v e s t i g a t e d ,  and was found not to  be r e t a in e d  under any pH 
c o n d i t i o n s .  F rusem ide  has a pKa o f  3.6, so  t h a t  a t  pH 5.0 the  
drug shou ld  have been io n ise d .  However, t h i s  pH i s  h ig h  enough 
f o r  the column to  e x h ib i t  c a t io n  exchange p r o p e r t ie s ;  hence 
n e g a t i v e ly  ch a rged  s o lu t e s  would be r e p e l le d  by th e  l ik e - c h a r g e d  
a lum ina  s u r fa c e ,  and th e re fo re  be u n re ta in e d  by th e  column.
6 .3 .2 .  E f f e c t  o f  i o n ic  s t r e n g th  on r e t e n t io n
The e f f e c t  o f  lo w e r in g  the i o n i c  s t r e n g t h  from 0.04 M to  0.02 M 
o f  the  p o ta s s iu m  phosphate  b u f fe r  was i n v e s t i g a t e d .  The pH o f  the  
aqueous component was 7.0 and a 1:4 aqueous t o  o r g a n i c  r a t i o  in  
the  m obile  phase  was m a in ta ined . The r e s u l t s  o f  t h i s  s tu d y  are  
presen ted  in  T a b le  6 .2 ,  where i t  can  be seen t h a t  d rug  r e t e n t io n  
in c re a s e s  a s  th e  i o n i c  s t r e n g th  i s  reduced. These o b s e r v a t io n s  
agree  w ith  o th e r  workers [4,21] who a l s o  found an in c re a se  in  
r e t e n t io n  on a lu m in a  a t  lower i o n i c  s t r e n g t h s .  These f i n d i n g s  are  
c o n s i s t e n t  w ith  th e  ion -exchange  th e o ry  o f  r e t e n t io n  which  
e x p la in s  enhanced s o lu t e  in t e r a c t i o n  in  te rm s o f  decreased  
co m p e t it io n  by th e  reduced number o f  com peting  c a t i o n s  f o r  the  
charged  s i t e s  on th e  column p a ck in g .
6 .3 .3 .  E f f e c t  o f  methanol c o n te n t  on r e t e n t io n
The e f f e c t  o f  v a r y in g  the  m e th a n o l-b u f fe r  r a t i o  from 9:1 to  3:7
( in  a m ob ile  phase  where the  aqueous component was 0.04 M 
phosphate b u f f e r ,  pH 7 .0 )  on the  r e t e n t io n  o f  n ine  o f  the  d rugs  
i s  shown in  T a b le  6 .3 .  From t h i s  i t  can  be seen t h a t  a s  the  
methanol c o n te n t  i s  reduced, th e re  i s  a c o r r e s p o n d in g  in c re a se  in  
drug r e t e n t io n ?  so  much so, t h a t  when th e  methanol c o n te n t  i s  
50%, o r  below most o f  the  d rugs  would appear  t o  be f u l l y  
re ta in e d ,  n o t  h a v in g  e lu te d  a f t e r  60 m in u te s  o r  more. These  
o b s e r v a t io n s  d i f f e r  from th o se  made by L a u re n t  e t  a l . [17], and 
Lingeman e t  a l . [21], who found a p o in t  o f  maximum r e t e n t io n  as a 
f u n c t io n  o f  methanol con tent ,  which a l t h o u g h  so lu te -d e p e n d e n t ,
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Table 6.2.
Effect of ionic strength on retention
DRUG RETENTION T IME (min)
0.02 M 0.04 M
A m i t r ip t y l i n e 18.3 6.0
A te n o lo l 3 .6 2.7
Acetoprom azine 6.3 3.6
C a f fe in e 1 . 8 * 1 .8*
Ch1orphen i ram i ne 11.1 7.2
Ch lo rp rom az ine 4 .5 3.6
D i l t ia z e m 2.1 1 .8*
D e s ip ram ine 1 1 .7 7.8
Dextromethorphan 3.9 3.0
F luph en az in e 2 .7 2.4*
Frusemide 1 .8 * 1 .8*
Im ip ram ine 8 .4 6.0
L id o c a in e 2.1 2.4
M e f lo q u in e 7 .4 5.1
M e p ivaca ine 2 .4 2 .1*
N o r t r i p t y l i n e 11 .4 7.5
Perphenaz ine 3.3 3.3
Phento loxam ine 4 .5 7.2
* = Drug u n re ta in e d  under th e se  c o n d i t i o n s
M o b i le  phase: phosphate b u f fe r ,  pH 7 .0 -m eth an o l  (1 :4 )
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TabIe 6.2. cont i nued
0.02 M 0.04 M
DRUG RETENTION TIME (mln)
Phenterm ine 6.3 3.3
Pheny1p ro pan o 1am i ne 4.8 4.8
P ro p ra n o lo l 5.1 3.5
P in d o lo l 3.0 2.4
Prom ethazine 6.3 5.1
P r o t r i p t y 1ine 10.5 6.9
Nitrazepam 1.8* 1 .8*
Q u in ine 3.0 3.0
Su lpham ethoxazo1e 1.8* 1 .8*
Trim ethoprim 1.8* 1 .8*
T r ipe le nnam in e 3.3 2.7
Tyramine 9.0 6.6
Verapam i1 2.9 2.4
* = drug  u n re ta in e d  under th e se  c o n d i t i o n s
M o b ile  phases phosphate  b u f fe r ,  pH 7.0-m ethanol (1 :4 )
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o ccurre d  a t  about b u f fe r-m e th an o l  ( 3 s 2) f o r  most compounds 
s tu d ie d .  Lau ren t  e t  a I . [17] a t t r ib u t e d  low s o lu t e  r e t e n t io n  a t  
h ig h  methanol co n te n t s  to  a d ec rea se  in  s o lu t e  i o n i s a t i o n ,  and a t  
low methanol c o n te n t s  to  reduced s o l v a t i o n  o f  the com peting  ion s.  
At any g iv e n  pH th e se  two mechanisms o p e ra te  in  o p p o s i t i o n  to  one 
another,  a s  ev idenced  by the  appearance o f  a r e t e n t io n  maximum, 
w ith  reduced s o lu t e  i o n i s a t i o n  p re d o m in a t in g  a t  h ig h  methanol 
co n te n t s ,  and reduced com peting ion s o l v a t i o n  p re d o m in a t in g  a t  
low methanol c o n te n t s .
The observed  d i f f e r e n c e  in e f f e c t  o f  m o d i f ie r  co n te n t  between 
t h i s  and p r e v io u s  s t u d ie s  may be accounted  f o r  by th e  n a tu re  o f  
the com peting  ion in  the  aqueous phase. As L a u re n t  e t  a l . [17] 
p o in t  out, i f  l i t h iu m  re p la c e s  th e  te t ra m e th y l  ammonium ion  as  
the  com peting  c a t io n ,  r e t e n t io n  t im e s  a re  a c t u a l l y  reduced  w ith  
i n c r e a s in g  c o n c e n t r a t io n  o f  a c e t o n i t r i l e .  A c c o rd in g  to  th e  Born  
model o f  s o l v a t i o n  [26], the lower d i e l e c t r i c  c o n s t a n t  o f  o r g a n ic  
s o lv e n t s  le a d s  to  a p o s i t i v e  v a lu e  f o r  the f re e  energy  change  
when an ion (such  a s  l i t h iu m )  i s  t r a n s f e r r e d  from w ater  t o  an 
o r g a n ic  s o lv e n t .  T h i s  i n d ic a t e s  t h a t  th e  ion  i s  l e s s  s o lv a t e d  in  
the  o r g a n ic  s o lv e n t .  And the  l e s s  s o lv a t e d  an ion  becomes, the  
g r e a te r  i t s  a b i l i t y  t o  compete f o r  s i t e s  on th e  column su r fa c e ,  
an e f f e c t  which ca u se s  a r e d u c t io n  in  th e  r e t e n t io n  o f  s o lu t e  
m o lecu le s .  However, f o r  qu a te rn a ry  a l k y l  ammonium io n s  (such  as  
tetramethylammonium h ydrox ide  which was used by Lau re n t  e t  a l . 
[1 7 ] ) ,  the  f re e  energy change f o r  t h i s  t r a n s f e r  was found to  be 
n e g a t iv e ,  i n d i c a t i n g  t h a t  such io n s  a re  a c t u a l l y  more s o lv a t e d  in 
methanol (and e s p e c i a l l y  a c e t o n i t r i l e )  than in  water, a s  a r e s u l t  
o f  s p e c i f i c  i n t e r a c t i o n s  [18,27].  The enhanced s o l v a t i o n  o f  the  
b u f fe r  c a t i o n  weakens i t s  co m p e t it io n  w ith  the  s o lu t e  io n s ,  thus  
p r o lo n g in g  a n a ly t e  r e t e n t io n  on the  column. I t  i s  q u i t e  p o s s ib le  
t h a t  in  the  p re se n t  s tudy ,  where the  com peting  ion i s  th e  
r e l a t i v e l y  sm a l l  p o ta ss iu m  ion, the  degree o f  b u f f e r  ion  
s o l v a t i o n  i s  reduced a s  the methanol c o n te n t  i s  in c re a se d ,  an 
e f f e c t  which would a c t  in  co n ce r t  w ith  reduced s o lu t e  i o n i s a t i o n  
to  m in im ise  th e  d ru g s  in t e r a c t io n  w ith  the s t a t i o n a r y  phase.
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Table 6.3.
Effect of methanol content on retention
DRUG RETENTION TIME (m in) a t  METHANOL CONTENT
30 50 70 80 90
A m i t r i p t y l i n e 17.1 6.3 3.3
C h lo rp rom az ine - - 9.3 3.5 3.0
Dextromethorphan - - 4.8 3.0 2.7
N itrazepam 9.6 3.6 2.1 1 .8 * 1 .8*
Perphenaz ine - - 6.9 3.0 2.4
P in d o lo l 6.9 3.9 3.0 2.6 2.4
Q u in in e - - 3.9 3.2 2.4
T r ip e le n n am in e - - 5.4 2.9 2.4
S u lfa m e th o x a z o le 1.8* 1 .8 * 1 .8* 1 .8* 1 .8 *
-  = Not e lu te d  a f t e r  60 m inutes
* = d rug  u n re ta in e d  under th e se  c o n d i t i o n s
M o b i le  phase : 0.04M phosphate b u f fe r ,  pH 7 .0 -m ethano l
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The e f f e c t  on i o n i c  s t r e n g t h  o f  c h a n g in g  the  r a t i o  o f  o r g a n i c  to  
aqueous phases was no t com pensated f o r  in  t h i s  experim ent, s in c e  
i t  would not appear to  be a m ajor c o n t r ib u t in g  f a c t o r  t o  the  
observed  s h i f t s  in  s o lu t e  r e t e n t io n .  I f  i t  d id  s i g n i f i c a n t l y  
a f f e c t  s o lu te  re te n t io n ,  one would expect t o  ob se rve  an in c re a se  
in  re te n t io n  time a t  h ig h e r  methanol co n te n t s ,  a s  fewer b u f fe r  
ion s  a re  a v a i l a b l e  to  compete w ith  a n a ly t e s  f o r  ch arged  s i t e s  on 
the column su r fa c e .  Adjustm ent o f  th e  i o n i c  s t r e n g th  would be 
f u r th e r  com p lica ted  by a c c o u n t in g  f o r  the  e f f e c t  o f  ch a n g in g  
m o d if ie r  content on the ch a rge  o f  th e  column, and on th e  degree  
o f  i o n i s a t i o n  o f  the b u f f e r  components.
6 .3 .4 .  Measurement o f  th e  ZPC o f  a lum ina in the  p resence
o f  n i t r a t e  io n s .
As d is c u s se d  p r e v io u s ly ,  the  n a tu re  o f  the b u f fe r  a n io n  
determ ines the ZPC o f  a lum ina  under a g iv e n  se t  o f  exp er im e nta l  
c o n d i t io n s .  As the s h i f t  in  ZPC b ro u gh t  about by the n i t r a t e  
an ion  was not a v a i l a b l e  in  th e  l i t e r a t u r e ,  i t  was d ec ide d  to  
measure t h i s  parameter e x p e r im e n t a l l y .  The ZPC was determ ined  in  
a t o t a l l y  aqueous environm ent, in  s p i t e  o f  the f a c t  t h a t  the  
m obile  phase in a l l  o th e r  ex p er im e n ts  co n ta in e d  methanol in  a 4:1  
r a t i o  w ith  the aqueous component. T h i s  was because p r e v io u s  
d e te rm in a t io n s  c a r r ie d  o u t  by o th e r  workers [11] were based  in  
aqueous r a th e r  than h y d r o -o r g a n ic  media, and i t  was so u g h t  to  
compare the r e s u l t s  p re sen ted  here  w ith  p re v io u s  s t u d ie s .
The chosen pH range  was 5.5  t o  10.0, and the pH was a d ju s te d  
u s in g  a pH meter.
The an io n  se le c te d  was b e n zo ic  a c id  (pKa = 4 .2 )  s in c e  i t  i s  
n e g a t iv e ly  charged  over a wide pH range, and b e s id e s ,  i t  had a l s o  
been used by Lau rent e t  a l . [11] in  d e te rm in in g  the  ZPC in  the  
presence  o f  phosphate, c i t r a t e  and a c e ta te  io n s .  A number o f  
p o t e n t ia l  b a s i c  t e s t  s o lu t e s  were in v e s t i g a t e d  a t  v a r io u s  v a lu e s  
o f  m obile  phase pH. I t  was found t h a t  some o f  the  l a r g e r  
compounds ( f o r  example, d e s ip ra m in e  and p i n d o l o l )  produced broad  
t a i l i n g  peaks even a t  low pH where th e  c a t i o n i c  c h a r a c t e r  o f  the
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column would be m in im a l.  T h i s  o b se rv a t io n  would i n d i c a t e  th a t  
there  a re  p o s s i b l y  f a c t o r s  o ther  than ion exchange  p r o c e s se s  
go v e rn in g  r e t e n t io n  on a lum ina, though th e se  mechanisms have not,  
a s  y e t  been e lu c id a t e d .  The b a s i c  compound chosen  was ty ram ine  
(pKa = 10 .2 )  s in c e  i t  would be p o s i t i v e l y  ch a rge d  o v e r  a wide  
pH ran ge .  Furtherm ore, ty ram ine  i s  a sm a l l  m o lecu le ,  and a p a r t  
from th e  amino fu n c t io n ,  i s  not r a d i c a l l y  d i f f e r e n t  in  s t r u c t u r e  
from b e n z o ic  a c id .  Hence, f a c t o r s  such a s  m o le c u la r  s i z e  would be 
l e s s  l i k e l y  t o  c o m p l ic a te  i n t e r p r e t a t io n  o f  th e  r e s u l t s .
As may be seen from th e  r e s u l t s  p resented  in  F i g u r e  6 .3 ,  the  
n e g a t i v e ly  charged  benzoate  ion i s  s t r o n g l y  r e t a in e d  below a pH 
va lued  o f  a p p ro x im a te ly  7.0, and un re ta in e d  a t  h i g h e r  pH v a lu e s ,  
w hile  th e  o p p o s i te  i s  t r u e  f o r  the p o s i t i v e l y  ch a rged  ty ram ine .  
The p o in t  a t  which both  compounds are  a lm o s t  c o m p le te ly  
u n re ta in e d  a p pears  t o  o ccu r  between pH 7.0 and pH 7 .6 .  Hence,the  
ZPC f o r  a lum ina  in  th e  p resence  o f  n i t r a t e  io n s  was ta k e n  to  be 
7.3 ( + 0 . 3 ) .  Chromatograms d e p ic t in g  the  change  in  e l u t i o n  o rde r  
between trym ine  and b e n zo ic  a c id  in the  r e g io n  o f  th e  ZPC, in  
a d d i t i o n  to  a p r o f i l e  o f  p in d o lo l  are  shown in  F i g u r e  6 .4 .
6 .3 .5 .  E f f e c t  o f  b u f fe r  type on r e t e n t io n
A com parison  in  term s o f  d rug  r e te n t io n  was made between the  
ammonium n i t r a t e  and p o ta ss iu m  phosphate b u f f e r  s y s te m s  a t  
c o n s ta n t  pH (7 .0 ) ,  b u f fe r -m e th a n o l  r a t i o  (1 :4 )  and i o n i c  s t re n g th  
(0.04 M). I f  th e  d i f f e r e n c e  in drug r e t e n t io n  u s i n g  th e  phosphate  
and n i t r a t e  b u f fe r  sy ste m s  was con s id e re d  p u r e ly  in  te rm s in  the  
d i f f e r e n c e  in  ZPC, i t  would be expected t h a t  r e t e n t io n  would  
a c t u a l l y  be g r e a t e r  w ith  the  phosphate b u f fe r ,  s in c e  i t  produces  
a g r e a te r  a c i d i c  s h i f t  (ZPC = 6 .5 )  than n i t r a t e  (ZPC = 7 .3 ) ,  
r e s u l t i n g  in  g r e a t e r  c a t i o n i c  c h a ra c te r  fo r  th e  co lum n a t  pH 7.0  
in  the presence  o f  phosphate  b u f fe r .  However, the  r e s u l t s  
presen ted  in  T ab le  6 .4 .  show t h a t  a t  the  s t a t e d  pH and i o n i c  
s t re n g th ,  r e t e n t io n  i s  g e n e r a l l y  g r e a te r  in  th e  p re se n c e  o f  the  
ammonium ion  th an  w ith  th e  p o ta ss ium  ion. These  f i n d i n g s  agree  
w ith  o th e r  workers [1 7 ,2 1]  who found th a t  th e  l a r g e r  com peting
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F ig u r e  6 .3 .
E s t im a t io n  o f  the zero  p o in t  charge  o f  th e  column  
u s in g  n i t r a t e  io n s  In  the m obile  phase
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Chromatogram o f  benzo ic  a c id  (BA) and tv ram ine  (T) in 0.1 M 
ammonium n i t r a t e  b u f f e r
F ig u r e  6 . 4 . a.
BA
■
BA
2 4  6
T IM E (m in ) ----------------------------
(a)s  mobile  phase pH 7 .0
2 4  6 2 4 6
(b )s  m ob ile  phase pH 7.5
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Figure 6.4.b.
Chromatogram of pindolol (P)
TIM E (m in ) ------------------------------------------------------------------------------------------------>
M o b ile  phase*  0 .1  M NH40H/NH4N03 , pH 7 .0
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Table 6.4.
Effect of buffer type on retention
DRUG RETENTION T IM E  (m in)
POTASSIUM PHOSPHATE AMMONIUM NITRATE
Acetoprom azine 3.6 7.2
A m i t r i p t y l i n e 6.0 8.4
A te n o lo l 2.7 3.3
C a f f e in e 1.8* 1.8*
C h 1orphen i ram i ne 7.2 11.4
C h lo rp ro m az ine 3.6 6.9
D i l t i a z e m 1.8* 3.3
D e s ip ram ine 7.8 8.3
Dextromethorphan 3.0 4.2
F luph en az in e 2.4 4.2
Frusem ide 1.8* 1.8*
Im ip ram ine 6.0 8.1
L id o c a in e 2.4 2.7
M e f lo q u in e 5.1 7.4
M e p iv a ca in e 2.1 3.0
N o r t r i p t y l i n e 7.5 7.6
M o b i le  phase*  0 .04 M b u f fe r ,  pH 7 . 0-methanol ( 1 :4 )
Table 6 .4 .  con t inued
DRUG RETENTION T IM E  ( a I n )
POTASSIUM PHOSPHATE AMMONIUM NITRATE
Perphenaz ine 3.3 5.4
Phento loxam ine 7.2 7.5
Phentermine 3.3 3.9
Pheny1pro pan o 1 am i ne 4.8 6.3
P ro p ra n o lo l 3.5 3.7
P in d o lo l 2.4 3.0
Prom ethazine 5.1 9.6
P r o t r i p t y l i n e 6.9 7.0
N itrazepam 1.8* 1 .8*
Q u in ine 3.0 4.5
S u 1phamethoxazo1e 1.8* CO *
T r im ethoprim 1.8* 2.5
T r ipe le nnam in e 2.7 4.5
Tyramine 6.6 9.0
V erapam i1 2.4 3.3
* = d ru g  u n re ta in e d  under th e se  c o n d i t i o n s  
M o b ile  phase: 0.04 M b u f fe r ,  pH 7 . 0-methanol (1 :4 )
recove ry  and p lasm a c le a n -u p .  I t  was found t h a t  a C18-  
c o n c e n t ra t io n  column r e t a in e d  l e s s  o f  the  endogeous p lasm a  
components than  the  C g -  p a ck in g  because  the  former i s  more 
hydrophob ic  and has l e s s  a f f i n i t y  f o r  the  r e l a t i v e l y  p o la r  p lasm a  
c o n s t i t u e n t s .
I n  the p re se n t  s tu d y ,  the  c o n c e n t r a t io n  column was d ry -p ack e d  
w ith  C o r a s i l  C i g  (25-40 /¿m) p a c k in g  m a te r ia l ,  and the wash 
s o lu t i o n  was f i l t e r e d  d e io n is e d  w ater d e l i v e r e d  a t  a f low  r a t e  o f
1.0 ml/min f o r  1.5  m in u te s.  B lan k  and sp ik e d  plasma a l i q u o t s  were 
prepared  a s  d e sc r ib e d  in the  exp er im e nta l s e c t io n  and 500 fi  1 
l o o p f u l s  were in je c te d  in to  the  ch ro m ato g ra ph ic  system.
The o b je c t i v e  o f  t h i s  s tu d y  was to  compare d r u g - f r e e  p lasm a  
p r o f i l e s  when th e  pH o f  the  aqueous component was in c re a se d  from  
pH 5.0 to  pH 8.0, and when the  i o n i c  s t r e n g th  was in c re a se d  from  
0.02 M to  0.04 M, in  th e  phosphate  b u f f e r  system. The n i t r a t e  
b u f f e r s  (0.04 M) i n v e s t i g a t e d  were pH 7.0 and pH 9.5. I n  a l l  
c a se s  the  b u f fe r -m e th a n o l  r a t i o  was 1 :4 .  The m obile  phases  
s tu d ie d ,  a lo n g  w ith  th e  r e s u l t a n t  chromatograms are  p re sen ted  in  
F ig u r e  6.6. (phosphate  b u f f e r )  and F i g u r e  6.7. ( n i t r a t e  b u f f e r ) ,  
where i t  can be seen t h a t  a s l i g h t l y  b e t t e r  b lank  plasma  
chromatogram i s  o b ta in e d  a t  the  h ig h e r  e lu e n t  pH w ith  l i t t l e  
d i f f e r e n c e  observed  when th e  i o n ic  s t r e n g t h  i s  doubled. The 
n i t r a t e  b u f fe r  system  y i e l d s  a s l i g h t l y  i n f e r i o r  b la n k  p lasm a  
chromatogram a t  pH 7 .0  than  a t  pH 9.5, though in a l l  c a s e s ,  the  
major peaks c o n t in u e  t o  e lu t e  e a r l y .
The e f f e c t  o f  pH on th e  r e t e n t io n  o f  p lasm a c o n s t i t u e n t s  i s  not  
as  m a n ife s t  a s  i t s  e f f e c t  on the  in d i v i d u a l  drug s p e c ie s .  To 
i l l u s t r a t e  t h i s  p o in t ,  a t e s t  compound, i . e .  f luph enaz ine ,  was 
e x t ra c te d  o n - l i n e  from s p ik e d  p lasm a p r i o r  to  chromatography  
u s in g  the  phosphate  b u f f e r  system . As may be seen from the  
chromatograms p re se n te d  in F ig u r e  6 . 8 . ,  the re  i s  a pronounced  
s h i f t  in  the r e t e n t io n  t im e o f  the d ru g  r e l a t i v e  to  t h a t  o f  the  
plasm a c o n s t i t u e n t s  a s  th e  pH i s  in c re a se d  from pH 5.0 to  pH 8 .0 .
322
F ig u r e  6.5.
E f f e c t  o f  th e  a d d i t i o n  o f  80% methanol 
on the  ap p are n t  pH o f  ammonium n i t r a t e  b u f f e r
Appai ent pH
In i t ial  pH
M o b i le  phase* 0 .025  M ammonium nitrate/am m onium  h ydro x id e ­
m ethanol (1 :4 )
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re co v e ry  and p lasm a c le a n -u p .  I t  was found t h a t  a C^g-  
c o n c e n t r a t lo n  column re ta in e d  le s s  o f  the  endogeous p lasm a  
components than  th e  C g -  p ack ing  because th e  former i s  more 
h ydro p h ob ic  and has  l e s s  a f f i n i t y  f o r  the  r e l a t i v e l y  p o la r  p lasma  
c o n s t i t u e n t s .
I n  th e  p re se n t  s tu d y ,  the c o n c e n t ra t io n  column was d ry -p ack ed  
w ith  C o r a s i l  (25-40 m) p a ck in g  m a te r ia l ,  and the  wash 
s o lu t i o n  was f i l t e r e d  d e io n ise d  water d e l i v e r e d  a t  a f lo w  r a t e  o f
1.0 m l/m in f o r  1 .5  m inutes. B lank  and s p ik e d  plasma a l i q u o t s  were 
prepared  a s  d e s c r ib e d  in  the exper im enta l s e c t io n  and 500 1
lo o p f u l s  were in je c te d  in to  the ch ro m a to g ra p h ic  system.
The o b j e c t i v e  o f  t h i s  s tudy  was to  compare d r u g - f r e e  p lasm a  
p r o f i l e s  when th e  pH o f  the aqueous component was in c re a se d  from  
pH 5.0 to  pH 8.0, and when the i o n i c  s t r e n g t h  was in c re a se d  from
0.02 M to  0.04 M, in  the  phosphate b u f f e r  system . The n i t r a t e  
b u f f e r s  (0 .04 M) i n v e s t i g a t e d  were pH 7.0  and pH 9.5 .  I n  a l l  
c a s e s  the  b u f fe r -m e th a n o l  r a t i o  was 1 :4 .  The m obile  phases  
s tu d ie d ,  a lo n g  w ith  the  r e s u l t a n t  chromatograms a re  p re sen ted  in  
F ig u r e  6 .6 . (phosphate  b u f fe r )  and F ig u r e  6 .7 .  ( n i t r a t e  b u f f e r ) ,  
where i t  can be seen th a t  a s l i g h t l y  b e t t e r  b lan k  p lasm a  
chromatogram i s  o b ta in e d  a t  the h ig h e r  e lu e n t  pH w ith  l i t t l e  
d i f f e r e n c e  ob se rved  when the i o n i c  s t r e n g t h  i s  doubled. The 
n i t r a t e  b u f f e r  system  y i e l d s  a s l i g h t l y  i n f e r i o r  b la n k  p lasm a  
chromatogram a t  pH 7.0  than a t  pH 9.5, though  in a l l  c a s e s ,  the  
major peaks  c o n t in u e  t o  e lu te  e a r l y .
The e f f e c t  o f  pH on th e  r e te n t io n  o f  p lasm a c o n s t i t u e n t s  i s  not  
a s  m a n i fe s t  a s  i t s  e f f e c t  on the in d i v i d u a l  drug s p e c ie s .  To 
i l l u s t r a t e  t h i s  p o in t ,  a t e s t  compound, i . e .  f lu p h e n a z in e ,  was 
e x t ra c te d  o n - l i n e  from sp iked  p lasm a p r i o r  t o  chrom atography  
u s in g  th e  phosphate  b u f fe r  system. As may be seen from the  
chromatograms p re se n te d  in  F ig u re  6 .8 . ,  th e re  i s  a pronounced  
s h i f t  in  th e  r e t e n t io n  tim e o f  the  d rug  r e l a t i v e  to  t h a t  o f  the  
p lasm a c o n s t i t u e n t s  a s  the pH i s  in c re a se d  from pH 5.0 to  pH 8.0 .
324
Figure 6.6.
Blank plasma chromatogramsi potassium phosphate buffer
TIME (min)----------------------------------------------------- >
Mobile phases (a): 0.02 M buffer, pH 5.0-methanol (1.4)
(b)t 0.02 M buffer, pH 8.0-methanol (1.4)
(c)s 0.04 M buffer, pH 8.0-methanol (1.4)
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Figure 6.7.
Blank plasma chromatograms? ammonium nitrate buffer
T IM E (m in )------------------------------------------------------------------------------------------------- >
M o b i le  phases?  (a ) s  0.04 M b u f f e r ,  pH 7.0-m ethanol (1 *4 )
(b ) :  0.04 M b u f f e r ,  pH 9.5-m ethanol (1 ?4 )
These r e s u l t s  d em onstra te  th a t  i t  i s  p o s s i b l e  to  m a n ip u la te  the  
m obile  phase t o  produce the most a p p r o p r ia te  r e t e n t io n  t im e s  f o r  
the  compounds o f  i n t e r e s t ,  w ith  l i t t l e  danger o f  in t r o d u c in g  
u n acce p ta b le  i n t e r f e r i n g  peaks from the  p lasm a m a t r ix .  Hence, 
t h i s  type  o f  chrom atography  would seem to  o f f e r  an a d v a n ta ge  over  
co n v e n t io n a l  bonded-phase  te ch n iq u e s ,  in  t h a t  the  p lasm a  
c o n s t i t u e n t s  a re  n o t  s u f f i c i e n t l y  io n i s e d  t o  be r e t a in e d  by the  
a lum ina  column, and a re  th e re fo re ,  r a p id l y  e lu te d .  An im p o rta n t  
example i s  c a f f e in e  which can in t e r fe r e  w ith  drug a n a l y s i s  in  
re v e r se d -p h a se  chrom atography: because i t  does no t  io n i s e ,  i t  
w i l l  no t  i n t e r a c t  w ith  a lum ina  by the  p r i n c i p a l  mechanism o f  
r e te n t io n ,  i . e .  ion  exchange, and a s  a r e s u l t  would e lu t e  to o  
e a r ly  to  i n t e r f e r e  w ith  any o f  the peaks o f  i n t e r e s t .
U s in g  a m o b ile  phase  c o n t a in in g  0.04 M phosphate  b u f f e r ,  pH 5 . 0 -  
methanol ( 1 :4 ) ,  f i v e  r e p l i c a t e  a n a ly s e s  o f  p lasm a c o n t a in in g  200 
ng/ml f lu p h e n a z in e  were made. The drug e lu te d  w ith  a mean 
r e t e n t io n  t im e  o f  7 .0  m inutes ( s ta n d a rd  d e v ia t i o n  0 .1  m in ) .  The 
mean drug peak h e i g h t  was 65.4 mm (± 2.3 mm ) u s in g  a d e te c to r  
s e n s i t i v i t y  s e t t i n g  o f  0.04 AUFS. The c o e f f i c i e n t  o f  v a r i a t i o n  
was 3.5%, and 73.1% o f  th e  drug  was recovered  from p lasm a when 
compared w ith  a u t h e n t ic  aqueous s ta n d a rd s  in je c te d  in  th e  same 
c o n c e n t r a t io n s  a s  s p ik e d  p lasm a. These r e s u l t s  i n d i c a t e  t h a t  i t  
shou ld  be p o s s i b l e  t o  deve lop  a f u l l y  v a l i d a t e d  b i o a n a l y t i c a l  
method in c o r p o r a t in g  o n - l i n e  s o l i d - p h a s e  e x t r a c t io n  f o r  any drug  
which can be se p a ra te d  u s in g  t h i s  ch ro m atograph ic  system .
6.4. CONCLUSION
A p r e l im in a r y  s tu d y  o f  th e  b e h av io u r  o f  d rug compounds and plasma  
e x t r a c t s  on an a lu m in a  column has been c a r r ie d  ou t .  R e s u l t s  would  
i n d ic a t e  t h a t  a lu m in a  p re se n t s  an a t t r a c t i v e  a l t e r n a t i v e  t o  
re v e r se d -p h a se  s e p a r a t i o n s  o f  b a s i c  d ru g s  which can p re se n t  
d i f f i c u l t i e s  a s s o c i a t e d  w ith  the  p resence  o f  un reacted  s i l a n o l  
m o ie t ie s  on th e  s i l i c a  s u r fa c e .  A lum ina has an a d van tage  over  
s i l i c a  in  t h a t  i t  i s  more s t a b l e  a t  h ig h  pH, and th u s  in  th e
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Figure 6.8.
Spiked plasma chromatograms
TIME (min)--------------------------------------------------- >
Plasma spiked with fluphenazine (F) 200ng ml-1
(a): Mobile phases 0.04 M phosphate buffer, pH 5.0-methanol (1:4)
(b)s Mobile phases 0.04 M phosphate buffer, pH 8.0-methanol (1:4)
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s e p a r a t io n  o f  b a se s ,  th e  c a t i o n i c  c h a r a c te r  o f  th e  column may be 
maximised w ith o u t  f e a r  o f  column d e g e n e ra t io n .  The r e t e n t io n  o f  
i o n i c  compounds i s  s t r o n g l y  in f lu e n c e d  by pH, i o n i c  s t r e n g t h ,  and 
the  p e rce n tage  m ethanol in  th e  m o b i le  phase. Any o r  a l l  o f  th e se  
param eters  may be m an ipu la te d  t o  produce th e  d e s i r e d  r e t e n t io n  
f o r  th e  compound o r  compounds o f  i n t e r e s t .  Chrom atography on 
a lum ina  would appear t o  be w e l l  s u i t e d  to  th e  a n a l y s i s  o f  d ru g s  
in  p lasm a sam p les  a s  i t  le n d s  i t s e l f  t o  th e  r a p id  and c o n v e n ie n t  
te ch n ique  o f  s o l i d - p h a s e  e x t r a c t i o n  by column s w i t c h in g .
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CHAPTER 7
EVALUATION OF DRUG-FREE PLASMA PROFILES
WITH VARYING ELUENT COMPOSITION
FOLLOWING O N -L IN E  SOLID-PHASE EXTRACTION
7.1. INTRODUCTION
The most w id e ly  used column p a c k in g s  f o r  modern l i q u i d  
chrom atography are  th o s e  w ith  s u r fa c e  re a c te d  (c h e m ic a l ly  bonded) 
o r g a n ic  s t a t i o n a r y  p h a se s .  Bonded-phase co lum ns were o r i g i n a l l y  
developed  to  e l im in a t e  th e  d is a d v a n ta g e s  o f  l i q u i d - l i q u i d  
chrom atography (LLC) based  on m e ch a n ica l ly  h e ld  s u p p o r t s .  They 
a re  g e n e r a l l y  more s t a b l e  than  the l a t t e r  because  the  s t a t i o n a r y  
phase i s  not e a s i l y  removed o r  l o s t  d u r in g  use. The a v a i l a b i l i t y  
o f  a wide v a r ie t y  o f  f u n c t io n a l  g roups  in  bonded-phase  p a c k in g s  
means th a t  both normal and re v e r se d -p h a se  chrom atography can be 
c a r r i e d  out in  a r e l a t i v e l y  s im p le  s t r a i g h t f o r w a r d  manner.
The most p o p u la r  r e v e r se d -p h a se  columns c o n t a in  porous  s i l i c a  
p a r t i c l e s  s u r fa c e  bonded w ith  C^g- o r  Cg- a l k y l  c h a in s .  The 
d i f f e r e n c e  in c h ro m a to g ra p h ic  p r o p e r t ie s  between th e se  p a ck in g s  
i s  s u b t le  r a th e r  than  major, and p ro b a b ly  most, i f  no t  a l l ,  
s e p a r a t io n s  can be a ch ie v e d  on e i t h e r  column [1]. Any apparent  
d i f f e r e n c e s  in  s e l e c t i v i t y  between com mercial C^g- and Cg- 
ph ases  a re  p ro b a b ly  overshadowed by s e l e c t i v i t y  d i f f e r e n c e s  among 
columns from d i f f e r e n t  m anu fac tu re rs  [2 ]. S e l e c t i v i t y  d i f fe r e n c e s  
are  l e s s  l i k e l y  between th e se  two p a ck in g  m a t e r i a l s  and other,  
more p o la r ,  bonded p h ase s ,  such a s  cyan o -  o r  p h e n y l -  columns  
which can a l s o  be used in  the  re v e r se d -p h a se  mode i f  adequate  
water i s  in co rp o ra te d  i n t o  the  m obile  phase. For  example, the  
cyano-bonded phase p r o v id e s  good s e l e c t i v i t y  f o r  s e p a r a t in g  
t r i c y c l i c  a n t id e p r e s s a n t s  [3 -5 ] .  The p re se n t  s tu d y  i s  based on 
th e  employment o f  C^g- and CN columns.
S e v e ra l  workers have i n v e s t i g a t e d  the  mechanisms in v o lv e d  in  
re v e r se d -p h a se  chrom atography [6 -8 ] ,  though a p p l i c a t i o n  o f  the  
proposed  mechanisms t o  r e a l  s i t u a t i o n s  i s  o f t e n  very  d i f f i c u l t .  
T h is  d i f f i c u l t y  can be t r a c e d  to  the f a c t  t h a t ,  a s  mentioned  
above, two columns g e n e r i c a l l y  l a b e l le d  as  e q u iv a le n t ,  may have 
v a s t l y  d i f f e r e n t  ch ro m a to g rap h ic  c h a r a c t e r i s t i c s .  D e s c r ip t io n  o f
7.1.1. Characterisation of stationary phases
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a column p u re ly  in  term s o f  the a l k y l  s u b s t i t u e n t  bonded onto  th e  
s i l i c a  su p p or t  does no t  adequate ly  d e s c r ib e  the  ch em istry  o f  a 
p a ck in g ,  and can, in  f a c t  p ro v id e  m is le a d in g  in fo rm a t io n  
r e g a r d in g  the  r e t e n t i v i t y  and s e l e c t i v i t y  o f  the  r e s u l t i n g  
ch ro m atog raph ic  colum n. The ch ro m atog raph ic  d i f f e r e n c e s  in  
s i m i l a r l y  l a b e l le d  colum ns a re  due both  t o  v a r i a t i o n s  in  the  
s i l i c a  m a te r ia l  used a s  a sup port  and th e  te ch n iq u e  used to  form  
the  bonded phase. S in c e  th e re  are  no agreed  s p e c i f i c a t i o n s  
r e g a r d in g  th e  c r i t i c a l  p r o p e r t ie s  o f  th e se  p a c k in g s ,  a l t e r n a t i v e  
methods f o r  column c l a s s i f i c a t i o n  a re  e s s e n t i a l .
A range  o f  te c h n iq u e s  have been used to  compare d i f f e r e n t  bonded  
phases,  i n c lu d in g  p y r o ly s i s - G L C  [9], but most methods a re  based  
on th e  re v e r se d -p h a se  se p a r a t io n  o f  a t e s t  m ix tu re .  The c a p a c i t y  
f a c t o r s  ( k 1) a re  then  used f o r  m a n u fa c tu re r s '  q u a l i t y  c o n t r o l  
[10-12] o r  f o r  co m par ison  o f  d i f f e r e n t  m a t e r i a l s  [2 ,13],  though  
many o f  th e se  t e s t s  can produce m is le a d in g  r e s u l t s  [14].
An e x h a u s t iv e  s tu d y  on r e t e n t i v i t y  and s e l e c t i v i t y  in v o lv in g  
numerous co m m e rc ia l ly  a v a i l a b l e  p a c k in g s  was undertaken by 
G o ldberg  [2 ]. C h a r a c t e r i s a t i o n  o f  the  p a c k in g  m a te r ia l s  was based  
both  on n o n -p o la r  h ydrocarbon s  and p o la r  s o lu t e s ,  a s  the l a t t e r  
are  o f te n  more r e v e a l i n g  in the  c r i t i c a l  in fo rm a t io n  they y i e l d  
co n ce rn in g  r e v e r se d -p h a se  p a c k in g s .  The e x p e c ta t io n  th a t  Clg- 
columns a re  more r e t e n t i v e  than Cg- p a c k in g s ,  and t h a t  the  
l a t t e r  are, in  tu rn ,  more r e t e n t iv e  than p a c k in g  m a te r ia l s  bound 
w ith  s h o r te r  a l k y l  c h a in s ,  was not r e a l i s e d  in  a number o f  ca se s ,  
even where th e  t e s t  s o lu t e s  used were the  h i g h l y  n o n -p o la r  
s o lu t e s  an thracene  and naphtha lene. Furtherm ore, the re  were some 
in s t a n c e s  where one brand o f  cyano column e x h ib i t e d  s t r o n g e r  
r e t e n t i v i t y  f o r  low - and medium- p o l a r i t y  s o l u t e s  than o ther  
brands o f  column packed w ith  Cg- m a te r ia l .
More fundamental s t u d ie s  have used n it ro b e n z e n e  in  hexane to  t e s t  
f o r  unreacted  s i l a n o l s  [15], o r  have determ ined  the p h y s ic a l  
param eters  o f  th e  column such a s  p o r o s i t y  [16 ] .  Most o f  these  and 
the  above-m entioned  r e t e n t io n  s t u d ie s  a re  b a sed  on the
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measurement o f  c a p a c i t y  f a c t o r s ,  bu t  th e re  has  been a r e a l i s a t i o n  
in  re c e n t  y e a rs  t h a t  a c c u ra te  d e te rm in a t io n  o f  the v o id  volume i s  
d i f f i c u l t  [17-19], th u s  g e n e ra t in g  c o n s id e r a b le  e r r o r s  in  
re p o r te d  k '  v a lu e s  f o r  compounds o f  s h o r t  r e t e n t io n  t im es.  An 
a l t e r n a t i v e  method f o r  r e p o r t in g  r e t e n t io n s  has  been proposed  
which u se s  the a l k y l  a r y l  ke tones  to  form a r e t e n t io n  index s c a le  
[20]. Sm ith  used t h i s  r e t e n t io n  index s c a l e  in  the  d e te rm in a t io n  
o f  d i f f e r e n c e s  between e i g h t  n o m in a l ly  s i m i l a r  o c ta d e cy l  colum ns  
under v a r y in g  c o n d i t i o n s  o f  e lu e n t  c o m p o s i t io n  [14]. D e t a i le d  
ex am inat ion  o f  the  r e t e n t io n  in d ic e s  showed t h a t  the  v a lu e s  f o r  
each o f  th e  s i x  re fe re n ce  s ta n d a rd s  i n v e s t i g a t e d  were more 
c o n s i s t e n t  than c a p a c i t y  f a c t o r  v a lu e s  and t h a t  ch an g in g  the  
e lu e n t  produced s y s te m a t ic  changes in  index v a lu e s .  U s in g  th e se  
in d ic e s ,  Sm ith  was a b le  to  dem onstrate  s i g n i f i c a n t  d i f f e r e n c e s  in  
the r e t e n t io n  c h a r a c t e r i s t i c s  among th e  t e s t  columns. He a l s o  
showed t h a t  fo r  a g iv e n  e lu t i o n  s t r e n g t h ,  th e  magnitude o f  th e se  
d i f f e r e n c e s  depended on the n a tu re  o f  the  o r g a n i c  m o d i f ie r  in  the  
m obile  phase.
The r o le  o f  the  column in  r e v e r se d -p h a se  chrom atography h as  been 
e x t e n s iv e ly  reviewed [21-24], and th e re  i s  abundant data  in  the  
l i t e r a t u r e  on the in -h o u se  p r e p a r a t io n  and e v a lu a t io n  o f  p a c k in g  
m a t e r i a l s  which a re  t a i l o r e d  by th e  e x p e r im e n to rs  t o  s u i t  t h e i r  
i n d i v id u a l  needs. The range o f  p a c k in g  m a t e r i a l s  which have been 
produced i s  extrem ely  la r g e  and i t  i s  beyond th e  scope o f  the  
p re se n t  s tu d y  to  d i s c u s s  them in d e t a i l .
7 .1 .2 .  M o b ile  phase c o n s id e r a t io n s
I n  re v e r se d -p h a se  chromatography, w ater  i s  u s u a l l y  used a s  the  
base s o lv e n t  w ith  v a r y in g  p r o p o r t io n s  o f  m i s c i b le  o r g a n ic s  added  
in  o rd e r  to  a d ju s t  the s o lv e n t  s t r e n g t h .  Methanol i s  the  most 
commonly used o r g a n ic  s o lv e n t  s in c e  i t  i s  r e l a t i v e l y  cheap and 
n o n - t o x ic .  A c e t o n i t r i l e  and t e t r a h y d r o f u r a n  a re  the next most 
commonly used s o lv e n t s ,  in  t h a t  o r d e r .  C h a n g in g  s e l e c t i v i t y  in  
re v e r se d -p h a se  chromatography i s  l e s s  e a s i l y  accom plished  than  in  
normal phase s e p a r a t io n s  because w ater  d om inate s  the  sample
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m obile  p h a s e - s t a t io n a r y  phase in t e r a c t i o n .  However, in  some 
c a se s ,  s i g n i f i c a n t  change s  in  s e p a r a t io n  s e l e c t i v i t y  can be 
ach ieved  by s w i t c h in g  between one o r g a n i c  s o lv e n t  and an o th e r.
Methanol appears  no t  to  a l t e r  th e  s e l e c t i v i t y  o f  water u n t i l  very  
h ig h  c o n c e n t r a t io n s  a re  used [25], and a l th o u g h  i t  i s  l e s s  
exp ens ive  than a c e t o n i t r i l e ,  i t  i s  more p o la r  than th e  l a t t e r  and 
more o f  i t  i s  r e q u i re d  to  p ro v id e  e q u iv a le n t  s o lv e n t  s t r e n g th ,  
which d ecreases  th e  c o s t  d i f f e r e n t i a l .  A c e t o n i t r i l e  a l s o  y i e l d s  a 
m obile  phase w ith  water t h a t  has a lower v i s c o s i t y  which makes 
the  column more e f f i c i e n t ,  and p r o v id e s  a lower pumping p r e s su re .  
T e trah yd ro fu ran  can o f f e r  f u r th e r  c o n t r a s t i n g  s o l u b i l i t y  
p r o p e r t ie s  ( i t  i s  l e s s  p o la r  than  a c e t o n i t r i l e  and i s  
n o n h y d ro x y l ic  r e l a t i v e  t o  m ethanol) and m igh t be c o n s id e re d  when 
a ttem pts  to  use methanol and a c e t o n i t r i l e  a re  u n s u c c e s s fu l .  
S tu d ie s  have shown t h a t  te r n a r y  aqueous m ob ile  phases  ( f o r  
in s ta n ce ,  m e th a n o l-d io x a n e -w a te r ) can  p r o v id e  un ique s e l e c t i v i t y  
f o r  c e r t a in  s e p a r a t io n s  [26-28].  Drug s e p a r a t io n  can be 
s i g n i f i c a n t l y  a f f e c t e d  by even a sm a l l  p r o p o r t io n  o f  a second  
o r g a n ic  m o d if ie r ,  e s p e c i a l l y  i f  the second s o lv e n t  i s  a s t r o n g  
e lu e n t  r e l a t i v e  t o  th e  m ob ile  phase b e in g  m o d if ie d .  T h i s  i s  
because such a s o l v e n t  tends  to  c o n c e n tra te  in , and change the  
c h a r a c t e r i s t i c s  o f  th e  bonded phase [27],
The pH range w i th in  which bonded-phase s i l i c a - b a s e d  p a c k in g s  can  
be used i s  t y p i c a l l y  about 2 .0 -7 .0 .  A t lower pH v a lu e s ,  the  
bonded groups a re  h y d ro ly se d .  At h ig h e r  pH v a lu e s  the  s i l i c a  
m a tr ix  i t s e l f  d i s s o l v e s  le a d in g  to  a r e le a s e  o f  bonded g ro u p s  
from the su r fa c e .  However, a s  d i s c u s s e d  in d e t a i l  in  ch a p te r  5, 
the  s t a b i l i t y  o f  s i l i c a  in  a l k a l i n e  media may be c o n s id e r a b ly  
enhanced by th e  in c o r p o r a t io n  o f  a p re -co lum n  between th e  pump 
and the in je c to r ,  by u s in g  a h ig h  p r o p o r t io n  o f  o r g a n ic  component 
and by em ploying ammonia as  the  sou rce  o f  h yd ro xy l io n s .  Changes  
in  pH can a l t e r  th e  s e p a r a t io n  s e l e c t i v i t y  f o r  i o n i s e d  s o lu t e s  
s in c e  charged  m o lecu le s  a re  p r e f e r e n t i a l l y  d i s t r i b u t e d  i n t o  the  
more p o la r  phase. V a r i a t i o n s  in  pH a re  n o rm a l ly  no t  e f f e c t i v e  in  
o b t a in in g  d e s i r e d  changes in  s e l e c t i v i t y  w ith  s o lu t e s  which do
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not i o n i s e .  The aqueous component o f  th e  m ob ile  phase f re q u e n t ly  
c o n t a in s  some k in d  o f  b u f f e r in g  s a l t  which p r i n c i p a l l y  s e rv e s  to  
c o n t r o l  e lu e n t  pH and so  p ro v id e  f o r  r e p r o d u c ib le  chrom atography.  
As d i s c u s se d  in  ch a p te r  5, changes in  i o n i c  s t r e n g th  e l i c i t  a 
profound  e f f e c t  on the  s o lu te  r e t e n t io n  where the  mechanisms o f  
r e t e n t io n  m a in ly  in v o lv e  ion exchange. R e te n t io n  and s e l e c t i v i t y  
in  re v e r se d -p h a se  chrom atograhy can a l s o  be in f lu e n c e d  by i o n i c  
s t r e n g th .  For in s ta n c e ,  the c o n c e n t r a t io n  o f  phosphate  in  the  
m obile  phase has been shown to  s i g n i f i c a n t l y  in f lu e n c e  not  o n ly  
k 1 v a lu e s  f o r  a s e r i e s  o f  non ap e p t id e s ,  bu t  the s e l e c t i v i t y  o f  a 
p a r t i c u l a r  s o lu t e  p a i r  [29]. I n  an o th e r  s tu d y ,  n o n - l in e a r  
in c r e a s e s  in  r e t e n t io n  f o r  a ro m a t ic  a c i d s  and b a se s  were rep orte d  
to  occu r  w ith  in c r e a s in g  s a l t  c o n c e n t r a t io n  [30]. Snyder proposed  
t h a t  when the  a d d i t i o n  o f  s a l t  i n c r e a s e s  th e  s o l u b i l i t y  o f  the  
s o lu t e  in the  m ob ile  phase ( s a l t i n g - i n  e f f e c t ) ,  r e t e n t io n  i s  
decreased, and t h a t  when the a d d i t i o n  o f  a s a l t  d e c re a se s  the  
s o l u b i l i t y  o f  the  s o lu t e  in th e  m o b i le  phase  
( s a l t i n g - o u t - e f f e c t ) , r e t e n t io n  t im e  i s  reduced  [31].
The r o l e  o f  b u f fe r  c a t i o n s  in  th e  r e t e n t io n  o f  a ro m a t ic  amines in
re v e rse d -p h a se  chrom atography has  been e x t e n s i v e l y  i n v e s t i g a t e d
by Papp and V igh  [32 ,33].  U s in g  a C18-  column and an e lu e n t
c o n t a in in g  94%, methanol they s tu d ie d  th e  e f f e c t  o f  v a r y in g  the
c o n c e n t ra t io n  o f  a s e r i e s  o f  commonly used s a l t s  on the  r e t e n t io n
c h a r a c t e r i s t i c s  o f  a s e r i e s  o f  a ro m a t ic  am ines. They found th a t
a t  c o n s ta n t  pH, the  lo 910 the  c a p a c i t y  f a c t o r  decreased
l i n e a r i l y  w ith  th e  lo g  o f  the  c a t i o n  c o n c e n ta t io n ,  and th a t
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the  r e t e n t io n -d e c r e a s in g  e f f e c t  o f  th e  c a t i o n  became s t r o n g e r  in  
the  o rd e r  o f  hydrogen, sodium and p o ta s s iu m  io n s ,  i r r e s p e c t i v e  o f  
the n a tu re  o f  the  amine s o lu te .  A t  c o n s t a n t  b u f fe r  ion  
c o n c e n t ra t io n  the  l o<310 k '  vs  pH c u rv e s  p a sse d  th rough  a 
maximum. They a t t r ib u t e d  these  phenomena to  ion  exchange between 
d i s s o c i a t e d  ( r e s i d u a l )  s i l a n o l  g ro u p s  on th e  s i l i c a  p a ck in g  and 
o p p o s i t e l y  charged  p ro tonate d  b a se s .  R e t e n t io n  o f  amines would  
th e re fo r e  be a f f e c t e d  by pH which c o n t r o l s  th e  degree  o f  s o lu te
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and s i l a n o l  i o n i s a t i o n ,  and by i o n i c  s t r e n g t h  which d e te rm in e s  
the  c o m p e t it io n  between the s o lu t e  and b u f f e r  io n s  f o r  ch a rged  
s i t e s  on the column. Papp and V igh  [33] and o th e r  w orkers  [34 ,35]  
f u r t h e r  add re sse d  t h i s  s u b je c t  by s tu d y in g  amine r e t e n t io n  a s  a 
f u n c t io n  o f  pH and s a l t  c o n c e n t r a t io n  in  th e  presence  o f  both  
h ig h  and low methanol c o n c e n t r a t io n s .  The f a c t  t h a t  under c e r t a in  
c o n d i t i o n s  o f  e lu e n t  c o m p o s it io n ,  amine r e t e n t io n  p a sse d  th ro ugh  
a minimum a s  a f u n c t io n  o f  m o d i f ie r  c o n c e n t r a t io n  was a t t r i b u t e d  
to  a dual h y d r o p h o b ic - s i l a n o p h i1i c  r e t e n t io n  mechanism o f  
r e t e n t io n .
Papp and V igh  [32 ,33] proposed  t h a t  f o r  am ines on r e v e r se d -p h a se  
s i l i c a s ,  the  s i l a n o p h i l i e  c o n t r ib u t io n  to  r e t e n t io n  i s  l a r g e  over  
the  e n t i r e  methanol c o n c e n t r a t io n  range ,  and t h a t  i t  i s  
d im in ish e d  by the  a d d i t i o n  o f  h ig h  c o n c e n t r a t io n s  o f  i n o r g a n i c  
and o r g a n ic  c a t i o n s .  They fu r t h e r  su g g e s te d  t h a t  r e t e n t io n  on 
re v e r se d -p h a se  column o f  u n io n ise d ,  p o l a r  s o lu t e s  was a l s o  
dependent on on th e  typ e  and c o n c e n t r a t io n  o f  the  c a t i o n  in  th e  
e lu e n t,  and t h a t  a t t e n t io n  sh o u ld  be p a id  t o  th e se  e f f e c t s  in  the  
d e s ig n  and c h a r a c t e r i s a t i o n  o f  a r e v e r se d -p h a se  l i q u i d  
ch ro m atog raph ic  system .
7 .1 .3 .  Chemometrics in  p h a rm a ce u t ic a l  a n a l y s i s
Chemometrics i s  a s c ie n c e  where c h e m is t ry  and p h arm ace u t ica l  
sc ie n c e  meet s t a t i s t i c s  and so f tw a re  developm ent. The p r im ary  
fo c u s  o f  chem ometrics in v o lv e s  the  use  o f  m athem atica l o r  
com p uta t iona l p roced ures  in  p a r t i c u l a r ,  both  to  o p t im is e  
a n a l y t i c a l  methods in  the  f i r s t  p la c e ,  and t o  a n a ly s e  th e  s i g n a l s  
and r e s u l t s  o b ta in e d .  The measurement p r o c e s s  may be d iv id e d  in to  
s e v e ra l  s t e p s ;  f i r s t  the  problem must be s p e c i f i e d ,  then a 
s u i t a b l e  a n a l y t i c a l  methodology must be s e le c te d  and o p t im is e d  
b e fo re  the  chem ica l d e te rm in a t io n  can be made. Once th e  raw d a ta  
has been o b ta in e d ,  i t  must be t r e a te d ,  u s in g  some k in d  o f  
s t a t i s t i c a l  procedure, fo l lo w e d  by i n t e r p r e t a t i o n  and v a l i d a t i o n .
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The f i r s t  s tep ,  i . e . ,  the  d e c i s i o n  a s  t o  which a n a l y t i c a l  method 
shou ld  be used, ( f o r  in s t a n c e  in  chrom atography, which  
chrom atograph ic  mode would be most a p p r o p r i a t e )  has o n ly  l a t e l y  
been ta c k le d  by chem ometrics [36]. Recent b reak th ou gh s  in  the  
a c c e s s i b i l i t y  o f  a r t i f i c i a l  i n t e l l i g e n c e  te ch n iq u e s  have made i t  
p o s s ib le  to  a p p ly  e x p e rt  system  te c h n o lo g y  to  in c o r p o ra te  
e x p e r t i s e - r e la t e d  knowledge in t o  computer packages  [37 -40].
An expert  system i s  an example o f  an i n t e l l i g e n t  know ledge -based  
system which c o n ta in s  encoded e x p e r t  knowledge and i s  c a p a b le  o f  
e x p lo i t i n g  t h i s  knowledge f o r  problem  s o l v i n g  p u rp o se s .  The 
in fo rm a t io n  s to re d  in a knowledge b a se  may be d e r iv e d  from a 
number o f  so u rce s .  N o rm ally ,  however, th e se  so u rce s  f a l l  in to  two 
c l a s s e s ,  p u b l i c  t h e o r e t i c a l  knowledge and p r iv a t e  exp er im e nta l  
knowledge. The p u b l i c  knowledge o f  a problem domain i s  t h a t  
knowledge which i s  a v a i l a b l e  from books o r  j o u r n a l  a r t i c l e s .  The 
p r iv a t e  knowledge i s  t h a t  accum ulated  by a human e x p e r t  and i s  a 
com binat ion  o f  the  b a s i c  t h e o r e t i c a l  knowledge and a number o f  
e m p i r i c a l l y  d e r ive d  f a c t s .
Expert  system s f o r  method s e l e c t i o n  in  HPLC [38] and f o r  method 
development [39,40] have been d e s c r ib e d .  R e c e n t ly ,  F e l l  e t  a l . 
reported  on the  d e s ig n  o f  a new e x p e r t  system  f o r  method 
s e le c t io n  in  h ig h  perform ance l i q u i d  chrom atography [41]. M a s sa r t  
and Buydens [37] have a l s o  p roposed  an e x p e r t  system f o r  method 
s e le c t io n .  I t s  o v e r a l l  s t r a t e g y  i s  based  on c e r t a in  o b s e r v a t io n s ,  
such as the  f a c t  t h a t  a l l  d ru g  d e te r m in a t io n s  can r e a d i l y  be 
c a r r ie d  out on a s i n g l e  s t a t i o n a r y  phase, th e  cyano bonded phase, 
which, a s  mentioned e a r l i e r ,  i s  s u i t a b l e  f o r  both normal and 
re v e rse d -p h a se  s e p a r a t io n s .
The next s tep ,  s e le c t i o n  o f  th e  o p t im a l  m ob ile  phase c o m p o s it io n  
in h igh  performance l i q u i d  ch rom atography  i s  a problem which may 
be approached in  a number o f  ways. One common approach  i s  the  
i n t u i t i v e  method wherein the  ch rom atog raph e r  makes an i n i t i a l  
s e le c t io n  o f  the  m obile  phase c o m p o s i t io n  based on th e  n a tu re  o f  
the  s o lu t e s  to  be separa ted ,  and then r e f i n e s  t h i s  s e l e c t i o n  on a
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t r i a l  and e r r o r  b a s i s .  T h i s  method o f t e n  f a i l s  when complex  
sam ples a re  encountered, o r  when th e  n a tu re  o f  th e  s o lu t e s  in the 
sam ples i s  unknown. An a l t e r n a t i v e ,  and v e ry  s u c c e s s f u l  approach  
i s  a s y s te m a t ic  se a rch  over a wide ra n ge  o f  s o l v e n t  co m p o s it io n s  
w ith  the a i d  o f  p r e d ic te d  or e x t r a p o la t e d  r e t e n t io n  d a ta  and a 
subsequent a sse s sm e n t  o f  the q u a l i t y  o f  r e s u l t a n t  chromatograms  
by a m athem atica l o p t im i s a t io n  c r i t e r i o n .
Chemometric te c h n iq u e s  are  w ide ly  used  in  th e  o p t im i s a t i o n  o f  
m obile  phase c o m p o s it io n  fo r  HPLC. One method which  h as  found  
p a r t i c u l a r  use  in  chrom atography i s  e n t i t l e d  "window d ia g ra m s"
[42], The f i r s t  a p p l i c a t i o n  o f  window d ia g ra m s  t o  chrom atography  
were f o r  th e  s e l e c t i o n  o f  s t a t i o n a r y  p h ase s  in  g a s  chromatography
[43], though, b e in g  a ge ne ra l method, i t  can  a l s o  be a p p l ie d  to  
HPLC [44]. Another o p t im i s a t io n  s t r a t e g y  i s  based  on th e  s o lv e n t  
s e l e c t i v i t y  t r i a n g l e  approach which was co n ce iv e d  by Snyder  [45], 
and f u r t h e r  deve loped  by G la jc h  [46]. T h i s  c l a s s i f i c a t i o n  has  
been t r a n s l a t e d  in t o  two s o lv e n t  s e l e c t i v i t y  t r i a n g l e s ,  one f o r  
normal phase  chrom atography and one f o r  r e v e r se d -p h a se  
chrom atography. By p l o t t i n g  the r e s o l u t i o n  between each s e t  o f  
peak p a i r s ,  i t  i s  p o s s i b l e  to  b u i l d  an o v e r la p p in g  r e s o lu t io n  
(ORM) map which w i l l  d e f in e  the m ob ile  phase  c o m p o s i t io n  which  
w i l l  p ro v id e  optimum r e s o lu t io n .
A w id e ly  used o p t im i s a t i o n  method i s  th e  S e q u e n t ia l  S im p lex  
procedure [47 ,48].  T h i s  i s  a ge n e ra l  m u l t i f a c t o r  o p t im i s a t i o n  
method in  which a l l  f a c t o r s  ( v a r i a b l e s )  a re  v a r ie d  a s  the  
experim enta l d e s ig n  seeks  to  p r o g r e s s  s e q u e n t i a l l y  tow ard s  the  
optimum r e g io n  o f  th e  s e le c te d  o p t im i s a t i o n  c r i t e r i o n .  The 
advan tage s  o f  u s in g  th e  S im plex  p rocedure  a re  t h a t  c a l c u l a t i o n s  
are  r e l a t i v e l y  s im p le ,  the r u le s  o f  the  p roced ure  a re  p r e c i c e l y  
d e fin e d ,  and th e  te ch n iq u e  i s  i d e a l l y  s u i t e d  to  autom ated  
o p t im i s a t i o n  [48]. The d is a d v a n ta g e s  o f  the  S im p le x  o p t im i s a t i o n  
procedure stems from th e  need to  use a ch ro m a to g ra p h ic  re sp o n se  
f u n c t io n  in  o rd e r  t o  e v a lu a te  th e  q u a l i t i e s  o f  th e  s e p a r a t i o n s  
ach ieved  and t o  g u id e  the procedure tow ards  th e  optimum. W ith  the  
advent o f  m ic r o p r o c e s s o r - c o n t r o l le d  ch rom atograph s ,  S im p le x
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p rocedures  have been used to  g u id e  the  automated o p t im i s a t i o n  o f  
n o rm a l-ph ase  s e p a r a t io n s  [49] and a v a r i e t y  o f  param eters  in  
r e v e r se d -p h a se  chrom atography [5 0 ,5 1 ] .  Many o p t im i s a t i o n  methods 
have been d e sc r ib e d  by B e r r id g e  [52] and Schoenmakers [53], and 
the  l i t e r a t u r e  c o n t a in s  a number o f  re v ie w s  on o p t im i s a t i o n  
p roced ures  which employ the  S im p le x  method in  the  o r i g i n a l  o r  
h ig h l y  e v o lv e d  form s which have been deve loped  s in c e  i t  was f i r s t  
in tro d u ce d .
Im p o rta n t  t o p i c s  in  chem ometrics a re  method development and 
q u a l i t y  a s su ra n c e .  Much o f  the v a l i d a t i o n  i s  to  do w ith  a ccu ra cy  
and p r e c i s i o n  and use w e ll e s t a b l i s h e d  s t a t i s t i c a l  p rocedures.  
Chem om etr ic ians  a re  in te r e s te d  in  d e v e lo p in g  methods to  do t h i s  
e f f i c i e n t l y .
A d i f f e r e n t  k in d  o f  problem i s  c re a te d  by th e  s u r f e i t  o f  
in fo rm a t io n  ge n e ra ted  by modern c h ro m a to g ra p h ic  o r  s p e c t r o s c o p ic  
methods. P a t te r n  r e c o g n i t i o n  may p la y  a r o l e  in  d i g e s t i n g  t h i s  
l a r g e  amount o f  in fo rm a t io n .  One consequence o f  au tom ation  i s  
t h a t  many v a r i a b l e s  can be determ ined  s im u lt a n e o u s ly  f o r  th e  same 
sample. P a t t e r n  r e c o g n i t i o n  methods use  the  a v a i l a b l e  d a ta  
s im u l t a n e o u s ly  r a t h e r  than  s e q u e n t i a l l y .  The se t  o f  measurements  
which i s  used to  c h a r a c t e r i s e  a sam ple i s  c a l l e d  a p a t te r n .  When 
o n ly  two v a r i a b l e s  a re  measured f o r  each sample, the  p a t te rn  may 
be re p re se n te d  g r a p h i c a l l y  by a s i n g l e  p o in t  w ith  two 
c o - o r d in a t e s  (x, y ) .  The p o in t  may a l s o  be d e f in e d  by a v e c to r ,  
drawn to  i t  from th e  o r i g i n  (a " d a t a  v e c to r " ) , -  the  c o -o r d in a t e  
system i s  known a s  the  "p a t te r n  space "  [54]. The b a s i s  o f  a l l  
p a t te rn  r e c o g n i t i o n  methods i s  t h a t  p a t te r n  v e c to r s  f o r  s i m i l a r  
sam ples l i e  c l o s e  to g e th e r  in  th e  p a t te r n  space  fo rm ing  c l u s t e r s .  
I n  two d im e n s io n s ,  t h i s  c l u s t e r i n g  can r e a d i l y  be d e te c te d  by the  
human eye. However, when more th an  two v a r i a b l e s  a re  measured, 
g r a p h ic a l  r e p r e s e n t a t io n  i s  no lo n g e r  p o s s ib le :  i f  n v a r i a b le s  
a re  measured, each sample w i l l  be re p re se n te d  by a p o in t  in  
n -d im e n s io n a l  space , and m athem atica l methods are  needed to  
d e te c t  c l u s t e r i n g .  One such method, known a s  p r in c ip a l  component 
a n a l y s i s ,  a l l o w s  th e  p a t te rn  v e c t o r s  t o  be p ro je c te d  onto  a p lane
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in  such  a s  way th a t  a s  l i t t l e  in fo rm a t io n  a s  p o s s i b l e  i s  l o s t .  In  
many c a s e s ,  o n ly  some o f  the  o r i g i n a l  v a r i a b l e s  f i g u r e  
s i g n i f i c a n t l y  in  th e se  l i n e a r  c o m b in a t io n s ,  and th u s  v a r i a b l e s  
which c o n t r ib u t e  most t o  the v a r i a t i o n  between p a t t e r n  v e c t o r s  
may be r e c o g n i se d .  The re m a in in g  v a r i a b le s ,  which convey  l i t t l e  
e x t r a  in fo rm a t io n ,  can be r e je c te d .  I f  to o  many v a r i a b l e s  a re  
used, a random and c h e m ic a l ly  m e a n in g le s s  s e p a r a t io n  in t o  c l a s s e s  
can r e s u l t ,  o r  the  " n o i s e "  from th e  s u p e r f lu o u s  c l a s s e s  may 
o b scu re  th e  a c tu a l  e x is te n c e  o f  c l a s s e s .
7 .1 .4 .  In t r o d u c t io n  to  the  p re se n t  s tud y
As o u t l i n e d  in  s e c t io n s  7 .1 .1 .  and 7 .1 .2 . ,  much e f f o r t  h as  been 
devoted  to  the  c h a r a c t e r i s a t i o n  o f  columns and m o b i le  p h ase s  in  
terms o f  t h e i r  a b i l i t y  to  s e p a r a te  v a r io u s  ty p e s  o f  s o l u t e s  which 
are  both  p o la r  and n o n -p o la r ,  i o n i c  and n o n - io n i c  in  n a tu re .  Much 
d ata  has  been p resen ted  r e g a r d in g  the  e f f i c a c y  o f  v a r io u s  
e x t r a c t i o n  schemes d e s ign ed  t o  e f f e c t  removal o f  d ru g s  from  
plasm a, serum o r  u r in e ,  but t h i s  in fo rm a t io n  i s  u s u a l l y  generated  
o n ly  in  r e l a t i o n  to  the  s e p a r a t io n  o f  the compounds o f  i n t e r e s t  
to  the  exper im entor  p r e s e n t in g  th e  r e s u l t s .  To d ate  th e re  has not  
been a s y s t e m a t ic  s tu d y  undertaken  on the c h a r a c t e r i s a t i o n  o f  
s t a t i o n a r y  p h ase s  p u re ly  in  r e g a rd  to  the s e p a r a t io n  o f  e x t ra c te d  
plasm a components. The c l o s e s t  ap p rox im at io n  to  a com prehensive  
s tu d y  in  t h i s  a rea  was an i n v e s t i g a t i o n  by B la n ch a rd  [55] in to  
the  r e l a t i v e  m e r it s  o f  d i f f e r e n t  methods o f  p r o te in  p r e c i p i t a t i o n  
which would l i b e r a t e  d ru g s  from b in d in g  s i t e s  and re n d e r  the  
p lasm a s u i t a b l e  f o r  d i r e c t  i n j e c t i o n  onto a ch ro m a to g ra p h ic  
column.
The o b j e c t i v e  o f  the  p re se n t  s tu d y  was to  i n v e s t i g a t e  d r u g - f r e e  
plasm a p r o f i l e s  on two d i f f e r e n t  a n a l y t i c a l  columns (C^8-  and 
C N -)  under a v a r ie t y  o f  m ob ile  phase  c o m p o s it io n s .  The v a r i a b l e s  
in  th e  e lu e n t  were the type  (methanol o r  a c e t o n i t r i l e )  and 
p erce n tage  o f  o r g a n ic  m o d i f ie r ,  and the pH and i o n i c  s t r e n g t h  o f  
the  aqueous component. The p la sm a  which was used was p o o le d  a t  
the  o u t s e t  so  t h a t  t h i s  would n o t  p ro v id e  a sou rce  o f  v a r i a t i o n
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d u r in g  the  co u rse  o f  th e  s tud y ,  and i t  was e x t r a c te d  u s in g  the  
o n - l i n e  column s w i t c h in g  te ch n ique  in o rde r  t o  p e rm it  r a p id  
a n a l y s i s  and to  m in im ise  the  fo rm at io n  o f  a r t e f a c t s .  The plasma  
p r o f i l e s  were e v a lu a te d  in  terms o f  the  number o f  i n t e r f e r i n g  
peaks in  the  a rea  o f  a n a l y t i c a l  i n t e r e s t  a lo n g  th e  chromatogram, 
and th e se  d a ta  were in c o rp o ra te d  in  a f a c t o r i a l  design-, the  
f a c t o r s  in  each ca se  b e in g  th e  column, the typ e  o f  o r g a n i c  
m o d i f ie r  and e i t h e r  th e  p e rce n t  o r g a n ic  m o d i f ie r ,  pH o r  the i o n ic  
s t r e n g th  a s  th e  t h i r d  f a c t o r .  I t  was a l s o  so u gh t  t o  determ ine  the  
type  o f  p a t te r n  ( i f  a n y )  which was o b ta ined  when one o r  more o f  
the  o p e r a t io n a l  v a r i a b l e s  were a l te r e d ,  and so  c o n s t r u c t  a k in d  
o f  " m i n i - l i b r a r y "  which would be u s e fu l  when o p t im i s in g  an 
a n a l y t i c a l  method f o r  th e  a n a l y s i s  o f  d rugs  in  p la sm a  o r  serum.
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7.2. EXPERIMENTAL
7 .2 .1 .  Reagents  and s o lv e n t s
Methanol and a c e t o n i t r i l e  (HPLC g ra d e )  were o b ta in e d  from Labscan  
A n a l y t i c a l  S c ie n c e s ,  D u b l in ,  I r e l a n d .  A na laR  g ra d e  sodium a ce ta te  
and a n a l y t i c a l  g rade  a c e t i c  a c id  were s u p p l ie d  by BDH Chem ica ls,  
P oo le ,  UK, and R ie d e l  de Haen, Hannover, West Germany, 
r e s p e c t i v e l y .  The d ru g s  and a number o f  b a tc h e s  o f  f ro ze n  plasma  
were r e c e iv e d  a s  a g i f t  from the I n s t i t u t e  o f  C l i n i c a l  
Pharm aco logy, D u b l in  I r e l a n d .  D e io n ise d  w ater  was o b ta in e d  by 
p a s s in g  f r e s h l y  d i s t i l l e d  water through  th e  M i l l i p o r e  M i l l i - Q  
water p u r i f i c a t i o n  system .
7 .2 .2 .  Drug and p lasm a s o lu t i o n s
S to ck  s o l u t i o n s  e q u iv a le n t  to  1 mg/ml o f  th e  d ru g s  in  methanol 
were p rep ared .  W orking s to c k  s o lu t i o n s  were p rep ared  in  
m ethano l-w ater  (1 :1 ) ,  and th e se  were d i l u t e d  w ith  m ob ile  phase  
im m ediate ly  p r i o r  to  i n j e c t i o n .  Sm all p o o l s  o f  mixed batches o f  
f ro z e n  d r u g - f r e e  p lasm a were thawed and then  p o o led  to  produce a 
s i n g l e  b a tch .  The p lasm a was d iv id e d  in to  10 ml a l i q u o t s  and 
p la c e d  in to  deep f re e z e  s to r a g e .  When r e q u ire d  f o r  use, one o f  
th e se  f r a c t i o n s  was thawed, vortexed, and d i l u t e d  1:1 w ith  
d e io n is e d  w ater  to  ge n e ra te  "b la n k "  p lasma s o l u t i o n s .
7 .2 .3 .  In s t r u m e n ta t io n  and o p e r a t in g  c o n d i t i o n s
D r u g - f r e e  p lasm a and a u t h e n t ic  drug s ta n d a rd s  were sep ara ted  on a 
S p h e r i s o r b  (Phase S e p a r a t io n s ,  Clywd, UK) C18-  (10 /¿m) and a 
S p h e r i s o r b  CN - (1 0 f i n )  column (both 250 mm x 4.6  mm i . d . ) .  They 
were p ro te c te d  by a Chrompak (M idde lburg ,  The N e th e r la n d s )  module 
c o n t a in in g  a 10 x 1 .5  mm s t a i n l e s s  s te e l  column d ry -p ack e d  with  
C o r a s i l  (W aters  A s s o c i a t e s ,  M i l f o r d ,  MA, USA) C ^ g -  (37—50ptm) 
o r  Su p e lco  ( B e l le f o n t e ,  PA, USA) CN- (24-40 ¿im) m a te r ia l .
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A s to c k  s o lu t i o n  o f  1 M sodium a c e ta te  was p repared  by d i s s o l v i n g  
the a p p r o p r ia te  amount o f  sub stan ce  in d e io n is e d  w ater. The pH o f  
t h i s  s o lu t i o n  was then a d ju s te d  by the a d d i t i o n  o f  0.1 M a c e t i c  
a c id .  The d e s i re d  i o n i c  s t r e n g th  was ob ta in e d  by d i l u t i o n  w ith  
d e io n is e d  water. M o b i le  phases  were made by m ix in g  the  aqueous  
component w ith  the  r e q u ire d  amount o f  methanol o r  a c e t o n i t r i l e .  
The m obile  phase was p assed  th rough  a 0 . 4 5 /¿m f i l t e r ,  and 
degasse d  by s o n ic a t io n  p r i o r  to  use.
The m obile  phase was d e l i v e r e d  by a Waters Model 501 HPLC pump 
(pump B) a t  a f low  r a t e  o f  1.0 m l/m in. The p lasm a was in tro d u ce d  
in to  the system u s in g  a Rheodyne (C o ta t i ,  CA, USA) Model 7125 
s i x - p o r t  i n j e c t io n  v a lv e .  The in j e c t o r  was f i t t e d  w ith  a 20 /¿ I 
loop  to  perm it  d i r e c t  i n j e c t i o n  o f  a u th e n t ic  s ta n d a rd s  o f  
s e le c te d  drug compounds.
For the  purposes  o f  column s w it c h in g ,  the i n j e c t o r  was f i t t e d  
w ith  a 500 f i 1 loop and a second pump (pump A) and the  
c o n c e n t ra t io n  column were connected  to  the  a n a l y t i c a l  a ssem b ly  
v i a  a Rheodyne Model 7000 s i x - p o r t  s w it c h in g  v a lv e .  The 10 x 1 .5  
mm i . d .  c o n c e n t r a t io n  colum ns were packed w ith  e i t h e r  C o r a s i l  
c 18-  or S e p r a ly t e  (A na ly t iche m  In t e r n a t io n a l ,  Harbour C i t y ,  CA, 
USA) C g -  m a te r ia l .  The w ash ing  e lu e n t  d e l iv e r e d  by pump A t o  
the c o n c e n t r a t io n  column was d e io n is e d  water which had been 
f i l t e r e d  th rough  a 0 . 4 5 ^  m membrane and degassed  by s o n ic a t io n .
I t  was d e l iv e r e d  a t  a f lo w  r a t e  o f  1.0 ml/min f o r  90 second s.  The 
pH o f  the  aqueous component o f  th e  m obile  phase was a d ju s te d  
u s in g  a s ta n d ard  g l a s s  e le c t r o d e  which was c a l i b r a t e d  d a i l y  u s in g  
aqueous s ta n d a rd s  pepared  on a weekly b a s i s .  D e te c t io n  was by 
u l t r a v i o l e t  a b s o r p t io n  a t  254 nm u s in g  a Shimadzu (Kyoto, Japan)  
Model SPD 6A sp e c t ro p h o to m e tr ic  d e te c to r  w ith  a s e n s i t i v i t y  
s e t t i n g  o f  0.01 AUFS. The r e s u l t a n t  chromatograms were recorded  
by a L i n s e i s  (Se lb ,  West Germany) re co rd e r  a t  a c h a r t  speed o f  
200 mm/min.
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7.2.4. Procedures
The e f f e c t  o f  v a r io u s  param eters  ( i n c lu d in g  m o b i le  phase  
co m p o s it io n  and typ e  o f  a n t ic o a g u la n t )  on b la n k  p lasm a p r o f i l e s  
were s tu d ie d .  B la n k  p lasm a chromatograms were ge n e ra te d  on two 
d i f f e r e n t  a n a l y t i c a l  co lum ns (C18-  and C N -)  f o l l o w in g  o n - l i n e  
s o l i d - p h a s e  e x t r a c t i o n  u s in g  the  column s w i t c h in g  te ch n iq u e  
d e sc r ib e d  in  ch ap te r  2. 500 /¿I q u a n t i t i e s  o f  p la sm a  w e re in je c te d  
onto  the c o n c e n t r a t io n  column, and except where a com par ison  was 
made between C ^ g -  and C g -  m a te r ia l s  in  the  c o n c e n t r a t io n  
colum s, a l l  s o l i d - p h a s e  e x t r a c t io n s  were c a r r i e d  o u t  on C o r a s i l  
C18_ p ack in g .
A f re sh  c o n c e n t r a t io n  column was used f o r  each d i f f e r e n t  m ob ile  
phase on both co lum ns, and a new 10 ml a l i q u o t  o f  f ro z e n  p lasm a  
was thawed and prepared  in  each case. The b la n k  p la sm a  was 
in je c te d  in  q u a d r u p l i c a t e  f o r  each se t  o f  exp e r im e n ta l  
param eters, and the  second, t h i r d  and fo u r th  i n j e c t i o n s  were used  
in  the a n a ly s e s .  The p lasm a p r o f i l e s  were a s s e s s e d  in  terms o f  
the  number o f  peaks g r e a t e r  than 2 mm o c c u r r in g  in  the  
chromatogram in  the  t im e  frame 5 m inutes to  20 m inutes  a f t e r  
i n j e c t io n .  T h i s  i s  th e  p r i n c i p a l  area o f  i n t e r e s t  in  terms o f  
drug  a n a l y s i s .  The r e s u l t s  o b ta ined  were su b je c te d  to  s t a t i s t i c a l  
a n a l y s i s  a s  d e sc r ib e d  in  s e c t io n  7.3.
7 . 2 .4 .1 .  E f f e c t  o f  typ e  and percentage  o r g a n i c  m o d i f ie r  on
b la n k  p lasm a p r o f i l e s  on both columns
The pH o f  the sodium a c e t a te  s to c k  s o lu t i o n  was a d ju s te d  to  pH
6.0 by the  a d d i t i o n  o f  a c e t i c  a c id .  I t  was d i l u t e d  t o  0.025 M by 
the  a d d i t io n  o f  d e io n i s e d  water. M o b ile  ph ases  were made by 
m ix in g  the aqueous component w ith  methanol in  the  r a t i o  3 s7, 4:6,  
5:5, 6:4, 7:3 o r  8:2 aqueous to  o r g a n ic  phase. T h i s  p rocedure  was 
repeated  f o r  a c e t o n i t r i l e  and the  12 e lu e n t s  were run  on both  the  
C ^ g -  and the CN- co lum ns.
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7 .2 .4 .2 .  E f f e c t  o f  pH on b lan k  p lasm a p r o f i l e s  on both
colum ns
A l i q u o t s  o f  the  1 M s to c k  s o lu t i o n  o f  sodium a c e t a te  were 
a d ju s te d  to  pH 7.0 , 6.0, 5.0, 4.0 and 3.0 by th e  a d d i t i o n  o f  
a c e t i c  a c id .  These were then d i lu t e d  to  0.025 M w ith  d e io n is e d  
water. Each o f  th e  r e s u l t i n g  s o lu t i o n s  were added t o  methanol to  
g i v e  m ix tu re s  c o n t a in in g  aqueous to  o r g a n i c  ph ase s  in  a r a t i o  
1:1 . T h i s  p rocedure  was repeated  f o r  a c e t o n i t r i l e  and th e  10 
e lu e n t s  were run on both  columns.
7 .2 .4 .3 .  E f f e c t  o f  i o n i c  s t r e n g th  on b la n k  p lasm a p r o f i l e s  
on both  columns
The pH o f  the  1 M s to c k  s o l u t i o n  o f  sodium a c e t a te  was a d ju s te d  
to  6.0 by th e  a d d i t i o n  o f  a c e t i c  a c id .  T h i s  was then  d i l u t e d  w ith  
d e io n is e d  water to  ge n e ra te  s o l u t i o n s  o f  0 .1 ,  0.025, 0.01 and
0.005 M. Each o f  th e se  s o l u t i o n s  was added to  methanol t o  g i v e  
m ix tu re s  c o n t a in in g  aqueous to  o r g a n ic  ph ases  in  a r a t i o  1 :1 .
T h i s  p rocedure  was repeated  f o r  a c e t o n i t r i l e  and th e  8 e lu e n t s  
were run on both  co lum ns.
7 .2 .4 .4 .  C o n c e n t r a t io n  column r e p r o d u c i b i l i t y  on a 
between-dav and w ith  in -d a y  b a s i s
R e p r o d u c ib i l i t y  was t e s t e d  on the  C18-  a n a l y t i c a l  column o n ly .
The m ob ile  phase was 0.025 M a c e ta te  b u f fe r ,  pH 6 . 0 - a c e t o n i t r i l e  
(1 :1 ) .  I n j e c t i o n s  were made on th ree  d i f f e r e n t  C ^ g -  
c o n c e n t r a t io n  columns on th re e  s u c c e s s iv e  d ay s  (n ine  
c o n c e n t r a t io n  colum ns in  t o t a l ) .  Column-to-columm r e p r o d u c i b i l i t y  
was measured on a w i t h i n -  and between-day b a s i s .
7 .2 .4 .5 .  E f f e c t  o f  typ e  o f  a n t i c o a g u la n t  on p lasm a p r o f i l e s
B lood  from a h e a lth y  v o lu n t e e r  was taken in to  evacuated  g l a s s  
tubes  c o n t a in in g  l i t h iu m  h e p a r in ,  f l u o r i d e  o x a la te ,  sodium
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c i t r a t e  (two b ran d s )  o r  d isod ium  e d e ta te  a s  a n t i c o a g u la n t s .  The 
b lo od  was c e n t r i fu g e d  im m ediate ly  and the  maximal volume o f  
plasm a recovered. Serum from the  same v o lu n te e r  was o b ta in e d  by 
t a k in g  b lood  in to  a tube w ith  no a n t i c o a g u la n t ,  and a f t e r  
a l l o w in g  30 min f o r  the  c l o t t i n g  p r o c e s s  t o  occur,  serum was 
se p a ra te d  by c e n t r i f u g a t i o n .  The p lasm a and serum sam ples  were 
f ro ze n  u n t i l  re q u ire d  f o r  use, whereupon th e y  were t r e a te d  in  the  
same manner a s  the f ro ze n  p lasm a in  f o r e g o in g  exper im ents.  They 
were sep ara ted  on the  C ^ g -  column w ith  a m ob ile  phase o f  0.025  
M a c e ta te  b u f fe r ,  pH 6 . 0 - a c e t o n i t r i l e  ( 1 s1),  and compared in  the  
same way a s  b lank  p la sm as  in  the  p r e v io u s  exper im ents.
7 . 2 .4 .6 .  Com parison o f  C^g-  and Cg c o n c e n t r a t io n
columns in  terms o f  p lasm a removal
The c o n c e n t ra t io n  column was packed w ith  C o r a s i l  C ^ g -  m a te r ia l
a s  h as  been used above, o r  w ith  S e p r a ly t e  C g -  m a te r ia l .  The 
wash s o lu t i o n  was a s  b e fo re ,  and th e  a n a l y t i c a l  m obile  phase was
0.025 M a c e ta te  b u f f e r - a c e t o n i t r i l e  ( 1 :1 ) .  A n a l y s i s  was performed  
on th e  C^g column. The two column were compared in  terms o f  the  
amount o f  plasma recovered .
7 . 2 .4 .7 .  Com parison o f  the  C18~ and CN- columns in terms
o f  drug r e t e n t io n
The w ork ing  s to ck  s o l u t i o n s  o f  d ru g s  were d i l u t e d  w ith  m obile  
phase (0.025 M a c e ta te  b u f fe r ,  pH 6 . 0 - a c e t o n i t r i l e  ( 1 :1 ) ) ,  and 
20 1 a l i q u o t s  in troduced  by d i r e c t  i n j e c t i o n  onto  both
a n a l y t i c a l  columns. Drug r e t e n t io n  on both  columns was measured  
and compared.
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7.3. RESULTS AND DISCUSSION
7 .3 .1 .  S e l e c t i o n  o f  v a r i a b l e s
The p r in c ip a l  o b j e c t i v e  o f  t h i s  s tud y  was to  examine d r u g - f r e e  
plasm a on two co lum ns under a range  o f  v a r y in g  e lu e n t  
co m p o s i t io n s .  H av ing  s e le c t e d  the  b i o l o g i c a l  m a tr ix  w h ich  would  
be te s te d ,  the next s t e p  was t o  d ec ide  what columns t o  u se .  As  
o u t l in e d  in the In t r o d u c t i o n  to  t h i s  chap ter,  i t  would  be q u i t e  
p o s s i b l e  to  s e le c t  two g e n e r i c a l l y  e q u iv a le n t  columns from  
d i f f e r e n t  m an u fac tu re rs  and o b ta in  co m p le te ly  d i f f e r e n t  r e s u l t s  
from them. Such an e x e r c i s e  would, however, be o f  l i t t l e  v a lu e  in  
t h i s  s tud y  s in c e  i t  was s o u g h t  to  c h a r a c t e r i s e  the d i f f e r e n c e s  in  
r e t e n t io n  beh av io u r  between d i f f e r e n t  types,  r a th e r  th an  
d i f f e r e n t  b rands o f  co lum ns.
Due to  time and o th e r  c o n s t r a i n t s ,  the p r o je c t  was l im i t e d  t o  th e  
i n v e s t i g a t i o n  o f  two co lum ns.  A C18_ column was chosen  b ecause  
i t  i s  the most w id e ly  used  s t a t i o n a r y  phase in b io p h a r m a c e u t i c a l , 
and many o th e r  ty p e s  o f  s e p a r a t io n s .  C g -  was r e je c te d  a s  th e  
second column s in c e ,  a s  m entioned by G e ise  [1], the  d i f f e r e n c e  in  
ch rom atograph ic  p r o p e r t i e s  between C18-  and Cg -  bonded 
m a t e r i a l s  i s  s u b t le  r a t h e r  than  m ajor. Ch rom atograph ic  modes such  
a s  normal phase were n o t  c o n s id e re d ,  s in c e  i t  was so u g h t  t o  u se  
the  same mobile  ph ases  on both  columns, and b e s id e s ,  normal phase  
chrom atography does n o t  lend  i t s e l f  to  the intended e x t r a c t i o n  
procedure  o f  o n - l i n e  s o l i d - p h a s e  e x t r a c t io n .  Hence, th e re  
remained such p o s s i b i l i t i e s  a s  C2- ,  p h e n y l-o r  cyano-bonded  
colum ns. The cyano column was chosen s in c e  i t  can be u sed  in  both  
the  normal and r e v e r s e d -p h a s e  modes and has been c la im e d  by  
M a s sa r t  [37] a s  an a lm o s t  u n iv e r s a l  s t a t i o n a r y  su p p o r t .  I n  
a d d i t io n ,  many s e p a r a t io n s  o f  b a s i c  d ru gs  have been s u c c e s s f u l l y  
ach ieved  on a cyano column in  t h i s  la b o ra to ry .  In  view o f  th e  
d i f f e r e n c e s  in  co lum ns from one m anufacturer  to  ano th e r,  bo th  the  
columns were S p h e r i s o r b ,  (10 m ) s u p p l ie d  by Phase S e p a r a t io n s .
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Methanol and a c e t o n i t r i l e  were chosen a s  th e  o r g a n i c  s o lv e n t s  
s in c e  they are  the  most commonly used o r g a n i c  m o d i f i e r s  and 
d i f f e r  in  t h e i r  s o l v e n t  s t r e n g t h  and s l i g h t l y  in  t h e i r  
s e l e c t i v i t i e s .  The chosen  p ercentage  range  was 30 t o  80% which 
r e f l e c t s  p r a c t i c a l l y  th e  com plete  range  which  would n o rm a l ly  be 
used on both co lum ns. H ig h e r  p e rce n tage s  o f  o r g a n i c  s o l v e n t  can 
be used on the  CN- column s in c e  water has s t r o n g e r  e l u t i n g  power 
on t h i s  su r fa c e  than  on C ^ g -  m a t e r ia l s .  U s in g  a h ig h e r  
p ercentage  o f  o g a n ic  m o d i f ie r  has adv a n ta ge s  in  te rm s o f  h e lp in g  
to  p revent column c o n ta m in a t io n  by s t r o n g l y  adsorbed  
contam inants,  and o f  e f f e c t i n g  a lm o st  com p le te  re n g e n e r a t io n  o f  
the c o n c e n t ra t io n  column d u r in g  the d e s o r p t io n  phase  o f  th e  
o n - l i n e  e x t r a c t io n  p roced ure .
The aqueous phase o f  th e  e lu e n t  was b u f fe re d  w ith  sodium a c e ta te  
s in c e  t h i s  b u f fe r  i s  w id e ly  used in  b io p h a rm a c e u t ic a l  
a p p l i c a t i o n s .  As o u t l i n e d  in  s e c t io n  7 .1 . ,  th e  pH o f  the  m ob ile  
phase a f f e c t s  d rug r e t e n t io n  and s e l e c t i v i t y  t o  a g r e a t e r  o r  
l e s s e r  extent depend ing  on whether the  a n a ly t e  i s  i o n i c  o r  not, 
i t s  pKa and i t s  p o l a r i t y .  The pH o f  the aqueous component in  
the m obile  phase was, th e re fo r e ,  v a r ie d  between pH 3.0 and pH 
7.0, which r e p r e se n t s  th e  range  where many s e p a r a t io n s  a re  
c a r r ie d  out. The e f f e c t  o f  i o n i c  s t r e n g th  o f  th e  aqueous  
component was s tu d ie d  s in c e  i t  can a l s o  a f f e c t  r e t e n t io n ,  
e s p e c i a l l y  on C18-  co lum ns where s e p a r a t io n s  i n v o l v in g  b a s i c  
compounds can proceed th ro u gh  i o n i c  i n t e r a c t i o n s  w ith  r e s id u a l  
charged  s i l a n o l  g ro u p s  on the  column s u r fa c e .  The i o n i c  s t r e n g th  
was v a r ie d  between 0 .005  M and 0.1 M, a l th o u g h  the  l a t t e r  
c o n c e n tra t io n  i s  p ro b a b ly  o u t s id e  the upper l i m i t  o f  i o n i c  
s t r e n g th s  commonly encountered  in  r e v e r se d -p h a se  a p p l i c a t i o n s .  
T h is  broad range was s e le c t e d  in  o rde r  to  d em onstra te  the  
e x is te n c e  o f  an e f f e c t  which te nd s  to  be l e s s  m a n i fe s t  on 
r e te n t io n  than o th e r  f a c t o r s  such as  the  ty p e  and perce n tage  
o r g a n ic  m o d if ie r .
As i t  would have been a major u n d e r ta k in g  t o  s tu d y  a l l  p o s s ib l e  
co m bina t ions  o f  pH, i o n i c  s t r e n g t h  and p e rc e n ta g e s  o f  o r g a n ic  
m o d if ie r  in th e  ra n ge s  l i s t e d  above, i t  was dec ide d  to  s e t  some
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v a r i a b le s  w h ile  e x a m in in g  o th e r s .  In  a d d i t i o n ,  e v a lu a t io n  would  
have been d i f f i c u l t  in  the  more e la b o r a te  s tud y ,  a s  a h ig h  o rd e r  
m u lt i f a c t o r  d e s ig n  would have been re q u ire d ,  and th e se  schemes 
are  com p lica ted  in  t h e i r  in t e r p r e t a t io n ,  e s p e c i a l l y  i f  many-way 
i n t e r a c t io n s  were p r e s e n t .  Hence, f o r  the  o r g a n i c  m o d i f ie r  s tu d y ,  
the  pH and i o n i c  s t r e n g t h  o f  the  aqueous component were se t  a t  pH
6.0 and 0.025 M r e s p e c t i v e l y ,  s in c e  th e se  v a lu e s  were deemed to  
be t y p i c a l  o f  the  k in d  o f  c o n d i t io n s  used in  s e p a r a t io n s  f o r  
b io p h arm ace u t ica l  a n a l y s i s .  As d i s c u s s e d  in  c h a p te r  5, the typ e  
and co n c e n tra t io n  o f  o r g a n i c  m o d i f ie r  does a f f e c t  the  apparen t  
pH, in  a d d i t io n  t o  th e  degree  o f  s o lu t e  and column i o n i s a t i o n ,  
but f o r  the p u rp o se s  o f  the  p re se n t  work i t  was assumed th a t  
th e se  in f lu e n c e s  were sm a l l  in  com parison  to  the  a c tu a l  e f f e c t  o f  
ch an g in g  the r a t i o  o f  aqueous to  o r g a n ic  components. L ik e w ise ,  
when s tu d y in g  the e f f e c t  o f  pH, the i o n i c  s t r e n g t h  was n o m in a l ly  
h e ld  a t  0.025 M, though  i t  i s  r e c o g n ise d  t h a t  sm a l l  changes in  
i o n i c  s t re n g th  o ccu r  w ith  a s h i f t  in  pH. For  th e  experim ent on 
the  e f f e c t  o f  i o n i c  s t r e n g th ,  the pH o f  th e  aqueous component was 
se t  a t  6.0, and in  each ca se  m obile  phases  were made c o n t a in in g  
a c e t o n i t r i l e - b u f f e r  ( 1 :1 )  and m e th a n o l-b u f fe r  (1 :1 ) .
The o n - l i n e  column s w i t c h in g  te ch n ique  o f  e x t r a c t i o n  was employed  
in  the  i n t e r e s t s  o f  a n a l y t i c a l  exped iency  and to  m in im ise  the  
fo rm at io n  o f  a r t e f a c t s  which, a s  d i s c u s s e d  in  ch a p te r  2, can pose  
c o n s id e r a b le  problem s w ith  l i q u i d - l i q u i d  e x t r a c t i o n s .  I t  must be 
re co gn ise d ,  however, t h a t  because the a n a l y t i c a l  m obile  phase i s  
a c t u a l l y  in vo lve d  in  th e  e x t r a c t io n  p ro c e s s  i t s e l f ,  the  
chrom atograph ic  p r o f i l e  w i l l  be a f u n c t io n  n o t  o n ly  o f  the  e lu e n t  
i n te r a c t io n  on the a n a l y t i c a l  column, but o f  how e f f i c i e n t l y  i t  
removes adsorbed p lasm a  components from th e  c o n c e n t r a t io n  column 
f o l l o w in g  the wash c y c le .  There fo re ,  one would expect t h a t  the  
" o p t im a l "  m obile  phase  f o l l o w in g  s o l i d - p h a s e  e x t r a c t i o n  to  d i f f e r  
from the "o p t im a l "  m o b i le  phase f o l l o w in g  o f f - l i n e  e x t r a c t io n  
where the e x t r a c t io n  e f f i c i e n c y  i s  independent o f  the m obile  
phase co m p os it io n .  T h i s  c o n s id e r a t io n  i s  d e a l t  w ith  in  fu r th e r  
d e t a i l  l a t e r .  The o p e r a t io n  o f ,  and in st ru m en t  arrangement f o r  
the column s w it c h in g  a ssem b ly  a re  d e sc r ib e d  in  ch ap ter  2.
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The commonly-used C ^ g -  C o r a s l l  p a ck in g  was used f o r  most 
experim ents in  t h i s  s tu d y .  I t  was rep lace d  w ith  C g -  p a c k in g  
o n ly  to  compare th e  two m a t e r i a l s  in  terms o f  p la sm a  rem ova l.  
S in c e  the f low  r a t e  o f  the  w ash ing s o lv e n t ,  a s  w e l l  a s  the  
d u ra t io n  o f  d e l i v e r y  i s  ( f o r  any p a r t i c u l a r  a p p l i c a t i o n )  
dependent on a number o f  f a c t o r s ,  in c lu d in g  the  n a tu re  o f  the  
s o lu te ,  the  type  o f  p a c k in g  m a te r ia l  in  the c o n c e n t r a t io n  column, 
and the s o lu t e s  b re a k th ro u gh  volume on th a t  column, i t  was 
n e cessa ry  to  choose  a r a t h e r  a r b i t r a r y  wash regim en, which, in  
t h i s  case  was 1 m l/m in  f o r  90 seconds.  S h o r te r  wash c y c le s  w i l l  
tend to  produce l e s s  band b roaden ing , but i t  was found  here t h a t  
more plasma was removed w ith  a 90 second r a t h e r  th an  a s h o r te r  
wash time, and a l th o u g h  t h i s  d i f f e r e n c e  was s l i g h t ,  th e  lo n ge r  
wash c y c le  was p r e fe r r e d  in  the i n t e r e s t  o f  p r e v e n t in g  
co n tam in a t io n  o f  the  a n a l y t i c a l  columns. Water was chosen  a s  the  
wash s o lv e n t  s in c e  i t  i s  w id e ly  used and p re se n t s  th e  l e a s t  
e la b o r a te  o p t io n ,  a l th o u g h  f o r  p a r t i c u l a r  a p p l i c a t i o n s ,  the  
a d d i t io n  o f  a b u f f e r i n g  s a l t  o r  a sm a ll  amount o f  o r g a n i c  
m o d i f ie r  may be a p p r o p r ia t e .
D i s t i l l e d  water was p a sse d  tw ice  through  the  water p u r i f i c a t i o n  
system, a s  minor im p u r i t i e s  may become co n ce n tra ted  on the  
c o n c e n t ra t io n  column and w i l l  ge ne ra te  s p u r io u s  peaks  on the  
chromatogram f o l l o w in g  th e  d e so r p t io n  s tep .  In  o rd e r  to  v e r i f y  
t h a t  i n t e r f e r in g  peaks  ob se rved  d u r in g  the a n a ly s e s  d id  a c t u a l l y  
o r i g i n a t e  in  the  p lasm a, th e  s w it c h in g  v a lv e  was a c tu a te d  w ith o u t  
h av in g  made an i n j e c t i o n  ( i . e .  w ith  the in j e c t o r  in  th e  " l o a d " )  
p o s i t i o n ,  and any ad so rbe d  con tam inan ts  o r i g i n a t i n g  in  th e  water  
would, a t  t h a t  s t a g e  be removed and de tected .  In  o rd e r  to  
e l im in a te  the p o s s i b i l i t y  t h a t  i n t e r f e r in g  peaks were d e r iv e d  
from the s y r in g e  o r  th e  i n j e c t i o n  loop, i n j e c t i o n s  o f  p u r i f i e d  
water were made p e r i o d i c a l l y ,  and sub jec ted  to  the  same wash 
regimen a s  the p lasm a s o l u t i o n s .
I n  the  same way t h a t  th e  wash regim en may be o p t im ise d  to  s u i t  a 
p a r t i c u l a r  a n a ly te ,  i t  i s  p o s s i b l e  to  va ry  the  d u r a t io n  o f  the
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d e so r p t io n  s t a g e  w ith  the  v a lv e  in  the " s w i t c h e d "  p o s i t i o n ,  and, 
by a s s o c i a t i o n ,  th e  le ngth  o f  t ime fo r  which the  c o n c e n t r a t io n  
column i s  r e - e q u i l i b r a t e d  w ith  water f o l l o w i n g  s w i t c h in g  o f  the  
v a lv e  back to  th e  " r e s e t "  p o s i t i o n .  The le n g t h  o f  t im e  f o r  which  
the  c o n c e n t r a t io n  column i s  p laced  in th e  stream  o f  the  
a n a l y t i c a l  m ob ile  phase w i l l  depend on how s t r o n g l y  adsorbed  the  
a n a ly t e  i s  and on th e  s o lv e n t  s t r e n g th  o f  th e  m o b i le  phase.  
G e n e ra l ly ,  i f  th e  m ob ile  phase c o n t a in s  h ig h  p r o p o r t io n  o f  
o r g a n ic  m o d i f ie r ,  i t  w i l l  desorb  the d rug  r a p i d l y  from the  
c o n c e n t r a t io n  column, but i t  w i l l  a l s o  remove any re m a in in g  
plasm a components which m ight in t e r fe r e  w ith  the  d ru g  peak. 
However, t h i s  l a t t e r  fe a tu re  a l s o  means t h a t  a s t r o n g  e lu e n t  i s  
more e f f e c t i v e  a t  r e g e n e r a t in g  the  c o n c e n t r a t io n  column than  
e lu e n t s  c o n t a in in g  low c o n c e n t r a t io n s  o f  o r g a n i c  s o l v e n t s .  I n  
f a c t ,  i f  a very  weak e lu e n t  i s  used, i t  m ig h t  be n e c e s sa ry  to  
in c o rp o ra te  a t h i r d  ( r e g e n e r a t io n )  s te p  in t o  th e  c y c le  to  a v o id  
h a v in g  to  change th e  c o n c e n tra t io n  column v e r y  f r e q u e n t ly .  The 
d is a d v a n ta g e  o f  u s in g  s t r o n g  e lu e n t s  i s  t h a t  they  a re  more l i k e  
to  cause  p r e c i p i t a t i o n  o f  r e s id u a l  p lasma components when 
co n tac te d  w ith  th e  c o n c e n t r a t io n  column, so  t h e i r  u se  n o rm a lly  
demands f a i r l y  th o rough  r e - e q u i l i b r a t i o n  o f  th e  c o n c e n t r a t io n  
column w ith  water b e fo re  the next i n j e c t io n  o f  raw p lasm a i s  
made.
S in c e  m ob ile  p h ase s  o f  v a r y in g  s o lv e n t  s t r e n g t h s  were to  be used  
in  t h i s  s tu d y ,  a s i n g l e  d e s o r p t i o n - r e - e q u i1i b r a t i o n  c y c le  co u ld  
n o t  be i d e n t i f i e d  a s  b e in g  s u p e r io r  to  a l l  o t h e r s .  I t  was 
dec ided, th e re fo r e ,  t h a t  f o l l o w in g  the 90 second wash phase, the  
c o n c e n t r a t io n  column would be in troduced  i n t o  the e lu e n t  stream  
f o r  a p e r io d  o f  20 m inutes,  and t h a t  i t  would be r e - e q u i l i b r a t e d  
w ith  water f o r  a f u r t h e r  10 m inutes b e fo re  making the  next  
i n j e c t i o n .  I t  was hoped t h a t  t h i s  would a l lo w  adequate  tim e f o r  
d e so r p t io n  u s in g  th e  weaker e lu e n t s  and adequate  t im e f o r  
r e - e q u i l i b r a t i o n  o f  th e  c o n c e n t ra t io n  column when the  s t r o n g e r  
e lu e n t s  were employed.
As d e sc r ib e d  in  th e  Exper im enta l s e c t io n ,  s m a l l  p o o l s  o f  mixed 
b a tch es  o f  fro ze n  d r u g - f r e e  p lasm a were thawed, poo led , d iv id e d
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in to  10 mi a l i q u o t s  and re f ro z e n  u n t i l  r e q u ire d  f o r  use. H a v in g  
re-thawed the  p lasm a i t  was mixed (1 :1 )  w ith  p u r i f i e d  water in  
order to  reduce i t s  v i s c o s i t y ,  and 500 1 l o o p f u l s  were in je c te d
onto the  c o n c e n t r a t io n  column. Because  th e  loop  co n ta in e d  e x a c t l y  
500 1, i t  was assumed t h a t  th e  i n j e c t i o n  volume would no t prove
to  be a sou rce  o f  v a r i a t i o n .  Four r e p l i c a t e  i n j e c t i o n s  u s in g  each  
o f  the  m ob ile  ph ases  were made. A n a l y s i s  was performed on th e  
second, t h i r d  and f o u r th  i n j e c t i o n s  o n ly .  T h i s  was because the  
chromatogram o f  the  f i r s t  i n j e c t i o n  d i f f e r e d  m arkedly from  
s u c c e s s iv e  i n j e c t i o n s  in  t h a t  i t  g e n e r a l l y  co n ta in e d  more and 
l a r g e r  p lasm a peaks.  T h i s  o b s e r v a t io n  may be accounted  f o r  by the  
f a c t  t h a t  th e  r e t e n t i v e  p r o p e r t ie s  o f  th e  c o n c e n t r a t io n  column  
are  c o n s id e r a b ly  reduced f o l l o w in g  even one in j e c t i o n  o f  p la sm a.
A s i m i l a r  e f f e c t  i s  a l s o  seen w ith  the  second and s u c c e s s iv e  
i n j e c t io n s ,  but to  a much l e s s e r  e x te n t .  I t  i s  q u i t e  p o s s i b l e  
t h a t  the f i r s t  p lasm a i n j e c t i o n  ca u se s  m ask ing  o f  exposed s i l a n o l  
groups on th e  column su r fa c e ,  th u s  d r a m a t i c a l l y  re d u c in g  i t s  
r e t e n t i v i t y ,  and t h a t  s u c c e s s iv e  i n j e c t i o n s  cause  s l i g h t  
m o d i f i c a t io n  o f  the  column s u r fa c e  th rough  a d s o r p t io n  o f  p lasm a  
components. T h i s  s u r f a c e  m o d i f i c a t i o n  would appear to  d im in i s h  
the  r e t e n t i v i t y  o f  the  column, s in c e  a s  more i n j e c t i o n s  a re  made, 
the  plasma peaks  co n t in u e  to  d im in i s h .
T h is  s u g g e s t io n  i s  supported  by the  f a c t  t h a t  the above e f f e c t  i s  
l e s s  m a n i fe s t  when an o r g a n i c - r i c h  e lu e n t  i s  used, which  
i n d ic a t e s  t h a t  th e  l a t t e r  removes more p lasm a components from the  
c o n c e n t ra t io n  column than  a weaker e lu e n t ,  and thus  m in im ise s  the  
ex te n t  o f  s u r fa c e  m o d i f i c a t i o n  am ounting  t o  e f f e c t i v e  
re g e n e ra t io n  o f  the  c o n c e n t r a t io n  column. C le a r l y ,  a la r g e  number 
o f  r e p l i c a t e  i n j e c t i o n s  would n o t  o f f e r  s i g n i f i c a n t  advan tage  
over a s m a l le r  number in  t h i s  ca se ,  s in c e  p lasm a p r o f i l e s  w i t h in  
a g iv e n  s e t  o f  exp er im en ta l p aram eters  depends on how many 
i n j e c t i o n s  have preceeded i t .  W h ile  i t  i s  r e c o g n ise d  t h a t  t h i s  
time e f f e c t  i s  im p ortan t,  i t  was beyond the  scope o f  the p r e s e n t  
work to  ta k e  accoun t o f  i t s  c o n t r ib u t io n  to  th e  observed  r e s u l t s ,  
and m easuring  th re e  r e p l i c a t e  i n j e c t i o n s  was s e t t l e d  upon a s  a 
s u i t a b le  compromise, where any t im e  dependence o r  s e r i a l
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c o r r e l a t i o n  o f  re sponses  was l i k e l y  t o  be ze ro .
From the f o r e g o in g  d i s c u s s i o n  i t  i s  c l e a r  t h a t  a new 
c o n c e n t ra t io n  column would be n e c e s sa ry  f o r  each m o b i le  phase  on 
both columns. The ( c o n c e n t r a t io n )  co lum n-to -co lum n  v a r i a b i l i t y  on 
both a between-day and w ith  in -d a y  b a s i s  was c o n s id e re d  in  c a se  a 
l a r g e  v a r i a t i o n  between colum ns was s e r v in g  to  c o m p l ic a te  
i n t e r p r e t a t io n  o f  the  d a ta .  The r e s u l t s  o f  t h i s  e x e r c i s e  a re  
d is c u s s e d  la t e r .
H av ing  d e f in e d  the v a r i a b l e s  and s e le c t e d  the  e x t r a c t i o n  
procedure, the  next s te p  was t o  d e c id e  how the  b la n k  p lasm a  
chromatograms would be e v a lu a te d .  O b v io u s ly  the  c r i t e r i o n  was 
t h a t  th e re  would be no i n t e r f e r i n g  p la sm a  peaks in  th e  a re a  o f  
ch ro m atog raph ic  i n t e r e s t .  I n  re g a rd  t o  the  l a t t e r ,  th e  f i r s t  5 
m inutes on the  chromatogram were e l im in a te d  s in c e  th e y  n o r m a l ly  
c o n ta in  the la r g e  e a r l y - e l u t i n g  p lasm a peak. Measurements would  
be made over a t ime frame o f  15 m inutes  (from 5 to  20 m in u te s )  
s in c e  a n a l y s t s  would n o rm a l ly  endeavour to  execute a 
ch rom atograph ic  run in  20 m inutes  o r  l e s s .
I t  i s  a s im p le  m atter t o  a s s e s s  th e  chromatograms q u a l i t a t i v e l y :  
i t  i s  q u i t e  o b v io u s  which chrom atogram s a re  " b e t t e r "  than  o th e r s  
based on the absence o f  sm a l l  o r  l a r g e  i n t e r f e r i n g  peaks,  how 
q u ic k ly  the  b a s e l in e  r e t u r n s  t o  th e  h o r i z o n t a l  and th e  m agn itude  
o f  the  p r in c i p a l  e a r l y - e l u t i n g  p lasm a peak. The l a t t e r  i s  n o t  a 
major c o n s id e r a t io n  s in c e ,  a s  o u t l i n e d  above, the chrom atography  
i s  u s u a l l y  developed such  t h a t  th e  d ru g s  have a lo n ge r  r e t e n t io n  
tim e than  the p r i n c i p a l  p lasm a peak. How q u i c k ly  the  b a s e l in e  
r e t u r n s  to  the h o r iz o n t a l  can be r e le v a n t  i f  a drug peak i s  
masked by the c u r v in g  p o r t io n  o f  the  chromatogram. I t  i s  no t  
uncommon to  see the d ru g  peak a p p e a r in g  to  r e s id e  on th e  curved  
p o r t io n  o f  the  plasma peak, when what i s  a c t u a l l y  b e in g  o b se rve d  
i s  th e  top  o f  a peak, th e  rem a inder  o f  which i s  under th e  t a i l i n g  
p lasm a peak. O b v io u s ly ,  t h i s  t a i l i n g  o f  a la r g e  p lasm a peak w i l l  
have s e r io u s  im p l i c a t i o n s  f o r  th e  l i m i t  o f  d e te c t io n  o f  a 
b io a n a l y t i c a l  method.
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I t  i s ,  however, the  i n t e r f e r i n g  peaks which appear l a t e r  on in  
the chromatogram which can p re se n t  the most d i f f i c u l t  p rob lem s in  
r e l a t i o n  to  drug a n a l y s i s  in b i o l o g i c a l  f l u i d s .  As mentioned  
above, chromatograms may be q u a l i t a t i v e l y  compared, b u t  i f  i t  i s  
d e s i r e d  to  q u a n t i t a t i v e l y  c h a r a c t e r i s e  a la r g e  s e r i e s  o f  
chromatograms such a s  was th e  ca se  in the  p r e s e n t  s tu d y ,  some 
k in d  o f  re sp o n se  v a r i a b l e  must be sou gh t.  I f  an e l e c t r o n i c  d a ta  
p r o c e s so r  ( i n t e g r a t o r )  had been used, i t  would have been p o s s i b l e  
to  measure th e  a r e a s  under th e  in d i v id u a l  i n t e r f e r i n g  peaks  in  
the  chromatogram, and t o  sum th e se  i f  so  d e s i r e d .  However, a 
problem w ith  u s in g  an i n t e g r a t o r  i s  t h a t  a typ e  o f  b a s e l i n e  must 
be d e f in e d  from which th e  i n t e g r a t o r  can make measurements. Hence 
i f  th e re  i s  a la r g e  t a i l i n g  p o r t io n  to  the  p lasm a peak and a 
h o r iz o n t a l  b a s e l in e  h as  been se t ,  a ve ry  l a r g e  peak a re a  w i l l  be 
computed, and t h a t  chromatogram would be c l a s s i f i e d  ( p o s s i b l y  
e r r o n e o u s ly )  a s  b e in g  i n f e r i o r  to  another.  C o n v e r se ly ,  i f  a 
s l o p in g  b a s e l in e  had been se t ,  and the chromatogram a t t a in e d  the  
h o r iz o n t a l  very  q u i c k ly ,  t h a t  chromatogram m ight be w ro n g ly  
judged  to  be s u p e r io r  to  ano th e r.
For a p a r t i c u l a r  a n a l y s i s ,  th e  m e r it s  o f  u s in g  an i n t e g r a t o r  over  
a c h a r t  re co rd e r  can n o t  be d isp u te d ,  s in c e  (among o th e r  f a c t o r s )  
the type  o f  b a s e l in e  a p p r o p r ia t e  to  t h a t  method i s  much e a s i e r  to  
d e f in e .  I n  the  p r e s e n t  ca se , however, a s  a la r g e  number o f  
exper im enta l c o n d i t i o n s  were to  be in v e s t i g a t e d ,  and bo th  curved  
and f l a t  b a s e l in e s  were to  be expected, i t  was dec ide d  t h a t  the  
r a p i d i t y  w ith  which th e  b a s e l in e  re tu rne d  t o  the  h o r i z o n t a l  
p o s i t i o n  would no t form p a r t  o f  the  a n a l y t i c a l  e v a lu a t io n ,  and 
measurement would be made o f  peaks  superim posed on th e  b a s e l in e ,  
i r r e s p e c t i v e  o f  whether i t  was curved  o r  f l a t .
As the peaks were u s u a l l y  q u i t e  sm a l l  and o f  in d e te rm in a te  shape,  
i t  would have been a d i f f i c u l t  t a s k  to  measure th e  a re a  under  
each one m anua lly  u s in g  th e  chromatograms gene ra ted  on th e  X - t  
re co rd e r .  Another p o s s i b i l i t y  was to  measure peak h e i g h t s  and to  
use the  t o t a l  peak h e i g h t  o f  a l l  i n t e r f e r i n g  peaks  in  each
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chromatogram as  a re sp o nse  f a c t o r .  A ga in  t h i s  would have been an 
arduous  t a s k  to  execute  m anua lly ,  and i t  would no t acco un t  f o r  
th e  number and lo c a t io n  o f  th e  peaks  c o n t r i b u t in g  t o  th e  o v e r a l l  
peak h e ig h t .  What appeared to  be a p r a c t i c a l  a l t e r n a t i v e  was to  
measure the  number o f  i n t e r f e r i n g  peaks  in  th e  area  o f  i n t e r e s t  
and to  use t h i s  a s  a re sp o n se  v a r i a b l e  in  e v a lu a t i n g  th e  the  
chromatogram. In  a s s e s s i n g  th e  d a ta ,  i t  became o b v io u s  t h a t  a 
l a r g e  number o f  ve ry  sm a l l  d e v i a t i o n s  around  th e  b a s e l in e  
appeared  in  most chromatograms; though  c l e a r l y  they o r i g i n a t e d  in  
the p lasm a, they co u ld  not be d e f in e d  a s  "p e a k s "  per s e . b e ing  
to o  s m a l l  and i l l - d e f i n e d  to  q u a l i f y  f o r  t h a t  d e f i n i t i o n .  And 
s in c e  th e se  sm a ll  d e v ia t i o n s  would no t,  in  most c a se s ,  i n t e r fe r e  
w ith  d rug  q u a n t i t a t i o n ,  i t  was d e c id e d  t h a t  o n ly  peaks o r  
d e v i a t i o n s  g r e a te r  than 2 mm (which r e p r e s e n t s  ap p ro x im a te ly  8 x 
10-  ^ ab sorbance  u n i t s )  would be counted  f o r  th e  p u rp o se s  o f  
chromatogram e v a lu a t io n .
H a v in g  ga the red  and counted the  d a ta ,  th e  n e x t  s te p  was to  
perform  the  a p p r o p r ia te  s t a t i s t i c a l  a n a ly s e s  in  o rd e r  to  
determ ine  whether r e a l  e f f e c t s  in  chromatogram q u a l i t y  were b e ing  
ob se rved  a s  the  exper im enta l p a ram e te rs  were v a r ie d .  S in c e  data  
were a v a i l a b l e  a s  a s e r i e s  o f  means (o f  th r e e  r e p l i c a t e  
i n j e c t i o n s ) ,  i t  was dec ided  to  use  an a n a l y s i s  o f  v a r ia n c e  t e s t  
(ANOVA) to  e s t a b l i s h  whether th e  d i f f e r e n c e  betweeen the  means 
was to o  g r e a t  to  be e x p la in e d  by random e r r o r .  The s t a t i s t i c a l  
a n a l y s i s  was c a r r ie d  o u t  by com puter u s in g  th e  " S t a t g a p h i c s "  
package. A three-w ay f a c t o r  d e s i g n  was used t o  a s s e s s  th e  e f f e c t s  
o f  typ e  o f  o r g a n ic  m o d i f ie r ,  column and e i t h e r  pe rce n t  o r g a n ic  
m o d i f ie r ,  pH or i o n i c  s t r e n g th  on th e  number o f  i n t e r f e r i n g  
p eaks.  The s i g n i f i c a n c e  o f  the  th r e e  p o s s i b l e  t w o - f a c t o r  
i n t e r a c t i o n  terms w i th in  each exp er im e n t  was a l s o  examined in  
o rd e r  t o  determ ine how s t r o n g l y  th e  e f f e c t  seen by ch a n g in g  one 
f a c t o r  was dependent on the  o th e r  two. The t h r e e - f a c t o r  
i n t e r a c t i o n  terms were not computed, s in c e  th e  t w o - f a c t o r  
i n t e r a c t i o n s  are  e a s i e r  to  examine v i s u a l l y ,  and hence, th e  k in d s  
o f  t r e n d s  which m e r it  more s o p h i s t i c a t e d  a n a l y s i s  may be r e a d i l y  
i d e n t i f i e d .  A two-way ANOVA was perform ed  on th e  d a ta  generated
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in  th e  r e p r o d u c i b i l i t y  s tu d y  a s  th e re  were, in  t h i s  c a se ,  o n ly  
two v a r i a b l e s  ( c o n c e n t r a t io n  column and d a y ) .  The r e s u l t s  o f  the  
o th e r  experim ents, co m p ar iso n  o f  d i f f e r e n t  a n t i c o a g u la n t s ,  
c o n c e n t r a t io n  column p a c k in g s ,  and com parison  o f  the two colum ns  
in  r e l a t i o n  to  r e t e n t io n  o f  pure  d rug  s o lu t i o n s ,  were e v a lu a te d  
q u a l i t a t i v e l y  and w i l l  be d i s c u s s e d  la t e r .
7 .3 .2 .  E f f e c t  o f  p e rce n ta g e  o r g a n ic  m o d i f ie r  on th e  number
o f  i n t e r f e r i n g  peaks
A b lo c k  d e s ig n  o f  the  number o f  peaks o b ta in e d  in th e  r e p l i c a t e  
a n a ly s e s  a t  each p e rc e n ta g e  le v e l  o f  both o r g a n ic  m o d i f i e r s  on 
the two columns i s  p re se n te d  in  T ab le  7 .1 . A l s o  shown i s  the  
ANOVA t a b le  fo r  the t h r e e - f a c t o r  d e s ig n  in  which the s o u r c e s  o f  
v a r i a t i o n  and t h e i r  c o r r e s p o n d in g  F - r a t i o s  a re  l i s t e d .  The 
c a l c u la t e d  F - r a t i o s  were compared w ith  c r i t i c a l  v a lu e s  in  
s t a t i s t i c a l  t a b le s  o f  th e  F - d i s t r i b u t i o n  in  o rde r  t o  determ ine  
whether any v a r i a t i o n s  seen in  th e  r e s u l t s  were due to  s y s te m a t ic  
d i f f e r e n c e s  o r  random e r r o r .  Where the e m p i r i c a l l y  d e r iv e d  
F - r a t i o  was g r e a te r  th an  th e  v a lu e  in  the  t a b le s ,  a s y s t e m a t ic  
e f f e c t  was co n s id e re d  t o  e x i s t .  For  the  a p p r o p r ia te  d eg re e s  o f  
freedom the F - r a t i o s  were compared a t  two le v e l s  o f  s i g n i f i c a n c e ,
i . e .  5% and 1% le v e l s .  So where a n u l l  h y p o th e s is  was r e je c te d  a t  
the 5% le v e l ,  the re  was a 95% chance t h a t  th e  v a r i a t i o n  in  
r e s u l t s  was due to  a s y s t e m a t i c  e f f e c t  r a t h e r  than random e r r o r ,  
and t h i s  i s  rep re se n te d  in  th e  t a b le  by a s i n g l e  a s t e r i s k .  Where 
th e re  was a 99% chance o f  th e  r e s u l t s  b e in g  due to  a s y s te m a t ic  
e f f e c t  i s  in d ic a te d  by two a s t e r i s k s .  Where the  c a l c u la t e d  
F - r a t i o  was sm a l le r  than  th e  t a b u la t e d  v a lu e  a t  the  5% le v e l  o f  
s i g n i f i c a n c e ,  the  n u l l  h y p o t h e s i s  was accepted  and the  v a r i a t i o n  
a s c r ib e d  to  random e r r o r .  Such c a s e s  are  in d ic a te d  in T a b le  7 .1 .  
by NS (no t  s i g n i f i c a n t )
I n t e r a c t i o n  terms were in c lu d e d  in  o rde r  to  determ ine whether the  
v a r i a t i o n  in  one f a c t o r  was dependent on ano th e r  f a c t o r ,  e . g . ,  i f  
the  v a r i a t i o n  in the  mean v a lu e s  a s  the  p e rce n t  o r g a n ic  m o d i f ie r  
was changed was dependent on th e  typ e  o f  column o r  th e  type  o f
357
T a b le  7.1.
E f f e c t  o f  percentage  o r g a n i c  m o d i f ie r  on the  number o f  i n t e r f e r i n g  
p e a k s .
Number o f  i n t e r f e r i n g  peak s(3  measurements per c e l l )  
Methanol % A c e t o n i t r i l e  %
30 40 50 60 70 80 30 40 50 60 70 80
Column
C18 3,3,3 433 4,5,6 6,5? 7,6,6 6,7,6 4,3,5 4,6,4 6,5,5 6,6,5 7,7,6 5,5,5
CN 444 443 434 333 3,2£ 312 889 455 323 100 000 000
i I i i  f t  i i ’ '  i f  ( i i 1 ♦ i » j  » i
M o b i le  phase: 0.025 M sodium a c e t a te  b u f fe r ,  pH 6.0 p lu s  
p erce n tage  and type  o r g a n i c  m o d i f ie r  a s  d e sc r ib e d  in t a b le
Three-wav A n a l y s i s  o f  V a r ia n c e  o f  above data
Source  o f  Sum o f  Squares  D egrees  o f  Mean Square F R a t io
V a r i a t i o n  (SSQ)____________  Freedom(DOF) (MSQ)__________________
Main e f f e c t s
A 13.8 5 2.8 3 .6 **
B 82.3 1 82.3 106.8
C 0.1 1 0.1 0.2  NS
2 - f a c t o r  i n t e r a c t io n
A-B  153.7 5 30.7 39 - 9! !
A -C  35.8 5 7.2 9.3
B -C  2.3 1 2.3 3.0 NS
R e s id u a l  40.9 53 0.8
T o ta l  328.9 71 -
Key: A: P e rce n tage  o r g a n i c  m o d i f ie r
B: Column (C18 o r  CN)
C: Type o f  o r g a n i c  m o d i f ie r  (MeoH o f  ACN)
* * :  s i g n i f i c a n t  a t  5% and 1% le v e l s  
NS* no t  s i g n i f i c a n t
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o r g a n ic  m o d i f ie r  b e in g  s tu d ie d .  As may be seen from T ab le  7 .1 . ,  
th e re  was, i f  one c o n s id e r s  the F - r a t i o s ,  a s u b s t a n t i a l  
d i f f e r e n c e  between th e  v a r io u s  p e rcent l e v e l s  o ve r  the  means f o r  
both columns and ty p e s  o f  o r g a n ic  m o d i f ie r s .  The r e s u l t s  a l s o  
show t h a t  th e  ob se rved  e f f e c t  w ith  c h a n g in g  o r g a n i c  m o d i f ie r  
c o n c e n t r a t io n  was s t r o n g l y  dependent on bo th  the  typ e  o f  column 
and the  typ e  o f  o r g a n i c  m o d if ie r  employed, i n d i c a t i n g  a s t r o n g  
i n t e r a c t i o n  between th e  percent o r g a n ic  m o d i f ie r  and th e se  
f a c t o r s .  The m agn itude  o f  these  i n t e r a c t i o n s  a re  in d ic a te d  by the  
l a r g e  v a lu e s  o f  F? 39.9 fo r  the in t e r a c t i o n  between percent  
o r g a n ic  m o d i f ie r  and th e  column,- and 9.30 f o r  th e  in t e r a c t i o n  
between th e  p e rce n t  and type o f  o r g a n ic  m o d i f ie r .
The f a c t  t h a t  th e  F - r a t i o  f o r  the  co lum n-typ e  o f  o r g a n ic  m o d i f ie r  
i n t e r a c t i o n  was below th e  ta b lu a te d  F - v a lu e  in d i c a t e s  t h a t  a t  
t h i s  le v e l  o f  s i g n i f i c a n c e ,  the v a r i a t i o n  in  r e s u l t s  between the  
two columns was no t  dependent on the typ e  o f  o r g a n i c  m o d if ie r ,  
though t h i s  does  no t  n e c e s s a r i l y  deny the  e x i s t e n c e  o f  an 
i n t e r a c t i o n .  There was a very  la r g e  d i f f e r e n c e  (F = 106.9)  
between th e  two ty p e s  o f  columns w ith  r e s p e c t  to  th e  means o f  
both  typ e s  o f  o r g a n i c  m o d i f ie r  and th e  p e rc e n ta g e s  in  which they  
were used. O v e r a l l ,  th e re  was no s i g n i f i c a n t  d i f f e r e n c e  between 
the  two ty p e s  o f  o r g a n i c  m o d i f ie r s  i f  th e  means o f  the  columns  
and p e rce n ta g e s  o f  o r g a n i c  m o d i f ie r s  were taken .  T h i s  i s  
in d ic a t e d  by th e  ve ry  sm a l l  F - r a t i o  f o r  the  typ e  o f  o r g a n ic  
m o d i f ie r  term.
The above e f f e c t s  may be demonstrated g r a p h i c a l l y  by c o n s t r u c t in g  
p l o t s  o f  the  r e le v a n t  mean v a lu e s .  F ig u r e  7 . 1 . a shows a p l o t  o f  
peak number a t  each le v e l  o f  percent o r g a n i c  m o d i f ie r  v e r su s  the  
p e rce n t  o r g a n i c  m o d i f ie r .  In  t h i s  ca se , th e  means o f  12 v a lu e s  
( i . e .  two co lum ns, two typ e s  o f  o r g a n ic  m o d i f ie r s ,  th ree  
r e p l i c a t e s  a t  each l e v e l )  were p lo t t e d .  T h i s  p l o t  shows th a t  
th e re  was a d e c re a se  in  the  number o f  i n t e r f e r i n g  peaks a s  the  
amount o f  o r g a n i c  m o d i f ie r  in  the  m ob ile  phase  was increased ,  
though th e re  were m inor in c re a se s  a t  th e  50% and 70% l e v e l s  
superim posed  on th e  o v e r a l l  s im p le  t re n d .  I n  o rd e r  to  examine 
t h i s  e f f e c t  on th e  two d i f f e r e n t  columns, th e  means o f  the
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column-percent organic modifier interaction terms were p lotted  as 
a function of the percent organic modifier (Figure 7 .1 ,b ) .  Like 
the previous values used in Figure 7 .1 .a, these values may be 
obtained from the computer programme used to caclu la te  the 
F-ratios for the 3-factor design. Alternatively, they may readily  
be calculated from the raw data by summing the appropriate c e l l s ,
i . e . ,  column 1, percent level 1, and column 2, percent level 1 
e tc .  The plot in Figure 7 .1 .b  shows that the e f fe c t  of increasing  
organic modifier produced v ir tu a l ly  the opposite e f f e c t s  on the 
C18-  and the CN- columns. The fact  that the two lines  are 
non-parallel, i . e .  that the pattern is  d ifferent for the two 
columns, suggests the presence of an interaction between these  
two factors. These findings must be considered in terms of the 
e lution  strength of the various eluents not ju st  on the 
analytical columns, but a lso  on the concentration column 
following the wash cycle .
Considering f i r s t  the Ci8 -  column: using low leve ls  of organic 
modifier, one would expect the plasma components swept o f f  the 
concentration column to have long retention times, (leading to 
the presence of many in terfering  peaks) due to the weak e lu tin g  
power of the mobile phase on th is  highly non-polar surface phase. 
The fact that the least  number of interfering peaks were observed 
on th is  column at the lowest level of percentage organic modifier 
( i . e .  30%) may be explained by the fact that the mobile phase 
also  has weak eluting power on the concentration column and 
therefore only a portion of the plasma components remaining after  
the the wash cycle were desorbed. Conversely, with a high 
proportion of organic modifier, more plasma was removed which 
produced a greater number of peaks in the chromatogram. As the 
percentage organic modifier was increased from 70 to 80%, the 
number of peaks began to decrease. This is  because rapid e lu tion  
of the plasma components from the analytical column outweighs the 
adverse e f fe c t s  of greater plasma desorption from the 
concentration column with increasing eluent strength.
The opposite e f fe c t  was seen with the CN- column. The number of
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peaks decreased with increasing eluent strength in th is  case. As 
the trend in extraction e f f ic ie n c y  remained unchanged, the 
differences between the two analytical columns may be accounted 
for purely in terms of the greater eluting power o f the mobile 
phase on the CN- phase. As pointed out ea r l ier ,  water is  a 
stronger eluent on the more polar CN- phase than the 020- 
phase, though c lear ly ,  the addition of the organic solvent  
enhances the solvent strength in relation  to both supports. Even 
though more plasma was removed as more methanol or a c e to n itr i le  
was added to the eluent, the overriding e f fe c t  was decreased 
retention time for the interfering peaks, which caused them not 
to appear in the area of in terest  in the chromatogram.
The means for the percent-type organic modifier interaction were 
also  plotted as a function of percentage organic modifier. The 
resultant graph is  presented in Figure 7 .1 .c ,  and i t  shows that 
( i f  the two columns were taken together) there is  a s l ig h t  
increase in the number o f peaks as the percent methanol was 
increased, but that i t  reached a plateau at about 50%. On the 
other hand, there was a decrease in the number o f peaks as the 
percent a c e to n itr i le  is  increased. These observations may be 
explained used the same general arguments as applied above. That 
i s ,  increasing amounts of both modifiers removed more desorbed 
plasma from the concentration column, but that with a ce to n itr i le ,  
th is  tendency was outweighed by i t s  enhanced e lu tin g  power on the 
analytical columns, whereas in the case of methanol, the opposing 
e f fe c t s  on the number of interfering peaks became almost equal at  
about the 50% leve l.
I f  i t  is  desired to separate the e f fe c t  of percent organic 
modifier between the two columns and the two organic modifiers, 
the means of each c e l l  ( i . e . ,  the three rep lica te  analyses) may 
be plotted as a function of percent organic modifier (Figure
7 .1 .d ) .  This graph again r e f le c t s  the increase in the number of 
peaks on the C18-  column, and the corresponding decrease on the 
CN column. However, i t  further depicts how the decrease in peak 
number in going from 70 to 80% organic modifier on the C18-
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column was due en tire ly  to the contribution from a ce to n itr i le  
since the number of peaks remain constant between 70 and 80% 
methanol on th is  column. In addition, the decrease in peak number 
on the CN column is  much more profound with increasing 
concentrations of a c e to n itr i le  rather than methanol.
The graph in Figure 7 .1 .e  shows that the interaction between the 
type of column and the type of organic modifier under the
employed experimental conditions is  very small. The F-ratio for
th is  interaction is  s l ig h t ly  below the 5% level of s ign if icance ,  
suggesting that the d ifference between the two columns was 
independent of the type o f organic modifier and that the
difference between the type of organic modifier is  independent of
the types of columns using these experimental parameters. I t  is  
recognised, however, that the column-type o f organic modifier 
interaction may become s ig n if ic a n t  i f  the experimental conditions  
were to be s l ig h t ly  varied.
The sa lien t  points which have emerged from th is  experiment are 
that the ratio  of water to a c e to n itr i le  seems to have a more 
pronounced e f fe c t  on retention ch a ra cter is t ic s  than the ratio  of  
aqueous to methanolic phases, particu lar ly  on the CN column; the 
c18" column provides better chromatograms at the lower leve ls  
of organic modifier, with the converse being true at higher 
percentages of organic modifier; and over the means of both 
columns, increasing a c e to n itr i le  concentration tends to reduce 
the number of interfering peaks, whereas there are more 
interfering peaks with increasing methanol concentration.
The above points are i l lu s tr a te d  chromatographica1ly in Figure
7.2. The chromatograms a lso  serve to  demonstrate that one se t  of  
parameters might be superior to another in one respect, but 
inferior in another respect. For example, in terms of the 
criter ion  used in th is  study, 70% methanol on the C18-  column 
offers  a better proposition than 30% a c e to n itr i le  on the C18-  
column. However, by studying the chromatograms themselves, i t  can 
be seen that although the peaks are more numerous in the former
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Figure 7.I.e.
Plot of peak number versus type of column and organic number- mean 
of percent organic modifier
Mean no
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Mobile phase: 0.025 M acetate buffer, pH 6 .0 -  organic modifier
Figure 7.2.
Chromatograms showing effect of organic modifier
Time (min)-
Mobile phases 0.025 M acetate buffer, pH 6.0 plus: 
a$ 70% methanol on the C18-  column 
b* 30% a c e to n itr i le  on the C18-  column
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case, they are larger in the la t te r  case and more l ik e ly  to  
operate to the detriment of a quantitative  determination. This is 
an example of one of the lim itations o f the chosen response 
variable: the s ize  of the peaks are not accounted for in 
evaluating the various mobile phases, and th is  can sometimes lead 
to  a misinterpretation as to what c o n s t itu te s  an in fer ior  or a 
superior chromatogram.
7 .3 .3 .  Effect of pH on the number o f interfering peaks
The pH of the aqueous component was varied in 1-unit increments 
over the range pH 3.0 to pH 7 .0 .  The ionic strength was set  at 
0.025 M and a constant organic-to-buffer r a t io  of 1:1 (with both 
methanol and a c e to n itr i le )  was employed. This yielded 20 c e l l s  of 
three rep lica te  in jections, which are presented in a block design 
in Table 7 .2 .  The three-way ANOVA tab le  for the determination of 
the s ign if icance  of the resu lts  is  a lso  shown in Table 7 .2 . The 
r esu lts  show that over the means o f both columns and types of  
organic modifiers, there was a systematic e f f e c t  observed with 
changing pH. Similarly, there was a systematic e f fe c t  seen 
between columns and between types of organic modifiers over the 
means o f the remaining two factors . As evidenced by the very 
large F-ratio , there was a strong in teraction  between the pH and 
the type of column, and an even larger interaction between the 
column and type of organic modifier! the pH-column interaction  
was marginally below the 5% level of sign ificance , though again, 
i t  was non-negligib le.
The graph in Figure 7 .3 .a. was generated by p lotting  the mean 
peak number at each pH level versus pH, discounting (for the 
moment) the e f fe c t  of column and type of organic modifier. This 
graph shows that there was a general decrease in the number of 
in terfering peaks with increasing pH. This e f f e c t  may be 
explained by the fact that many endogenous plasma components are 
acid ic  in nature and therefore, in more basic  eluents, they would 
become more ionised and tend le ss  to  p a rt it io n  into the 
stationary phase. Hence, they would e lu te  rapidly o f f  the column
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Table 7 .2 .
E f fe c t  o f pH on th e  number o f  in te r f e r in g  peaks.
Number of in terfering  peaks(3 measurements per c e l l )
50% Methanol 50% A ceton itr ile
pH 3 pH 4 pH 5 pH 6 pH 7 pH 3 pH 4 pH 5 pH 6 pH 7
Column
C18 2,1^ - 1,1,1 2,2,2 22,2 3,2,2 7,67 6,7.5 55.4 3,5,4 4£?
CN 4,4,3 3,33 31,2 3,33 232 4,43 3,23 331 ^23 UP
Mobile phases 0.025 M sodium acetate buffer, plus 50% organic 
modifier. pH as described in tab le .
Three-wav Analysis o f Variance of above data
Source of Sum of Squares Degrees of Mean Square F Ratio
Variation ( S S Q ) _______  Freedom(DOF) ( M S Q ) __________
Main e fec ts
A 16.4 4 4.1 8.4**
B 11.3 1 11.3 23.1
C 29.4 1 29.4 60.0
2-factor interaction
A-B 4.9 4 1.2 2 .4 J
A-C 16.4 4 4.1 8.4
B-C 56.1 1 56.1 114.5**
Residual 21.4 44 0.5
Total 155.9 59
Key: As pH
Bs  Column (C18 or CN)
Cs  Type o f  organic modifier (MeoH of A C N )
* * s  s ig n if ic a n t  a t 5% and 1% levels  
N S s  not s ig n if ic a n t
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and not appear in the area of chromatographic in ter est .  I f  th is  
graph is  broken down between the the two types of organic 
modifier (Figure 7 .3 .b ) ,  the resulting p lo ts  show that increasing 
pH caused a marked reduction in the number of peaks i f  
a c e to n itr i le  was used in the mobile phase, and a less-defined  
e f fe c t  in the presence of methanol which showed a s l ig h t  decrease 
between pH 3.0 and 4 .0 , and between pH 6.0 and 7 .0 , with a s lig h t
increase between pH 5.0 and 6.0.
I f ,  on the other hand, Figure 7 .3 .a is  broken down between the 
two columns (Figure 7 .3 .c ) ,  i t  may be seen that the trend was for 
fewer peaks to  appear at the higher pH values. A breakdown on the
types of organic modifiers and columns (Figure 7 .3 .d )  reveals
that with a c e to n itr i le  on both columns there is  a marked decrease 
in the number of peaks with increasing pH. The fa c t  that at most 
pH lev e ls ,  there was a greater number of peaks seen with 
a c e to n itr i le  may be accounted for by the fa c t  that i t  removed 
more plasma from the concentration column than methanol, and thus 
more peaks appeared on the chromatogram at the 1:1 
buffer-to-organic ra t io  employed in th is  experiment. I t  is  quite  
possible  that the more dramatic e f fe c t  seen with a c e to n itr i le  was 
due to the fact  that in th is  case, there was a greater number of  
peaks present upon which changing pH could exert an influence.
The s ituation  is  le s s  c lear with methanol. On the CN- column, the 
general tendency was for a decrease in peak number to  occur, with 
a small increase between pH 5.0 and pH 6 .0 . On the C18-  column, 
there was a greater number of peaks in the chromatogram at higher 
pH values. There was, however, a small increase in peak number 
and from a chromatographic point of view, would not represent a 
serious deterioration  in chromatogram quality . Studying the 
chromatograms presented in Figure 7 .4. explains th is  observation. 
The general appearance of the chromatograms in the presence of 
methanol remained almost constant between pH 5.0 and pH 7.0,  
whereas there was a noticeable difference between quality  of the 
chromatograms with a c e to n i tr i le .  This e f f e c t  was most pronounced 
on the CN column. Thus, studying the chromatograms serves to  
i l lu s t r a te  the value o f a qu a lita tive  assessment in certain
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Figure 7.3.C.
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instances. Another example is that whereas there may be a quite a 
number of peaks present on the columns with a c e to n itr i le ,  the 
large peak at about 7.5 minutes seen on the C^g- column with 
methanol could present s ig n if ica n t  problems in the development of 
a biopharmaceutical assay using th is  particular combination of 
column and mobile phase.
I t  may be seen from Table 7 .2 . that there is  a strong interaction  
between the column and type of organic modifier terms. The graph 
shown in Figure 7 .3 .e  further i l lu s tr a te s  the inter-dependence of 
type of column and type of organic modifier on the changing peak 
number.
7 .3 .4 .  E ffect o f ionic strength on the number o f
in terfering peaks
The ionic strength o f the aqueous component was varied between
0.005 M and 0.1 M acetate buffer at a constant pH of 6 .0 .  Mobile 
phases containing e ith er  methanol-buffer (1:1) or 
a ce to n itr ile -b u ffer  (1*1) were prepared. A block diagram showing 
the resu lts  for the 16 c e l l s  is  presented in Table 7 .3 .  Also 
shown is the three-way AN0VA table used to determine the 
sign ificance  of the observed re su lts .
From these data i t  may be seen that there was a s t a t i s t i c a l l y  
s ig n if ica n t  e f f e c t  with varying ionic strength at both the 5% and 
1% leve ls  of s ig n if ica n ce .  Over the range of ionic strengths  
studied, there was a s ig n if ic a n t  difference between the columns 
and between the organic modifiers as indicated by the large 
values of F (35.2 and 75.2 resp ective ly ) .  There were a lso  
s ig n if ica n t  in teractions between the ionic strength and the 
columns and the ionic strength and the types of organic modifier, 
though in the former case th is  interaction was only s ig n if ic a n t  
at the 5% lev e l .  By p lo tt in g  the number of peaks (averaged over 
both columns and organic modifiers) as a function of ionic  
strength (Figure 7 .5 .a ) ,  i t  may be seen that there was a general 
decrease in peak number with increasing ionic strengh. Breaking
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Figure 7 .3 .e .
Plot of peak number versus type of column and organic number- mean 
of a l l  pH levels
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Mobile phases 0.025 M acetate buffer, pH 6 .0 -  organic modifier
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Figure 7.4
Chromatograms showing effect of pH on C18- column
Time (min)-
Mobile phase (aqueous-organic phase, 1 » 1 ) s 
a? acetate buffer, pH 5.0-methanol <1 s 1 ).
b: acetate buffer, pH 7.0-methanol (1*1).
cs acetate buffer, pH 5 .0-aceto n itr i  le (1:1).
d: acetate buffer, pH 7 .0 -a c e to n i tr i le (1:1).
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Figure 7.4 continued
Chromatograms showing effect of pH on CN- column
r
b
n H
1 « 9 I I  13 I I  21 3 6 9 13 15 U  31 3 6 9  13 IS  I I  21 3 6 9  «  15 IS  21
Time (min)-
Mobile phase (aqueous-organic phase, 1*1): 
as acetate buffer, pH 5.0-methanol (1:1).
bs acetate buffer, pH 7.0-methanol ( l s l ) .
cs acetate buffer, pH 5.0-acetonitrile (1:1).
ds acetate buffer, pH 7.0-ace toni tri le ( l s l ) .
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Number of interfering peaks(3 measurements per cell) 
50% Methanol 50% Acetonitrile
IONIC STRENGTH (M)
0.005 0.01 0.025 0.1______ 0.005 0.01 0.025 0.1
Table 7.3.
Effect of ionic strength on the number of Interfering peaks.
Column
C18 3,3,3 3,2,4 2,2,2 1,2,2
CN 5,5,3 4,3,4 3,3,3 2,1,1
5,7,6 6,6,5 5,5,5 7,6,6
4,4,3 3,4,2 3,2,3 3,3,2
Mobile phase: sodium acetate buffer, pH 6.0, plus 50% organic 
modifier. Ionic strength as described in table.
Three-way Analysis of Variance of above data
Source of Sum of Squares Degrees of Mean Square F Ratio
Variation (SSQ)________ Freedom(DOF) ( M S ) ________________
Main effects
A 13.4
B 14.1
C 30.1
2-factor interaction
A-B
A-C
B-C
Residual
Total
5.1
6.4
36.7
14.1
119.9
3
3
1
35
47
4.5
14.1
30.1
1.7
2.1
36.7
0.4
11 . 2
35.2
75.2
* *
**
* *
4.2
5.2 
91.8
* *
**
Keyi A: Ionic strength 
B: Column (C^g or CN)
C: Type of organic modifier (MeoH of ACN)
**: significant at 5% and 1% levels 
* « significant ot 5% level only 
NS: not significant
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th is  graph down between the two columns (Figure 7 .5 .b )  shows that  
whereas peak number decreased across the range on the CN- column, 
there was a decrease between 0.005 M and 0.025 M on the Clg -  
column, followed by an increase between 0.025 M and 0.1 M. 
S p litt in g  Figure 7 .5 .a. between the two types of organic 
modifiers (Figure 7 .5 .c )  shows that an almost identical pattern  
is  seen between methanol and a c e to n itr i le  mobile phases, except 
that the e f fe c t  reaches a higher level of s ign if ican ce  because 
the e f fe c t  i s  s l ig h t ly  more pronounced. By p lotting  the mean 
number of peaks in each c e l l  (Figure 7 .5 .d ) ,  i t  becomes apparent 
that except for a c e to n itr i le  on the Clg -  column, the changing 
trend was for the number of peaks to  decrease with increasing  
ionic strength. The e f f e c t  appeared to be most pronounced for 
methanol on the CN- column. As shown by the large value of F 
(91.8), there was a strong interaction between the change in peak 
number between columns and type of organic modifier, with the 
same applying in the reverse when comparing the e f fe c t s  of the 
types of organic modifiers. This is  a lso  depicted graphically in 
Figure 7 .5 .e .
As discussed in the Introduction section , the e f fe c t  of ionic  
strength in reversed-phase chromatography is  more d i f f i c u l t  to 
define than in ion exchange chromatography. In the la tter  case 
the e f fe c t  of ionic strength is  readily  explained in terms of the 
number of ions availab le  to compete with so lute molecules for  
s i t e s  on the column surface. With reversed-phase chromatography, 
the same argument has been put forward to explain the behaviour 
of strongly basic amines in reversed-phase systems, i . e .  that  
ionised bases interact with oppositely-charged residual s ilan o l  
groups on the reversed-phase column, and therefore their  
retention times are strongly affected  by ionic strength [32,33].  
I t  is  known that species which are uncharged under the employed 
experimental conditions are a lso  a ffected  by ionic strength 
[31,32,33], though the nature of these e f f e c t s  have not been 
fu lly  c la r i f ie d .  Snyder [31] proposed that when the addition o f a 
sa lt  to the mobile phase increases the so lu b i l i ty  of a so lu te in 
the mobile phase, retention  decreases, and that when i t  decreases
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Plot of peak number verses ionic strength- mean of types of column 
and organic modifier
Figure 1.5.a.
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Figure 7.5.b.
Plot of peak number versus ionic strength- breakdown on column 
types
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Figure 7 .5 .c .
Plot of peak number verses ionic strength- breakdown on types of 
organic modifier
mean no
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Figure 7 .5 .d .
Plot of peak number versus ionic strength- breakdown on types of 
column and organic modifier
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the s o lu b i l i ty  o f the solute In the mobile phase, retention is  
increased. Hence, the resu lts  in the present study might possibly  
be explained by a "salting-in" e f fe c t  which lead to decreased 
retention of the peaks, thus causing them to e lu te  near the 
solvent front and be undetectable in the area of in terest  along 
the chromatogram. This i s ,  however, a ten ta t iv e  speculation, 
since the natures of the interferences have not been identif ied ,  
and i t  is  a lso  possib le , i f  they possessed a basic function, that  
decreased retention is  due to reduced competition at the charged 
s ilan o l s i t e s .
Referring to the chromatograms presented in Figure 7 .6 . ,  i t  can 
be seen that as with the experiment on varying pH, the appearance 
of the chromatograms with a given column-organic modifier 
combination did not vary greatly between the higher and lower 
ionic strengths. This figure indicates that particularly  on the 
C18~ c° l umn. the d ifferences were s l ig h t ,  although the 
appearance of s l ig h t ly  more minor peaks at the lower s a lt  
concentrations, gave, under the s t a t i s t i c a l  analysis applied 
here, the impression of a marked change in chromatogram quality .  
The sa lie n t  point to be taken from th is  experiment was that i f  i t  
is  desired to increase the ionic strength in order to improve the 
chromatographic ch aracter ist ics  of particular analytes, th is  
measure is  unlikely to adversely a f fe c t  the blank plasma p rofile  
as shown by s t a t i s t i c a l  and q u a lita t iv e  analysis .
7 .3 .5 .  Effect of anticoagulant on the number of
interfering peaks
Interference by materials in blood c o l le c t io n  tubes is  well 
documented in the literatu re  [56-62]. The kinds of problems which 
can ar ise  include a red istr ibution  of drugs into erythrocytes 
brought about by a certain p la s t ic iz e r  in the stopper, or the 
presence of interfering peaks in the chromatogram originating in 
the body of p la s t ic  c o l le c t io n  tubes [59]. Some workers found 
that heparin caused the introduction of an interfering peak in 
the chromatographic analysis  o f frusemide with fluorescence
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Plot of number of peaks versus types of column and organic 
modifier- mean o f ion ic  strengths
Figure 7.5.e.
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Figure 7.6.
Chromatograms showing effect of ionic strength on the C18 column
~1----- 1---- 1---
6 9  12 15 18
M
i—  i----- r— i----r~
3  é  f  12 13 | |
Time (min)-
Mobile phase:
a: 0.005 M buffer, pH 6.0-methanol (1:1) 
b: 0.1 M buffer, pH 6.0-methanol (1:1) 
c: 0.005 M buffer, pH 6.0-acetonitrile (1:1) 
d: 0.1 M buffer, pH 6.0-acetonitrile (1:1)
detection [56]. Vacutainer tubes containing EDTA (as the 
potassium s a l t )  resulted in no interference using both 
fluorescence and u ltra v io le t  absorbance detection.
Since the reports were usually a r e su lt  of a problem arising  
during an assay for a particular drug, i t  was decided to 
investigate  the e f fe c t  of various anticoagulants on blank plasma 
p r o f ile s  using the on-line so lid  phase extraction technique, and 
to  observe whether differences in anticoagulants were detectable  
under constant mobile phase conditions.
Blood from a healthy volunteer was drawn into evacuated tubes 
containing various anticoagulants, in order to separate the 
plasma fraction , and into an empty tube in order to  c o l le c t  
serum. As the blood from which th is  plasma was derived had a 
d ifferen t  origin than the pooled plasma used in previous 
experiments, comparisons were not made between the two. In 
addition, since the plasma used in th is  section  was not screened, 
the p o s s ib i l i t y  that some of the peaks may be due to  xenobiotic  
products rather than endogenous plasma components must be 
recognised.
The plasma and serum samples were subjected to the same treatment 
in terms of preparation and extraction as the pooled plasma in 
previous experiments. The mobile phase was 0.025 M sodium acetate  
buffer, pH 6 .0 -a c e to n itr i le  (1:1). A ceton itr ile  was chosen since  
i t  generates more peaks in the chromatogram under these  
experimental conditions, and differences between anticoagulants  
would be more obvious. The types of anticoagulants investigated  
and the resu lts  obtained from three rep lica te  in jections of each 
plasma type are presented in Table 7 .4 .  These data show that 
there were considerable d ifferences between the numbers of peaks 
depending on the type of anticoagulant. The least number of peaks 
were obtained with lithium heparin and the greatest number with 
sodium c i t r a te .  The chromatograms presented in Figure 7 .7 .  
demonstrate more e x p l ic i t ly  the d ifferences  between some of the 
anticoagulants, since in some cases the peaks may have been more
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Table 7.4
E ffect of type of anticoagulant on blank plasma p r o f i le s  
Type of anticoagulant Number of interfering peaks
Injection number
1 _________ 2___________3
No anticoagulant * 5 5 6
Lithium heparin 2 2 2
Fluoride oxalate 5 5 4
Sodium Citrate
brand A 6 6 7
Sodium c itr a te
brand B 7 7 7
Disodium edetate 5 6 5
* Serum
Mobile phases 0.025 M sodium aceta te , pH 6 .0 -a c e to n itr i le  ( l s l )
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Figure 7.7.
Chromatograms showing effect of anitcoaaulant on peak number
Time (min)------------------------------------------------------------------------------ >
a: sodium c itr a te  brand B 
b: 1ithium heparin
Mobile phases 0.025 M acetate buffer, pH 6 .0 -a c e to n itr i le  ( l i l )  
Columns C18
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numerous but of smaller s iz e ,  and v ice  versa. Although th is  was 
not an exhaustive study on the e f f e c t  of anticoagulants, i t  does 
serve to i l lu s tr a te  that th is  element cannot be ignored when 
designing an analytical method for a drug in plasma or serum. 
Clearly, the type of anticoagulant should be defined when 
developing an analytical method and care should be taken to use 
the same one for method development and for the analysis  of real 
samples, unless i t  can be established  that the type of 
anticoagulant has no e f fe c t  on the method being used.
7 .3 .6 .  Effect of type of packing in the concentration
column
Using a mobile phase of 0.025 M acetate buffer, pH 6 .0 -  
a c e to n itr i le  (1:1) on the C^g- analytica l column and the same 
wash regimen as used previously, the packing material in the 
concentration column was replaced with Cg- material in order to 
demonstrate the d ifference in the amount of plasma recovered from 
the two concentration columns.
The resu lts  obtained are i l lu s tra ted  by the chromatograms 
presented in Figure 7 .8 .  This figure shows that in agreement with 
previous findings in Chapters 5 and 6, more plasma was retained 
by the Cg- column. The type of packing material used in the 
concentration column is  usually d ictated  by the physico-chemical 
properties of the so lu te to be analysed, but where there is  a 
choice, i t  would appear that C^ 8_ material presents the more 
a ttractive  a ltern ative . The observed d ifferences might be 
explained by the fact that the le ss  hydrophobic Cg- material 
has greater re te n t iv ity  for the r e la t iv e ly  polar plasma 
constituents than the C^g- material. However, as outlined in 
the Introduction to th is  chapter, the chromatographic differences  
between the two materials are subtle , and frequently, variations  
between d ifferen t brands are responsible for observed differences  
between and within generic types of columns.
386
Figure 1 .8 .
Chromatograms showing e f fe c t  of type of packing in concentration 
column on amount of plasma recovered
Time (min)-
s Sepralyte C8-  concentration column 
s Corasil C1S-  concentration column 
Mobile phase: 0.025 M acetate buffer, pH 6 .0 -a c e to n itr i le  (1*1) 
Column* C18
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7.3.7. Concentration column reproducibility
In order to estab lish  that the d ifferences between concentration 
columns themselves were not contributing s ig n if ic a n t ly  to the 
trends observed in the foregoing experiments, reproducibility  
among d ifferent concentration columns was measured both on a 
within-day basis and a between-day bases. The wash regimen was
1.0 ml/min o f deionised water for 90 seconds, and the analytical  
mobile phase was 0.025 M acetate buffer, pH 6 .0 -a c e to n itr i le  
(1:1) on the C18-  column. Three rep lica te  in jections were 
analysed on each of three Corasil C^g- concentration columns on 
each of three consecutive days (9 columns, 27 in jec tio n s) .  Having 
counted the number of peaks greater than two mm on the 
chromatograms, the resu lts  were analysed by carrying out a 
two-way ANOVA in order to  identify  s ig n if ic a n t  d ifferences among 
the columns within days and between days.
A block diagram of the number of peaks obtained on each column is  
presented in Table 7 .5 . ,  in addition to the resu lts  of the ANOVA 
analysis . These findings show that the d ifferences among the 
columns, on e ither a within- or between-day basis ,  were not 
s t a t i s t i c a l ly  s ig n if ica n t ,  though as indicated by the higher 
F-ratio, the between-day variation was, as expected, greater than 
the between-column variation . The r esu lts  further demonstrate 
that the day-column interaction was not s ig n if ica n t  indicating  
that the variation in peak number between columns is  not 
dependent on the day the analysis  was carried out. Based on these  
resu lts ,  i t  can be concluded that variation among concentration 
columns did not contribute s ig n if ic a n t ly  to the systematic 
e f fe c ts  seen in previous experiments, although It must be 
recognised that even r e la t iv e ly  small variations among columns 
may have contributed s l ig h t ly  to the trends observed within a 
given set of experimental parameters.
7 .3 .8 .  Drug retention on the two columns
Finally, in order to  demonstrate d ifferences  between the two
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Table 7.5.
Reproducibility study of concentration columns
Number of interfering peaksO measurements per c e l l )
Concentration column
1 2 3
Day 1 4 ,4 ,4 4 ,3 ,4 4 ,5 ,4
Day 2 4 ,5 ,4 5 ,4 ,4 4 ,4 ,4
Day 3 5 ,4 ,4 4 ,5 ,4 4 ,4 ,5
Mobile phase: 0.025 M sodium acetate buffer, pH 6 .0 -a c e to n itr i le  
(1:1). Analytical column: Cl g .
Two-way Analysis of Variance of above data
Source of Sum of Squares Degrees of Mean Square F Ratio
Variation (SSQ)___________  Freedom(DOF) (MSQ)__________________
Main e f fe c t s
A 0.5
B 0.1
2-factor interaction
A-B 0.8
Residual 4.7
Total 6.1
Key: A: Day
B: Concentration column number
NS: not s ig n if ica n t
2 0.3 1.0 NS
2 0 .1  0.1 NS
4 0.2 0.8 NS
18 0.3
26
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columns in terms of drug retention c h a ta c te r ls t ic s ,  a se lection  
of drugs of varying polarity and pKa values were introduced in 
20 fil a liquots  by d irect in jection  onto both analytical columns. 
The mobile phase was 0.025 M aceta te  buffer, pH 6 .0 -a c e to n itr i le  
(1:1). The resu lts  of th is  experiment are presented in Table 7.6 
in which drug retention times on both columns are tabulated. For 
many of the drugs, retention times were lower on the CN- column 
than on the C^ 8-  column, as th is  mobile phase has stronger 
eluting  power on the more polar column. I t  would seem, however, 
that the difference in many cases was not very large, and with 
some drugs (chloramphenicol and diazepam, for instance) there was 
no d ifference in their  retention times on the two columns.
S e le c t iv ity  d ifferences between the two columns is  i l lu stra ted  by 
the fact that the three benzodiazepine drugs (diazepam, 
nitrazepam and chlordiazepoxide) had v ir tu a l ly  the same retention  
times on the CN- column, but were retained to varying degrees on 
the C18-  column. On the other hand, the t r i c y c l i c  drugs, 
desipramine and imipramine, in addition to  quinine and piroxicam, 
had extremely long retention times on the C^ 8-  column, but 
eluted with more acceptable retention  times on the CN surface.
The poor chromatographic ch a ra cter is t ic s  of the t r ic y c l ic  drugs 
on the C^8 material is  due to ionic interaction with residual 
s ilanol m oieties, as previously discussed.
The fact  that the two columns have sim ilar retention properties  
for certain  drug compounds, and highly d iss im ilar  retention  
properties for plasma components, means that changing from one 
column to another may achieve separation between the compounds of 
in terest  and endogenous in terferents , without the need for 
radical change in mobile phase composition.
7 .4 . CONCLUSION
The d ifference in s e le c t iv i ty  between a C18-  and a CN- column 
for extracted plasma components has been demonstrated. I t  has 
been shown that the percentage organic modifier exerts a profound
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Table 7.6,
Drug retention times on the C^q- and CN-columns
Retention time (min)
Drug ^1B CN
Chloramphenicol
J.O
2.7 2.7
Ch1ord i azepox i de 4.8 3.0
Chlorthalidone 2.4 2.7
Ch1orphenIram i ne 1.8 2.4
Desipramine NE 18.0
Diazepam 5.4 3.0
Frusemide 1.8 1.8
Imipramine NE 21.9
Nitrazepam 3.9 2.7
Piroxicam NE 1.8
Quinine NE 24.9
Sulphamerazine 3.3 2.7
Theophylline 3.3 3.0
Trimethoprim 5.4 4.5
VerapamiI 10.2 12.3
NE = Not eluted after 60 minutes
Mobile phases 0.025 M sodium acetate, pH 6.0-acetonitrile (1:1)
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e f fe c t  on blank plasma p ro file s  and that th is  e f f e c t  is  strongly  
dependent on the column, and the the type and percent organic 
modifier employed. Based on the chosen response variable, best  
resu lts  were obtained on the cyano-column at high percentages of 
a c e to n itr i le ,  and on the C18-  column with low percentages of  
methanol. These findings have been accounted for in terms of the 
d ifferen t p o la r i t ie s  o f the columns, the r e la t iv e  solvent  
strengths of methanol and a ce to n itr i le  and the on -lin e  method of 
plasma extraction .
The number of in terfering  peaks was also affected  by eluent pH 
and ionic strength, though not to the same extent as by 
percentage organic modifier. The observed e f fe c t s  were a lso  
dependent on the type o f column and organic modifier. Using the 
number of peaks c r iter io n ,  the differences with changing pH and 
ionic strength seemed greater than was shown by the general 
apearance of the chromatogram, which suggests that an a ltern ative  
response variable may be more appropriate when evaluating the 
influence of these factors .
I t  has been shown that more plasma components are recovered from 
the Cg- concentration column than from the C^g- concentration  
column. This may be due to the more polar packing having a 
greater a f f in i ty  for the polar plasma constituents, although 
between-brand v a r ia b i l i ty  may be the principal contributing  
factor to the observed d ifferences . Evidence suggests that the 
type of anticoagulant a f fe c ts  the quality of the blank plasma 
p ro f ile s ,  although the pattern found in th is  study may change 
depending on the column, mobile phase, the detection mode and 
origin of the plasma. S e le c t iv ity  differences between the two 
columns as regards retention  of a number of drug compounds has 
also been demonstrated. Under the employed experimental 
conditions, some of the drugs exhibit similar retention indices  
on both columns, a feature which may be exploited in the 
resolution o f d i f f i c u l t  separations of drugs and plasma.
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The 3-factor analysis  of variance design using the peak number 
response variable served to demonstrate the s ign if ican ce  of the 
e f fe c ts  resu lting  from changing mobile phase composition, 
particularly  in relation  to percentage organic modifier. I t  also  
highlighted some very s ign if ican t  two-factor interactions within 
each se t  of experiments, and the s ign if ica n ce  of more than two of 
the three possib le  interaction terms in each case is  strong 
presumptive evidence that a s ig n if ica n t  higher order interaction  
is  present. The s ign ificance of th is  3 -factor interaction was not 
tested  as the 2-factor interactions are e a s ie r  to v isu a l ise  and 
interpret. I t  i s ,  however, recognised that since th is  term was 
not extracted from the residual term, the r e su lts  for both main 
e f fe c t s  and interactions were conservative, and that th is  
interaction may account for some findings, particu larly  in 
relation  to the pH and ionic strength experiments. The 
incorporation of a 2-factor analysis o f  variance design tested  
the variation among concentration columns on a within-day and a 
between-day b asis .  The non-significance o f the resu lts  was taken 
as evidence that reproducibility  among columns s u f f ic ie n t  to  
identify  trends resulting from changing column and mobile phase 
compostition.
The on-line extraction technique proved useful for the evaluation  
of plasma extracts in th is  study. Because of the speed and 
convenience of the method, a large number of samples could be 
analysed; because of the inherent reproducib ility  of the method, 
e f fe c ts  resu lting  from changing mobile phase composition were 
easy to iden tify . However, as the amount of plasma extracted is  
related to the analytical mobile phase, an in teresting  exercise  
would be to perform a similar investigation  based on o f f - l in e  
solid-phase extraction or the more trad it ion a l 1iqu id-1iquid 
extraction. On account of the large variety  o f possible o f f - l in e  
so lid -  and liquid-phase extraction schemes, there is  considerable 
potential for further research in th is  area o f  biopharmaceutical 
analysis .
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